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Summary 
PrimPol is a recently identified member of the archaeo-eukaryotic primase (AEP) family 
of proteins. It possesses both primase and polymerase activities and is involved in the 
replication of both nuclear and mitochondrial DNA. PrimPol is predicted to possess an 
AEP polymerase and a UL52-like zinc finger domain. This thesis establishes the roles 
of these domains in the context of PrimPol’s catalytic activities. Although apparently 
dispensable for polymerase activity, the zinc finger is essential for maintaining primase 
activity and also appears to play an important role in regulating the processivity and 
fidelity of PrimPol’s extension activities. A recently study identified a PrimPol mutation 
(Y89D) that is potentially associated with the development of high myopia in humans. 
Here, the biochemical defects associated with this mutant are analysed and described. 
This protein variant has a significant reduction in polymerase activity. Mutational 
analysis suggests that the hydrophobic ring of tyrosine is important for retaining wild-
type DNA extension activity. Biophysical analysis of the secondary structure and 
stability of this PrimPol variant suggests that this PrimPol variant has reduced α-helical 
content and is less stable than the wild-type protein. 
 
Finally, the interaction of PrimPol with single-stranded DNA binding protein replication 
protein A (RPA) is investigated. Previous studies have identified an interaction of 
PrimPol with RPA. Here, it is demonstrated that PrimPol has two separate RPA 
interaction motifs and a crystal structure is presented of one such motif in PrimPol 
bound to RPA that reveals the molecular basis for this interaction. 
 
Together, these studies provide molecular insights into the catalytic mechanism of 
PrimPol as well as some of the key intramolecular and intermolecular mechanisms of 
that regulate the activities of PrimPol. 
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CHAPTER 1 
 
 
Introduction 
  
  
 2 
1. Introduction 
This thesis is introduced by the experimentally tested scientific theories that preceded 
the undertaking of the work presented here. The topics covered include the replication 
of the genome, damage to the genome and how it is managed, the replication of DNA 
through damaged genome components, polymerases that synthesise novel DNA 
strands including the archeao-eukaryotic primase (AEP) superfamily of proteins, and a 
protein of this superfamily, PrimPol (previously named coiled-coil domain containing 
protein 111, CCDC111, FLJ33167). PrimPol is an AEP that is found in humans and 
other eukaryotes and is the main subject of this investigation. 
 
1.1. The Genetic Code 
DNA is the genetic blueprint for life on Earth; within this impressive molecule lies the 
information required for the development, functioning and survival of a diverse array of 
living organisms (Avery et al., 1944; Griffith, 1928; Hershey and Chase, 1952). In 1953, 
using the X-Ray data of Wilkins and Franklin and information of the base ratio data 
from Chargaff, Watson and Crick published their ground-breaking discovery of the 
structure of DNA (Chargaff et al., 1952; Watson and Crick, 1953; Zamenhof et al., 
1952). DNA is a double helical molecule, with two anti-parallel strands of 
polynucleotides, each consisting of nucleotide monomers composed of a deoxyribose-
phosphate backbone and an inward-facing perpendicular nitrogenous base. 
Phosphodiester bonds join the monomers and the two strands are held together by 
non-covalent hydrogen bonds that are complementary between adenine and thymine, 
and guanine and cytosine. Watson and Crick had hypothesised, based on their double-
helical model of DNA, that replication occurs in a semi-conservative fashion i.e. novel 
copies of DNA contain one daughter strand and one parent strand, which was 
subsequently proved correct (Meselson and Stahl, 1958). Experiments in the following 
years determined how DNA provided the genetic code for the production of proteins. 
The DNA is transcribed into mRNA, which is subsequently translated to produce 
proteins (Crick, 1970). Three bases, known as a ‘codon’, code one amino acid and the 
following three bases code the next amino acids; these codons do not overlap (Crick et 
al., 1961; Tsugita and Fraenkel-Conrat, 1960). The Nobel Prize for “cracking the 
genetic code” was ultimately awarded to Khorana and Nirenberg, who were 
responsible for mapping each of the codons to the amino acids that they code 
(Nirenberg et al., 1965). 
 3 
 
1.2. Genome Replication 
Replication of a genome is a herculean task. Each time a human cell divides it needs to 
copy ~3 x 109 base pairs at a rate of ~1,200 bp min-1 per replication fork, and it must do 
so faithfully else risk permanent changes in the genetic information that can pass on to 
daughter cells and, potentially, lead to deregulated metabolic processes and cancer 
(Lebofsky et al., 2006). Maintaining genomic integrity is a fundamental aspect of life 
and requires a specialised, highly tuned machinery to do so. The replication of the 
genome occurs in three stages: initiation, elongation and termination. 
 
1.2.1. Origins of Replication – Where to Begin 
Given the rate of replication in human cells, if there were only one origin of replication 
on each chromosome it would take around 70 days to replicate the entire genome. As 
such, there are multiple origins of replication in each cell and, in mammals, this number 
of these parallel synthesis sites is around 30,000-50,000 (Cairns, 1966; Huberman and 
Riggs, 1968; 1966). There are three steps in the setting of replication origins, which 
include recognition of origins, the assembly of a pre-replication complex (pre-RC) and 
the activation of the pre-RC (Figure 1.1). The pre-RC is assembled in G1 phase (Rao 
and R. T. Johnson, 1970). The origin of replication complex (ORC) is a heterohexamer 
with DNA-dependent ATPase activity (S. P. Bell and Stillman, 1992). Despite having a 
consensus sequence in Saccharomyces cerevisiae (reviewed in (Newlon and Theis, 
1993)), there is no consensus sequence for metazoan origins of replication (Vashee et 
al., 2003). Following ORC binding to an origin, two factors, known as cell divison cycle 
6 (CDC6) and CDC10 Target 1 (CDT1) are recruited to the origin and load the mini-
chromosome maintenance (MCM) helicase complex MCM2-7 in an ATP-dependent 
manner in a process known as licensing (Remus et al., 2009). MCM9 also works in 
concert with CDT1 to load the MCM2-7 complex (Lutzmann and Méchali, 2008). 
Licensing marks the end of the pre-RC complex assembly and the complex is ready to 
be activated. Two kinases that are S phase-specific are required prior to the activation 
of the pre-RC complex; these kinases are the Dfb4-dependent kinase (DDK) and a 
cyclin-dependent kinase (CDK) and phosphorylate the MCM complex and CDC6, 
respectively (Jiang et al., 1999a; 1999b). There are a growing number of other factors 
involved in activation of the replication origin and these include Cdc45 and the four 
GINS proteins that, together with phosphorylated MCM2-7, form the CMG complex 
(Ilves et al., 2010; Im et al., 2009). The licenced origin is now activated and DNA 
  
 
 
 
Figure 1.1. Assembly of the pre-replication complex (pre-RC) at DNA replication 
origins in eukaryotes.  
The heterohexameric origin of replication (ORC) complex recognises a DNA replication 
origin. ORC recruits cell division cycle 6 (CDC6) and CDT1. CDT1 acts in concert with 
minichromosome maintenance protein 9 (MCM9) and, along with CDC6, loads the 
MCM2-7 helicase complex in an ATP-dependent manner to form the pre-RC complex. 
MCM2-7 forms a CMG complex with CDC45 and the four GINS and requires a number 
of other factors for pre-RC activation. 
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begins to be unwound by the helicase complex. Despite the CMG complex being 
loaded onto double stranded DNA, the CMG complex is remodelled once loaded and 
forms a single-stranded 3’-5’ DNA translocase with a steric exclusion unwinding 
mechanism (Fu et al., 2011). The pre-RC complex is regulated by geminin (Lutzmann 
et al., 2006; Rao and R. T. Johnson, 1970). Geminin prevents rereplication by binding 
Cdt1 that is already undergoing licensing. Not all origins will lead to initiation of 
replication in every cell cycle and the question is therefore raised as how individual 
origins are selected. DNA combing studies have suggested that the firing of origins is 
stochastic and independent between cell cycles, with no genetic or epigenetic markers 
to prevent one origin from firing in the next round of replication (Patel et al., 2005). 
 
1.2.2. Initiating Genome Replication 
Once the pre-RC has been licenced and activated and the cell has progressed into S 
phase, genome replication can begin. The replisome forms at the bubble caused by the 
helicase unwinding by MCM2-7. Copying DNA occurs in two major steps, production of 
a short RNA primer and elongation using deoxyribonucleotides to produce a DNA copy. 
There are three main polymerases involved in replicating the bulk of DNA, these are 
DNA polymerases α, δ and ε; these polymerases all replicate DNA in a 5’-3’ direction. 
The first, DNA polymerase α (pol α), has both DNA priming and polymerase activity 
and is the only polymerase of the three capable of initiating de novo primer synthesis 
(reviewed in (Burgers, 1998)). Historically, CDC45 has been the main candidate for 
recruitment of pol α to the replication complex. There are a number of supporting 
factors for this, such as the temporal coregulation of the two proteins in vivo as well as 
physical interactions between CDC45 and pol α in Xenopus and humans (Aparicio et 
al., 1999; Kukimoto et al., 2001; Mimura and Takisawa, 1998). However, a physical 
interaction was not observed in S. cerevisiae and an initiation defective mutant of 
CDC45 in S. pombe did not affect chromatin loading of pol α to the DNA, suggesting 
that CDC45 is not directly involved in pol α loading (Aparicio et al., 1999; Uchiyama et 
al., 2001). MCM10 is a protein that is required for the stimulation of phosphorylation of 
the MCM2-7 helicase by DDK and is another candidate for the recruitment factor of pol 
α (Lee, 2003). There is an increasing body of evidence suggesting that MCM10 is 
responsible for recruitment of pol α to the complex, including a number of studies 
suggesting its involvement in binding pol α and stabilising its association to chromatin 
(Chattopadhyay and Bielinsky, 2007; Ricke and Bielinsky, 2004; Warren et al., 2009; X. 
Yang et al., 2005; W. Zhu et al., 2007). Recently however, it has been revealed that a 
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trimer of Ctf4 may tether pol α to the CMG complex (A. C. Simon et al., 2014), both pol 
α and the Sld5 subunit of GINS contain Ctf4 binding motifs that bind Ctf4, this 
interaction is confirmed crystallographically and through size-exclusion 
chromatography but the interaction in vivo remains to be proven.  Upon loading of pol 
α, it synthesises a short RNA primer of up to 15 nucleotides and extends from this 
about 20 nucleotides of DNA, from which other polymerases can extend (Conaway and 
Lehman, 1982a; 1982b; Kunkel, 2011).  
 
Upon helical unwinding of the DNA, a protein known as replication protein A (RPA) is 
required to stop the DNA winding back on itself, forming secondary structures, or being 
degraded (reviewed in (Wold, 1997)). This protein binds pol α and was first identified 
through a Simian Virus 40 (SV40) replication system supplemented with mammalian 
cell extracts (Dornreiter et al., 1992; Fairman et al., 1988; Fairman and Stillman, 1988; 
Wold and Kelly, 1988).  As SV40 requires only its large T antigen (TAg) from its own 
genome and all other replication components are derived from a mammalian host, this 
made it a prime candidate to study which proteins are required for the replication of its 
genome. These studies also identified the replication factor C (RFC), proliferating cell 
nuclear antigen (PCNA), topoisomerase I and topoisomerase II proteins as replication 
factors (Fairman et al., 1988; Prelich et al., 1987).  
 
Following production of this DNA/RNA primer hybrid, the polymerase is switched to 
allow the replication complex to take over elongation. RFC is a heteropentameric 
complex that preferentially binds single stranded DNA and its main function is to load 
PCNA onto the DNA in an ATP-dependent manner (Jonsson et al., 1997; X. Li and 
Burgers, 1994). It has been demonstrated that the polymerase switching mechanism 
occurs in a two-step protein competition mechanism in which pol α is competed from 
RPA by RFC, which loads PCNA to the DNA, the replicative polymerase pol δ 
subsequently competes with RFC for RPA and PCNA (Yuzhakov et al., 1999). PCNA is 
a homotrimeric complex that encircles the DNA and is an example of a DNA clamp. 
 
1.2.3. Elongation and Progression of the Replisome 
The polymerase switching marks the switch to elongation. Elongation involves the 
highly processive, high fidelity replication of the bulk of the DNA by pols δ and ε. These 
two processive polymerases both have 3’-5’ exonuclease (exo) activity to ensure 
fidelity (M. Simon et al., 1991; Tran et al., 1999). Whilst the SV40 studies had identified 
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a requirement for two polymerases, pol α and pol δ, studies in S. cerevisiae prior to this 
had found that a third DNA polymerase is required, pol ε (A. Morrison et al., 1990; 
Waga and Stillman, 1994). There is a topological problem in the replication of DNA at a 
fork that moves in a single direction, the two strands are antiparallel but all 
polymerases replicate DNA in a 5’-3’ direction. The generally accepted model, initially 
provided by the Sugino lab and supported by the Kunkel lab, has been that pol α 
initiates replication prior to polymerase switching and the two pols, pol ε and pol δ, 
produce DNA on opposite strands, with pol ε producing a continuous strand of DNA 
opposite the leading strand and pol δ extending DNA primers in a discontinuous 
manner, producing disconnected strands of DNA opposite the lagging strand of 
approximately 200 nucleotides’ length, known as an Okazaki fragment (Figure 1.2) 
(reviewed in (Kunkel and Burgers, 2008; Stillman, 2008)). There is a body of evidence 
that supports this model as it has been established that the exo of pol δ, but not of pol 
ε, corrects errors made by pol α, suggesting only pol δ has access to the primer termini 
on the lagging strand at the beginning of an Okazaki fragment (Pavlov et al., 2006). 
Exo mutations in pols δ and ε resulted in an increase the frequency of mutations on 
opposite DNA strands, suggesting that they do indeed act on opposite strands 
(Shcherbakova and Pavlov, 1996). Additionally, a number of studies into catalytic site 
mutations of pols δ and ε have shown these proteins to act on opposite strands in both 
fission yeast and budding yeast (Miyabe et al., 2011; Nick McElhinny et al., 2008; 
Pursell et al., 2007). There is emerging, however, a new distinct model based on recent 
evidence and discrepancies in evidence for the old model that, following elongation, as 
pol ε moves away from the origin of replication it dissociates from the DNA and is 
replaced by pol δ, which subsequently continues elongation (reviewed in (Pavlov and 
Shcherbakova, 2010)).  
 
The Okazaki fragments produced through lagging strand synthesis must be joined to 
create a continuous strand of DNA opposite the lagging strand. As the polymerase 
reaches the RNA primer of the previously produced Okazaki fragment it peels away the 
primer, leaving a 5’ overhang (or “flap”) (Maga et al., 2001). This flap is cleaved by the 
flap endonuclease FEN1, which is stimulated through PCNA binding and can 
subsequently be ligated by DNA ligase I in an ATP-dependent manner (Barnes et al., 
1990; Lehman, 1974; X. Li et al., 1995; Pascal et al., 2004). 
 
  
 
 
 
 
 
 
Figure 1.2. The eukaryotic replication fork.  
The MCM2-7 helicase unwinds DNA at the replication fork. Torsional stress upstream 
of the replication fork is relieved by topoisomerases. Single-stranded DNA is bound by 
RPA to prevent formation of secondary structures and to protect from degradation. 
Leading and lagging strand replication both occur in a 5’-3’ direction. The lagging 
strand is replicated in a discontinuous manner, with pol α producing a short RNA/DNA 
hybrid primer, before extension by pol δ. Leading strand replication occurs in a 
continuous manner with Pol ε extending primers produced by pol α. PCNA is expected 
to act as a processivity factor for pols δ and ε.  
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As a DNA helicase unwinds DNA and the polymerase replicates DNA, the DNA goes 
through a complete rotation every 10 nucleotides. As a result of positive supercoiling 
caused by this helicase unwinding, torsional stress upstream of the replisome is built 
up that needs to be released (Figure 1.3A). There are molecules that are specialised in 
the release of this torsional stress, known as topoisomerases. There are four types of 
DNA topoisomerases, type IA, IB, IIA and IIB and, of these, IB and IIA are the main 
candidates in involvement in replication fork progression (reviewed in (Champoux, 
2001; J. C. Wang, 1996)). Type IB topoisomerases, such as topoisomerase I (Topo I), 
introduce a nick into the DNA and forms a covalent linkage with the DNA upstream of 
the nick through transesterification (Figure 1.3B). The two DNA segments can then 
rotate relative to one another prior to being reunited. Type IIA topoisomerases, such as 
topoisomerase II (Topo II) operate through an ATP-dependent manner to transport a 
DNA double helix through another by forming an enzyme-mediated gate in one of the 
double strands (reviewed in (J. C. Wang, 1998)). Topo I is likely to resolve positive 
supercoiling ahead of the fork, whilst also contributing to the prevention of interference 
between transcription and replication (Tuduri et al., 2009). Topo II, on the other hand, 
acts behind the fork to remove precatanae. 
 
1.2.4. Genome Replication Termination 
Replication forks initiate and elongate in a bidirectional manner and only come to a halt 
when fused with an adjacent replication fork. This fusion appears to occur randomly in 
a stretch of DNA with an average length of 5 kbp and contains fork pausing elements 
(Fachinetti et al., 2010; Greenfeder and Newlon, 1992a; J. Zhu et al., 1992). Unlike 
during transcription, termination of replication is not necessarily controlled by specific 
DNA sequences but primarily by where DNA replication is initiated and indeed, 
changing the site of initiation will change the site in which DNA replication terminates 
(Greenfeder and Newlon, 1992a). Within regions of termination, there are replication 
fork barriers that arrest one of the two forks in an orientation-dependent manner to 
allow the forks to fuse. There are a number of sites that slow DNA replication and could 
potentially result in replication fork fusion and these include, but are not limited to, sites 
of highly transcribed genes, centromeres and tRNA genes (Admire et al., 2006; 
Azvolinsky et al., 2009; Brewer and Fangman, 1988; Greenfeder and Newlon, 1992b).  
As the replication forks converge, topo I can no longer resolve supercoiling ahead of 
the fork and the fork must rely on topo II for relieving the torsional stress. Topo II can 
then remove the final catenations prior to segregation of the two DNA helices (Baxter 
  
 
 
 
 
Figure 1.3: The action of topoisomerases.  
(A) The helicase action of the replication fork introduces positive supercoils into the 
DNA upstream of the fork. The positive supercoiling results in torsional stress in the 
DNA. This stress is relieved by topoisomerases. (B) The mechanism of catalysis of 
type IB topoisomerases. The phosphate group of the DNA backbone undergoes 
nucleophilic attack by a tyrosyl group of the topoisomerase. This results in a covalent 
enzyme-DNA intermediate. An intact strand can be passed through the transient 
breakage to relieve the positive supercoiling.   
A 
B 
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and Diffley, 2008; Fachinetti et al., 2010; Sundin and Varshavsky, 1981). The 
mechanism by which this disassembly of the replisome occurs has previously been 
unknown until very recently through novel insights from a collaboration between the 
Labib and de Piccoli laboratories. The CMG complex (Cdc45-MCM-GINS) is transiently 
ubiquitylated during the final stages of chromosome replication in budding yeast (Maric 
et al., 2014). SCFDia2 is an E3 ubiquitin ligase important for maintaining genome 
stability and it was found that there is no disassembly of the replisomes at the end of S 
phase without SCFDia2. This SCFDia2 ligase is responsible for the ubiquitylation of the 
CMG complex and, upon examination of each of the subunits of the CMG complex, it 
was found that this ubiquitylation occurs only on MCM7(Maric et al., 2014). This 
ubiquitylated form of the CMG complex is only transient before the helicase complex is 
disassembled but this CMG-Ub is essential for disassembly. The transient nature of 
this ubiquitylation is Cdc48-dependent, and auxin-induced degradation of Cdc48 results 
in the persistence of this ubiquitylation (Maric et al., 2014). 
 
1.2.5. Mitochondrial Genome Replication 
Despite laboratory-cultivated vertebrate cells having the ability to grow anaerobically in 
the absence of mitochondrial DNA (mtDNA) multicellular organisms such as the simple 
nematode worm Caenorhabditis elegans, cannot survive without mtDNA (Bratic et al., 
2009; Desjardins et al., 1985; King and Attardi, 1989). Mitochondrial DNA in protozoa 
exists as a closed circular DNA of around 15 kbp, encoding 22 tRNAs, 2 rRNAs and 13 
mRNAs, which are translated into the proteins required for aerobic respiration 
(reviewed in (Wilson et al., 1985)). The replication mechanism in mitochondria is similar 
to nuclear DNA replication, with a number of corresponding proteins (Figure 1.4). The 
enzymes required for mtDNA replication include DNA polymerase γ, Twinkle DNA 
helicase, mitochondrial RNA polymerase (polRMT), DNA ligase III, RNase H1, 
mitochondrial transcription factor A (TFAM), single-stranded DNA binding protein 
(mtSSB) and topoisomerases (Cerritelli et al., 2003; Hance et al., 2005; Simsek et al., 
2011; Spelbrink et al., 2001; Tyynismaa et al., 2004; Van Goethem et al., 2001). The 
nuclear helicases PIF1 and Dna2 have also been reported in the mitochondria (Duxin 
et al., 2009; Futami et al., 2007). Instead of using a specialised primase to generate 
primers, the mitochondrial transcription machinery produces short RNA transcripts at 
their origins of replication. Mitochondria have two distinct origins of replications on their 
two strands of DNA, the heavy strand (G-rich) and the light strand (C-rich). The heavy 
strand synthesis origin, known as OH, is situated in a region of the mitochondrial 
  
 
 
 
 
 
Figure 1.4. Replication of mitochondrial DNA.  
Transcription Factor TFAM binds DNA at the origin of replication and unwinds part of 
the DNA. polRMT is then able to produce a strand of complementary RNA opposite the 
light chain of mtDNA. This RNA strand is processed by RNase MRP, the resulting 
primer is extended by pol γ. Twinkle helicase, along with topoisomerases can unwind 
the rest of the mtDNA whilst pol γ extends from the RNA primer around the closed 
circular DNA. 
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genome that contains all noncoding parts of mtDNA (Noncoding Region; NCR) (Pham 
et al., 2006). The light strand synthesis origin, known as OL, is within a cluster of tRNA 
genes around two-thirds of the way around the genome relative to OH and is not 
triggered until the heavy strand synthesis is around two-thirds complete (Chang and 
Clayton, 1985). TFAM belongs to a group of high-mobility group (HMG)-box family of 
proteins that characteristically bind and unwind DNA. TFAM binds the mtDNA 
upstream of the replication initiation site at OH and permits the transcription of the 
unwound DNA (Dairaghi et al., 1995; Fisher et al., 1987). The next step is the 
production of an RNA primer from the origin of replication by polRMT (Chang and 
Clayton, 1985; Chang et al., 1985). The RNA primer is the same for transcription of 
mitochondrial genes and for replication of mtDNA but for replication it must be 
processed; this processing is carried out by a site-specific endoribonuclease known as 
RNase MRP (Topper and Clayton, 1990). The primer can then be extended by the A 
family polymerase DNA polymerase γ (pol γ). Pol γ is composed of two subunits, a 
140kDa catalytic subunit and a 55kDa accessory subunit (Ropp and Copeland, 1996; 
Y. Wang et al., 1997). The RNA primer is recognised by the accessory subunit in a 
fashion similar to the recognition of mRNA by tRNAs and it is proposed that this 
enzyme has an additional role as a processivity factor, similar to PCNA but without the 
requirement for a clamp loader (Fan et al., 1999; Lim, 1999). The helicase used in 
mitochondria, Twinkle, was identified in patients exhibiting ophthalmoplegia and was 
noted for its similar sequence to the T7 primase/helicase, with its helicase domain 
exhibiting conserved organisation to other helicases (Z. Liu et al., 2008). Twinkle acts 
as a hexamer and unwinds DNA in a 5’-3’ direction, it does this without a specialised 
protein to load it onto the closed circular mtDNA (Jemt et al., 2011; Korhonen et al., 
2003). In combination with tetremeric mtSSB and pol γ, a processive replication 
machinery is formed that can synthesise long DNA molecules (see Figure 1.4) 
(Korhonen et al., 2004). The mechanism through which lagging strand synthesis occurs 
from OL remains unknown and the primase that assists in the discontinuous synthesis 
of the lagging strand remains undetermined.  The reason for the requirement of 
RNaseH1 and DNA ligase III has not been established, though given their activities 
elsewhere it is suggested that they are required for the removal of primers in the 
synthesis of the leading and/or lagging strand and the joining together of nicks resulting 
from the removal of primers and subsequent gap-filling. 
 
1.3 DNA Polymerases 
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1.3.1 The Discovery of DNA Polymerases 
Biochemistry in the era predating the discovery of DNA polymerases was predicated on 
work with the emphasis of energy production, as opposed to the metabolic processes 
of biosynthetic production. It was presumed that, since individual reactions could be 
reversed, entire pathways could be; this rationale seems reasonable when one 
considers that the production of glycogen from glycogen phosphorylase is a possibility 
– why not just reverse the action of exonucleases? After all, the idea that a mechanism 
by which an enzyme depended entirely on its substrate for instruction as a template 
was unprecedented in Biochemistry at the time. DNA was expected to be a primer for 
growth of a chain like glycogen was previously shown to be (Cori et al., 1943). During 
the 1950s, however, it became increasingly clear that the pathways for energy 
production and metabolic biosynthesis pathways were distinct, with biosynthetic 
pathways themselves having discrete synthesis and breakdown pathways.  
 
The term “polymerase” was coined in 1958 upon the first purification and 
characterisation of an enzyme from Escherichia coli capable of performing nucleotidyl 
transfer of radioactive (14C)-thymidine, from the form of dTTP, into DNA (Lehman et al., 
1958). There are two basic features of the synthesis of DNA; the first is the nucleotidyl 
transfer, in which an active nucleoside triphosphate is transferred onto the growing 
strand of DNA following a nucleophilic attack on the triphosphate between the α and β 
carbons, removing two of the phosphate moieties, which provides the energy for the 
formation of a phosphodiester bond through a condensation reaction in an overall 5’-3’ 
direction (Kornberg, 1962). The second is the base pair matching to the template 
strand, this ensures fidelity of the genetic code between cells after genome replication; 
adenine is paired with thymine and cytosine with guanine, this accuracy is achieved 
through the large difference in enthalpy between matched base pairs and mismatched 
base pairs (Petruska et al., 1988). Polymerases must exhibit high processivity and 
fidelity if they are to replicate the genome rapidly and accurately enough for cells’ 
demands. Polymerases cannot, however, synthesise novel strands of DNA de novo as 
they cannot produce the initial short strands from which they can extend. This is carried 
out by specialised proteins, known as DNA primases (See section 1.7).  
 
1.3.2. Structure and Function of DNA Polymerases 
There are a large number of DNA polymerases that have been classified into seven 
different families, based on primary sequence and structural data: A, B, C, D, X, Y and 
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RT (reverse transcriptases) (Table 1.1) (Braithwaite and J. Ito, 1993; J Ito, 1991; Joyce 
and Steitz, 1994).  Despite a huge variation in sequences between these families, 
nearly all polymerases share a common domain organisation and mechanism of action. 
The first polymerase structure to be resolved crystallographically was the C-terminal 
polymerase domain of E. coli pol I, known as the Klenow fragment (Klenow and 
Overgaard-Hansen, 1970; Ollis et al., 1985). The structure of the Klenow fragment in 
complex with DNA revealed further topological information about the polymerase 
(Beese et al., 1993). Following the initial structural studies of this Klenow fragment an 
analogy was drawn up of the polymerase resembling a right hand, with its subdomains 
referred to as the fingers, palm and thumb domains (Figure 1.5). 
 
The domains form a crevice that has the palm subdomain at its base and is lined with 
the fingers and thumb subdomains. The substrate DNA is largely coordinated by amino 
acids in the thumb subdomain whilst the fingers subdomain is more important for the 
binding of the incoming nucleotide to be added to the nascent DNA strand. The 
polymerase active site, in which all the essential catalytic amino acids reside, is in the 
palm subdomain. This is an architecture shared across a diverse array of polymerases. 
Y family polymerases share the domain organisation of other polymerases but have a 
smaller fingers and thumb subdomains to give a more open, solvent-accessible active 
site (Reviewed in (Pata, 2010)). Additionally, they have a polymerase-associated 
domain (PAD; commonly also referred to as the ‘little finger domain’ in archaeal and 
bacterial systems).  
 
The mechanism by which dNTPs are incorporated by polymerases is depicted in 
Figure 1.6. The first step in addition of nucleotides to a nascent DNA chain is the 
binding of the DNA substrate. There is a minimal change in the fingers and palm 
domain in the binding of DNA but there is a conformational change in a helix-loop-helix 
motif the thumb domain that closes in on the DNA (Figure 1.7; (Y. Li et al., 1998a; 
1998b)). The dNTP is bound in the fingers domain, but distal (10-15 Å) from the active 
site, in the second step. The third step involves a large conformational change in the 
polymerase fingers subdomain (Figure 1.7; (Y. Li et al., 1998b)). There is a small 6° 
rotation in the core of the fingers subdomain, which is subsequently followed by a 
larger 40° rotation in the helices towards the tip of the enzyme, allowing the enzyme to 
close around the DNA and bring the incoming dNTP into contact with the catalytic 
centre. This conformation change step is vital for the discrimination of incorporation of 
 Family Examples Functions Exonuclease 
Activity 
A T7 DNA polymerase,  
E. coli pol I, 
Taq pol I, 
Eukaryotic pols γ, ν, 
θ. 
Chromosomal and 
mitochondrial DNA 
replication.  
Filling in gaps from the 
removal of nucleotides. 
Okazaki fragment 
processing. 
 
5’-3’ for the 
removal of Okazaki 
fragments. 
3’-5’ for 
proofreading. 
 
B Eukaryotic pols α, δ, 
ε, ζ, 
T4 DNA polymerase, 
E. coli pol II, 
Some viral and 
archaebacterial 
polymerases. 
 
Chromosomal DNA 
replication. These 
enzymes are generally 
tethered by a 
processivity factor and 
stimulated by a single-
stranded binding 
protein. 
Pol ζ used in DNA 
damage bypass. 
 
3’-5’ for 
proofreading. 
 
C Bacterial DnaE, 
E. coli pol III, 
Bacillus subtilis pol III. 
 
Chromosomal 
replication. DNA 
damage bypass. 
 
3’-5’ for 
proofreading. 
 
D Euryachaeota 
polymerases 
including Pyroccocus 
furiosus DNA 
polymerase II. 
 
Poorly characterised but 
suggested to be a 
replicative polymerase 
 
3’-5’ for 
proofreading. 
 
X Eukaryotic pols β, μ, 
λ, 
Yeast pol IV, 
African Swine Fever 
Virus pol X, 
Human Terminal 
Deoxynucleotide 
Transferase. 
 
Involved in DNA 
damage processing 
including base excision 
repair and double strand 
break repair 
 
- 
Y Eukaryotic pols η, κ, ι 
and REV1, 
E. coli DinB, UmuC. 
 
DNA damage bypass. 
V(D)J 
 
RT (Reverse 
Transcriptase) 
HIV RT,  
Moloney murine 
leukaemia virus RT,  
Hepatitis B RT, 
Telomerase 
 
Reverse transcription of 
viral genomes. 
Telomerase has an 
innate RNA component 
to synthesise GC-rich 
repeats at telomeres 
 
- 
 
Table 1.1. The families of DNA polymerases.  
An overview of the seven families of DNA polymerases describing examples of each 
family and their putative functions in vivo, as well as whether or not the family of 
polymerases generally have exonuclease activity. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. The structure of Thermus aquaticus (Taq) polymerase.  
The structure of the Klenow fragment of Taq polymerase (PDB ID = 3E0D) resembles a 
right hand with its fingers (blue), thumb (red) and palm (green) subdomains through 
which the DNA is threaded. The template and nascent DNA strands are shown in gold. 
  
  
 
 
 
 
 
 
 
 
Figure 1.6. The Kinetic Pathway and Mechanism of Polymerase Catalysis.  
(A) 1.) The nascent DNA chain binds to the polymerase. 2.) The binding of a nucleotide 
to the polymerase forms a polymerase-DNA-dNTP complex. 3.) The polymerase 
undergoes a conformational change to bring the nucleotide close to the active centre. 
4.) The nascent DNA chain binds to the nucleotide and forms a new phosphodiester 
bond. The formation of a phosphodiester bond results in the release of a 
pyrophosphate ion. 5) The pyrophosphate ion is released from the enzyme ready for 
the next nucleotide addition. Distributive enzymes may release the DNA and begin at 
step 1, processive enzymes will remain bound to the DNA and continue from step 3. 
(B) A catalytic triad of amino acids (blue) coordinates two magnesium ions (light blue). 
These magnesium ions orientate the 5’ base of the reaction (green) and the incoming 
dNTP (purple) to facilitate the nucleophilic attack on the α-phosphate, resulting in a 
pentavalent intermediate state. The reaction continues through an elimination reaction 
that removes the pyrophosphate from the α-phosphate. 
 
A 
B 
  
 
 
 
 
 
 
 
 
Figure 1.7. Conformational changes during Taq polymerase catalysis.  
(A) Superposition of apo (orange; PDB ID = 5TKQ) and open DNA bound (blue; PDB 
ID = 2TKQ) Taq polymerase. Upon binding DNA, there is a small conformational 
change in the thumb domain from the apo Taq polymerase to the open conformation of 
DNA bound polymerase. The DNA is omitted from this figure for simplicity. (B) 
Superposition of open DNA bound (blue; PDB ID = 2TKQ) Taq polymerase and its 
closed (green; PDB ID = 4TKQ) conformation. There is a rotation in the fingers 
subdomain that closes the polymerase around the DNA (shown in magenta) to orient 
the DNA for catalysis. 
 
A 
B 
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dNTPs, as well as the phosphoryl transfer. The protein forms a close-fitting structure 
around the nascent base pair, providing a steric hindrance to the incorporation of 
incorrect base pairs (Y. Li et al., 1998a; Y. Li and Waksman, 2001). Due to the large 
conformational change in the DNA, it was initially presumed that this was the rate 
limiting step but a FRET analysis of this subdomain determined it to be significantly 
quicker than the kinetically determined rate-limiting step (Rothwell et al., 2005) and this 
rate-limiting step is now generally accepted to occur in the closed state.  
 
The phosphoryl transfer reaction can then occur. Despite the protein scaffolds around 
the catalytic centres being divergent, the structures of polymerases have long been 
known to share a congruence in the coordination of two metal ions by acidic amino acid 
residues that are presumed to stabilise a pentavalent transition state caused by a 
nucleophilic attack in the polymerisation of oligonucleotide chains (see Figure 1.6B; 
(Steitz, 1999; Steitz et al., 1994)). Two divalent cations are held by three essential 
acidic amino acids 3.8Å apart. In some polymerases, all three amino acids are 
aspartates but in others two are aspartate residues and one is a glutamate; only the 
metal ions are directly required for catalysis with the acidic residues providing a 
structural framework in which to coordinate the ions. Whilst metal coordination differs 
between structures the metal ions are positioned identically relative to the primer 
terminus and α-phosphate of the incoming deoxynucleotide triphosphate (dNTP). This 
reaction is then followed by a further conformational change to allow the release of the 
pyrophosphate. Following the release of pyrophosphate, the next nucleotide can then 
be added to the nascent DNA chain or, if the polymerase is a distributive enzyme, the 
chain can be released (Figure 1.6A). 
 
1.4 DNA Damage 
DNA is not an inert molecule, rather the opposite, and it is susceptible to damage from 
the environment, whether this is the immediate endogenous environment or the wider 
exogenous environment. The integrity and stability of DNA are paramount for viability 
and genomic consistency and in Section 1.5 I will discuss the ways in which cells deal 
with damaged DNA. In this section we take a look at the insults that cause DNA 
damage, There are an estimated 50,000-100,000 chemical DNA modifications 
predicted to occur in a single cell every day (Hübscher and Maga, 2011). This section 
will discuss the most common causes of DNA damage. 
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1.4.1. Ionising radiation and its effects on DNA 
Ionising radiation is radiation with enough kinetic energy to cause the release of an 
electron from an atom, thereby ionising it. Ionising radiation was the first external agent 
shown to be able to cause mutation in living organisms in Drosophila melanogaster fruit 
flies (Muller, 1927). Ionising radiation has the potential to act both directly and indirectly 
to alter the structure of DNA. Ionising radiation with high linear energy transfer, such as 
α particles, neutrons or β particles, can act directly on DNA. Ionising radiation such as 
X-rays can also interact with intracellular molecules including oxygen and water to 
produce reactive oxygen species, such as hydroxyl radicals, that can subsequently 
damage DNA (see section 1.4.3.).  
 
Ionising radiation causes a wide spectrum of DNA lesions and these include damages 
to nucleobases, double-stranded DNA breaks (DSBs) and single-stranded DNA breaks 
(SSBs). SSBs are caused by the reaction of hydrogen atoms in the deoxyribose moiety 
of DNA and are readily repaired by ligation (Dean et al., 1969; Vanankeren et al., 
1988). They are far more prevalent than DSBs (about 1000 cell-1 Gy-1 compared to 25-
40 cell-1 Gy-1 for DSBs), which are more lethal to the cell as simple religation is not an 
option (Olive, 1998). 
 
1.4.2. Ultraviolet Light and its Effects on DNA 
Ultraviolet (UV) irradiation, mainly from solar sources, has a mutagenic effect on cells. 
At wavelengths approaching the maximum absorbance of DNA (i.e. 260 nm) adjacent 
pyrimidines can form bulky covalent linkages (Figure 1.8) (Friedberg et al., 1995; 
Rastogi et al., 2010). 70-80% of these covalent lesions are cyclobutane pyrimidine 
dimers (CPDs) and around 20-30% are pyrimidine (6-4) pyrimidone photoproducts ((6-
4)PPs). The generation of 6-4 photoproducts is the result of an oxetane intermediate 
transferring a hydroxyl group at the carbon at the 4’ position of the 3’-nucleobase to the 
carbon in position 6’ of the 5’ nucleobase. This product can then be converted to its 
Dewar valence isomer by irradiation of lower energy UV light with wavelengths of 
approximately 300-350 nm (Taylor, 1990; Taylor and Cohrs, 1987).  
 
CPDs bend the helical axis by 30° and unwind the DNA by approximately 9°; the bases 
remain stacked enough for CPDs to continue to form Watson-Crick base pairs, albeit 
with one hydrogen bond lost between the 5’-thymine and adenine (Park et al., 2002). 
(6-4)PPs result in a much higher distortion to the DNA and the two adjacent bases are 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. Formation and structure of different types of DNA lesions caused by 
UV irradiation of two adjacent (thymine) pyrimidines.  
(A) Around 70-80% of covalent lesions caused by UV light are cyclobutane pyrimidine 
dimers (CPDs) and 20-30% of lesions are thymine-thymine pyrimidine (6-4) pyrimidone 
dimers ((6-4)PPs), which can subsequently be converted into the Dewar valence 
isomer. hc/λ is the energy of a photon, where λ represents the wavelength of the 
electromagnetic radiation,  h is the Planck constant and c is the speed of the 
electromagnetic radiation. (B) Structures of DNA duplexes showing the presence of UV 
lesions (in green) of CPD, (6-4)PP, and (6-4)PP Dewar isomer. (B) adapted from 
Rastogi et al., 2010.  
A 
B 
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found at approximately right angles to one another. The helical bending at these 
lesions is estimated to be closer to 44° and phosphorus atoms in the paired bases are 
found within a distance of 6.13 Å as opposed to the 7.11 Å average at other base 
pairing steps. 
 
1.4.3. Oxidative Damage to DNA 
Guanine moieties in DNA have a high oxidative potential in cells (they are the 
nucleobases with the lowest Eox) and readily oxidise to 8-oxo-2’-deoxyguanosine (8-
oxo-G). A number of oxidising agents have been shown to induce 8-oxo-G formation 
(See Figure 1.9) (Halliwell and Aruoma, 1991). The fibres of asbestos cause their 
toxicity through the production of reactive oxygen species from hydrogen peroxide 
(Mahmood et al., 1994). Reactive radical species that induce the formation of 8-oxo-G 
within both isolated and cellular DNA are also produced by exposure to ionising 
radiation; this is predominantly carried out by a singlet oxygen species as the reactive 
intermediate (Devasagayam et al., 1991; Dizdaroglu, 1985).  
 
The structure of the DNA double helix is such that a π-stacked array is formed by the 
heterocyclic base pairs, allowing the migration of charge across large distances; it has 
been revealed that oxidation of guanine to 8-oxo-G can occur up to 37Å away from the 
site of the reactive species, thereby increasing the likelihood of formation (Hall et al., 
1996). Two  adjacent guanine moieties are preferred sites for oxidative reaction to 
occur, with the 5’ guanine being the more reactive (Prat et al., 1998). Quantum 
mechanical calculations of hole (areas of localisation of DNA radical cations) spatial 
distribution in ionised oligomers containing the sequence 5’-U/T-G-G-U/T-3’ have 
approximately equal radical cation density on the guanines when the sequence is 5’-
TGGT-3’ and 5’-UGGU-3’. However, oxidation of 5’-TGGT-3’ by electromagnetic 
irradiation gives a ratio of 5’-G oxidation to 3’-G oxidation of 6.1, while this ratio for 5’-
UGGU-3’ is just 3.4 (Prat et al., 1998). The methyl group of thymine, therefore, exerts a 
significant steric hindrance of the formation of 8-oxo-G on the 3’ guanine. As a result, it 
can be deduced that both steric and electronic factors affect the rate of reaction 
(referred to as ktrap, as it is the rate at which electrons are irreversibly trapped at a site 
of oxidation as opposed to hopping between bases). 8-oxo-G is mutagenic to cells 
because, whilst 8-oxo-G can be overcome by the replicative polymerases DNA pols α, 
δ and ε, the replicative enzymes all most commonly insert an incorrect adenine 
opposite an 8-oxo-G as opposed to the correct cytosine as a result of Hoogsteen base 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9. Oxidation of guanine and its subsequent mutagenicity.  
(A) Formation of 8-oxoguanine (8-oxo-G) from guanine as a result of superoxide 
molecules and other reactive oxygen species in the cell. Superoxide radicals can be 
found in the cell as a result of oxidative phosphorylation in the mitochondria or through 
the action of ionising radiation. These radicals can be metabolised to hydrogen 
peroxide, which can be used to oxidise iron molecules and results in the release of 
hydroxide ions and hydroxyl radicals. These hydroxyl radicals react with guanine to 
produce 8-oxoguanine. (B) 8-oxoguanine in its anti- conformation can form Watson-
Crick base pairs with cytosine, as guanine does. However, in its syn- conformation, it 
forms Hoogsteen base pairs with adenine. Replicative polymerases constrain 8-
oxoguanine to its syn- conformation and incorporate an incorrect adenine opposite this 
damaged base. 
A 
B 
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pairing, thus generates a GC ! TA transversion following replication (Figure 1.9) (van 
Loon et al., 2010). 
 
Despite the fact that adenine has a lower Eox than thymine, if there is no suitable 
guanine moiety available, oxidation occurs at two adjacent thymine moieties with the 
formation of thymine glycol (Tg), among other products, in a process initiated by the 
hydration of the thymine radical cation carbon double bond (Ghosh et al., 2008). This is 
because the activation free energy for the thymine radical cation is lower than that for 
reaction at the adenine radical cation; the relative yields of products is determined by 
the difference in free energy of the transition states (δΔ‡G), not by the relative 
abundance of the intermediates, which would indeed be determined solely by Eox 
(Curtin-Hammett principle).  
 
1.4.4. Chemical Agents and Their Effects on DNA 
There are a huge number of chemicals that can induce DNA damage, including 
oxidising agents (see Section 1.4.3.), alkylating agents and intercalators. Bifunctional 
alkylating agents such as nitrogen mustards and cis-platin and their related compounds 
have been used in cancer chemotherapy for a long time; these molecules crosslink 
DNA (Rink et al., 1993; Rosenberg et al., 1969).  
 
The type of adduct caused by alkylating agents depends on their nucleophilicity; those 
with a high nucleophilicity, such as MMS, will undergo bimolecular (SN2) substitutions, 
whereas those with a low nuclepohilicity, such as N-ethyl-N-nitrosurea (ENU), will 
undergo unimolecular (SN1) substitutions (Hoffmann, 1980). SN2 substitutions generally 
result in adducts at the nitrogens at position 7 of guanine and position 3 of adenine. 
The high nucleophilic reactivity of the nitrogen at position 7 of guanine and position 3 of 
adenine results in the formation of methylated adducts N7-methylguanine (7meG) and 
N3-methyladenine (3meA) respectively as induced by alkylating agents. 7meG is the 
major methylated adduct (60-80% of methylated lesions) but is not itself mutagenic or 
cytotoxic; however, it is prone to the formation of apurinic/apyrimidinic (AP) sites by 
depurination (See Section 1.4.5.). Conversely, 3meA, which accounts for around 20% 
of methylated lesions, can block the DNA polymerase machinery and is thus highly 
cytotoxic (Drabløs et al., 2004). SN1 substitutions are less common; they are also likely 
to cause adducts at the nitrogen of position 7 of guanine but can also alkylate the 
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oxygen at position 6 of guanine (Hoffmann, 1980); O6-methylguanine mispair with 
thymine causing A!T transition mutations. 
 
Another common covalent modifier of DNA is Benzo[a]pyrene, which itself is a 
procarcinogen found in cigarette smoke and pollution and is sequentially oxidised by 
cytochrome P450 to benzo[a]pyrenediolepoxide (BPDE) (Sims et al., 1974). BPDE is 
carcinogenic and can covalently bind DNA (see Figure 1.10) as well as intercalating 
within DNA to induce mutation (Geacintov et al., 1984). 
 
Intercalating agents do not cause any direct covalent modifications to DNA, but rather 
interfere with base stacking and can induce point mutations. These aromatic 
compounds unwind DNA and fit between the base pairs. Anthracyclines are a class of 
intercalators that are currently used in chemotherapeutic treatment and include 
daunorubicin and doxorubicin (reviewed in (Minotti et al., 2004)). These molecules 
consist of a common sugar moiety (daunosamine) and a tetracyclic aglycone group.  
 
1.4.5. Endogenous DNA Damage 
In addition to naturally occurring oxidative damage and alkylation, there are is a huge 
risk from endogenous sources to the integrity of DNA. Hazards to DNA stability include 
spontaneous depurination, spontaneous deamination, DNA replication errors and 
chromosomal rearrangements. 
 
Depurination of nucleotides by hydrolysis occurs a predicted 9000 times per cell per 
day (Nakamura et al., 1998). It is a consequence of the removal of the base at the 
glycosyl bond and results in an AP site. AP sites can inhibit DNA replication but also 
cause base substitution mutations (Loeb and Preston, 1986). As AP sites are found as 
an intermediate in base excision repair (BER; see section 1.5.2.) they are often 
repaired by this machinery.  
 
Spontaneous deamination of cytosine results in uracil bases (Figure 1.11) (Duncan and 
Miller, 1980). Uracil is found naturally in RNA in cells and base pairs to adenine; as a 
consequence of this adenine base pairing, cytosine deamination results in G!A 
transition mutation. Additionally, uracils are removed from DNA by the enzyme uracil 
DNA glycosylase and this removal leads to an AP site. 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.10. Covalent modification of guanine by benzo[a]pyrene.  
Benzo[a]pyrene is oxidised by cytochrome P450 to produce an epoxy intermediate. 
This epoxy intermediate is then hydrolysed by epoxy hydrolase to form a diol. This diol 
is further oxidised by cytochrome P450 to produce Benzo[a]pyrene diolepoxide 
(BPDE). The amine group of guanine then attacks the epoxide ring to form a mutagenic 
bulky adduct. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. Deamination of cytosine to uracil and its subsequent mutagenicity.  
(A) Cytosine undergoes spontaneous hydrolysis and is deaminated to a uracil base. 
(B) If uracil bases persist into replication they will base pair with adenine resulting in 
transition mutations. 
 
 
  
A 
B 
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Whilst estimates of mutation rates are as low as 1.2 x 10-10 mutations/base pair/cell, a 
lot of this is attributable to post replication repair (Loeb, 1991). The main replicative 
enzymes, pol δ and pol ε, have inherent replication errors of 4.5 x 10-6 and 2 x 10-5 
mutations/base pair respectively (Schmitt et al., 2009; Shcherbakova and Pavlov, 
1996). Occasionally, polymerases will also insert or delete bases as a result of 
substrate misalignment.  Breakages in the DNA that are subsequently rejoined in an 
alternative arrangement can also lead to chromosomal rearrangements. One famous 
example includes the fusion gene created through a rearrangement of the BCR gene 
on chromosome 22 to chromosome 9 adjacent to the Abl1 gene to produce an 
elongated chromosome 9 known as the Philadelphia chromosome. This BCR-ABL 
gene fusion product is a highly oncogenic tyrosine kinase and is responsible for chronic 
myelogenous leukaemia and some forms of acute lymphoblastic leukaemia (Deininger 
et al., 2000). 
 
1.5 DNA Damage Repair 
Damaged DNA must be repaired to ensure cell viability. Cells that don’t repair their 
damage can become senescent, apoptotic or malignant (Bertram, 2000; Collado et al., 
2005). Defects in DNA repair pathways are the cause of a number of hereditary 
diseases, including ataxia-telangiectasia (AT) and xeroderma pigmentosum (XP). AT 
patients are unable to repair oxidative damage in the cerebellum, resulting in a 
degenerative motor condition and have a weakened immune system (Savitsky et al., 
1995). XP patients have defects in their UV repair pathway and show an increased 
sensitivity to UV light (Lehmann, 2003). The different types of DNA repair pathways will 
be discussed in this section, with an overview shown in Figure 1.12. 
 
1.5.1. Direct DNA Damage Reversal 
Methylation of guanine and damage by UV light are both known to be reversed directly 
by specialised enzymes known as O6-methylguanine-DNA-methyltransferase (MGMT) 
and photolyase respectively. Photorepair of UV damage caused by UV irradiation was 
first demonstrated in 1949; it was shown that cells rendered non-viable by UV 
irradiation that were then exposed to higher wavelength light (visible light) for longer 
periods of time showed a greater recovery to viability than those that were kept in the 
dark (Kelner, 1949).  This photoreactivation is a direct, high fidelity and energetically 
favourable method of reversing pyrimidine linkages to their monomeric form; 
photoreactivation is catalysed by an enzyme known as photolyase (Minato and Werbin, 
  
 
 
 
 
 
 
 
 
 
Figure 1.12. Cellular repair mechanisms of the damage caused to DNA.  
DNA is damaged through a wide variety of exogenous and endogenous chemicals and 
high-energy ionising radiation. The DNA becomes damaged in a number of different 
ways and these different types of damage are removed by specialised repair 
mechanisms including base excision repair (BER), nucleotide excision repair (NER), 
mismatch repair (MMR), double-strand break repair and direct reversal. Non-
homologous end-joining (NHEJ) and homologous recombination (HR) are two 
mechanisms through which double strand breaks are repaired. DNA damage that is 
unrepaired prior to genome replication undergoes DNA damage tolerance at the 
replication fork. 
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1972). These proteins are monomeric, and range between 53 and 66kDa, depending 
on the organism (G. B. Sancar, 1990). Photolyases can be found in fish, reptiles and 
marsupials, but appear to be absent in humans and other placental mammals. There 
are two related genes in humans (CRY genes) but encode blue light photoreceptors 
involved in setting circadian rhythms, not photoreactivation (Todo et al., 1996).  
 
Photolyases depend on the cofactor flavin adenine dinucleotide (FAD). The UV lesion 
is flipped out of the DNA enters a cleft in the protein between two helix bundles wthin 
which FAD is held in a ‘U-shaped’ conformation (Park et al., 1995). FAD causes a 
reductive cleavage, leading to the breaking of CPDs and (6-4)PPs (A. Sancar, 2003). 
FAD is a redox catalyst with the potential for one- and two- electron transfer reactions; 
it is a ubiquitous molecule and is involved in a number of metabolic processes. In its 
fully reduced form (i.e. catalytically active), FAD absorbs light in the blue (visible light) 
and near-UV ranges of visible light (G. B. Sancar, 1990). Additionally, a second 
cofactor with a large extinction coefficient acts as a photoantenna that absorbs light 
and, through resonant energy transfer to FAD, improves the reaction efficiency. 
Organisms that do not possess photoreactivation-capable enzymes must find an 
alternative method of tolerating UV damage. 
 
DNA methylated at position O6 (See Section 1.4.4.) can be repaired by MGMT. MGMT 
stoichiometrically repairs DNA adducts and self-inactivates, it is therefore a very energy 
rich mechanism of repairing methylation. MGMT operates by the transfer of the methyl 
group of the guanine-associated adduct to a cysteine residue in the catalytic cleft of the 
enzyme, thus restoring the DNA to its undamaged state (Kaina et al., 2007). 
 
1.5.2. Single Strand DNA Damage Repair 
In the case of DNA damage to nucleotides on a single strand of DNA, the DNA can be 
repaired using its complementary strand as a template. Three such mechanisms exist 
to remove damaged nucleotides and replace them with undamaged counterparts; these 
are base excision repair (BER), nucleotide excision repair (NER) and mismatch repair 
(MMR). 
 
BER is used to repair base lesions from reactive oxygen species, ionising radiation, 
some genotoxic chemicals and spontaneous deamination (Almeida and Sobol, 2007; 
Hitomi et al., 2007). Also, as AP sites and SSBs are formed as intermediates of the 
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BER pathway, the BER machinery can also repair these lesions. In BER, damaged 
bases are excised before strand incision, gap filling then ligation. 
 
Damaged bases distort the DNA helix and are recognised by specific DNA 
glycosylases. There are two types of DNA glycosylases: monofunctional glycosylases, 
which hydrolyse the glycosidic bond between the base and the deoxyribose sugar 
before allowing strand incision by AP endonuclease (APE1), and bifunctional 
glycosylases, which have their own AP lyase activity so can carry out strand incision 
(Hazra et al., 2007; Hitomi et al., 2007). XRCC1 interacts with glycosylases and acts as 
a scaffold to bring APE1 to the site of damage (Vidal, 2001). Pol β then performs repair 
synthesis to insert a base into the gap left by strand incision (Dianova et al., 2004). 
Finally, a complex formed through the binding of DNA ligase III to XRCC1 seals the 
DNA. 
 
Lesions that are refactory to short patch repair can undergo long patch BER. In long 
patch BER strand incision occurs as above then polymerases δ, ε, or β, combined with 
PCNA, poly(ADP-ribose) polymerase 1 (PARP1) and DNA Ligase I synthesis DNA to 
fill the gap and, in doing so, displace a DNA flap of up to 13 bases in length (Fortini et 
al., 1998; Gary, 1999; Prasad, 2001; Prasad et al., 2000; Stucki et al., 1998). FEN1 
then breaks down the resulting flap and DNA Ligase I ligates the DNA. 
 
Unlike BER, NER doesn’t have a set of specific enzymes that detect different lesions, 
rather the distortion caused in the backbone of DNA by lesions; consequently, NER 
recognises a huge range of DNA damage. NER is used to remove bulky DNA adducts 
such as those caused by BPDE, nitrosamines, crosslinking agents such as cis-platin, 
and UV lesions including CPDs and (6-4)PPs (Hess et al., 1997; Kuraoka et al., 2000; 
Pfeifer, 2008; Reardon et al., 1999). During NER, a damaged strand is identified and 
bound, before incision and removal of a stretch of the damaged DNA strand spanning 
the lesion and filling in of this stretch using replicative enzymes. NER proteins are 
named for their associations with hereditary diseases, the xeroderma pigmentosum 
group A-G proteins (XPA-G) and Cockayne Syndrome proteins A and B (CSA and 
CSB). 
 
NER begins through the preferential binding of XPC, along with HR23B and centrin2, to 
distorted DNA (Araki et al., 2001; Sugasawa et al., 1998). The DNA-damage binding 
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complex, composed of DDB1 and XPE, also binds damaged DNA and this step is more 
critical in the repair of damage that is not so distorting of the DNA e.g. CPDs (Tang and 
Chu, 2002). A multiprotein transcription and repair complex, transcription factor IIH 
(TFIIH) is then recruited to the damaged site at the XPC/HR23B/centrin2 complex 
(Volker et al., 2001). Subsequent recruitment of XPA and RPA prompts the detachment 
of the cyclin-dependent kinase-activating kinase (CAK) subcomplex of TFIIH. 
Detachment of CAK and the subsequent recruitment of XPG cause the unwinding of 
duplex DNA and release of XPC/HR23B/centrin2 (Coin et al., 2008). An XPF/ERCC1 
complex then cuts in the 5’ direction, and XPG cuts in a 3’ direction, to produce an 
ssDNA region of 24-32 nucleotides in length (J. C. Huang et al., 1992; Matsunaga et 
al., 1996; O'Donovan et al., 1994). The resulting gap is filled in by DNA polymerases δ 
or ε, PCNA and RPA and is ligated by either DNA ligase I or a complex of XRCC1 and 
Ligase III (Moser et al., 2007; Popanda and Thielmann, 1992; Shivji et al., 1992). 
 
NER can also be coupled with transcription. RNA polymerase II stalls when it reaches 
damaged DNA and recruits ATP-dependent chromatin remodelling factor CSB. CSB 
then recruits a number of additional factors including the p300 histone 
acetyltransferase TFIIH, RPA, a CSA-DDB1 complex and other core NER proteins prior 
to incision and gap-filling as above (Fousteri et al., 2006; Svejstrup, 2002). 
 
The MMR pathway can confer an additional 1000-fold level of fidelity to replication 
(Hsieh and Yamane, 2008). MMR begins through the recognition of mismatches; 
eukaryotic MutS homologues recognise DNA mismatch. MutS binds mismatched DNA 
with an affinity of between 10 and >1500 times higher than regular DNA (Gradia, 2000; 
Schofield et al., 2001). MMR is an ATP-dependent pathway and 2 MutS subunits in a 
heterodimer are required for ATPase activity (R. R. Iyer et al., 2006). This MutS 
heterodimer is joined by a heterodimer of eukaryotic MutL homologues to initiate MMR 
(R. R. Iyer et al., 2006). The DNA is then nicked either on either the 5’ or 3’ side of the 
mismatch and the DNA is excised in a bidirectional manner by exonuclease I and 
terminates at around 150 base pairs from the mismatch (Dzantiev et al., 2004; R. R. 
Iyer et al., 2006). RPA, RFC, PCNA and pol δ are then recruited to allow resynthesis in 
this region (R. R. Iyer et al., 2006). 
 
1.5.3. DNA Double Strand Break Repair 
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There are a number of DSB repair pathways including the non-homologous end-joining 
(NHEJ) and the homologous recombination (HR) pathways. Whilst NHEJ mediates the 
error-prone direct re-ligation of DNA DSBs and is not restricted to any particular cell 
cycle phases, the more error-averse HR requires a homologous template from the 
sister chromatid and is only active during the S and G2 phases, due to availability of 
the sister chromatids. 
 
NHEJ is initiated through the binding of a Ku heterodimer to the DSB (Mari et al., 2006; 
Walker et al., 2001). Ku is a ring-like structure that quickly associates to DSBs as a 
result of its high relative abundance and its high affinity for DNA ends (Km = 2.4 x 10-9 
M) (Blier et al., 1993; Mimori et al., 1986; Walker et al., 2001). Ku binds to the sugar-
phosphate backbone and, as such, is sequence independent (Walker et al., 2001). Ku 
then serves as a scaffold to recruit the other NHEJ proteins, including DNA-PKcs, X-
ray cross complementing protein 4 (XRCC4), DNA Ligase IV, XRCC4-like factor (XLF) 
and Aprataxin-and-PNK-like factor (APLF) to DSBs (Costantini et al., 2007; Grundy et 
al., 2013; Mari et al., 2006; Uematsu et al., 2007; Yano et al., 2007). XRCC4 interacts 
with Ku and forms superhelical filaments with XLF that are able to bridge broken DNA 
strands (Andres et al., 2012; Hammel et al., 2011).  
 
Once brought together, the two ends then require processing to make them ligatable. 
Aprataxin and polynucleotide kinase/phosphatase (PNKP) are involved in the removal 
of end-blocking groups (Ahel et al., 2006; Bernstein et al., 2005). APLF, Werner and 
artemis are all proteins responsible for the resection of DNA ends (Kanno et al., 2007; 
Kusumoto et al., 2008; Perry et al., 2006; Povirk et al., 2007). Any gaps that need filling 
are performed by the family X polymerases μ and λ (Nick McElhinny et al., 2005). All of 
these processing enzymes bind to the Ku/XRCC4 scaffold. The final step in NHEJ is 
the ligation of the broken ends by DNA ligase IV (Grawunder et al., 1997). 
Ubiquitination of Ku then mediates its dissociation from the now-continuous DNA 
strand (Feng and J. Chen, 2012). By virtue of its inherent propensity for generation of 
mutations, NHEJ is also used in V(D)J recombination, the mechanism used to create a 
diverse collection of T and B cells (Reviewed in (Malu et al., 2012)). Unlike homolgous 
recombination, NHEJ is utilised across all three domains of life, including bacteria and 
archaea, as well as the eukaryotic mechanism described here (Bartlett et al., 2013; 
Della et al., 2004; G. R. Weller et al., 2002). 
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HR is used for the restoration of DSBs and removal of interstrand crosslinks, as well as 
being vital for telomere maintenance, chromosome segregation and maintaining the 
karyotype in meiosis. Mutations in the HR enzymes cause extreme sensitivity to 
ionising radiation in S. cerevisiae and, in humans, can cause heritable diseases such 
as Fanconi anaemia, a cancer-prone disease, and familial breast cancer (Game and 
Mortimer, 1974; Kennedy and D'Andrea, 2006).  
 
Homologous recombination is stimulated by the production of a DSB and is initiated 
through the binding of the MRN (Mre11, Rad50, Nbs1) complex either side of the break 
(van den Bosch et al., 2003). The ends are subsequently resected by nucleases, CtlP, 
and Dna2 in concert with the BLM helicase to give ssDNA tails with 3’-OH ends 
(Mimitou and Symington, 2009). DNA pairing and strand exchange is then carried out 
by the Rad51 recombinase; this process is stimulated by Rad52 and RPA (New et al., 
1998). Rad51 is an essential gene that exists as a homohexamer in cells; it assembles 
onto ssDNA to form helical presynaptic filaments, assisted by BRCA2 (X. Yang et al., 
2005). The presynaptic filament then binds and stretches a duplex DNA molecule at 
random points to search for homology (Klapstein et al., 2004). Once homology is 
found, strand invasion occurs and the presynaptic filament becomes topologically 
intertwined with the duplex DNA, in the process creating a displacement loop (D Loop).  
 
Following strand invasion, HR can take one of two distinct routes – double strand break 
repair (DSBR) and synthesis-dependent strand annealing (SDSA) (Helleday et al., 
2007). In DSBR, the second DSB end is then captured through annealing to the 
extended D loop and a double Holliday junction is formed. The resolution of the 
Holliday junction through the action of nicking endonucleases results in both crossover 
and non-crossover products (Helleday et al., 2007). In SDSA, however, there is no 
association with crossover products. The SDSA invading 3’ strand is extended by a 
DNA polymerase and then released from the D-loop. This strand is then able to anneal 
to the second end of the DSB and can be ligated following processing (Helleday et al., 
2007). 
 
1.6 DNA Damage Tolerance 
The replication fork proceeds at a very high fidelity and processivity, it needs to if it is to 
faithfully replicate all 3 billion base pairs of the human genome. However, there is a flip 
side to this intricate replication machinery in that it is very sensitive to damage on the 
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template it is copying. If DNA damage persists into S phase, the replication fork will 
stall at these lesions. DNA damage tolerance mechanisms exist to bypass these 
lesions during S phase. There are three major types of DNA damage tolerance 
mechanisms and these include firing of dormant origins downstream of the lesion, 
recombination-mediated restart and template switching, and Y or B family polymerase-
mediated translesion DNA synthesis (TLS) using specialised polymerases (Figure 
1.13). 
 
Replication origins initiate a pair of bidirectional forks when they fire. If one of a pair of 
converging forks stalls at a DNA lesion, the second incoming fork can compensate this. 
However, if both of a pair of replication forks stall at separate DNA damage sites, the 
intervening DNA is not replicated. As discussed in Section 1.2.1., not all origins are 
fired in a round of DNA replication, many lie unused or ‘dormant’. Although origins are 
licensed before S phase, if two adjacent forks have stalled then the cell is able to 
licence additional forks that were previously dormant (Blow et al., 2011). Whilst the 
regulation of this mechanism remains unknown one hypothesis is that the ataxia 
telangiectasia and Rad3-related kinase (ATR), which is activated at stalled forks, can 
phosphorylate the MCM helicase to promote the initiation of dormant origins (Blow et 
al., 2011). 
 
Replication can be restarted by a recombination-mediated mechanism, promoted by 
DNA helicases such as Bloom syndrome helicase or Werner syndrome ATP-
dependent helicase (Machwe et al., 2006). This involves a fork regression after the 
replication machinery has stalled, forming a so-called ‘chicken foot’ Holliday junction 
structure, followed by one of three proposed mechanisms (Petermann and Helleday, 
2010). Firstly the double-stranded DNA end of the chicken foot Holliday junction can 
undergo strand invasion back into the template DNA to form a D loop with the 
assistance of Rad51 (Petermann et al., 2010). This D loop allows re-loading of the 
replication machinery but a double Holliday junction structure is formed, this structure 
then requires dissolution, which avoids recombination products being generated 
(Petermann and Helleday, 2010). If stalling persists for an extended period, the 
replication fork collapses and fork-associated double-strand breaks can be generated 
by the crossover junction endonuclease MUS81-EME1 through cleavage of the chicken 
foot Holliday junction (Hanada et al., 2007; 2006). This can then be restored by 
homologous recombination and a new replication fork can be begun by dormant origin 
  
 
Figure 1.13: DNA damage tolerance mechanisms.  
Cells harbour a number of mechanisms for tolerating DNA damage during replication. These include the bypass of lesions by specialised DNA 
polymerases known as translesion DNA synthesis (TLS); a mechanism of recombination-mediated restart following the production of DNA in a 
‘chicken foot’ structure; and the firing of a downstream dormant origin.  
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firing in order to replicate the intermediate DNA (Petermann and Helleday, 2010). 
Finally, it has been proposed that restart could occur through fork remodelling; this 
would include the reversal or degradation of the chicken foot Holliday junction 
(Petermann and Helleday, 2010). However, fork restart by remodelling would require 
dissociation of the replication machinery and the machinery would need to be loaded 
back onto the DNA and it remains unclear how this would occur. 
 
TLS involves the use of specialised, low-fidelity polymerases that can extend nascent 
DNA chains over damaged DNA bases. TLS polymerases include pols η, ι, κ and 
REV1 from the Y family, pol μ from the X family and pol ζ from the B family of 
polymerases (Hübscher and Maga, 2011). These polymerases maintain little sequence 
homology with replicative polymerases, however they share a similar overall structure. 
Like replicative polymerases, these TLS polymerases’ catalytic domains resemble a 
right hand in topology, with fingers, thumb and palm domains (Biertümpfel et al., 2010; 
Ling et al., 2001). In contrast, unlike replicative polymerases, they have a larger active 
site capable of accommodating bulky adducts. Some also contain a little finger domain, 
responsible for making DNA contacts close to the site of the lesion. As a different 
polymerase is required to replicate through the lesions, there must exist a mechanism 
for switching the polymerases from the replicative polymerase to the lower-fidelity TLS 
polymerases. There are two essential mechanisms for the regulation of TLS, one of 
which occurs during replication and requires the non-catalytic function of REV1 and 
one which occurs postreplicatively and requires the monoubiquitination of PCNA. 
 
Following UV irradiation, the processivity factor PCNA becomes ubiquitinated and this 
ubiquitination linkage is formed via Lys-63, rather than the more common Lys-48 
ubquitin linkage that directs proteins for degradation (Hoege et al., 2002; Kannouche et 
al., 2004). Specialised ubiquitin binding domains on TLS polymerases (UBM or UBZ 
domains) increase their affinity for ubiquitinated PCNA (Lehmann et al., 2007). The 
current prevalent theory for which polymerase is chosen is that the polymerase is 
selected by mass action, if ubiquitinated PCNA is located at a lesion, one of the TLS 
polymerases will bind and attempt to bypass the lesion and subsequently, if unable to 
do so, another polymerase will attempt to bypass the lesion (Lehmann et al., 2007). As 
REV1 is able to interact with all of the other TLS polymerases, combined with the fact 
that removal of its dCMP transferase activity does not abrogate its requirement in yeast 
for UV-induced mutagenesis, this suggests REV1 may have an additional role in acting 
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as a scaffold for other TLS polymerases and allowing switching between the two, 
allowing one polymerase to insert nucleotides opposite a lesion and a second 
polymerase to extend from such insertion (Friedberg et al., 2005). As TLS often results 
in mismatches, it may be that the initial TLS polymerase cannot extend from the base it 
has inserted and it may require pol ζ, which can extend from mismatches to 
subsequently elongate the chain following insertion opposite the lesion (Acharya et al., 
2006). It remains unclear whether PCNA becomes de-ubiquitinated following 
translesion DNA synthesis and further work is required to establish whether this is the 
mechanism for regulation of TLS following lesion bypass (Friedberg et al., 2005; Liang 
et al., 2014). 
 
1.6.1. DNA Damage Tolerance in the Mitochondria 
The mitochondrial matrix is a highly oxidative environment. Consequently, the level of 
oxidative DNA damage, such as 8-oxo-G, as well as AP sites is often high in the 
mitochondria. Whilst less critical than replication of the nuclear genome due to the 
mitochondria having multiple DNA copies, it remains important to maintain the 
mitochondrial genetic code as mutations are associated with aging (Rose et al., 2010). 
The replicative polymerase of mitochondria, pol γ (see Section 1.2.5) is hindered by 
most forms of DNA damage.  Pol γ deals poorly with 8-oxo-G moieties, and this lesion 
forms an impediment to DNA replication by pol γ (Garcia-Gomez et al., 2013; 
Graziewicz et al., 2007). In the case of AP sites, pol γ does show significant inhibition, 
but is able to incorporate an adenine opposite an abasic site (Garcia-Gomez et al., 
2013; Pinz et al., 1995). Pol γ is inhibited by UV lesions such as CPDs; however exo-
deficient pol γ is able to bypass these lesions with low efficiency, choosing to insert 
guanine opposite the 3’-thymine of the CPD (Kasiviswanathan et al., 2012). In 2006, 
Zhang and colleagues indicated that REV mutant strains of S. cerevisiae exhibited a 
reduction in UV-induced frameshifts in the mitochondria (H. Zhang et al., 2006). 
Additionally, this group also showed that the N-termini of REV1 and Pol ζ were capable 
of directing GFP to the mitochondria (H. Zhang et al., 2006). Taken together, along with 
more recent evidence that REV-deficient strains of S. cerevisiae result in a 20-fold 
increase in UV-induced mitochondrial point mutations (Kalifa and Sia, 2007), suggests 
that there is also an alternative pathway of DNA damage tolerance in mitochondria to 
bypass UV lesions involving REV1 and Pol ζ.  
 
1.7 DNA Primases 
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As previously remarked, DNA polymerases, the proteins that carry out the bulk of DNA 
replication, are unable to initiate the de novo polymer synthesis reaction. As early 
studies could find no evidence that DNA strands were initiated by DNA polymerases, 
Kornberg and colleagues postulated that DNA replication initiation required RNA 
transcription (Brutlag et al., 1971). This two-step mechanism of replication was then 
confirmed the next year: the first step requires a ssDNA template, ribonucleotides 
(rNTPs), and enzymes in a reaction that is rifampicin-sensitive; this is followed by a 
second step that requires dNTPs and enzymes in a rifampicin-resistant reaction 
(Wickner et al., 1972). This first step became known as ‘priming’. Soon after, the first 
enzyme capable of priming, later to come known by the term ‘primase’, was discovered 
in E. coli as the product of the dnaG gene (Bouché et al., 1975).  
 
For decades, the perception of primases existed as specialised DNA-dependent RNA 
polymerases that were involved in replication initiation. However, more recently a body 
of evidence has established that primases actually represent a much broader and 
functionally diverse family of polymerases with a variety of nucleotidyl transferase 
activities and this will be discussed further in this section. 
 
1.7.1. Evolution of DNA Primases 
A number of mechanisms have evolved for the generation of primers (see Table 1.2), 
but the overwhelming majority of systems utilise the specialised DNA primases to 
produce short de novo nucleotide strands opposite a templating strand that can 
subsequently be extended by DNA polymerases (Frick and Richardson, 2001). The 
characteristics of archaeal genomes are similar to that of bacteria: they arrange their 
genes into operons, their DNA is not contained in a nucleus, chromosomes are circular 
and nearly all their mRNAs lack introns. However, the DNA replication machinery of 
archaea distinctly resembles eukaryotes more than bacteria (Edgell and Doolittle, 
1997) and this extends to DNA primases. Primases are differentiated on the basis of 
their structural features, whether they contain an archaeal/eukaryotic fold (L. M. Iyer et 
al., 2005) or a toprim architecture found in bacterial and phage primases, such as 
DnaG (Aravind et al., 1998). The superfamily of proteins that contain an 
archaeal/eukaryotic fold are known as archaeo-eukaryotic primases, or AEPs. This 
pattern of little or no homology between the achaeal/eukaryotic and bacterial primases 
extends to other replicative proteins of these domains, including polymerases and 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.2: Mechanisms of generating primers.  
As polymerases are unable to synthesis de novo nucleotide polymer strands, different 
mechanisms have evolved in order to provide a free 3’-hydroxyl for polymerases to 
extend from using deoxyribonucleotides to initiate DNA replication. 
Mechanism of Priming Utilised In 
An endogenous host tRNA is used as a 
primer for converting the RNA genome 
into DNA (Mak and Kleiman, 1997).  
Retroviruses 
 
Instead of using a specialised primase, 
the mitochondrial RNA Polymerase 
produces short RNA transcripts that are 
then elongated by pol γ (Pham et al., 
2006).  
 
Mitochondria 
 
A serine from the terminal protein forms 
a phosphodiester bond with dCMP at 
the 5’ side of the dCMP, which can be 
elongated at its 3’ side by DNA 
polymerase (Pronk and van der Vliet, 
1993).  
 
Adenovirus 
 
Rolling circle replication (RCR) is 
utilised by a number of DNA viruses. 
RCR endonuclease nicks one of the 
DNA strands. The free 3’-OH is 
elongated by a DNA polymerase whilst 
the 5’end of the nicked strand is 
transferred onto a tyrosine residue of 
the nuclease (Noirot-Gros and Ehrlich, 
1996).  
Several DNA virus families 
(including parvoviruses, 
geminiviruses and circoviruses) 
(Ilyina and Koonin, 1992)  
A specialised enzyme, known as a 
primase, is utilised to produce de novo 
nucleotide strands opposite a template 
strand at an initiation site (Frick and 
Richardson, 2001).  
-All other known systems 
including all cellular systems  
 
 27 
helicases (Edgell and Doolittle, 1997). There are two major theories as to why there are 
two distinct groups of replication proteins (Figures 1.14-1.15). 
 
The first model suggests that, as a result of divergence of sequence but convergence 
of function, DNA replication, or at least the enzymes involved in nascent strand 
production, may have evolved twice independently (Leipe et al., 1999) (Figure 1.14). 
Despite the replicative machinery proteins of bacteria and archaea/eukaryotes being 
highly divergent, the core components of the transcription and translation machinery 
including DNA ligases, PCNA, RNAse HII, clamp-loaders, the DNA-dependent RNA 
polymerase etc are conserved across domains (Leipe et al., 1999; Sweetser et al., 
1987). Leipe, Aravind and Koonin hypothesise that the two replicative systems evolved 
independently from a common ancestor that carried out reverse transcription to 
replicate an RNA/DNA genome (Leipe et al., 1999). Reverse transcription is the 
process by which an RNA genome would be reverse-transcribed into an RNA/DNA 
heteroduplex, the RNA strand would then be degraded by a protein with RNase H 
nuclease activity and the resulting single-stranded DNA would act as a template for the 
synthesis of the double stranded DNA; RNA would then subsequently be transcribed 
by a DNA-dependent RNA polymerase for protein production. Following the evolution 
of DNA replication-competent cells, selective pressure would result in the elimination of 
the reverse transcription pathway. This is supported by the evidence that a number of 
primases and polymerases inherently, or can be modified to, exhibit reverse 
transcriptase activity (Gill et al., 2014; Jozwiakowski and Connolly, 2011; Myers and 
Gelfand, 1991; Ong et al., 2006). This model suggests that the transcription in this last 
universal common ancestor would occur more directly using the RNA/DNA genome 
and, as such, this would account for the conservation of core components of the 
transcription and translation machinery between archaea/eukaryotes and bacteria. 
There remains a number of reverse transcribing genetic elements including, for 
example, reverse transcriptases but they are not necessarily indispensible for viability 
(Greider and Blackburn, 1989).  
 
A second model suggests that the last universal common ancestor employed a dual-
primase system (Hu et al., 2012)(Figure 1.15), consisting of both an AEP and a toprim 
primase. These two groups of primases have both been described in both bacteria 
(Koonin et al., 2000) and in archaea (Zuo et al., 2010). In addition to a dual-primase 
role in replication, the AEP and toprim primases could have served roles in NHEJ 
  
 
Figure 1.14. Evolution of primases (1).  
The first model of primase evolution suggests that primases evolved twice independently from a last universal common ancestor (LUCA). 
Bacterial ancestors evolved toprim primases and archaeal and eukaryotic ancestors evolved AEP primases.  Subsequent horizontal gene 
transfer occurred between the two lineages to account for AEP primase’s role in NHEJ in bacteria and toprim-type primase’s role in archaeal 
RNA degradation. 
  
Figure 1.15. Evolution of primases (2).  
The second model of primase evolution suggests that the last universal common ancestor (LUCA) had a dual primase replication mechanism, 
consisting of both AEP and toprim primases. During the evolution of bacteria, they lost the replicative function of the AEP primases but retained 
them for the auxiliary function of NHEJ. During the evolution of the archaeal/eukaryotic lineage, the replicative function of toprim primases were 
lost, but their auxiliary role in archaeal RNA degradation was retained. 
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processes and RNA degradation respectively in the last universal common ancestor. In 
bacteria selective pressure resulted in the loss of AEPs as replicative primases but 
retained for their role in NHEJ (Della et al., 2004; G. R. Weller and A. J. Doherty, 2001) 
and in archaea toprim primases were lost as a replicative primase, but still retained for 
their non-essential role in RNA degradation (Le Breton et al., 2007; Walter et al., 2006). 
This model predicts that, in eukarya, toprim primases are lost and other proteins have 
evolved to take its place (Hu et al., 2012). 
 
An alternative scenario to these two models could be that the DNA replication 
machinery of a common ancestor underwent dramatic evolutionary events to cause the 
dissimilarity in core replicative proteins under unknown, but serious and distinct, 
evolutionary pressures (Figure 1.16). 
 
1.7.2 The Archaeo-Eukaryotic Primase (AEP) Superfamily of 
Proteins 
Archaeo-Eukaryotic Primases (AEPs) share a catalytic core of an (αβ)2 unit that has no 
equivalent structure to any other proteins of the PDB database. This catalytic core 
harbours three conserved motifs (motifs I, II and III), namely an hhhDhD/E motif (where 
‘h’ is a hydrophobic residue), an sxH motif (where ‘s’ is a small residue and ‘x’ is any 
residue) and an hD/E motif (Figure 1.17) (L. M. Iyer et al., 2005). The first and third of 
these motifs are involved in metal coordination for catalysis; despite divergent 
sequences in the scaffolds of polymerases and primases, they share a common two 
metal mode of catalysis (see Section 1.3.2) and the metal ion coordinating core of pol β 
is superimposable to that of the replicative primase (Augustin et al., 2001; Lao-Sirieix et 
al., 2005; Lipps et al., 2004). The sxH motif is required for nucleotide binding. Multiple 
mutagenesis studies have shown these motifs to be essential for catalysis (Augustin et 
al., 2001; Bianchi et al., 2013; Copeland and Tan, 1995; Della et al., 2004; Galal et al., 
2012b; Klinedinst and Challberg, 1994; Lao-Sirieix and S. D. Bell, 2004; Lipps et al., 
2003; Mikhailov and Rohrmann, 2002). Almost all primases also have zinc-binding 
motifs that are required for catalysis and exceptions to this will be discussed later in 
this section. In addition to the AEP polymerase domain, some AEPs have a number of 
associated domains, including zinc-binding domains and helicase domains, these are 
illustrated in Figure 1.18. 
 
  
 
 
Figure 1.16. Evolution of primases (3).  
The third model of primase evolution suggests that the last universal common ancestor (LUCA) had either an AEP or toprim-like primase. 
Significant, unknown evolutionary pressures could then have driven whichever type of primase was present to the other type. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17. Conserved motifs of the AEP superfamily.  
The AEP superfamily is formed of three conserved motifs. The first motif is a hhhDhD/E, where ‘h’ is a hydrophobic residue. The second motif 
is an sxH motif, where ‘s’ is a small residue and ‘h’ is any residue. The third motif is an hD/E motif. The first and third motifs are responsible for 
metal ion binding in catalysis and the second motif is responsible for nucleotide binding.  
  
  
 
Figure 1.18. Domain organisation of different families of the AEP superfamily.  
The AEP superfamily is formed of a number of divergent families with different domain organisations. The three motifs of the AEP polymerase 
domain are depicted (red) along with any accessory domains of examples of each of these biochemically-characterised families. The blue, red, 
green and purple backgrounds correspond to the domain of life in which the primase family is found.  
 
 29 
There is currently no structural information for the initiation step of any AEPs therefore 
the exact mechanism of primase activity remains unclear. The current proposition is 
that a quarternary complex is formed of primase, DNA template and two nucleoside 
triphosphates; the primase in this case has two incoming nucleotide binding sites (Frick 
and Richardson, 2001). However, the recent structure of the RNA-dependent RNA 
polymerase from the Hepatitis C virus may help shed some light on the mechanism 
proteins use to form dinucleotides and extend from this structure (Appleby et al., 2015). 
These polymerases are the viral replicative polymerases and, unlike other replicative 
polymerases, are capable of both de novo polymer synthesis and primer extension. A 
β-loop insertion in the thumb domain of the polymerase acts as a priming platform to 
buttress the initial priming nucleotide and allow the formation of a dinucleotide. 
Following this initial step, the β-loop recedes from the catalytic core of the polymerase, 
supporting and guiding the nascent RNA chain along through an exit channel. 
 
As previously mentioned, there is a growing body of evidence that primases, 
particularly those of the AEP superfamily, have a range of nucleotidyl transferase 
activities, these are described in the upcoming sections and are summarised in Figure 
1.19 and Table 1.3. 
 
1.7.2.1. Eukaryotic AEP Primases 
Primase activity in eukaryotes was first associated with the polymerase α complex as 
early as 1982 (Conaway and Lehman, 1982b). Pol α consists of a 180 kDa subunit, 
responsible for the DNA polymerase activity of the complex, a 70 kDa subunit, with no 
catalytic functions, and two subunits of 49 kDa (Prim1/PriS) and 58  kDa (Prim2/PriL) 
(T. S. F. Wang, 1991). PriS alone has primer extension activities using ribonucleotides 
but requires PriL for efficient priming activity (Copeland and T. S. Wang, 1993). The 
average length of the primers produced by pol α range between 8 and 15 nucleotides 
(Brooks and Dumas, 1989; Conaway and Lehman, 1982a; T. S. Wang et al., 1984). 
The primase activity of pol α is of moderate fidelity but this can be reduced through the 
addition of manganese (Kirk and Kuchta, 1999a). PriL is predicted to be important for 
the dinucleotide synthesis and translocation activities of the primase as well as 
regulation of the length of the elongation products of the primase complex (termed 
‘counting’) of pol α (Arezi et al., 1999; Zerbe and Kuchta, 2002). This PriL subunit, in 
higher eukaryotes, also contains an iron-sulphur cluster that is indespensible for 
primase activity in its C-terminal region (Klinge et al., 2007; Vaithiyalingam et al., 2010; 
  
 
Figure 1.19. Nucleotidyl transferase activities reported in AEP primase-polymerases.  
AEP primases have more activities than priming DNA for replication. The reported additional nucleotidyl transferase activities for different AEPs 
are depicted including polymerase activity (either DNA-dependent DNA polymerase or DNA-dependent RNA polymerase), lesion bypass, 
terminal transferase and strand displacement. See Table 1.3 for examples of which primases have been shown to have the activities described 
above. 
  
  
 
 
References: 1. Brooks and Dumas, 1989; 2.  Conaway and Lehman, 1982; 3. Copeland and Wang, 1993; 4. Bianchi et al., 2013; 5. Garcia-Gomez et al., 2013; 6. Keen et al., 
2014; 7. Hines and Ray, 2010; 8. Hines and Ray, 2011; 9. Desogus et al., 1999; 10. Liu et al., 2001; 11. De Falco et al., 2004; 12. Le Breton et al., 2007; 13. Hu et al., 2012; 
14. Jozwiakowski et al., 2014; 15. Bartlett et al. 2013; 16. Lipps et al., 2003; 17. Prato et al., 2008; 18. Gill et al., 2014; 19. Della et al., 2004; 20. Pitcher et al., 2005; 21. Gong 
et al., 2005; 22. Pitcher et al., 2007; 23. Takechi and Itoh, 1995; 24. Takechi et al., 1995; 25. Sanchez-Berrondo et al., 2012; 26. Crute and Lehmann,1991; 27. Klinedinst and 
Challberg, 1994; 28.Mikhailov and Rohrmann, 2002; 29. De Silva et al., 2009;  30. Halgasova et al., 2012. 
 
 
Table 1.3. Nucleotidyl transferase activities of biochemically characterised AEPs.  
The reported nucleotidyl transferase activities from Figure 1.18 for AEPs that have been biochemically characterised. It should be noted that the 
primases listed here have not necessarily been tested for all of these activities. 
Domain Protein Family Primase Polymerase Lesion 
Bypass 
Terminal 
Transferase 
Strand 
Displacement 
References 
Eukarya PriS/Prim1 ✔ ✔    1-3 
Eukarya PrimPol ✔ ✔ ✔ ✔  4-6 
Eukarya PRI1/2 ✔     7-8 
Archaea PriS ✔ ✔ ✔ ✔ ✔ 9-14 
Archaea NHEJ Pol  ✔  ✔ ✔ 15 
Archaea prim-pol 
(ORF904/Rep) 
✔ ✔  ✔  16-17 
Archaea PolpTN2 ✔ ✔    18 
Bacteria LigD ✔ ✔ ✔ ✔ ✔ 19-22 
Bacteria ColE2 Rep ✔     23-24 
Bacteria BcMCM ✔ ✔    25 
Viral UL52 ✔     26-27 
Viral Lef-1 ✔ ✔    28 
Viral D5 ✔ ✔    29 
Viral 
(phage) 
gp43 ✔ ✔    30 
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Weiner et al., 2007); this motif remains absent from the archaeal proteins that have 
thus far been investigated. The crystal structure of this iron-sulphur cluster reveals that 
this motif is integral to the structure of PriL and contributes to the C-terminal region’s 
binding to primer-template DNA (Vaithiyalingam et al., 2010). However, given the 
complexity of an iron-sulphur cluster it is unlikely that the role of this motif has evolved 
as a purely structural one and it may have additional uncharacterised biochemical 
activities; it has recently been reported to have an undefined role in the loading of the 
polymerase complex at replication origins, and that pol α loading is affected by the 
redox state of the cell (L. Liu and M. Huang, 2015). It should also be noted that iron-
sulphur clusters, whilst their biochemical activities remain largely unknown, are present 
in other DNA processing proteins of DNA repair pathways such as DNA glycosylases 
of BER and DNA helicases of NER and have been suggested to harbour the ability to 
discern damaged DNA (Fan et al., 2008; Lukianova and David, 2005). 
 
Recently, a second family of primases was discovered in higher eukaryotes, Primase-
Polymerase (PrimPol). This primase is introduced extensively in Section 1.8 and is the 
main topic of this thesis. 
 
1.7.2.2. Archaeal AEPs 
Unlike the eukaryotic replicative primase, whose activities are limited to priming and 
primer extension using ribonucleotides, AEPs of the archaeal domain have an array of 
activities (Bocquier et al., 2001). The first archaeal primase to be described 
biochemically was the replicative PriS-like primase from the euryarchaeon 
Methanococcus jannaschii (Desogus et al., 1999). This primase showed the ability to 
prime opposite homopyrimidine ssDNA templates poly(dT) and poly(dC) (Desogus et 
al., 1999). 
 
This initial characterisation only looked at the ribonucleotide priming activity opposite 
DNA templates. Subsequent investigations into the deoxyribonucleotide priming activity 
of a range of archaeal primases has revealed that these proteins are actually capable 
of producing DNA primers with varying efficiency. The primase from Thermococcus 
kodakaraensis preferentially primes using rNTPs, with a binding constant about 2-4 fold 
lower than dNTPs (Galal et al., 2012b). However, this is the only replicative archaeal 
primase reported to preferentially incorporate rNTPs; Pyrococcus abyssi had binding 
constants for rNTPs and dNTPs in the same range (Le Breton et al., 2007), but 
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primases from other archaeal species Pyrococcus horikoshii, Solfolobus solfataricus 
and Pyrococcus furiosus all have a preference for priming using dNTPs over rNTPs 
(Lao-Sirieix and S. D. Bell, 2004; L. Liu et al., 2001; Matsui et al., 2003). 
 
Unlike the replicative primase of pol α, archaeal primases are capable of efficiently 
extending primers using both rNTPs and dNTPs, with a marked preference for dNTPs. 
These DNA primer extension products can range in size from less than 500 bases in 
length to over 7 kilobases (Bocquier et al., 2001; Galal et al., 2012b; Lao-Sirieix and S. 
D. Bell, 2004; Le Breton et al., 2007; L. Liu et al., 2001). This has lead to the 
suggestion that not only do these replicative primases act as the PriS/L primase of pol 
α but also the 180 kDa polymerase subunit of pol α (L. Liu et al., 2001); instead of 
undergoing a mechanism in which the initial primer is handed over to a separate 
subunit in which pol α polymerase activity can then extend from this short primer before 
a replicative polymerase takes over, the primers produced by these primases are 
sufficient for archaeal replicative polymerases to extend. This DNA polymerase activity 
of many AEPs has lead to the recommendation that AEPs should be identified as 
primase-polymerases. 
 
The primases from M. jannaschii and S. solfataricus have both been shown to be 
capable of terminal nucleotidyl transferase activity at the 3’ end of synthetic 
oligonucleotides in the presence of manganese (De Falco et al., 2004; Lao-Sirieix and 
S. D. Bell, 2004). This terminal transferase activity allows archaeal primases to 
undergo template-dependent polymerisation across discontinuous templates (Hu et al., 
2012). Consequently, it is proposed that these primases could serve a role in double-
strand break repair in archaea. The evidence that Pyrococcus abyssi has strand-
displacement and gap-filling activities reinforces this notion that archaeal replicative 
primases could have a function in archaeal DNA damage repair (Le Breton et al., 
2007). Given that archaea lack family X polymerases, that pols β and λ also possess 
strand-displacement and gap-filling activities, and that the family X polymerases are 
related to primase (see Section 1.7.2.1) it is not implausible that archaeal replicative 
primases could have a role in DNA damage repair.  
 
Whereas some archaeal species possess the Y family polymerase paralogue Dpo4, 
many do not have any Y family polymerases (Kelman and White, 2005). Two such 
species lacking Dpo4 are Archaeoglobus fulgidus and P. furiosus, it has recently been 
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shown through work from our lab that the replicative primases from these species are 
DNA damage tolerant (Jozwiakowski et al., 2015). A well-documented feature of 
archaeal replicative polymerases is their ability to discern, and stall at, uracil base 
adducts (Fogg et al., 2002) caused by the deamination of cytosine (see Section 1.4.5). 
This cytosine deamination is particularly relevant in the extreme conditions faced by 
some of the thermophilic as it is a process that is considerably sped up by heat 
(Lindahl and Nyberg, 1974). The primases of A. fulgidus and P. furiosus are both 
capable of replication through uracil bases and can rescue a replicative polymerase 
bound to PCNA stalled at a uracil base (Jozwiakowski et al., 2015). Additionally, these 
primases were also capable of bypass of an 8-oxo-G oxidative lesion (Jozwiakowski et 
al., 2015). Somewhat surprisingly, both of these archaeal primases were also capable 
of the error-free bypass of CPDs, inserting two adenines opposite the two thymines of 
this distortive UV lesion. 
 
Linked with this inherent tolerance of archaeal DNA primases is a curious finding 
regarding the T. kodakaraensis replicative primase. Independent of a DNA template, 
the primase from T. kodakaraensis was able to produce discrete bands that migrated to 
corresponding chain lengths of around 16 and 25 nucleotides (Galal et al., 2012b). 
NMR and LC-MS/MS analysis revealed these products to be dNMP-Tris and dNMP-
glycerol adducts (Galal et al., 2012a). Frick and Richardson propose a model for 
synthesis of primers that involves 2 binding sites for NTPs, one initiation site that 
accommodates the 5’ nucleotide and one elongation site that accommodates the 3’ 
nucleotide triphosphate (Frick and Richardson, 2001). In this case it is predicted that 
tris or glycerol is in the 5’ nucleotide site, with the incoming dNTP in the 3’ site (Galal et 
al., 2012a). Although not identified as the same products, similar-sized products were 
evident in activity tests from another AEP, PolpTN2 (see Section 1.7.2.3) (Gill et al., 
2014). These dNMP-Tris and dNMP-glycerol products represent a highly tolerant active 
site of archaeal AEPs. 
 
1.7.2.3. NHEJ AEP polymerases 
Bacterial homologues of PriS were identified through a thorough bioinformatics search 
(Koonin et al., 2000; G. R. Weller et al., 2002; G. R. Weller and A. J. Doherty, 2001). A 
subsequent bioinformatics study, exploring homology of ku in bacteria identified that 
bacterial homologues of ku were either operonic with, or located close to, these 
bacterial homologues of PriS, suggesting a novel family of end-joining proteins (Aravind 
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and Koonin, 2001). A subsequent biochemical analysis of these proteins, designated 
LigD, revealed that they are indeed involved in NHEJ in bacteria and consist of a ligase 
domain, nuclease domain and an AEP primase-polymerase domain (PolDom/LigD Pol) 
(Della et al., 2004; G. R. Weller et al., 2002; G. R. Weller and A. J. Doherty, 2001).  
This represents the first evidence that AEPs may have additional roles to replication of 
DNA and expanded on the capabilities of these proteins. 
 
PolDom has an array of nucleotidyl transferase activities and can perform extension of 
primers in a template-dependent manner using both DNA and RNA, as well as having 
gap-filling, strand displacement, TLS, and terminal transferase activities (Della et al., 
2004; Gong et al., 2005; Pitcher et al., 2007; 2005; H. Zhu et al., 2006). However, 
unlike replicative AEPs, PolDom is incapable of producing a de novo primer from single 
nucleotides opposite a DNA template (Brissett et al., 2011). The crystal structure of the 
DNA synaptic complex of Mycobacterium tuberculosis PolDom revealed that PolDom 
mediates the synapsis of DNA ends that are not necessarily compatible through a 
variety of interactions, including microhomology base pairing, base mismatches and 
flipped out bases to form a stable end-joining complex (Brissett et al., 2007).  
 
Recently, an NHEJ repair complex from the archaeon Methanocella paludicola was 
reconstituted in vitro (Bartlett et al., 2013). The proteins of this repair complex has 
activities consistent with their prokaryotic equivalents (Bartlett et al., 2013) and this 
complex has been hypothesised in a range of euryachaeota, but appears absent in the 
other main group of archaea, crenarchaeota (Nair et al., 2010). The polymerase (Pol) 
subunit of this complex is an AEP polymerase capable of gap-filling and strand-
displacement with a marked preference for rNTPs over dNTPs. The structure of this 
polymerase is similar to the prokaryotic NHEJ AEPs (Bartlett et al., unpublished). 
 
Although eukaryotes do not appear to contain specialised AEP polymerases for NHEJ, 
as is the case in archaea or bacteria, they do share a sequence similarity with the 
family X polymerases, particularly pol β, both in the catalytic and regulatory regions of 
these proteins (Kirk and Kuchta, 1999b)(Figure 1.20). Also, despite having a unique 
structural arrangement, the family X polymerases are superimposable at their catalytic 
sites with AEPs (Kirk and Kuchta, 1999b; Kuchta and Stengel, 2010). These 
polymerases exhibit gap-filling, strand-displacement and terminal transferase activity 
and are involved in repair processes such as base excision repair and indeed NHEJ in 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.20. Alignment of family X polymerases with DNA primase.  
The catalytic regions of human polymerases β, λ and μ are aligned with the small subunit of the pol α primase (Prim1/PriS). The residues 
highlighted in yellow are the invariant catalytic residues. Those in light blue are conserved charged residues and the residues in green 
represent conserved hydrophobic regions.   
Pol β  182  RRGAESSGDMDVLLTHPS  252  HRRIDIRLIPKDQY 
Pol λ  419  RRGKATCGDVDVLITHPD  486  HRRLDIIVVPYSEF 
Pol µ  322  RRGKLQGHDVDFLITHPK  414  AVRVDLVVAPVSQF 
Primase 101  AQEKELVFDIDMTDYDDV  302  FPRLDINVSKGINH 
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eukaryotes (Yamtich and Sweasy, 2010). More recently, the family A polymerase pol θ 
has been implicated in a novel DNA repair mechanism, microhomology-mediated end 
joining (MMEJ). Pol θ is shown to exhibit gap-filling and strand-displacement activities 
from DNA that has formed synapses at 3’ overhangs following resection (Kent et al., 
2015). 
 
1.7.2.3 Extrachromosomal DNA Replicative AEPs 
In addition to the replicative AEP primase-polymerases, some archaea possess 
additional AEPs encoded in extrachromosomal plasmids. The first of these to be 
identified was ORF904 from the pRN1 plasmid of Sulfolobus islandicus. This primase is 
predicted to function in the replication of the pRN1 plasmid. ORF904 represents a 
novel family of primases present sporadically in crenarchaeal plasmids and Gram-
positive bacterial plasmids, called the prim-pol family (L. M. Iyer et al., 2005). ORF904 
is a multifunctional enzyme composed of a helicase domain and an AEP primase-
polymerase domain, and harbouring ATPase, primase and polymerase activities (Lipps 
et al., 2003). ORF904 polymerase activity is dNTP-dependent and priming 
preferentially utilises dNTPs over rNTPs (Lipps et al., 2003). Unlike other AEPs, 
ORF904 shows sequence specificity to a 12-base long, pyrimidine-rich sequence with 
an indispensible GTG motif (Beck and Lipps, 2007).  
 
A highly related protein, Rep, also of the prim-pol family has both helicase and AEP 
primase-polymerase domains; Rep has been identified and characterised from the pIT3 
plasmid of Sulfolobus solfataricus (Prato et al., 2008). The replicative N-terminal 
domain of this protein, termed Rep245, also harbours DNA polymerase activity, as well 
as dNTP and rNTP primase activities. Unlike ORF904 though, this archaeal plasmid 
primase domain has 3’ terminal deoxynucleotide transferase activities (Prato et al., 
2008). It remains to be seen whether this terminal transferase activity is retained for the 
full-length Rep protein.  
 
Bacteria, like archaea, often harbour extrachromosomal plasmid DNA. Two decades 
ago, a Rep protein from the colicin E2 (ColE2) plasmid was found to have DNA 
primase activity (Takechi and Itoh, 1995; Takechi et al., 1995). 10 years later, it was 
shown that this primase was a member of the AEP family, distantly related to the prim-
pols of ORF904 (pRN1) and Rep (pIT3) (L. M. Iyer et al., 2005). This protein, like 
 35 
ORF904 but unlike other AEPs, shows sequence specificity to a defined origin 
sequence in its primase activity (Takechi and Itoh, 1995).  
 
A protein with an AEP primase-polymerase domain has also been identified in the 
bacterial plasmid of Bacillus cereus RSF1010 (Samuels et al., 2009). This protein was 
identified through a homology search for eukaryotic MCMs and is formed of an AEP 
primase-polymerase domain fused with a helicase domain at its C-terminus (Samuels 
et al., 2009; Sanchez-Berrondo et al., 2012).  
 
A third plasmid-encoded primase family has recently been described that is formed of 
subunits analogous to the PriS catalytic subunit and PriL regulatory subunit of the 
replicative AEPs in a single protein product (Gill et al., 2014). It is from the pTN2 
plasmid from Thermococcus nautilus and is denoted PolpTN2 (Gill et al., 2014). The 
only other member of this family to be identified is from the pP12-1 plasmid of 
Pyroccocus sp.12-1 (Soler et al., 2010). This primase-polymerase will only prime and 
extend from a primer using dNTPs, it will not utilise rNTPs (Gill et al., 2014). In addition 
to these activities, PolpTN2 has terminal transferase activity, which is greatly enhanced 
upon the removal of the PriL-like portion of the protein (Gill et al., 2014). This removal 
of the PriL-like portion of PolpTN2 also confers reverse transcriptase activity to the 
primase (Gill et al., 2014). 
 
The zinc-binding motif of primases is present across every AEP primase described with 
the exceptions of PolpTN2 and Rep(pIT3) (Gill et al., 2014; Prato et al., 2008). Even 
the ORF904 primase of the pRN1 plasmid contains a zinc-binding motif and has a 
conserved active core in common with replicative AEPs (Lipps et al., 2004). However, 
the zinc-binding motif of ORF904 is in a distinct position relative to the zinc-binding 
motif of the replicative primases (See Figure 1.21) (Lipps et al., 2004). This hints at the 
two primase families having an evolutionary ancestor that had no zinc finger. Perhaps 
these plasmid gene products, PolpTN2 and Rep(pIT3), represent evolutionarily 
ancestral AEP primases.  
 
Kinetoplastids are a group of single-celled protozoa characterised by the presence of 
kinetoplasts; a kinetoplast is a network of circular DNA, both maxicircles (20-40 kb) and 
minicircles (0.5-1 kb) found inside a single, large mitochondrion (reviewed in (Shapiro 
and Englund, 1995)). Until recently, the kinetoplastid replication machinery could not be 
  
 
 
 
 
 
 
 
 
Figure 1.21. Difference in location of zinc-binding motif of replicative AEPs and ORF904 of the plasmid pRN1.  
The zinc-binding motif of replicative AEPs (left) is in a distinct position relative to the conserved AEP core (green) to ORF904 (right), suggesting 
that the AEPs potentially evolved from a zinc-independent plasmid. This figure is adapted from Lipps et al. 2004. 
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reconstituted because it was not capable of de novo nucleotide chain synthesis, but the 
primase for this system had not been identified. Two such primases have since been 
characterised found in kinetoplastid mitochondria, PRI1 and PRI2, responsible for 
maxicircle and minicircle replication initiation, respectively (Hines and Ray, 2011; 
2010). These primases are capable of producing primers of up to 70-80 nucleotides in 
length. PRI1 and PRI2 are from the nucleo-cytoplasmic large DNA virus (NCLDV)-
herpesvirus clade of primases, which suggests they are an archaic primase acquired 
from a viral source (L. M. Iyer et al., 2005). 
 
1.7.2.5. Viral AEPs 
The UL5-UL8-UL52 heterotrimeric primase-helicase complex in herpes viruses is 
perhaps the most well characterised of the viral primases (Crute and Lehman, 1991). 
The UL5 protein is responsible for the helicase activities of the complex (Gorbalenya et 
al., 1989) and the UL52 protein is an AEP responsible for the priming activities of the 
complex (Crute and Lehman, 1991; Klinedinst and Challberg, 1994). Whilst UL8 is not 
a requirement for either the core primase or helicase activities, it is predicted to be 
required for the efficient utilisation of the primers by polymerase (Marsden et al., 1997; 
Sherman et al., 1992). A recent bioinformatics report has suggested that UL8 is 
distantly related to the B family of polymerases but has lost its active site and has lost 
most of its DNA binding motifs (Kazlauskas and Venclovas, 2014). Where most 
primases have a zinc-binding motif in their catalytic domains (Augustin et al., 2001; 
Lao-Sirieix et al., 2005; Lipps et al., 2004), UL52 has a strand-rich zinc finger domain 
that is separate at its C-terminus that is absolutely required for the protein’s activity in 
vivo (Biswas and S. K. Weller, 1999). Similar to the pol α primase in eukaryotes, the 
UL52 primase produces ribonucleotide primers of around 8-12 nucleotides in length 
(Crute and Lehman, 1991).  
 
The Lef-1-like primases of baculoviruses represent a family of AEPs that are closely 
related to the replicative primases of eukaryotes and archaea (L. M. Iyer et al., 2005). 
However, they are capable of producing RNA primers that extend up to several 
kilobases in length (Mikhailov and Rohrmann, 2002), suggesting an RNA polymerase 
activity for these primases. This is a trait shared by the D5-like proteins of poxvirus 
NCLDVs (De Silva et al., 2009). D5 has been characterised from the vaccinia virus and 
is conserved across all poxviruses (De Silva et al., 2009). D5, unlike Lef-1, is formed of 
an AEP polymerase domain and a helicase domain. (De Silva et al., 2009).  
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Another family of AEPs, the gp43-like proteins of corynephage BFK20, does not share 
this incorporation of rNTPs in viral AEPs (Halgasova et al., 2012). gp43 is related to the 
prim-pol family of proteins, including ORF904 and Rep(pIT3), and has both primase 
and polymerase activities but will only incorporate dNTPs, not rNTPs (Halgasova et al., 
2012). Unlike prim-pols ORF904 and the Rep protein of ColE2, gp43 does not show 
any apparent sequence specificity (Halgasova et al., 2012). This gp43-like protein has 
been identified in at least 13 mycobacteriophages and ReqiPine5, a Rhodococcus 
phage (Halgasova et al., 2012). 
 
Taken together, these studies establish that AEPs fulfil a wide range of tasks in 
archaea, bacteria and viruses including priming, polymerase, lesion bypass, terminal 
transferase, gap filling and strand displacement activities. This plethora of activities 
illustrates that AEPs function in both DNA repair mechanisms and DNA damage 
tolerance during replication, in addition to the known role in priming DNA for replication. 
This suggests that during the evolution of eukaryotes with larger genomes, cells 
developed more complex mechanisms using a variety of specialised polymerases for 
DNA damage repair and tolerance, in particular the X and Y families of polymerases 
that remain absent from most archaeal and prokaryotic species. As such, the pol α 
primase is only required for the DNA-dependent RNA priming of DNA in eukaryotes. 
 
1.8. Discovery of Eukaryotic Primase-Polymerase 
Until recently, the only AEP identified in higher eukaryotes was the pol α-associated 
primase small subunit PriS. An in silico analysis of the AEP superfamily identified the 
existence of an additional uncharacterised DNA primase in eukaryotes called Primase-
Polymerase, or PrimPol (alternative names CCDC111, FLJ33167, EukPrim2 and 
hPrimPol1) (L. M. Iyer et al., 2005). This novel protein belongs to the NCLDV-
herpesvirus clade of AEPs, which includes the mitochrondrial primases of 
kinetoplastids, UL52 of the herpesviruses and D5 of the poxviruses (Section 1.7.2.5)(L. 
M. Iyer et al., 2005). PrimPol is present across a broad range of unicellular and 
multicellular eukaryotes across animals, plants, protists and fungi (Figure 1.22). It is, 
however, notably absent in a number of eukaryotes, including Caenohabditis elegans 
and Drosophila melanogaster, and has only been identified in a small handful of fungal 
species. This distribution suggests that PrimPol was acquired from a viral source 
  
 
 
 
Figure 1.22. Conserved motifs of PrimPol.  
PrimPol is conserved across a range of eukaryotes from protists to humans. PrimPol consists of an N-terminal AEP polymerase domain and C-
terminal putative zinc-finger domain. All PrimPol family members share conserved motifs; these motifs include the invariant DhE of AEP motif I 
(blue stars), SxH of AEP motif II (purple stars), hD of motif III (blue stars) and the -C-H-C-C- zinc coordinating amino acids of the zinc finger 
(green stars).  
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through horizontal gene transfer and subsequently lost independently on a range of 
occasions (L. M. Iyer et al., 2005).  
 
PrimPol is composed of two discernable domains, an AEP polymerase domain at its N-
terminus and a putative UL52-like zinc finger at its C-terminus (Figure 1.22). The AEP 
polymerase consists of the three canonical motifs of an AEP, motif I shares the 
consensus sequence LYFDLE, motif II shares the consensus sequence SxH and motif 
III the consensus sequence VD. The only other AEP identified so far with a glutamate 
residue in the final position of motif I (i.e. hhhDxE) is ORF904 (Figure 1.17). The zinc 
finger of PrimPol is a CHCC-type zinc finger and is conserved across the NCLDV-
herpesvirus clade of AEPs (L. M. Iyer et al., 2005). Recent characterisation of PrimPol 
by a number of groups has shown that this protein has both DNA-dependent primase 
and polymerase activity, hence the designation of the name PrimPol (Bianchi et al., 
2013; Garcia-Gomez et al., 2013; Keen et al., 2014; Mourón et al., 2013; Rudd et al., 
2014; 2013; Wan et al., 2013). 
 
PrimPol is required for the efficient progression of the replication fork during the 
replication of chromosomal DNA (Bianchi et al., 2013; Mourón et al., 2013; Wan et al., 
2013). It also plays a role in the maintenance of mitochondrial DNA replication (Garcia-
Gomez et al., 2013). This is consistent with the finding that, upon fractionation of HeLa 
cells, PrimPol is distributed between the cytosol (47%), nucleus (19%) and 
mitochondria (34%) (Garcia-Gomez et al., 2013).  
 
This thesis aims to investigate the biochemical and biophysical properties of PrimPol 
and how this contributes to the roles it plays in both standard and perturbed replication 
of chromosomal and mitochondrial DNA. We started this study by probing the domain 
architecture of PrimPol (Chapter 3) and investigating which parts of the protein are 
required for the different catalytic and DNA binding activities associated with PrimPol. 
The enzymatic characterisation of PrimPol is also explored in Chapter 4; this chapter 
examines both its kinetic parameters relative to other primases and polymerases, as 
well as its lesion bypass proficiencies in the presence and absence of the zinc finger of 
PrimPol. Chapter 5 elucidates the biochemical characteristics of a mutation in PrimPol 
that has been reported to have clinical relevance (Zhao et al., 2013). The final chapter 
(Chapter 6) introduces the work towards researching PrimPol’s binding partners in vivo. 
These chapters will also describe the additional background studies that were carried 
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out in the Doherty lab in parallel with this study that complement this work. Each 
chapter will be briefly introduced by the experiments that preceded and informed the 
studies described in the chapter to supplement my introduction to PrimPol here. 
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CHAPTER 2 
 
 
Materials and Methods 
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2.1. Molecular Biology Methods 
2.1.1. Production of Competent DH5α E. coli 
DH5α cells were plated on LB agar plates (LB medium solidified with 1.5% (w/v) agar; 
LB = lysogeny broth (1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 1 % (w/v) NaCl, pH 
7)). 3 mL of LB was then inoculated with a single colony of DH5α cells selected from 
this plate and grown overnight at 37°C with shaking at 180 rpm. This culture was then 
diluted in 250 mL super optimal broth (SOB) medium (2% (w/v) tryptone, 0.5% (w/v) 
yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgSO4 and 10 mM MgCl2) and placed 
in an 18°C incubator until an optical density at 600 nm (OD600) of 0.4. Cells were cooled 
for 10 minutes on ice and then collected by centrifugation (4,000 rpm, 10 minutes, 4°C, 
Sorvall Legend RT, 75006445 rotor). The cells were resuspended in transformation 
buffer (100 mM PIPES (pH 6.7), 15 mM CaCl2, 250 mM KCl, 55 mM MgCl2) and 
incubated for 10-30 minutes on ice. Cells were then pelleted again and resuspended in 
15 mL transformation buffer supplemented with 7% (v/v) dimethyl sulphoxide (DMSO). 
Cells were incubated on ice for 10 minutes before aliquoting into 50-100 μL aliquots 
and frozen in liquid nitrogen and stored at -80°C. 
 
2.1.2. Transformation of Competent E. coli 
1 μL of plasmid DNA from a Miniprep (~50-100 ng)(Section 2.1.3) or 5 μL of a ligation 
reaction (Section 2.1.7) was added to 50 μL chemically competent E. coli cells. The E. 
coli and DNA mix was incubated on ice for 30 minutes prior to a 35 second heat shock 
at 42°C before returning to ice for 2 minutes. 300 μL of SOB was added before 
incubation at 37°C for 1 hour. 100 μL of this cell growth was plated on a pre-warmed 
LB agar plate containing appropriate antibiotics and incubated overnight at 37°C to 
allow colony growth. Kanamycin was used at 34 μg mL-1 final concentration. 
 
2.1.3. Plasmid DNA Amplification and Purification 
Single E. coli colonies that had been transfected with plasmid DNA (Section 2.1.2.) 
were inoculated into 5 mL of LB medium containing the appropriate antibiotic and 
incubated at 37°C overnight with shaking at 180 rpm. Following overnight incubation, 
the plasmid DNA was purified using the QIAprep Spin Miniprep Kit (Qiagen) according 
to the manufacturer’s instructions. Plasmid DNA was eluted in 50 μL and stored at -
20°C. The yield of the plasmid DNA was determined using an ND-1000 NanoDrop 
spectrophotometer (Thermo Scientific) at a wavelength of 260 nm.  
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2.1.4. Agarose Gel Electrophoresis of DNA 
DNA was resolved on a 1% (w/v) agarose gel containing TAE (200 mM Tris, 100 mM 
Acetic Acid, 5 mM EDTA) and ~0.3 μg mL-1 ethidium bromide. DNA samples were 
supplemented DNA loading buffer (5% (v/v) glycerol, 3.3 mM Tris pH 8, 0.04% 
bromophenol blue) prior to loading and were loaded alongside a 1 kb DNA ladder (New 
England Biolabs) or 100 bp DNA ladder (New England Biolabs) as appropriate. Gels 
were electrophoresed at 100-120 V for ~20 minutes in TAE buffer. DNA was visualised 
using a UV illuminator (Syngene InGenius Gel Analysis System) and images were 
analysed using GeneSnap (Syngene) 
 
2.1.5. Polymerase Chain Reaction (PCR) 
PCR reactions of 50 μL were assembled in 200 μL reaction tubes using 1 μM of each 
of a reverse and forward primer, ~5 ng of template plasmid, 1 mM dNTPs, 10 mM 
MgCl2, 20% DMSO and 1 U Phusion high-fidelity DNA polymerase (New England 
Biolabs). The primers were designed to have a typical Tm ~55-65°C and are flanked by 
an appropriate restriction digestion site and a lead ‘anchor’ sequence for efficient 
digestion; the nucleotide sequences of primers used can be found in Table 2.1. The 
PCR conditions used for each reaction (i.e. temperatures, times and cycles) can be 
found in Table 2.2. Reactions were carried out using a Professional Trio Thermocycler 
(Biometra). PCR products were confirmed by agarose gel electrophoresis (Section 
2.1.4), loaded alongside a no-polymerase control. 
 
Upon confirmation of DNA amplification, PCR products were electrophoresed on an 
agarose gel (Section 2.1.4) and detected using a UV transilluminator (UVP). Bands 
were excised from the gel and purified using the QIAquick Gel Extraction kit (Qiagen) 
according to the manufacturer’s instructions.  
 
2.1.6. Restriction Digestion 
Typically 20 μL of purified plasmid DNA or 30 μL of PCR product was digested in a 50 
μL reaction containing 10 U of each of the appropriate double-digestion restriction 
enzymes (New England Biolabs), 100 μg mL-1 bovine serum albumin (BSA), and the 
appropriate restriction buffers. Reactions were incubated at 37°C for 3-4 hours. Purified 
plasmid DNA was supplemented with Antarctic phosphatase buffer (50 mM Bis-Tris-
# Primer Sequence (5’-3’) 
1 Human PrimPol 1 Forward GTTTCTTCATATGAATAGAAAATGGGAAGCAAAACTG 
2 Human PrimPol 24 Forward GTTTCTTCATATGCCGTTGTCCTCAGTGTATAGACC 
3 Human PrimPol 39 Forward GTTTCTTCATATGTCCATCTGGAGACTATTTCATCGAC 
4 Human PrimPol 372 Forward GTTTCTTCATATGCAGTGTTCTCCCTATCCTGAAGTTG 
5 Human PrimPol 480 Forward GTTTCTTCATATGACAACAGATGAAGCAGATGAAAC 
6 Human PrimPol 276 Reverse CAAAGAAGCGGCCGCCTAATGCTTCTCTCCCATGTTATTCTTCAC 
7 Human PrimPol 354 Reverse CAAAGAAGCGGCCGCCTATTTTTGTTTATTCTGAGATGGCTCAC 
8 Human PrimPol 560 Reverse  CAAAGAAGCGGCCGCTTACTCTTGTAATACTTCTATAATTAGTTC 
9 Human PrimPol K300stop Forward CATCAAAAATTGGATAGCGTGTGGCTTTGG 
10 Human PrimPol K300stop Reverse CCAAAGCCACACGCTATCCAATTTTTGATG 
11 Human PrimPol R488stop Forward GAAACTTAGAGCAATGAAACCCAGAATCC 
12 Human PrimPol R488stop Reverse CATTGCTCTAAGTTTCATCTGCTTCATC  
13 Human PrimPol C419A/H426A Forward GTAAATATCGGTGGGCTGAAAACATTGGAAGAGCCGCTAAGAGTAATAATATAATG  
14 Human PrimPol C419A/H426A Reverse CTCTTAGCGGCTCTTCCAATGTTTTCAGCCCACCGATATTTACAAATATCATAAACCAGTAATTC  
15 Human PrimPol Y89D Forward GAATTTTGGTTTGACTATAAATCCAGAAAAAATCTCTTACACTGCTATG 
16 Human PrimPol Y89D Reverse GATTTATAGTCAAACCAAAATTCAGCATAGGTTGTCACAAG 
17 Human PrimPol Y89F Forward GAATTTTGGTTTTTCTATAAATCCAGAAAAAATCTCTTACACTGCTATG 
18 Human PrimPol Y89F Reverse GATTTATAGAAAAACCAAAATTCAGCATAGGTTGTCACAAG 
19 Human PrimPol Y89S Forward GAATTTTGGTTTTCATATAAATCCAGAAAAAATCTCTTACACTGCTATG 
20 Human PrimPol Y89S Reverse GATTTATATGAAAACCAAAATTCAGCATAGGTTGTCACAAG 
21 Mouse PrimPol 24 Forward GTTTCTTCATATGAGACCAAGACTGGCCAAGCCAGAAG 
22 Mouse PrimPol 39 Forward GTTTCTTCATATGTCCATCTGGAGACTATTTCATCG 
23 Mouse PrimPol 338 Reverse CAAAGAAGCGGCCGCCTAAGCCCGCTTTCGTTTAGTCTGAGATGGG 
24 Mouse PrimPol S315stop Forward CTGGTGTGAAATGTCAGATTCTCAG 
25 Mouse PrimPol S315stop Reverse GACATTTCACACCAGGGAAGATAGG 
26 Xenopus PrimPol 1 Forward GTTTCTTGGATCCATGAAAGCATGTGGAGGACTGGCAGATTATTATAG 
27 Xenopus PrimPol 699 Reverse GACATGTAGCAACCCTGACTATCGAACAAGCAAATAGCTCGAGAAGAAAC 
 
Table 2.1. Primers used in PCR and site directed mutagenesis to produce expression vectors. The primers listed here are used in the 
construction of expression vectors listed in Table 2.3. 
  
# Initialisation Denaturation Annealing Extension Cycles Finalisation Hold 
1 98°C (1:00) 95°C (0:35) 56°C (0:35) 68°C (1:10) 30 68°C (3:30) 4°C 
2 95°C (1:00) 95°C (0:30) 55°C (0:30) 70°C (7:30) 22 70°C (15:00) 4°C 
3 95°C (1:00) 95°C (0:30) 55°C (0:30) 60°C (7:30) 21 60°C (15:00) 4°C 
4 98°C (1:00) 95°C (0:35) 56°C (0:35) 72°C (3:00) 30 72°C (9:00) 4°C 
 
Table 2.2. PCR methods used in the generation of novel expression plasmids.  
The PCR conditions used to construct the expression vectors in Table 2.3 are listed here. The initialisation, denaturation, annealing, extension 
and finalisation temperatures are listed with the associated times in brackets as (minutes:seconds). The cycles indicate cycling between 
denaturation, annealing and extension steps with the number of cycles listed. 
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Propane-HCl pH 6, 1 mM MgCl2, 0.1 mM ZnCl2) and treated with Antarctic 
phosphatase (New England Biolabs) for 30 minutes to prevent plasmid 
recircularisation. The restriction products were purified using the QIAquick PCR 
Purification kit (Qiagen) according to the manufacturer’s instructions. 
 
2.1.7. Ligation of DNA 
 
Restriction digested plasmid DNA and PCR products were ligated using T4 DNA ligase 
(New England Biolabs). The concentration of digested DNA was determined using a 
ND-1000 NanoDrop spectrophotometer (Thermo Scientific) at a wavelength of 260 nm. 
Ligation reactions were set up at a ratio (n) of 6:1 or 3:1 of Insert (I) to Vector (V) using 
the following equation: !(!") = !!!!!(!")!!!!(!")!(!")  
 
Reactions were supplemented with 200 units T4 DNA ligase, T4 DNA ligase buffer (50 
mM Tris HCl pH 7.5, 10 mM MgCl2, 1 mM ATP, 10 mM DTT) and incubated at room 
temperature for 1 hour. 5 μL of reaction was transformed into DH5α (Section 2.1.2). 
The remainder of the ligation was incubated overnight at 12°C and transformed again if 
required.  
 
Ligations were typically set up twice and the second reaction was subjected to heat 
inactivation after 1 hour at 95°C for 10 minutes. This reaction was then subject to 
restriction digestion by a restriction enzyme that was present in the polylinker of the 
vector that had been excised prior to ligation but not present in the PCR product to 
ensure any recircularised vector is linearised. This reaction was incubated at room 
temperature for 1 hour and subsequently 5 μL of reaction was transformed into DH5α 
(Section 2.1.2). 
 
Colonies were screened by restriction digest (Section 2.1.6) and sequences confirmed 
by DNA sequencing (Section 2.1.9). 
 
2.1.8. Site-Directed Mutagenesis 
Site-directed mutagenesis primers were designed using either the QuickChange 
protocol (Stratagene), using complementary primer pairs, or a modified version using 
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partially overlapping primers to reduce primer dimerisation (Zheng et al., 2004). 
Primers for site-directed mutagenesis can be found in Table 2.1. Site-directed 
mutagenesis reaction reagents are the same as those in Section 2.1.5. and the 
reaction conditions for PCR can be found in Table 2.2. Products were screened by 
agarose gel electrophoresis (Section 2.1.4) alongside a no polymerase control. 
Successfully amplified products were digested using 10 U DpnI (New England Biolabs) 
in a 30 μL reaction for ~3 hours at 37°C. 3 μL of reaction products were transformed 
into DH5α (Section 2.1.2). Positive site-directed mutagenesis clones were confirmed by 
DNA sequencing (Section 2.1.9). 
 
2.1.9. Sequencing of DNA products 
Sequencing of plasmid DNA was performed by GATC biotech using universal primers 
or gene-specific primers. The sequencing chromatogram was read using 4Peaks 
(Mekentosj). 
 
2.2. Purification of Recombinant Proteins 
2.2.1. Preparation of Chemically Competent E. coli strains 
Chemically competent BL21, Tuner and Rosetta E. coli strains were prepared in the 
same manner as DH5α (Section 2.1.1). Chemically competent SHuffle were also 
prepared in the same manner with the exception that they were not grown at a 
temperature above 30°C. 
 
2.2.2. Strain Optimisation of Protein Expression 
Chemically competent E. coli expression strains were transformed (Section 2.1.2) with 
expression plasmids (Table 2.3). Colonies from each expression strain were inoculated 
into 5 mL of LB medium supplemented with 34 μg mL-1 kanamycin and incubated 
overnight at 37°C (30°C for SHuffle cells) with shaking at 180 rpm. 1 mL of overnight 
growth was added to 50 mL of LB supplemented with 34 μg mL-1 kanamycin and 
allowed to continue to grow. Upon reaching an OD600 of 0.4, as determined by 
spectrophotometry on a Cary 50 Bio spectrophotometer (Varian), growths were rapidly 
cooled on ice for 10 minutes. Expression was subsequently induced through the 
addition of 400 μM isopropyl β-D-1-thiogalactopyranoside (IPTG) and growths were 
split into incubators at temperatures ranging from 16-30°C for 3-16 hours. 
 
# Gene Product Vector Source Primers PCR Method 
H1 Wild-Type Human PrimPol pET28a Dr. Julie Bianchi N/A N/A 
H2 Human PrimPol 1-354 pET28a PCR, plasmid H1 1, 7 1 
H3 Human PrimPol 24-354 pET28a PCR, plasmid H1 2, 7 1 
H4 Human PrimPol 39-354 pET28a PCR, plasmid H1 3, 7 1 
H5 Human PrimPol 1-276 pET28a PCR, plasmid H1 1, 6 1 
H6 Human PrimPol 39-276 pET28a PCR, plasmid H1 3, 6 1 
H7 Human PrimPol 39-299 pET28a SDM, plasmid H4 9, 10 2 
H8 Human PrimPol 1-487 pET28a SDM, plasmid H1 11, 12 2 
H9 Human PrimPol 372-560 pET28a PCR, plasmid H1 4, 8 1 
H10 Human PrimPol 480-560 pET28a PCR, plasmid H1 5, 8 1 
H11 Human PrimPol C418A/H425A (ZF-KO) pET28a SDM, plasmid H1 13, 14 2 
H12 Human PrimPol 372-560 ZF-KO pET28a SDM, plasmid H9 13, 14 2 
H13 Human PrimPol Y89D pET28a SDM, plasmid H1 15, 16 2 
H14 Human PrimPol 1-354 Y89D pET28a SDM, plasmid H2 15, 16 2 
H15 Human PrimPol Y89F pET28a SDM, plasmid H1 17, 18 2 
H16 Human PrimPol Y89S pET28a SDM, plasmid H1 19, 20 2 
H17 Human PrimPol D514R,D518R,D519R,D524A (RBM-A-
KO) 
pET28a Dr. Nigel Brissett N/A N/A 
H18 Human PrimPol 480-546 pET28a Dr. Nigel Brissett N/A N/A 
H19 Human PrimPol 480-546/RBM-A-KO pET28a Dr. Nigel Brissett N/A N/A 
H20 
 
Human PrimPol D514R, D518R, D519R, D551R, I554A, 
I555A (RBM-A-KO/RBM-B-KO) 
pET28a Dr. Nigel Brissett N/A N/A 
M1 Mouse PrimPol 1-338 pET28a Dr. Laura Bailey N/A N/A 
M2 Mouse PrimPol 24-338 pET28a PCR, plasmid M1 21, 23 1 
M3 Mouse PrimPol 39-338 pET28a PCR, plasmid M1 22, 23 1 
M4 Mouse PrimPol 1-314 pET28a SDM, plasmid M1 24, 25 3 
X1 Xenopus PrimPol Full Length pET28a PCR, Genscript Synthesis 26, 27 4 
X2 Xenopus PrimPol 1-334 pET28a Dr. Stanislaw Jozwiakowski N/A N/A 
X3 Xenopus PrimPol 1-472 pET28a Dr. Stanislaw Jozwiakowski N/A N/A 
 
Table 2.3. Plasmid expression vectors and their associated gene products.  
All gene products are located within the polylinker of the pET28a plasmid for expresion. The source is given with polymerase chain reaction 
(PCR) and site-directed mutagenesis (SDM) products indicated and the plasmid that was used as a template. Those plasmids that were 
donated by other scientists are also indicated. Plasmid X1 was subcloned from a gene synthesised by Genscript. The PCR/SDM primers used 
are the primer numbers (#) from Table 2.1. The PCR method used are the method numbers (#) listed in Table 2.2. 
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1.5 mL samples were taken from each growth. Cells were resuspended in lysis buffer 
(300 mM NaCl, 50 mM Tris-HCl pH 7.5, 30 mM imidazole, 10% (v/v) glycerol, 17 μg 
mL-1 phenylmethanesulfonylfluoride (PMSF), 34 μg mL-1 benzamidine, 0.1% IGEPAL).  
Samples were sonicated using a Vibra-Cell sonicator (Sonics) for 10 seconds at 30% 
amplitude and centrifuged in a benchtop centrifuge at 13,000 rpm for 1 hour at 4°C to 
clear insoluble cell debris from the lysate. 0.5 μL of the soluble fraction was diluted into 
buffer then subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) (Section 2.3.1) to analyse protein expression in different strains, at 
different induction temperatures, at different induction lengths. 
 
2.2.3. Recombinant Protein Expression and Preparation 
Following strain optimisation if required, colonies from protein expression strains of E. 
coli are inoculated into 5 mL of LB medium supplemented with 34 μg mL-1 kanamycin 
and incubated overnight at 37°C (30°C for SHuffle cells). 3 mL of overnight growth was 
then added to a large volume (1-6 litres) of LB medium or terrific broth (1.2% tryptone, 
2.4% yeast extract, 72 mM K2HPO4, and 1% (v/v) glycerol) (TB) and grown at 37°C 
(30°C for shuffle cells) with shaking at 180 rpm. Upon reaching an optical density at an 
OD600 of 0.4 for growth in LB or 0.6 for growth in TB, growths were cooled at for 30 
minutes at 4°C and subsequently induced through the addition of 400 μM IPTG and 
allowed to continue to grow. The growth and induction conditions for each of the 
proteins in this thesis can be found in Table 2.4. 
 
Cells were collected by centrifugation (4,000 rpm, 15 minutes, 4°C, Sorvall Evolution, 
SLC-6000 rotor) and resuspended in lysis buffer (15 mL per litre of culture grown). To 
this resuspension, 1 mg mL-1 of chicken egg lysozyme was added and this stirred for 
30-45 minutes. Lysate was then sonicated using a Vibra-Cell sonicator (Sonics) at 30% 
amplitude for 6 second pulses, with a 10 second rest between pulses, for a total of 6 
minutes sonication time. Insoluble cell debris was cleared by centrifugation (18,000 
rpm, 1 hour, 4°C, JA 25-50 rotor). The soluble fraction was then passed through a 0.45 
μM filter (Millipore) and kept on ice for protein purification by chromatography. 
 
2.2.4. Affinity Chromatography of Recombinant Proteins 
Table 2.5 outlines the purification strategies for the different proteins purified in the 
scope of this work. Immobilised metal affinity chromatography (IMAC) was used to 
purify all recombinant proteins fused with an N-terminal 6x-His tag. 5 mL or 25 mL of 
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nickel-nitrolotriacetic acid (Ni-NTA) agarose (Qiagen) was packed into chromatography 
columns. These Ni-NTA columns were then subjected to chromatography using an 
ÄKTAprime (GE Healthcare) or ÄKTAprime plus (GE Healthcare) system. All buffers 
and protein samples were kept on ice. Columns were pre-equilibrated using IMAC 
Buffer A (300 mM NaCl, 50 mM Tris-HCl pH 7.5, 30 mM imidazole, 10% (v/v) glycerol, 
17 μg mL-1 phenylmethanesulfonylfluoride (PMSF), 34 μg mL-1 benzamidine, 2 mM β-
mercaptoethanol). Cell lysates were loaded at a constant rate of 3 mL min-1. Columns 
were then washed using buffer A until all non-specifically bound proteins were eluted 
as measured by absorbance at a wavelength of 280 nm (A280) returning to basal levels. 
Columns were subjected to a wash using 5% IMAC Buffer B (as IMAC Buffer A, except 
300 mM imidazole) to remove any weakly bound proteins. The bound proteins were 
then eluted using 100% buffer B. Samples were taken from the insoluble fraction, load, 
flow-through, wash, 5% buffer B wash and 100% B elution and subjected to SDS-
PAGE analysis (see Section 2.3.1). 
 
Some proteins (see Table 2.5) were subsequently purified through the use of a 5 mL 
HiTrap Heparin HP column (GE Healthcare) connected to an ÄKTAprime (GE 
Healthcare) or ÄKTAprime plus (GE Healthcare) system. Heparin-sepharose functions 
as a mixed-mode chromatography column as both an affinity column for DNA-binding 
proteins, as well as a cation exchanger. Columns were equilibrated using pre-chilled 
Heparin Buffer A (50 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% (v/v) glycerol, 2 mM 
DTT). Proteins were diluted 1:10 into Heparin Buffer A to reduce the salt and imidazole 
concentrations and loaded onto the column at a flow rate of 2.5 mL min-1. The column 
was then washed using Heparin Buffer A to elute any non-specifically bound proteins. 
Proteins were eluted by gradient elution up to 50% Heparin Buffer B (as Heparin Buffer 
A but 2 M NaCl). Protein-contaning fractions were determined by A280 level and 
samples of these fractions were subjected to SDS-PAGE analysis (see Section 2.3.1). 
 
2.2.4. Ion-Exchange Chromatography Recombinant Proteins 
Some recombinant proteins (see Table 2.5) were subjected to ion-exchange 
chromatography based on their predicted isoelectric point (pI) (see Section 2.5.4). 5 mL 
HiTrap Q Sepharose FF columns (GE Healthcare) were used as anion exchangers and 
5 mL HiTrap SP Sepharose FF (GE Healthcare) were used as cation exchangers 
connected to an ÄKTAprime (GE Healthcare) or ÄKTAprime plus (GE Healthcare) 
 
Table 2.4. Growth conditions for recombinant PrimPol proteins.  
The strain of E. coli used in the growth of recombinant proteins is listed along with the growth medium used. E. coli growths were induced at an 
OD600 of 0.4 for Lysogeny Broth (LB) or 0.6 for Terrific Broth (TB), following a period of rapid cooling. The induction temperature and length is 
listed.  
 
 
Protein E. coli strain Growth Medium Induction Temperature and Length 
Wild-Type Human PrimPol SHuffle LB 16°C overnight 
Human PrimPol 1-354 BL21 TB 25°C overnight 
Human PrimPol 24-354 BL21 TB 25°C overnight 
Human PrimPol 39-354 BL21 TB 25°C overnight 
Human PrimPol 1-276 BL21 LB 25°C overnight 
Human PrimPol 39-276 BL21 LB 25°C overnight 
Human PrimPol 39-299 BL21 LB 25°C overnight 
Human PrimPol 1-487 SHuffle LB 16°C overnight 
Human PrimPol 372-560 BL21 LB 25°C overnight 
Human PrimPol 480-560 BL21 TB 20°C overnight 
Human PrimPol C418A/H425A (ZF-KO) SHuffle LB 16°C overnight 
Human PrimPol 372-560 ZF-KO BL21 LB 25°C overnight 
Human PrimPol Y89D SHuffle LB 16°C overnight 
Human PrimPol 1-354 Y89D BL21 LB 25°C overnight 
Human PrimPol Y89F SHuffle LB 16°C overnight 
Human PrimPol Y89S SHuffle LB 16°C overnight 
Human PrimPol RBM-A-KO BL21 TB 20°C overnight 
Human PrimPol 480-546 BL21 TB 20°C overnight 
Human PrimPol 480-546/RBM-A-KO BL21 TB 20°C overnight 
Human PrimPol RBM-A-KO/RBM-B-KO BL21 TB 20°C overnight 
Mouse PrimPol 1-338 BL21 TB 20°C overnight 
Mouse PrimPol 24-338 BL21 TB 22.5°C overnight 
Mouse PrimPol 39-338 BL21 TB 25°C overnight 
Mouse PrimPol 1-314 BL21 LB 20°C overnight 
Xenopus PrimPol Full Length SHuffle TB 16°C overnight 
Xenopus PrimPol 1-334 BL21 TB 25°C overnight 
Xenopus PrimPol 1-472 SHuffle LB 16°C overnight 
Protein Affinity Ion Exchange Size Exclusion 
Ni-NTA IMAC Heparin Q SP Gel Filtration 
Wild-Type Human PrimPol ✓ ✓    
Human PrimPol 1-354 ✓ ✓  ✓ ✓ 
Human PrimPol 24-354 ✓ ✓   ✓ 
Human PrimPol 39-354 ✓ ✓   ✓ 
Human PrimPol 1-276 ✓     
Human PrimPol 39-276 ✓     
Human PrimPol 39-299 ✓     
Human PrimPol 1-487 ✓ ✓    
Human PrimPol 372-560 ✓  ✓   
Human PrimPol 480-560 ✓  ✓  ✓ 
Human PrimPol C418A/H425A (ZF-KO) ✓ ✓    
Human PrimPol 372-560 ZF-KO ✓  ✓   
Human PrimPol Y89D ✓ ✓    
Human PrimPol 1-354 Y89D ✓ ✓    
Human PrimPol Y89F ✓ ✓    
Human PrimPol Y89S ✓ ✓    
Human PrimPol RBM-A-KO ✓  ✓  ✓ 
Human PrimPol 480-546 ✓  ✓  ✓ 
Human PrimPol 480-546/RBM-A-KO ✓  ✓  ✓ 
Human PrimPol RBM-A-KO/RBM-B-KO ✓  ✓  ✓ 
Mouse PrimPol 1-338 ✓ ✓  ✓ ✓ 
Mouse PrimPol 24-338 ✓ ✓  ✓ ✓ 
Mouse PrimPol 39-338 ✓ ✓  ✓ ✓ 
Mouse PrimPol 1-314 ✓ ✓    
Xenopus PrimPol Full Length ✓ ✓    
Xenopus PrimPol 1-334 ✓ ✓   ✓ 
Xenopus PrimPol 1-472 ✓     
 
Table 2.5. Purification strategies for recombinant PrimPol proteins.  
The chromatography columns used in the purification of recombinant proteins are listed.  
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system. Ion-exchange chromatography was carried out in the same manner as 
chromatography using a HiTrap Heparin HP column (see Section 2.2.3). 
 
2.2.5. Size-exclusion chromatography 
The final step of purification for some of the proteins (see Table 2.5) was size-exclusion 
chromatography (SEC) using either an S75 or S200 10/300 GL gel-filtration column 
(GE Healthcare), depending on protein size. An ÄKTApurifier 10 or ÄKTAFPLC system 
was used for SEC. Columns were pre-equilibrated with SEC Buffer (typically 50 mM 
Tris-HCl (pH7.5), 300 mM NaCl, 10% (v/v) glycerol and 0.5 mM tris(2-
carboxyethyl)phosphine (TCEP)) that had been sterile-filtered using a 0.2 μm pore size 
vacuum filtration system (Nalgene). Protein samples were concentrated to less than ~4 
mL using a Vivaspin sample concentrator (GE Healthcare) with an appropriate 
molecular weight cut off. These protein samples were loaded onto a 5 mL loop that was 
pre-filled with SEC Buffer. The SEC columns were run at a flow rate of 2.2 mL min-1 
and fractions were collected following 100 mL of flow-through (void volume). Protein-
containing fractions were determined by A280 level and samples of these fractions were 
subjected to SDS-PAGE analysis (see Section 2.3.1). 
 
2.2.6. Removal of 6x-Histidine Tag 
For some proteins that were to be screened for crystallisation, the hexahistidine tag at 
the N-terminal was removed following purification. The histidine tag linker in pET28a 
includes a thrombin cleavage site. Thrombin was used to cleave the histidine tag at a 
concentration of 1 unit per mg purified protein for 2 hours at room temperature. The 
thrombin and cleaved His-tag was then separated from the purified protein by 
chromatography using a 1 mL HisTrap HP column (GE Healthcare) connected in series 
to a HiTrap Benzamidine FF column (GE Healthcare). The cleaved protein sample was 
compared with uncleaved protein by SDS-PAGE (see Section 2.3.1).  
 
2.2.7. Storage of Recombinant Proteins 
Proteins-containing fractions were pooled and concentrated to a volume of less than 5 
mL using a Vivaspin sample concentrator (GE Healthcare) with an appropriate 
molecular weight cut off. The protein concentration was determined by 
spectrophotometry using either an ND-1000 NanoDrop (Thermo Scientific) or Cary 50 
Bio (Varian) spectrophotometer at a wavelength of 280 nm. If not present in the 
purification buffer, samples were supplemented with 10% (v/v) glycerol and aliquoted 
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into small volumes (typically 200 μL). Aliquots were snap frozen in liquid nitrogen and 
stored at -80°C. 
 
2.3. Biochemistry Methods 
2.3.1. SDS Polyacrylamide Gel Electrophoresis 
Protein samples were resolved using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). SDS-PAGE gels were prepared in 1 mm Novex Gel 
cassettes (Invitrogen) and consisted a stacking gel layer cast over resolving gel 
(Sambrook and Russell, 2006). The resolving gel was typically 12% polyacrylamide 
(40% (v/v) acrylamide/bisacrylamide (37.5:1) 30% mix (National Diagnostics), 375 mM 
Tris-HCl (pH 8.8), 0.1% (w/v) SDS, 0.1% ammonium persulphate (APS), 0.04% 
N,N,N’,N’-Tetramethylethylenediamine (TEMED)). The resolving gel was allowed to set 
under a layer of isopropanol, upon setting the isopropanol was discarded and topped 
with a layer of stacking gel of 5% polyacrylamide (17% (v/v) acylamide/bisacrylamide 
(37.5:1) 30% mix (National Diagnostics, 125 mM Tris-HCl (pH 6.8), 0.1% (w/v) SDS, 
0.1% (w/v) APS, 0.04% (v/v) TEMED) before a well comb was added and allowed to 
set. The XCell SureLock Mini-Cell Electrophoresis System (Invitrogen) was used for 
SDS-PAGE. Samples were prepared through the addition of Laemmli sample buffer 
(2% (w/v) SDS, 10% v/v β-mercaptoethanol, 20% (v/v) glycerol, 0.02% bromophenol 
blue, 125 mM Tris-HCl (pH 6.5)) (Laemmli, 1970), and were boiled for 10 minutes at 
95°C. Protein samples were run alongside a Precision Plus (Bio-Rad) or Precision Plus 
Dual Marker (Bio-Rad) for Coomassie staining (Section 2.3.1.1) or western blotting 
(Section 2.3.1.2) respectively. Samples were electrophoresed at 150 V until the 
bromophenol blue dye reached the bottom of the gel (typically ~90 minutes). 
 
2.3.1.1. Coomassie Staining 
SDS polyacrylamide gels were stained in Coomassie blue solution (50% (v/v) 
methanol, 10% (v/v) acetic acid, 0.5% (w/v) Coomassie brilliant blue) for ~10 minutes 
with shaking. Coomassie blue solution was then removed and gel was gently washed 
with water before the addition of destaining solution (10-20% (v/v) methanol, 10% (v/v) 
acetic acid) and returning to the rocker for 2-16 hours until sufficient decolouration of 
the background dye so that protein bands were properly visible. Gels were then stored 
in water with 1% (v/v) glycerol and air-dried using the GelAir Drying System (Bio-Rad). 
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2.3.1.2 Western Blotting 
Samples to be analysed by western blot were initially resolved by SDS-PAGE (Section 
2.3.1). The SDS polyacrylamide gel was equilibrated with transfer buffer (20mM Tris, 
50mM glycine, 10% (v/v) methanol). Concurrently, a polyvinyladine fluoride (PVDF) 
membrane (Millipore) was activated with methanol. Proteins were transferred to the 
PVDF membrane using the XCell II Blot Module (Invitrogen) according to the 
manufacturer’s instructions. Transfer was performed at 25 V for 60 minutes in transfer 
buffer. The membrane was then blocked with blocking buffer (Tris-buffered saline 
(TBS; 280 mM NaCl, 20 mM Tris) supplemented with 0.05% (v/v) Tween 20 and 5% 
(w/v) non-fat dried milk (Marvel)) for at least one hour at room temperature. The 
primary antibody was diluted into 2.5 mL fresh blocking buffer and added to the 
membrane and incubated on a roller at 4°C overnight. The membrane was then 
washed three times in TBS supplemented with 0.05% (v/v) Tween for ~10 minutes per 
wash. For western blots that required a secondary antibody, secondary antibody was 
added in 2.5 mL blocking buffer and incubated at room temperature for 1 hour on a 
roller. The membrane was then washed three more times. Following antibody 
exposure, chemiluminescent detection with Amersham ECL Western Blotting Detection 
reagent (GE Healthcare) was performed according to the manufacturer’s instructions. 
Light emission was captured with Amersham Hyperfilm (GE Healthcare) 
autoradiography film and developed using a Xograft compact X4 developer. Rabbit 
anti-human PrimPol primary antibody was previously purified in the Doherty lab and 
used at a dilution of 1/1000. Anti-Rabbit secondary antibody conjugated with 
horseradish peroxidase (HRP) (Abcam) was used at a dilution of 1/3000. Anti-6xHis 
Tag conjugatd with HRP (Abcam) primary antibody was used at a dilution of 1/5000. 
 
2.3.2. Annealing of Primer-Template Substrates 
The DNA oligonucleotides used in primer extension assays, polymerase processivity 
assays, electrophoretic mobility shift assays (EMSAs), and single turnover kinetic 
assays are detailed in Table 2.6. Prof. Shigenori Iwai donated DNA containing a (6-
4)PP. ATDBio or Sigma-Aldrich manufactured all other DNA oligonucleotides. 
 
Oligonucleotides were annealed to a final concentration of 200 nM in annealing buffer 
(50 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl (pH 7.5)) to a final volume of 500 μL. 
Oligonucleotides were heated to 95°C for 10 minutes and allowed to return to room 
temperature to allow annealing. Annealed oligonucleotides were stored at -20°C. 
# Primer Direction Label Sequence  
1 Undamaged substrate 
(50/20mer) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
2 50mer ssDNA 5’-3’ 5’-Hex TGTCGTCTGTTCGGTCGTTCGGTCTTCAAGGCTGTTGTGCGCCCTGCGCG 
3 50mer dsDNA 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCAAGGCTGTTGTGCGCCCTGCGCG 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
4 Poly(dA) 5’-3’ 5’-Biotin AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
5 Poly(dC) 5’-3’ 5’-Biotin CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC 
6 Poly(dG) 5’-3’ 5’-Biotin GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG 
7 Poly(dT) 5’-3’ 5’-Biotin TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 
8 Single-incorporation 
kinetics substrate 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCA 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
9 Fidelity substrate (AA) 
 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGAACCGACAACACGCGGGACGCGC 
10 Fidelity substrate (CC) 
 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGCCTTGACAACACGCGGGACGCGC 
11 Fidelity substrate (GG) 
 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGGGCCGACAACACGCGGGACGCGC 
12 Fidelity substrate (TT) 
 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
13 Mismatch substrate 
(A/AA) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCA 
ACAGCAGACAAGCCAGCAAGCCAGAAGAACCGACAACACGCGGGACGCGC 
14 Mismatch substrate 
(C/AA) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCC 
ACAGCAGACAAGCCAGCAAGCCAGAAGAACCGACAACACGCGGGACGCGC 
15 Mismatch substrate 
(G/AA) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCG 
ACAGCAGACAAGCCAGCAAGCCAGAAGAACCGACAACACGCGGGACGCGC 
16 Mismatch substrate 
(T/AA) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCT 
ACAGCAGACAAGCCAGCAAGCCAGAAGAACCGACAACACGCGGGACGCGC 
17 Mismatch substrate 
(A/CC) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCA 
ACAGCAGACAAGCCAGCAAGCCAGAAGCCCCGACAACACGCGGGACGCGC 
18 Mismatch substrate 
(C/CC) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCC 
ACAGCAGACAAGCCAGCAAGCCAGAAGCCCCGACAACACGCGGGACGCGC 
19 Mismatch substrate 
(G/CC) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCG 
ACAGCAGACAAGCCAGCAAGCCAGAAGCCCCGACAACACGCGGGACGCGC 
20 Mismatch substrate 
(T/CC) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCT 
ACAGCAGACAAGCCAGCAAGCCAGAAGCCCCGACAACACGCGGGACGCGC 
21 Mismatch substrate 
(A/GG) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCA 
ACAGCAGACAAGCCAGCAAGCCAGAAGGGCCGACAACACGCGGGACGCGC 
22 Mismatch substrate 
(C/GG) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCC 
ACAGCAGACAAGCCAGCAAGCCAGAAGGGCCGACAACACGCGGGACGCGC 
23 Mismatch substrate 
(G/GG) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCG 
ACAGCAGACAAGCCAGCAAGCCAGAAGGGCCGACAACACGCGGGACGCGC 
24 Mismatch substrate 
(T/GG) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCT 
ACAGCAGACAAGCCAGCAAGCCAGAAGGGCCGACAACACGCGGGACGCGC 
25 Mismatch substrate 
(A/TT) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCA 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
26 Mismatch substrate 
(C/TT) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCC 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
27 Mismatch substrate 
(G/TT) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCG 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
28 Mismatch substrate 
(T/TT) 
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCT 
ACAGCAGACAAGCCAGCAAGCCAGAAGTTCCGACAACACGCGGGACGCGC 
29 CPD Substrate 1 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGT=TCCGACAACACGCGGGACGCGC 
30 CPD Substrate 2 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGT=TCCGACAACACGCGGGACGCGC 
31 CPD Substrate 3 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTCA 
ACAGCAGACAAGCCAGCAAGCCAGAAGT=TCCGACAACACGCGGGACGCGC 
32 (6-4)PP Substrate 1 5’-3’ 
3’-5’ 
5’-Hex 
None 
CACTGACTGTATGATG 
GTGACTGACATACTACT^TCTACGACTGCTC 
33 (6-4)PP Substrate 2 5’-3’ 
3’-5’ 
5’-Hex 
None 
CACTGACTGTATGATGT 
GTGACTGACATACTACT^TCTACGACTGCTC 
34 (6-4)PP Substrate 3 5’-3’ 
3’-5’ 
5’-Hex 
None 
CACTGACTGTATGATGA 
GTGACTGACATACTACT^TCTACGACTGCTC 
35 (6-4)PP Substrate 4 5’-3’ 
3’-5’ 
5’-Hex 
None 
CACTGACTGTATGATGC 
GTGACTGACATACTACT^TCTACGACTGCTC 
36 8-oxo-G Substrate 1 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAG8oGCCGACAACACGCGGGACGCGC 
37 8-oxo-G Substrate 2 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAG8oGCCGACAACACGCGGGACGCGC 
38 Tg Substrate 1 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGTgCCGACAACACGCGGGACGCGC 
39 Uracil Substrate 1 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGUCCGACAACACGCGGGACGCGC 
40 Uracil Substrate 2 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGUCCGACAACACGCGGGACGCGC 
41 AP Substrate 1 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGAPCCGACAACACGCGGGACGCGC 
42 Fidelity Substrate 
(CCCC)  
5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGCCCCGACAACACGCGGGACGCGC 
43 AP Substrate 2 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGAPCCGACAACACGCGGGACGCGC 
44 Tg Substrate 2 5’-3’ 
3’-5’ 
5’-Hex 
None 
TGTCGTCTGTTCGGTCGTTCGGTCTTC 
ACAGCAGACAAGCCAGCAAGCCAGAAGTgCCGACAACACGCGGGACGCGC 
Crystallography Substrates 
C1 Crystallography 
Substrate 1 
5’-3’ 
3’-5’ 
None 
None 
GCGTCAT 
CGCAGTATTACT 
 
Table 2.6. List of oligonucleotide substrates.  
The oligonucleotide substrates used in the experimental analysis of PrimPol. Mismatched bases are coloured in orange (i.e. those that do not 
conform to Watson-Crick base pairs) and damaged bases are coloured in red. 
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2.3.3. Primer Extension Assays 
Primer extension assays were based on a previously described method (Jozwiakowski 
and Connolly, 2011). Hex-labelled DNA primers were annealed to oligomer templates 
(see Table 2.6). Reactions were incubated at 37°C with 20 nM DNA, 10 mM Bis-Tris-
Propane-HCl (pH 7.0), 10 mM MgCl2, 1.0mM DTT and 250 μM dNTPs to a final volume 
of 20 μL unless otherwise specified. Protein concentrations in the reactions were 100 
nM for wild-type and C-terminal truncated constructs of PrimPol, and 34 nM for the 
polymerase domain of PrimPol alone. Control lanes contained no enzyme. Unless 
otherwise specified, time points were taken at 0.5, 1, 3, 5 and 60 minutes. The 
reactions were terminated by the addition of 2x stop buffer (95% formamide, 0.09% 
xylene cyanol, 0.05% bromophenol blue, 200 nM competitor oligonucleotide) and 
boiled at 95°C for 5 minutes. Samples were resolved by electrophoresis on a 15% 
polyacrylamide gel (37.5% (v/v) acrylamide/bisacrylamide (19:1) 40% mix (National 
Diagnostics), 7 M urea, TBE (89 mM Tris, 2mM EDTA, 0.89 M boric acid, pH 8.3) 0.1% 
(w/v) APS, 0.03% (v/v) TEMED). Gels were pre-run at a constant power of 15 W (~850 
V) for 30-60 minutes. Samples were loaded and electrophoresed at 850V for 2.5 hours 
in TBE buffer. Fluorescently labelled DNA oligomers were detected by scanning using 
a Fujifilm FLA-5100 image reader. 
 
2.3.4. Polymerase Processivity Assays 
Polymerase processivity assays were based on a previously described method 
(Washington et al., 1999). Hex-labelled DNA primers were annealed to oligomer 
templates (see Table 2.6). Protein was preincubated at 37°C with 100 nM protein, 
60nM DNA, 10 mM Bis-Tris-Propane-HCl (pH 7.0), 1 0mM MgCl2 and 1.0 mM DTT for 
one hour.  Reactions were initiated through the addition of 250 μM dNTPs and an 
excess of sonicated herring sperm DNA (1 mg mL-1) as an enzyme trap. Reactions 
were quenched at time points of 15, 30, 60, 120 and 360 seconds through the addition 
of 2x stop buffer. To test the effectiveness of the trap, each of the enzymes were also 
preincubated with excess of herring sperm DNA (1 mg mL-1), as well as 60 nM DNA, 10 
mM Bis-Tris-Propane-HCl (pH 7.0), 10 mM MgCl2 and 1 mM DTT and reactions 
initiated with the addition of 250 μM dNTPs. To ensure the trap did not disrupt the 
processivity of the enzyme, the experiment was also carried out with the Klenow 
fragment of Taq polymerase. Samples were resolved by electrophoresis on a 15% 
polyacrylamide gel as with primer extension assays and fluorescently labelled DNA 
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oligomers were detected by scanning using a Fujifilm FLA-5100 image reader. The 
band intensities were measured using ImageQuant software (GE Healthcare). The 
percentage of active polymerase at a given nucleotide position is given by the following 
equation: 
 
% active polymerases at n = (In + In+1 + In+2…) x 100% / (I1 + I2 + I3…) 
Where I1 is the intensity at position 1, In is the intensity at position n and so on. 
 
2.3.5. Electrophoretic Mobility Shift Assays 
Electrophoretic mobility shift assays (EMSAs) were carried out on hex-labelled DNA 
primers, either single-stranded or annealed to oligomer templates (see Table 2.6). 
Varying concentrations of proteins were added to 40-60 nM DNA, 10mM Bis-Tris-
Propane-HCl (pH 7.0), 10mM MgCl2 and 1.0 mM DTT to a final volume of 20 μL and 
incubated at 25°C for 60 minutes. The reactions were supplemented with 2 μL 25% 
(w/v) ficoll. Samples were resolved by electrophoresis on a 5% polyacrylamide gel 
(12.5% (v/v) acrylamide/bisacrylamide (19:1) 40% mix (National Diagnostics), 0.5x TBE 
(44.5 mM Tris, 1mM EDTA, 0.445 M boric acid, pH 8.3), 0.1% (w/v) APS, 0.03% (v/v) 
TEMED) cast in a 1 mm Novex Gel cassette (Invitrogen). Gels were run at 75 V for 1 
hour in 0.5x TBE buffer in the XCell SureLock Mini-Cell Electrophoresis System 
(Invitrogen). Fluorescently labelled DNA oligomers were detected by scanning using a 
Fujifilm FLA-5100 image reader. 
 
2.3.6. Single Turnover Kinetic Assays 
The single turnover assays were based on a previously described method (Nemec et 
al., 2012). Hex-labelled fluorescent DNA (Table 2.6) was incubated with 200 nM 
protein. The DNA/protein mixture was incubated with varying concentrations of dATP 
for time points ranging from 0.5-60 minutes and each reaction was carried out in 
triplicate. Reactions were quenched by the addition of 2x stop buffer. The products 
were resolved by electrophoresis as in the primer extension assays (Section 2.3.3). 
The concentrations of extended and unextended fluorescent DNA primers were 
measured using ImageQuant software (GE Life Sciences). The concentration of 
extended product relative to total fluorescent DNA loaded was plotted as a function of 
time and the data were fit to a single-exponential curve to obtain the kobs for the 
different dATP concentrations using the following exponential equation:  
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 [!"#$%&'] = !(1 − !!!!"#!) 
 
A secondary plot of kobs as a function of dATP concentration was fitted to the following 
hyperbolic equation: !!"# = ! !!"#[!"#$]!! !"#$ + [!"#$] 
where kpol is the rate of polymerisation and Kd(dNTP) is the equilibrium dissociation 
constant for dATP. 
 
2.3.7. Analysis of Protein Interaction by Gel Filtration 
Protein interaction was analysed by size-exclusion chromatography on a Superdex S75 
10/30 GL gel filtration column (GE Healthcare). The column was calibrated using 
albumin (67,000 Da), ovalbumin (43,000 Da), chymotrypsinogen A (25,000 Da), 
ribonuclease A (13,700 Da), and aprotinin (6,512). The protein was loaded at 0.5 mL 
min-1. Retention volume of the protein was plotted against the molecular weight of the 
protein to reliably predict protein molecular weights. The column was pre-equilibrated in 
a buffer containing 50 mM Tris-HCl, 100 mM NaCl and 2mM TECEP that had been 
sterile-filtered using a 0.2 μm pore size vacuum filtration system (Nalgene). 0.5 mL of 
protein was loaded at a concentration of 35 μM. Protein-containing fractions were 
determined by A280 level and samples of these fractions were subjected to SDS-PAGE 
analysis (see Section 2.3.1). 
 
2.4. Biophysical Methods 
2.4.1. Inductively Coupled Plasma Mass Spectrometry 
The concentrations of zinc ions in protein samples were determined using inductively 
coupled plasma mass spectrometry (ICP-MS). For this analysis of human PrimPol, the 
proteins were gel filtered in zinc-free solutions to minimise the concentration of zinc 
ions that were not chelated by protein. Quantitative calibrations were made using 
standards prepared from zinc solutions containing 0, 100, 500 and 1000 ng mL-1. Each 
sample was measured in triplicate and background measurements of buffer without 
protein were determined and subtracted from the appropriate readings. A wash was 
performed between standards and samples using 2% nitric acid. 
 
2.4.2. In-gel Digestion and Mass Spectrometry  
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Samples for mass spectrometry analysis were resolved by SDS-PAGE (Section 2.3.1) 
and Coomassie stained (Section 2.3.1.1). Bands of interest were excised and 
destained with a solution of 50% acetonitrile and 25 mM ammonium bicarbonate whilst 
vortexing. Bands were dehydrated for 5 minutes using a speedvac. Bands were 
rehydrated with 50μL of 10 mM DTT in 25 mM ammonium bicarbonate for 45 minutes 
at 50°C to reduce proteins. Bands were then allowed to return to room temperature and 
excess DTT solution was removed and replaced with 500 mM iodoacetamide in 25 mM 
ammonium bicarbonate and this was incubated for 45 minutes in the dark. Bands were 
subsequently dehydrated as before and rehydrated in a 1 μg μL-1 trypsin solution and 
left on ice for 5 minutes. Excess trypsin was removed and bands were covered with 25 
mM ammonium bicarbonate and incubated overnight at 37°C. Formic acid was then 
added to the gel bands to a final concentration of 5% (v/v). Bands were vortexed, 
centrifuged on a benchtop centrifuge at 13,000 rpm for 10 minutes and the supernatant 
was extracted to a separate tube. This was repeated with one volume of acetonitrile. 
The volume of protein solution was reduced to ~8 μL through concentration by 
speedvac. Protein solutions were stored at -20°C until required for mass spectrometry.  
 
Samples were analysed by mass spectrometry on an LTQ Orbitrap XL. Mass 
spectrometry was scanned across a mass/charge ratio of 200-2,000 and data was 
acquired using Xcalibur 2.1 software (Thermo Scientific). Proteins were loaded at a 
flow rate of 0.3 μL min-1 in a buffer of 0.1% formic acid, 1% acetonitrile onto a reverse 
phase HPLC column and eluted using a gradient up to 20% acetonitrile in 0.1% formic 
acid over a period of 40 minutes. Eluted peptides were analysed using a spray voltage 
of 2.2-3.0 kV. 2 μL of initial BSA standard (25 fmol μL-1) was loaded prior to individual 
protein samples. Raw files were converted into mgf format using proteomic analysis 
software Compass (Wenger et al., 2011) and proteins were identified from primary 
sequence databases using Mascot (Perkins et al., 1999). 
 
2.4.3. Circular Dichroism Spectroscopy 
Samples were buffer exchanged into a buffer of 400 nM NaF, 15 mM Tris-HCl (pH 7.5) 
and concentrated to 3 mg mL-1. The concentration of recombinant protein was 
determined before and after the circular dichroism (CD) scans, to ensure accurate 
secondary structure predictions. Samples were placed in a 0.1 mm quartz cuvette 
(Starna, Essex, UK) and measurements were taken using a JASCO J-715 
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spectropolarimeter (JASCO). The CD spectrum of the empty buffer was subtracted 
from that of the sample and time constant was set to 4 s with a scan rate of 50 nm min-
1. The bandwidth was 1 nm and the sensitivity set to standard. Scans were performed 
in triplicate from 320 to 180 nm with a 0.1 nm data pitch and continuous scan mode. A 
Peltier device was used to maintain a temperature at 20°C.  
 
2.4.4. Thermal Denaturation 
Proteins were buffer exchanged into a buffer of 200 mM NaF, 15 mM Tris-HCl (pH7.5). 
45 μl of 1 μM protein solution was added to 15 μl of SYPRO Orange, resulting in a final 
protein concentration of 0.75 μM. A control of 45 μl buffer was also added to 15 μl of 
SYPRO Orange. 20 μl of each sample was aliquoted in triplicate into an opaque 96 well 
plate. Protein melting experiments were carried out using the LightCycler 480 System II 
(Roche). The instrument was configured with a detection format of 465 nm as the 
wavelength of excitation and 580 nm as the emission wavelength to detect SYPRO 
Orange-specific signal. Denaturation curve fluorescent signal was acquired within a 
range of 20°C to 80°C using a ramping rate of 0.03°C s-1 and an acquisition of 20 data 
points per degree Celsius. Melting temperatures (Tm) were determined through the 
measurement of the lowest point of the negative differential of the denaturation curve. 
Data was corrected for the background signal of the buffer conditions and presented as 
units of fluorescence with respect to temperature ± 1 standard deviation. 
 
2.4.5. Protein Crystallisation 
2.4.5.1. Pre-crystallisation Trials 
Proteins were buffer exchanged into a suitable buffer for crystallography, typically to 
remove glycerol or to lower salt concentration. Pre-crystallisation trials were performed 
for each protein prior to crystallographic screening to estimate a suitable protein 
concentration for screening. Trials were constructed using the Pre-Crystallization Test 
(PCT) (Hampton Research) according to the manufacturer’s instructions. 
 
2.4.5.2. Crystallographic Screening 
Crystallographic screening was conducted using a Phoenix liquid handling system (Art 
Robbins Instruments) and a number of optimised crystallisation screens. These 
screens include Crystal Screen I (Hampton Research), Structure Screen II (Molecular 
Dimensions), PEGs Suite (Qiagen), MPD Suite (Qiagen), Ammonium Sulphate Screen 
(Qiagen), Nucleix Suite (Qiagen), Stura Footprint Screen (Molecular Dimensions), 
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MacroSol (Molecular Dimensions), ProPlex (Molecular Dimensions), and MIDAS 
(Molecular Dimensions). Crystallisation screens were set up in a sitting drop format 
with a 0.35 μL protein solution typically mixed 1:1 with 0.35 μL reservoir condition, with 
reservoir volume of 75 μL. Screens were sealed and incubated at a fixed temperature, 
generally 12°C. 
 
Crystallography screening by capillary diffusion was also set up using the Crystal 
HARP screen (Molecular Dimensions) according to the manufacturer’s instructions. 
This was incubated at 12°C.  
 
2.4.6. Determination of Protein Atomic Structure by X-ray Diffraction 
2.4.6.1. Protein Crystal Cryogenic Protection 
Crystal samples were mixed with cryo-protectant to protect crystals from ice crystals 
upon cooling. Protein crystals were looped from the drop using 100-200 μm aperture 
Micro Mounts (MeTeGen) and wafted into a drop of mother liquor containing cryo-
protectant, typically 2-methyl-2,4-pentanediol (MPD) or ethylene glycol.  
 
2.4.6.2. Crystallographic Analysis 
Following cryo-protection, crystals were mounted onto the goniometer of an X-ray 
generator. Single wavelength diffraction data were collected for a number of crystals 
using Rigaku MicroMax 007-HF (University of Sussex), and an RPA70N-PrimPol480-560 
crystal at station I03 Diamond Light Source, Didcot, UK. Diffraction data was analysed 
for protein content at perpendicular φ angles of 0° and 90°. Given sufficient quality 
data, a larger range data set was collected for crystals. The diffraction data were 
processed with iMOSFLM (Battye et al., 2011) and programs from the CCP4 suite 
(Collaborative Computational Project, Number 4, 1994 (E. Potterton et al., 2002; L. 
Potterton et al., 2004)). 
 
Molecular replacement and refinement was carried out by Dr. Nigel Brissett. All 
structural images were prepared using CCP4mg (McNicholas et al., 2011). A LigPlot 
schematic of the interactions between PrimPol and RPA70N was produced using the 
LigPlot+ software (Laskowski and Swindells, 2011). 
 
2.5. Bioninformatic and Analytic Tools 
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2.5.1. Secondary Structure Prediction Tools 
Secondary structure predictions of PrimPol were made using the University College 
London PSIPRED 2.0 server (Buchan et al., 2013; Jones, 1999). The secondary 
structure prediction of human PrimPol is shown in Appendix I. 
 
2.5.2. Identification of Protein Homologues 
Protein homologues were identified using the NCBI position-specific iterative basic 
local alignment search tool (PSI-BLAST) (Altschul et al., 1997). 
 
2.5.3. Gene Sequence Acquisition and Alignment 
Gene sequences were retrieved using the National Centre for Biotechnology 
Information from GenBank (Benson et al., 2009; Sayers et al., 2010). Multiple 
sequence alignments were created using Clustal Omega (Sievers et al., 2011) and 
analysed using JalView and CLC Sequence Viewer (CLCBio, 2014; Waterhouse et al., 
2009).  
 
2.5.4. Computation of Physical and Chemical Parameters of Proteins 
The program ProtParam, from the ExPASy server, was used for gathering the physical 
and chemical parameters of proteins as estimated from their primary protein sequence 
including pI, molecular weight and molar extinction coefficient (Gasteiger et al., 2005).  
 
2.5.5. Analysis of DNA fibre length from DNA combing experiments 
DNA fibre progression and immunolabelling experiments were carried out as described 
previously (Edmunds et al., 2008) by Dr. Laura Bailey. The data generated from these 
experiments were analysed using the OMERO 5 software package (The Open 
Microscopy Environment). Jackson and Pombo calculate that 1 μm represents 2.59 kb 
of DNA (Jackson and Pombo, 1998) and given a fixed length of time, in our case 20 
minutes, the rate of synthesis can be calculated from the length of the fibres in μm as 
follows: 
 !"#$%&'(!"#!!"#$!(!"! "#!!) = !"#$%ℎ!!"!!"#$% !" !×!!"#$!!"#$%!!"#!!"!(2.59!!"!!"!!)!"#$!(!"#)  
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CHAPTER 3 
 
 
Dissecting the Domain Architecture of 
Eukaryotic PrimPol 
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3.1. Introduction 
Until recently, the Pol α-associated DNA primase small subunit (PriS) responsible for 
de novo polymer synthesis through the production of RNA primers was considered to 
be the sole AEP superfamily member present in eukaryotes (Frick and Richardson, 
2001). However, bioinformatic analysis identified the existence of an additional 
uncharacterized DNA primase in eukaryotes called PrimPol, which belongs to the 
‘NCLDV-herpesvirus clade’ of viral AEPs (L. M. Iyer et al., 2005). Recent studies have 
reported that PrimPol is a DNA primase, with the ability to synthesise primers using 
either rNTPs or dNTPs with a preference for DNA primer production (Bianchi et al., 
2013; Garcia-Gomez et al., 2013; Keen et al., 2014; Mourón et al., 2013; Rudd et al., 
2013; Wan et al., 2013). 
 
Comparative analysis of the amino acid sequence of eukaryotic PrimPols identified the 
presence of two distinct domains (L. M. Iyer et al., 2005), an enzymatic AEP 
polymerase domain and a UL52-like zinc finger domain (see Figure 1.22). Mutation of 
the conserved zinc-chelating cysteine residues in the UL52 subunit of herpes simplex 
virus resulted in a severe reduction in DNA binding (Biswas and S. K. Weller, 1999; Y. 
Chen et al., 2005). The AEP polymerase domain of PrimPol contains the three 
signature catalytic motifs (see Figure 1.22); a highly conserved DxE motif (motif I) 
together with an aspartate residue from motif III forms the divalent metal binding site, 
and the SxH of motif II forms part of the putative nucleotide binding motif. Mutagenesis 
of these motifs abolishes the catalytic activities of these polymerases (Bianchi et al., 
2013; Garcia-Gomez et al., 2013; Lao-Sirieix and S. D. Bell, 2004; Lipps et al., 2004; 
Rudd et al., 2013).  
 
In this chapter, the molecular architecture of PrimPol is dissected to define the activities 
associated with its two major functional domains. PrimPol from Homo sapiens (human), 
X. tropicalis and Mus musculus (mouse) are examined (Figure 3.1). We demonstrate 
that the zinc finger domain is a single-stranded DNA binding motif that is crucial for 
primase activity. Polymerase activity, on the other hand, appears to be largely 
independent of the zinc finger domain. The AEP polymerase domain, responsible for 
both polymerase and primase activity is determined to bind both single-stranded and 
double-stranded DNA, as it would at a primer-template junction.  
 
3.2. Expression and Purification of Wild-type PrimPol 
 
 
 
Figure 3.1. Alignment of eukaryotic PrimPol homologues.  
The alignment of the three PrimPol homologues that are analysed biochemically in this 
thesis from Homo sapiens (Human), Mus musculus (Mouse), and Xenopus tropicalis. 
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The PrimPol constructs that were produced to assess their biochemical activities are 
shown in Figure 3.2. In order to assess the activities of PrimPol domains relative to the 
wild-type protein, we purified the wild-type PrimPols from both Homo sapiens (human) 
and X. tropicalis.  
 
3.2.1. Human PrimPol Purification 
The human PrimPol expression construct (plasmid H1, Table 2.3) was provided by my 
colleague Dr. Julie Bianchi and was expressed and purified as described in Tables 2.4 
and 2.5. Previous studies in the lab have shown that human PrimPol shows greatest 
soluble expression levels in Escherichia coli SHuffle competent cells. These SHuffle 
cells are a variant of the K12 strain of E. coli that have been engineered to express 
molecular chaperones to assist with the folding of proteins with multiple disulphide 
bonds, including the disulphide bond isomerase DsbC (Bessette et al., 1999; Levy et 
al., 2001). The pET28a expression vector was utilised for expression as it allowed a 
(6x-His) Affinity tag to be fused to the N-terminus of PrimPol thus allowing for 
purification by affinity of the aromatic hydrocarbon rings to nickel affinity resin. PrimPol 
was eluted from the nickel affinity chromatography column by imidazole (see Section 
2.2.4) and the correct size confirmed by SDS-PAGE (Figure 3.3A). PrimPol was further 
purified using heparin column chromatography, a pseudo-affinity column that acts as a 
DNA mimetic for proteins that bind nucleic acids (Figure 3.3A). 
 
In addition to the wild-type human PrimPol, a zinc finger knockout (ZF-KO) variant of 
PrimPol was also constructed (plasmid H11, Table 2.3). The first invariant cysteine and 
the invariant histidine of the zinc finger (C418 and H425 in human PrimPol) were 
mutated to alanines by site directed mutagenesis for the construction of this zinc finger 
knockout. The PrimPolZF-KO recombinant protein was purified by my colleague Dr. 
Stanislaw Jozwiakwoski for use in experiments described in this thesis. 
 
3.2.2. Purification of Xenopus tropicalis PrimPol  
A homologue of human PrimPol in X. tropicalis was purified to allow confirmation of our 
results using PrimPol from two different organisms, one mammalian and one 
amphibian. X. tropicalis PrimPol (XPrimPol) was identified by the PSI-BLAST program, 
an amino acid sequence homology search program. This sequence (accession number 
NP_001015920) is a truncated form of the protein, providing only the N-terminal 180 
amino acids. Reannotation of this gene by introducing frameshift mutations close to the 
 
 
 
 
Figure 3.2. Recombinant PrimPol variants.  
The human (blue), X. tropicalis (orange) and mouse (red) PrimPol variants analysed in 
this chapter are shown. Truncated PrimPol variants are depicted by their relative length 
and compared to the domain architecture shown above. Zinc finger knockout variants, 
denoted by ZF-KO, have two mutations in zinc-coordinating residues, C418A and 
H425A. 
 
 
 
 
 
 
 
 
Figure 3.3. The purification of wild-type Human and Xenopus PrimPol.  
(A) Purification of wild-type Human PrimPol (68.9 kDa). SDS-PAGE analysis of 
samples taken from the insoluble fraction and soluble fraction (load) from the growth 
and expression of PrimPol in BL21 as well as IMAC purification samples. The protein-
containing fractions from the heparin column are also shown. (B) Purified Xenopus 
tropicalis PrimPol (83.5 kDa). SDS-PAGE analysis of the heparin column fractions of X. 
tropicalis PrimPol following IMAC affinity and heparin column purification is shown. 
A 
B 
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region of the stop codon produced an extended gene product that aligned well with 
human PrimPol. This reannotated construct (plasmid X1, Table 2.3) was produced 
through subcloning of a synthetic construct (GenScript). This protein was purified in the 
same manner as human PrimPol (Figure 3.3B; see also Tables 2.3 and 2.4). This 
protein is ~83 kDa and this X. tropicalis PrimPol was used to produce a polyclonal 
antibody. This polyclonal antibody was purified and utilised in in vivo experiments in 
Xenopus laevis extracts, the protein identified in vivo was also an approximate size of 
~83 kDa. A more recent alignment of this reannotated X. tropicalis PrimPol with an X. 
laevis PrimPol gene (Appendix II) demonstrates that the two proteins align well up the 
C-terminus of both proteins, validating that our reannotated X. tropicalis PrimPol using 
frameshift mutation is the correct annotation of X. tropicalis PrimPol. 
 
3.3. Expression and Purification of PrimPol Truncations 
A number of PrimPol truncations were constructed for the biochemical and structural 
analysis of PrimPol activity in the absence of different parts of the protein. All 
truncations described in this chapter are depicted in Figure 3.2.  
 
3.3.1. Human PrimPol C-terminal Truncation (PrimPol1-487) 
The C-terminus of PrimPol, downstream of the zinc finger (amino acids 488-560), was 
removed by the introduction of a premature stop codon through site-directed 
mutagenesis (plasmid H8, Table 2.3). This PrimPol1-487 construct was also expressed 
and purified in the same manner as wild-type human PrimPol (Figure 3.4A). The 
section of the protein C-terminal of the zinc finger domain is not predicted to be well 
structured and, indeed, removal of this part of the protein increases the protein’s 
stability (see Section 6.2). This PrimPol1-487 variant was constructed to determine 
whether there were any effects on catalytic activity caused by the removal of the C-
terminus of PrimPol. 
 
3.3.2. Human PrimPol Polymerase Domain (PrimPol1-354) 
The predicted polymerase domain of PrimPol (amino acids 1-354) was constructed by 
PCR from the wild-type variant (plasmid H2, Table 2.3). PrimPol1-354 was expressed in 
BL21 E. coli cells, which offered a significantly greater yield of this truncated variant of 
the PrimPol protein. As this protein was also to be screened for crystallographic 
studies, additional cation exchange and size-exclusion chromatography steps were 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Purification of Human PrimPol1-487  and PrimPol1-354 truncation 
variants.  
(A) SDS-PAGE analysis of the purification of PrimPol1-487 (56.4kDa). PrimPol1-487  was 
purified by IMAC affinity and a heparin column. (B) SDS-PAGE analysis of the 
purification of PrimPol1-354 (43.2 kDa). PrimPol1-354 was purified by IMAC affinity 
chromatography, heparin column and by size-exclusion chromatography and the 
protein-containing fractions are shown. The breakdown products evident in the 
purification of PrimPol1-354 are analysed in Section 3.12.1. 
A 
B 
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carried out and protein purity was determined by SDS-PAGE analysis (Figure 3.4B). As 
distinctly evident in Figure 3.4B, there is are two proteolysis products at lower 
molecular weights than the desired product; these well-defined bands were consistently 
evident and subjected to mass spectrometry to determine their composition (see 
Section 3.12.1). 
 
3.3.3. Human PrimPol Zinc Finger Domain (PrimPol372-560) 
The zinc finger domain of PrimPol (amino acids 372-560) was also constructed by PCR 
from the wild-type variant of PrimPol (plasmid H9, Table 2.3). PrimPol372-560 was also 
expressed in BL21 E. coli cells. However as this protein had a predicted pI of 4.32, an 
anion exchange chromatography column was used to purify this protein following 
nickel-affinity chromatography (Figure 3.5A). 
 
In addition to the zinc finger domain, a mutated zinc finger knockout variant of the zinc 
finger domain was constructed (PrimPol372-560/ZF-KO). This was constructed by site 
directed mutagenesis of the 372-560 human PrimPol construct, resulting in the same 
C418A and H425A mutations as the PrimPolZF-KO construct. This mutated zinc finger 
domain was purified in the same manner as the zinc finger domain (Figure 3.5B). 
 
3.3.4. Xenopus tropicalis PrimPol Truncations 
Two X. tropicalis PrimPol truncations were constructed to discern their activities relative 
to the equivalent human constructs. These X. tropicalis PrimPol constructs were amino 
acids 1-334 and 1-472 (plasmids X2 and X3, Table 2.3). These amino acid positions 
were determined to be analagous to human 1-354 and 1-487 by sequence alignment 
(Figure 3.1). The XPrimPol1-472 protein was expressed in SHuffle E. coli cells and was 
purified by nickel-affinity chromatography only, but SDS-PAGE analysis illustrates that 
it was purified to sufficient homogeneity (Figure 3.6A). The XPrimPol1-334 protein was 
expressed in BL21 E. coli cells and purified using nickel-affinity chromatography 
column, a heparin column, and a gel-filtration column (Figure 3.6B). 
 
3.4. PrimPol is an Active Polymerase 
Previous studies had shown that PrimPol is indeed an active polymerase (Bianchi et 
al., 2013; Garcia-Gomez et al., 2013). This was activity was confirmed for both human 
and X. tropicalis PrimPol by standard primer extension assays using unmodified 
 
 
 
 
 
 
 
 
Figure 3.5. Purification of PrimPol372-560 and PrimPol372-560/ZF-KO.  
(A) SDS-PAGE analysis of the purification of PrimPol372-560 (24.0kDa). Samples from 
the insoluble and soluble (load) fractions are analysed along with samples from the 
IMAC affinity purification of PrimPol372-560. Also shown are the samples of the protein-
containing fractions from the Q column anion exchange chromatography of PrimPol372-
560. (B) SDS-PAGE analysis of the purification of PrimPol372-560/ZF-KO (23.9kDa). Samples 
from the Q column anion exchange chromatography of PrimPol372-560/ZF-KO are shown. 
Not shown here is the IMAC affinity chromatography of PrimPol372-560/ZF-KO. 
  
A 
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Figure 3.6. Purification of X. tropicalis PrimPol truncation variants.  
(A) SDS-PAGE analysis of the purification of XPrimPol1-472 (56.6 kDa). XPrimPol1-472 
purified using by IMAC affinity chromatography. (B) SDS-PAGE analysis of the 
purification of XPrimPol1-334 (40.5 kDa). XPrimPol1-334 was purified through the use of 
IMAC affinity, heparin column and size exclusion chromatography. The breakdown 
products evident here are similar to those seen in Figure 3.4B in the purification of 
Human PrimPol1-354 that are analysed in Section 3.12.1. 
  
A 
B 
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synthetic primers and dNTPs (Figure 3.7). The polymerase activity of the Klenow 
fragment (exonuclease deficient) of the polymerase from Thermus aquaticus (Klenow 
Taq) was also tested as a positive control enzyme (Figure 3.7). PrimPol is an active 
polymerase from both human and X. tropicalis, however from this experiment alone it is 
immediately evident that the polymerase activity of PrimPol is much slower than that of 
Klenow Taq. Whilst it takes an hour for the PrimPol to fully extend the primer DNA, it 
takes Klenow Taq less than 30 seconds. 
 
The removal of the unstructured C-terminus of PrimPol gave no reduction in the 
polymerase activity in both human and X. tropicalis systems (Figure 3.8). In fact, in 
both cases, there appears to be an apparent increase in the activity of both PrimPol1-487 
and XPrimPol1-472 relative to their wild-type counterparts. Fully extended product is 
evident as early as 3 minutes incubation when the C-terminus is truncated. 
 
3.5. PrimPol Polymerase Activity is Independent of the Zinc 
Finger Domain 
As PrimPol exhibits polymerase activity and it was previously demonstrated that this 
polymerase activity localises to the AEP polymerase domain of PrimPol (Bianchi et al., 
2013), we wanted to ascertain whether the zinc finger domain was simply dispensible 
for polymerase activity or if it played any crucial ancillary roles. The polymerase activity 
of PrimPol without the contribution of its putative zinc finger was measured in two 
ways: the first was a 1-354 truncation mutant that lacked the domain completely and 
the second was a double point mutant in which zinc-chelating C418 and H425 residues 
of human PrimPol were mutated to alanine (ZF-KO). Again, a X. tropicalis PrimPol 
truncation equivalent (1-334) was constructed to measure activity from two different 
organisms’ PrimPols.  
 
The removal of the zinc finger did not disrupt the polymerase activity of PrimPol and 
actually increased its apparent rate of incorporation relative to both wild-type and the 
C-terminus truncation of PrimPol (Figure 3.9). The concentration of the polymerase 
domain of PrimPol in these primer extension reactions was 3-fold lower than with the 
wild-type and C-terminus truncation (34 nM in comparison to 100 nM), yet the dNTP 
incorporation was comparable or higher in these assays. The PrimPolZF-KO construct of 
PrimPol was also an active polymerase but its activity was not increased relative to the 
wild-type PrimPol (Figure 3.9). 
 
 
Figure 3.7. Polymerase activity of  PrimPol.  
Human and X. tropicalis PrimPol was incubated with dNTPs and substrate 1 from 
Table 2.6 at 0.5, 1, 3, 5 and 60 minute time points, along with a control containing no 
protein. PrimPol is proficient at extending an undamaged oligonucleotide substrate 
using dNTPs. The proteins were also analysed in the absence of dNTPs and no activity 
was observed. As a positive control for polymerase activity, the Klenow fragment of the 
replicative polymerase from Thermus aquaticus (Klenow Taq), was analysed and 
significant polymerase activity is evident.  
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Polymerase activity of PrimPol1-487 and XPrimPol1-472. PrimPol1-487 and 
XPrimPol1-472 were incubated with dNTPs and substrate 1 from Table 2.6 at 1, 3, 5 and 
30 minute time points alongside a control containing no protein. Both proteins are 
proficient at extending an undamaged oligonucleotide substrate using dNTPs. The 
proteins were also analysed in the absence of dNTPs and no activity was observed. 
The C-terminus of PrimPol, predicted to be unstructured, is not necessary for 
polymerase activity. 
 
 
 
 
Figure 3.9. Polymerase activity of PrimPol1-354 and XPrimPol1-334, PrimPolZF-KO.  
PrimPol1-487 and XPrimPol1-472 were incubated with dNTPs and substrate 1 from Table 
2.6 at 0.5, 1, 3, 5 and 60 minute time points alongside a control containing no protein. 
All three proteins are proficient at extending an undamaged oligonucleotide substrate 
using dNTPs. The proteins were also analysed in the absence of dNTPs and no activity 
was observed. The zinc finger of PrimPol is dispensable for PrimPol’s polymerase 
activity.  
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3.6. PrimPol Cannot Utilise Ribonucleotides to Extend a Primer 
As discussed in Section 1.7 many AEPs are able to produce and extend primers 
utilising both rNTPs and dNTPs. Surprisingly, PrimPol and its truncations PrimPol1-487 
and PrimPol1-354 are unable to incorporate rNTPs when extending a DNA primer (Figure 
3.10), despite being able to produce RNA primers (Bianchi et al., 2013). XPrimPol1-334 
was also assessed for its ribonucleotide incorporation activity to investigate whether 
this absent activity was limited to human PrimPol but it appears to be congruous across 
organisms (Figure 3.10). An example of an AEP with a preference for extending DNA 
with rNTPs is M. paludicola NHEJ pol (Bartlett et al., 2013), and this protein was used 
as a positive control to compare against the ribonucleotide incorporation activity of 
PrimPol; indeed, there is an extension of two rNTPs onto the DNA primer terminus as 
previously described (Bartlett et al., 2013) (Figure 3.10). It remains to be seen whether 
PrimPol can extend an RNA primer using rNTPs. 
 
3.7. The Polymerase Domain of PrimPol can bind DNA 
Independently of the Zinc Finger 
As PrimPol can extend primer DNA at a primer-template junction, we decided to test 
whether the AEP polymerase domain of PrimPol binds to single-stranded DNA, double-
stranded DNA, or both. Electrophoretic mobility shift assays (EMSAs) were performed 
with increasing protein concentrations to analyse the DNA binding capabilities of the 
AEP polymerase domain of PrimPol. PrimPol1-354 was found to bind to both ssDNA and 
dsDNA with approximately equal proficiency, binding was evident at 500 nM protein 
and a complete shift of substrate at 5 μM protein (Figure 3.11). The observed DNA 
binding specificity reflects the likely presence of two closely clustered binding sites 
allowing recognition of a primer-template junction, which is an essential requirement for 
all DNA polymerases. This relatively weak coordination of DNA substrate is also 
consistent with previously postulated biological functions of human PrimPol in TLS 
(Bianchi et al., 2013; Garcia-Gomez et al., 2013; Rudd et al., 2013).  
 
As a positive control for these EMSAs, a known DNA-binding protein M. paludicola Ku, 
which binds specifically to double-stranded DNA, was used to confirm that the DNA 
was shifted as a result of protein binding (Figure 3.11). To ensure that the DNA shift 
was not a result of molecular crowding caused by an increased concentration of 
protein, BSA was added to an overhanging DNA with both ssDNA and dsDNA; there is 
 
 
 
Figure 3.10. Assessment of the DNA-dependent RNA polymerase activity of 
PrimPol.  
PrimPol, PrimPol1-487, PrimPol1-354 and XPrimPol1-334 were incubated with rNTPs and an 
undamaged DNA substrate (substrate 1 from Table 2.6) at 0.5, 1, 3, 5 and 60 minute 
time points alongside a control containing no protein. PrimPol is unable to extend a 
DNA primer using ribonucleotides opposite a DNA template. PolDom from M. 
paludicola (Mpa) was also analysed for its ribonucleotide incorporation activity as a 
positive control and incorporates two ribonucleotides. 
 
 
 
Figure 3.11. The polymerase domain of PrimPol binds both single stranded and 
double stranded DNA.  
PrimPol1-354 was analysed for DNA binding activity on 40 nM of both a single stranded 
and double stranded template (substrates 2 and 3 from Table 2.6, respectively) by 
EMSA at protein concentrations of 0, 0.05, 0.1, 0.5, 1.0, 5.0, 10.0 and 20.0 μM. 
PrimPol is able to bind both templates with comparable affinities as illustrated by the 
shift of the fluorescent oligonucleotide template on the polyacrylamide gel. Ku from M. 
paludicola (Mpa) was analysed as a positive control for DNA binding on the double 
stranded DNA template at concentrations of 0, 0.005, 0.01, 0.05, 0.1, 0.5, 1.0 and 5.0 
μM. To ensure that the shift was not caused by molecular crowding by increasing 
protein concentration, protein shifts were analysed using an overhanging DNA 
substrate (substrate 1 from Table 2.6) and bovine serum albumin (BSA) at 
concentrations of 0, 0.05, 0.1, 0.5, 1.0, 5.0, 10.0 and 20.0 μM. 
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no shift when BSA was added at increasing concentrations to the fluorescent DNA 
(Figure 3.11). Upon testing full-length, wild-type PrimPol for its ability to bind single-
stranded and double-stranded DNA, the DNA became shifted in a concentration-
dependent manner but the shift caused a smearing on the gel with a significant portion 
of protein-DNA complexes remaining in the wells of the gel. 
 
3.8. PrimPol’s Zinc Finger Chelates a Zinc Ion 
As described in Section 1.8, the C-terminal domain of human PrimPol contains a highly 
conserved UL52-like Cys-His-Cys-Cys (CHC2) motif, predicted to fold into a functional 
zinc finger motif (Figure 1.22). To establish if this is a bona fide zinc-binding motif, we 
produced C-terminal truncations in PrimPol containing either an intact (PrimPol372-560) or 
mutated (PrimPol372-560/ZF-KO) zinc finger motif. PrimPol372-560/ZF-KO has the first two 
invariable residues of the zinc finger motif mutated to alanine. The proteins were gel 
filtered in the absence of zinc and concentrations of zinc were then measured using 
inductively coupled plasma mass spectrometry (ICP-MS) (Table 3.1). ICP-MS is used 
for elemental analysis, typically that of metal ions. Samples are dried, vapourised, 
atomised and ionised in plasma composed of argon ions at a temperature of over 6000 
K. Ions are filtered by their mass/charge ratio using a quadrupole mass filter and, 
finally, analysed by mass spectrometry. The ICP-MS analysis revealed that the 
concentration of the zinc in the UL52-like domain represented an occupancy of 
80.38%, suggesting that a small fraction of the protein is either unfolded or has another 
divalent metal ion chelated. This is a much higher zinc concentration than evident for 
the AEP BcMCM (11%) (Samuels et al., 2009); however, zinc concentration for 
BcMCM was determined following purification in the absence of zinc and subsequent 
dialysis into another buffer that lacked zinc, allowing for the titration out of zinc ions at a 
number of steps. 
 
In contrast, the zinc finger knockout (PrimPolZF-KO) had an occupancy of ~3.90%, 
suggesting that the first two cysteine and histidine residues of this motif are required for 
the coordination of zinc; the presence of a minute level of zinc suggests that either the 
protein folds into a structure that has some weak zinc-binding activity or that some of 
the zinc was transferred into the gel filtration buffer from earlier in the purification. We 
also measured the zinc occupancy in the polymerase domain (PrimPol1-354) after 
purification in the absence of zinc and the occupancy in this case was ~1.57%.  The 
detection of low levels of zinc in the polymerase domain is to be expected as it contains 
 
 
 
 
 
 
 
 
 
 
Protein Construct Protein Concentration Zinc Concentration Occupancy 
PrimPol372-560 80.0 64.34 ±  1.29 80.38% 
PrimPol372-560/ZF-KO 30.0 1.17 ± 0.05 3.90% 
PrimPol1-354 32.5 0.51  0.023 1.57% 
 
 
 
 
 
 
 
 
 
Table 3.1. Zinc occupancy of PrimPol domains.  
The PrimPol zinc finger domain (PrimPol372-560) and zinc finger domain knockout (PrimPol372-560/ZF-KO) were gel filtered in the absence of zinc to 
remove any zinc that was not chelated by protein. They were subsequently tested for zinc concentration by inductively coupled plasma mass 
spectrometry (ICP-MS). The zinc finger domain exhibits zinc occupancy of 80.43%, whereas the zinc finger knockout only has occupancy of 
3.9%, suggesting that the zinc chelation requires the intact amino acids that form the zinc finger motif (Cys-His-Cys-Cys, not Ala-Ala-Cys-Cys). 
The 1-354 polymerase domain was purified in the absence of zinc and was also subsequently tested for zinc occupancy, but only had 1.57% 
occupancy. 
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divalent cation-binding motifs. These motifs generally bind magnesium or manganese, 
which have respective ionic radii of 86 and 81 pm, but could conceivably bind zinc, with 
a comparable ionic radius of 88 pm (Shannon, 1976). 
 
3.9. The Zinc Finger Domain Binds Single-Stranded DNA 
Having established that the putative zinc finger does indeed chelate a zinc ion, we 
aimed to determine whether it was capable of binding DNA. The zinc finger domain is 
presumed to be a DNA-recognition domain, in addition to contributing to its primase 
activity, as previous studies demonstrated altered DNA binding activity associated with 
mutations in the related zinc finger domain of UL52 (Biswas and S. K. Weller, 1999; Y. 
Chen et al., 2007). EMSAs were performed with increasing protein concentrations to 
analyse the DNA binding capabilities of the zinc finger of PrimPol, controls for this 
experiment are described in Section 3.7. 
 
In contrast with the AEP polymerase domain, PrimPol’s zinc finger domain was unable 
to bind dsDNA but did show specific binding to ssDNA (Figure 3.12), albeit with a low 
apparent dissociation constant. This intriguing result provides experimental evidence 
supporting the potential importance of the zinc finger module in 
recognition/coordination of the single-stranded template DNA upstream of the primer-
template junction. To determine if it was indeed the zinc finger that performed DNA 
binding, we assayed a zinc finger knockout mutant domain (PrimPol372-560/ZF-KO) for DNA 
binding activity (Figure 3.12) and observed an abolishment of binding with this mutant, 
confirming the importance of the zinc finger motif for nucleic acid recognition. 
 
3.10. An Intact Zinc Finger is Required for Primase Activity 
It was previously shown that PrimPol has DNA primase activity in vitro (Bianchi et al., 
2013; Garcia-Gomez et al., 2013; Wan et al., 2013). Although the zinc finger of PrimPol 
is not required for its polymerase activity, it may have been a requirement for primase 
activity. Primase assays were carried out in collaboration with my colleague Dr. 
Stanislaw Jozwiakowski. Primers were synthesised de novo opposite homopolymeric 
templates that were 5’-biotinylated using either ribonucleotides or 
deoxyribonucleotides. Primers were extended using 2 U Klenow Taq supplemented 
with a fluorescence nucleotide analogue to allow for the fluorescent labelling of primers. 
Reactions were quenched and DNA bound to streptavidin-coated beads and excess 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12. The zinc finger of PrimPol binds single stranded DNA. 
PrimPol372-560 and PrimPol372-560/ZF-KO were analysed for DNA binding activity on 40 nM 
of both single stranded and double stranded templates (substrates 2 and 3 from Table 
2.6, respectively) by EMSA at protein concentrations of 0, 0.05, 0.1, 0.5, 1.0, 5.0, 10.0 
and 20.0 μM. PrimPol372-560 is only capable of binding ssDNA, with the shift on dsDNA 
much less pronounced. PrimPol372-560/ZF-KO is unable to bind either single-stranded or 
double-stranded DNA. An intact zinc finger is required for PrimPol C-terminal binding of 
ssDNA. 
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nucleotides were washed prior to resolution on a polyacrylamide gel and detection by 
fluorescence scanner (Keen et al., 2014). 
 
The zinc finger motif of the related AEP UL52 is an absolute requirement for primase 
activity (Biswas and S. K. Weller, 1999; Y. Chen et al., 2005). As previously observed 
(Bianchi et al., 2013; Rudd et al., 2013), wild-type PrimPol exhibited primase activity on 
a 60-mer poly-dT ssDNA template, however PrimPolZF-KO showed no detectable 
primase activity (Figure 3.13). Furthermore, we analysed the primase activity of two 
deletion mutants, PrimPol1-487 and PrimPol1-354, which were constructed to determine 
whether elimination of primase activity resulted from a structural change brought about 
by the point mutations or whether the zinc-finger domain is necessary for primase 
activity. As expected, the PrimPol1-354 deletion mutant lacking the entire zinc finger 
showed no detectable primase activity (Figure 3.13). However, PrimPol1-487, containing 
the entire zinc-finger domain but lacking the smaller C-terminal portion was an active 
DNA primase (Figure 3.13). Notably, the observed primase activity of PrimPol1-487 was 
lower than the activity observed for the parental enzyme, as this truncation possibly 
results in partial loss of the zinc finger domain structure and functionality.  
 
Together, our data provide experimental evidence that the zinc-finger domain, but not 
the disordered C-terminal region proximal to this domain, is essential for the primase 
activity of human PrimPol. PrimPol without an intact zinc finger can, therefore, be used 
as a “separation of function” mutant to help determine which catalytic functions, either 
the primase activity or polymerase activity of PrimPol, are required in vivo. 
 
3.11. PrimPol’s Polymerase Domain is Essential for the 
Maintenance of Normal Replication Fork Rate in Unperturbed 
Cells 
It was previously shown by our laboratory that avian DT40 cells that had their PrimPol 
knocked out (PrimPol-/-) showed a significant reduction in replication fork progression 
rate (Bianchi et al., 2013). Given the biochemical data established in this chapter, we 
aimed to evaluate the requirement for the zinc finger for replication fork rate 
progression. It was previously shown that stably expressing wild-type PrimPol in these 
PrimPol-/- DT40 cells would successfully restore near wild-type replication fork levels 
rates (Bianchi et al., 2013). This in vivo analysis was carried out in collaboration with 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13. DNA primase activity of PrimPol.  
PrimPol, PrimPolZF-KO, PrimPol1-487 and PrimPol1-354 were all analysed for DNA-
dependent primase activity on homopolymer substrates (substrates 4-7 in Table 2.6) 
using either rNTPs or dNTPs. PrimPol and PrimPol1-487 both have de novo primer 
production activity using both rNTPs and dNTPs on poly(dT) substrates, with a 
preference for utilisation dNTPs. Neither PrimPolZF-KO nor PrimPol1-354 exhibit de novo 
primase activity.  The experiments shown here were carried out by Dr. Stanislaw 
Jozwiakowski. 
 
 67 
my colleague Dr. Laura Bailey. Replication fork rates were measured by DNA fibre 
analysis, which involves the pulse labelling of exponentially growing DT40 cells using 
CldU for 20 minutes, followed by IdU for 20 minutes. Labelled DNA was then detected 
using anti-CldU and anti-IdU antibodies (Edmunds et al., 2008). Replication rates were 
then calculated as described in Section 2.5.5. 
 
We confirmed that normal replication fork rates are restored by adding back human 
PrimPol (Figure 3.14); however, this replication fork defect is not corrected by adding 
back the catalytically dead PrimPolAXA mutant (Motif I DxE!AxA; D114A, E116A 
mutant) (Figure 3.14). Next, we measured the replication fork speed in PrimPol1-354 and 
PrimPolZF-KO complemented clones. We observe that both proteins were able to restore 
replication fork rates to near wild-type levels (Figure 3.14). This suggests that only the 
polymerase activity of PrimPol, not the primase activity, is required for the maintenance 
of fork progression in unperturbed replication. PrimPol1-354 complemented cells show 
even greater average replication fork rates compared to wild type cells (Figure 3.14), in 
accordance with its moderately superior polymerase activity in vitro (Section 3.5). 
These in vivo findings are in accordance with other studies (Mourón et al., 2013). 
 
3.12. Towards the Structural Characterisation of Human 
PrimPol 
To gain a better understanding of the amino acids required for catalysis and how 
PrimPol carries out its catalytic activities, we aimed to crystallise the AEP polymerase 
domain of PrimPol. The catalytic domain alone was selected for attempting to resolve 
the structure of PrimPol as previous investigations, including those in our own 
laboratory, had often been successful in the first instance in crystallising the catalytic 
subunit before attempting to crystallise with accessory peptides (Augustin et al., 2001; 
Brissett et al., 2007; N. Ito et al., 2003).  The polymerase domain PrimPol1-354 was 
chosen to attempt crystallisation but following extensive screening I was unable to 
produce any crystals of any suitable size for X-ray diffraction and those small crystals 
that did develop were unfortunately not reproducible. 
 
As the first predicted α helix of human PrimPol is not conserved between human and 
X. tropicalis (Figure 3.1, Appendix I), we decided to remove this first helix and attempt 
crystallisation again. The first 24 amino acids of human PrimPol were removed from 
the polymerase domain and the resulting protein was purified (Figure 3.15A). Similar to 
 
 
 
 
 
Figure 3.14. PrimPol polymerase activity is required for maintaining replication 
fork rate in vivo.  
(A) PrimPol−/− DT40 cells were complemented with wild-type, AXA (D114A/E116A), 1-
354, and ZF-KO variants of PrimPol and their in vivo expression confirmed by western 
blot. (B) Unperturbed replication fork rates were analysed by DNA fibre analysis using 
CldU and IdU labels for all the complemented cell types. The data represent the mean 
of three or more experiments with error bars showing the mean standard deviation. 
Experiments shown here carried out by Dr. Laura Bailey. 
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Figure 3.15. Purification and polymerase activity of PrimPol24-354.  
(A) SDS-PAGE analysis of PrimPol24-354 showing samples from the protein-containing 
fractions from the size exclusion chromatography of PrimPol24-354 (40.3 kDa). 
Breakdown products are evident and these products are analysed by mass 
spectrometry in Section 3.12.1. The second gel (top right) represents SDS-PAGE 
analysis of the size exclusion chromatography fraction samples upon expression and 
purification of PrimPol24-354 in the presence of increased benzamidine and PSMF 
protease inhibitors showing the persistence of PrimPol breakdown products. (B) 
PrimPol24-354 was incubated with dNTPs and substrate 1 from Table 2.6 at 0.5, 1, 3, 5 
and 60 minute time points, along with a control containing no protein. PrimPol24-354 is 
proficient at extending an undamaged oligonucleotide substrate using dNTPs.  
A 
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PrimPol1-354 (Figure 3.4) and XPrimPol1-334 (Figure 3.6) two smaller protein bands are 
evident on the PrimPol24-354 purification SDS-PAGE gel. As it was initially suspected 
that these breakdown bands were caused by proteases from purification, I increased 
the protease inhibitor concentration two-fold and attempted to re-purify the protein 
(Figure 3.15A). However, these protein degradation bands were still present, 
suggesting either that these bands represented peptides that were not PrimPol24-354 but 
interacted with PrimPol during purification, peptides that have the same 
chromatography column-binding profiles as PrimPol24-354, or PrimPol24-354 having an 
exposed site that is susceptible to nicks in the protein through a protease inhibitor-
resistant means. These degradation bands are analysed in section 3.12.1. PrimPol24-354 
was confirmed to retain its polymerase activity upon removal of this putative first α helix 
(Figure 3.15B). Unfortunately, following more extensive screening with PrimPol24-354, 
the same issues were experienced as with PrimPol1-354 in attempted generation of 
protein crystals. 
 
3.12.1. Identification of PrimPol Degradation Products 
As described in the section above, when purifying the human and X. tropicalis 
polymerase domains, two smaller peptides are evident on the SDS-PAGE analysis 
gels. To identify whether these proteins are PrimPol and, if so, where the protein is 
being nicked, these protein bands were analysed by in-gel protease digestion and 
mass spectrometry (see Section 2.4.2). The resulting short peptides identified the 
smaller proteins observed on the gels to indeed be truncated forms of PrimPol’s 
polymerase domain.  
 
The largest protein band observed on the gel was confirmed to be PrimPol and 
peptides covered the length of the protein (Figure 3.16A). The middle band at around 
30 kDa on the protein did not produce any peptides beyond amino acid 271, 
suggesting that the protein degrades at residue 271 or somewhere slightly further 
towards the C-terminus (Figure 3.16B). The lower band’s digestion products ranged 
from amino acids 170-344 (result not shown); as a single protein product this size 
represents a protein around 20 kDa and the band in the gel suggests this protein is 
much smaller than that, it is likely that this band actually represents the amino acids C-
terminal of this truncation at around residue 271 and other peptides present are 
contaminating small peptides one might expect to be present in small quantities 
towards the bottom of the electrophoresed polyacrylamide gel. 
 
 
 
 
 
Figure 3.16. Identification of PrimPol24-354 breakdown products.  
In-gel digestion and mass spectrometry of breakdown products of PrimPol24-354 
compared with the major, non-truncated protein band. Protein fragments are depicted 
as block colours beneath corresponding amino acids. Numbers correspond to the 
amino acid numbers in human PrimPol. (A) The protein fragments from the major band 
of purified PrimPol24-354 range the length of the protein as expected. (B) The top 
breakdown band protein fragments from in-gel digestion range up to amino acid 271 
suggesting that the protein is truncated at some point after residue 271. 
A 
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3.12.2. Hydrogen-Deuterium Exchange Reveals the Unstructured 
Regions of Human PrimPol 
We aimed to identify more of the unstructured regions that were hindering 
crystallisation by probing human PrimPol through hydrogen-deuterium exchange. This 
work was carried out in collaboration with the Skehel laboratory at the MRC Laboratory 
of Molecular Biology in Cambridge. The principle of this approach involves the analysis 
of peptides following a period of exchange between hydrogen and its heavier isotope 
deuterium ( H!! ) in a solution of D2O. Following this exchange, peptides are analysed for 
their level of exchange by mass spectrometry; high exchange suggests a more 
exposed, external region of the protein, whilst less exchange suggests more of a 
central, internal region of the protein. 
 
The hydrogen-deuterium exchange profile of PrimPol is shown in Figure 3.17. As 
expected, the core, conserved amino acids show less exchange with D114 and E116 
of motif I, S167 and H169 of motif II, and D280 of motif III all found in low-exchange 
regions of the protein. There is a high-exchange region in the catalytic domain from 
around amino acid 220. Intriguingly, part of this high-exchange region is absent from 
both X. tropicalis and Mus musculus (Mouse) PrimPol (Figure 3.17), suggesting 
perhaps this unstructured region is unnecessary for catalysis and may be mobile, thus 
impeding crystallisation. The hydrogen-deuterium exchange data indicates that, at the 
beginning of the protein, the amino acids on the N-terminus of residue 41 are exposed 
and flexible as demonstrated by their propensity for hydrogen-deuterium exchange. At 
the C-terminus of the polymerase domain, there appears to be exchange as early as 
amino acid 291. This suggests the polymerase domain could be further truncated to 
construct a more minimal and, consequently, stable polymerase domain for structural 
studies. 
 
3.12.3. A Minimal PrimPol AEP Polymerase Domain 
As our mass spectrometry data suggested that the protein had a fragile site at around 
amino acid 271 or slightly higher (Section 3.12.1), the protein was truncated on the N-
terminal side of a predicted beta sheet at amino acid 276 (Appendix I). This resultant 
recombinant protein was, as expected, inactive (Figure 3.18) as it precludes the third 
essential motif (D at position 280) for catalysis. Concurrently, we also produced a 
construct of amino acids 39-276. Amino acid 39 was selected as it offers a 2 amino 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17. Hydrogen-Deuterium Exchange of PrimPol.  
Protein areas of high isotopic exchange are indicated in red and those areas of lower isotopic exchange are indicated in blue. Low exchange is 
indicative of the more protected, central regions of protein, whilst high exchange is indicative of more exposed, external regions of protein. 
These experiments were carried out in the laboratory of J. Mark Skehel. 
More Exchange Less Exchange 
1   MNRKWEAKLK QIEERASHYE RKPLSSVYRP RLSKPEEPPS IWRLFHRQAQ AFNFVKSCKE DVHVFALECK VGDGQRIYLV TTYAEFWFYY KSRKNLLHCY  100 
101 EVIPENAVCK LYFDLEFNKP ANPGADGKKM VALLIEYVCK ALQELYGVNC SAEDVLNLDS STDEKFSRHL IFQLHDVAFK DNIHVGNFLR KILQPALDLL  200 
201 GSEDDDSAPE TTGHGFPHFS EAPARQGFSF NKMFTEKATE ESWTSNSKKL ERLGSAEQSS PDLSFLVVKN NMGEKHLFVD LGVYTRNRNF RLYKSSKIGK  300 
301 RVALEVTEDN KFFPIQSKDV SDEYQYFLSS LVSNVRFSDT LRILTCEPSQ NKQKGVGYFN SIGTSVETIE GFQCSPYPEV DHFVLSLVNK DGIKGGIRRW  400 
401 NYFFPEELLV YDICKYRWCE NIGRAHKSNN IMILVDLKNE VWYQKCHDPV CKAENFKSDC FPLPAEVCLL FLFKEEEEFT TDEADETRSN ETQNPHKPSP  500 
501 SRLSTGASAD AVWDNGIDDA YFLEATEDAE LAEAAENSLL SYNSEVDEIP DELIIEVLQE 560 
 
 
 
 
 
Figure 3.18. Polymerase activity of PrimPol1-276, PrimPol39-276 and PrimPol1-299. 
PrimPol1-276,  
PrimPol39-276 and PrimPol1-299 were constructed and purified as indicated in Tables 2.3-
2.6. Each variant was incubated with dNTPs and DNA substrate 1 from Table 2.6 at 
0.5, 1, 3, 5 and 60 minute time points, along with a control containing no protein. 
Neither PrimPol1-276 nor PrimPol39-276 had any polymerase activity. PrimPol1-299 had 
some residual polymerase activity but also showed some exonuclease activity, 
suggesting the presence of contaminating proteins. 
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acid buffer to the putative highly structured amino acids that begin at position 41, as 
predicted from both our secondary structure prediction and our hydrogen-deuterium 
exchange data; the protein would also then begin with a proline to aid in demarcating 
the desired the protein and the N-terminal tag. PrimPol39-276, too, was inactive as 
expected (Figure 3.18). The third construct we tested was PrimPol1-299. 1-299 was 
chosen as the hydrogen-deuterium data determined that the region C-terminal of 
residue 291 was more exposed; additionally, the amino acids C-terminal of 299 are 
less well conserved between human and X. tropicalis than the amino acids to the N-
terminal side of 299. PrimPol1-299, however, showed a significant reduction in activity 
(Figure 3.18). There is only evidence of extension at 60 minutes and it is limited. As 
PrimPol1-299 was only purified by affinity chromatography it cannot also be ruled out that 
the meagre activity that is present may be the result of contaminating proteins, which 
could also account for the small amount of exonuclease activity also present at 
increasing time points. In either case, this protein exhibits very little activity in 
comparison to PrimPol1-354 or PrimPol24-354. 
 
In addition to these three constructs, PrimPol39-354 was also cloned. PrimPol39-354 
purified and tested for activity (Figure 3.19). This PrimPol39-354 construct had an unusual 
activity, whilst it was reduced relative to PrimPol1-354 or PrimPol24-354 it also had peculiar 
signature of primer extension products, only extending primers around halfway up the 
length of the template. Despite this altered activity, we went ahead with screening for 
crystallography products; the first human Y-family polymerase structure was resolved 
on a truncated form of pol κ that had reduced polymerase activity but whose 
polymerase domain remained intact (Uljon et al., 2004). Again though, following 
extensive crystal screening, this protein remained recalcitrant to producing crystals 
suitable for X-ray diffraction. 
 
3.13. Towards the Structural Characterisation of Mouse PrimPol 
To overcome the intractability of the human protein, we chose to study the M. musculus 
(Mouse) PrimPol, which has a highly similar sequence to human PrimPol. However, 
absent from mouse PrimPol’s AEP polymerase domain are a number of amino acids 
(Figure 3.1) that are present in the human PrimPol but are predicted to be unstructured 
by hydrogen-deuterium exchange and could represent an unnecessary mobile loop 
element that posed a hindrance to crystallography trials. Given this, structural studies 
were continued using the mouse PrimPol as a potential candidate for crystallography 
 
 
 
 
 
 
Figure 3.19. Purification and polymerase activity of PrimPol39-354.  
(A) SDS-PAGE analysis of PrimPol39-354 showing samples from the protein-containing 
fractions from the size exclusion chromatography of PrimPol39-354 (38.6 kDa). PrimPol 
breakdown products of remain evident. (B) PrimPol39-354 was incubated with dNTPs and 
substrate 1 from Table 2.6 at 0.5, 1, 3, 5 and 60 minute time points, along with a 
control containing no protein. PrimPol39-354 has a strange signature of activity, 
appearing to stall at various points when extending the substrate primer; there is little 
evidence of full extension, even after 60 minutes. 
A 
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trials. The equivalent construct of the human PrimPol AEP polymerase domain was 
initially constructed; in mouse PrimPol this was amino acids 1-338 (MPrimPol1-338). This 
protein was purified and, unlike the human or X. tropicalis polymerase domains, there 
is no evidence of any degradation products on the gel (Figure 3.20A). The reason for 
this lack of protein breakdown, or rather the presence of this breakdown in human and 
X. tropicalis purifications, remains elusive. 
 
MPrimPol1-338 was shown by primer extension assays to be an active polymerase 
(Figure 3.20B). The protein was then screened for protein crystal production; however, 
in keeping with the human PrimPol polymerase domain, this domain was recalcitrant to 
crystallisation. The protein was then screened for crystals in the presence of a DNA 
template at a protein-DNA molar ratio of 1:1.5, and 4mM MgCl2. The DNA template 
(substrate C1, Table 2.6) was chosen based on the DNA template for the crystallisation 
of pol η (Biertümpfel et al., 2010), with the length altered to a minimal length that the 
polymerase domain of PrimPol would still extend from (results not shown). This 
screening garnered reproducible crystals, in a diammonium phosphate condition, that 
were large enough in size to potentially undergo X-ray diffraction (Figure 3.21A). 
However, a simple crush test confirmed that these crystals were extremely unlikely to 
contain protein and were more likely to be salt crystals. 
 
Despite a pre-crystallisation test (PCT) suggesting that the optimal concentration for 
screening MPrimPol1-338 was 8.5 mg mL-1, this concentration of protein gave a high 
proportion of sitting drops that exhibited large amounts of precipitation. As such, the 
protein concentration was lowered to 7 mg mL-1 and the DNA concentration adjusted to 
maintain a 1:1.5 molar ratio and the protein was re-screened for crystals. Crystals 
developed in two similar conditions containing similar reservoir buffers. These buffers 
were supplemented with 20% ethylene glycol as a cryoprotectant and X-ray diffraction 
data was collected and a diffuse pattern suggests that there is no ice crystal formation 
(representative example in Figure 3.21B). The crystals from the two conditions were 
then both analysed by X-ray diffraction (Figure 3.21C-D). Both diffraction patterns are 
indicative of salt crystals, high intensity spots at mid-high resolution; the increased 
number of spots in Figure 3.21D suggest that the salt crystals in this condition may 
contain some low level of protein. 
 
 
 
 
 
 
 
 
 
 
Figure 3.20. Purification and polymerase activity of MPrimPol1-338.  
(A) Purification of MPrimPol1-338. MPrimPol1-338 was purified in four chromatography 
steps and the SDS-PAGE analysis of samples from fractions at each stage is shown 
(39.2 kDa). Unlike purification of the human polymerase domain, MPrimPol1-338 does 
not exhibit any proteolytic breakdown products. (B) MPrimPol1-338 was incubated with 
dNTPs and substrate 1 from Table 2.6 at 0.5, 1, 3, 5 and 60 minute time points 
alongside a control containing no protein. MPrimPol1-338 is proficient at extending an 
undamaged oligonucleotide substrate using dNTPs. MPrimPol1-338 was also analysed in 
the absence of dNTPs and no activity was observed. 
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Figure 3.21. Crystallographic screening of MPrimPol1-338.  
(A) MPrimPol1-338 was screened at 8.5mg ml-1 at a molar ratio of 1:1.5 with DNA in the presence of 4 mM MgCl2. Reservoir Condition 0.2M 
(NH4)2HPO4, 40% MPD. Crush test confirmed these crystals to be salt. (B) An example of an ice crystal formation test. Mother Liquor conditions 
were supplemented with 20% ethylene glycol as cryoprotectant and diffraction patterns are taken at φ angles of 0 and 90°. The diffuse pattern 
shown here with no apparent diffraction suggests that there are no ice crystals. (C) MPrimPol1-338 was screened up at 7 mg ml-1 at a molar ratio 
of 1:1.5 with DNA in the presence of 4 mM MgCl2. Crystals were present in the reservoir condition 0.09M NPS (NaNO3; Na2HPO4; (NH4)2SO4 
mix), 0.1M Tris Bicine (pH 8.5), 30% PEG (PEG MME 500; PEG 20,000 mix). X-ray diffraction patterns were taken φ angles of 0 and 90° and 
the evident high intensity spots at mid-high resolution are indicative of salt crystals. (D) Mouse 1-338 PrimPol was screened up at 7 mg ml-1 at a 
molar ratio of 1:1.5 with DNA in the presence of 4 mM MgCl2. Crystals were formed in the reservoir condition 0.09M NPS (NaNO3; Na2HPO4; 
(NH4)2SO4 mix), 0.1M Tris Bicine (pH 8.5), 30% precipitant (MPD; PEG 1000; PEG 3350 mix). X-ray diffraction patterns were taken φ angles of 
0 and 90° and the multiple high intensity spot pattern is evident of salt crystals that may contain protein. (E) MPrimPol1-338 was screened up at 7 
mg ml-1 at a molar ratio of 1:3 with DNA in the presence of 4 mM MgCl2. Crystals were formed in the same reservoir condition as in (C) and 
show a similar salt diffraction pattern. (F) Mouse 1-338 PrimPol was screened up at 7 mg ml-1 at a molar ratio of 1:1.5 with DNA in the presence 
of 4 mM MgCl2 and 5 mM dideoxyadenosine triphosphate (ddATP). Crystals were formed in the reservoir condition 0.09M NPS (NaNO3; 
Na2HPO4; (NH4)2SO4 mix), 0.1M Tris Bicine (pH 8.5), 30% precipitant (Glycerol; PEG4000 mix). The X-ray diffraction patterns taken φ angles of 
0 and 90° are similar to that of (E). The DNA substrate used in these crystal screens is substrate C1 from Table 2.6. 
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The protein was also screened at 7 mg mL-1, with a DNA concentration such that the 
molar ratio was adjusted to 1:3. Crystals developed in one of the same condition as 
above but again the diffraction pattern is indicative of salt crystals. Finally, the protein 
was screened in the presence of all of DNA, MgCl2 and a non-hydrolysable adenosine 
triphosphate (ATP) analogue, adenylyl imidodiphosphate (AMP-PNP). Again, crystals 
developed in a similar condition as above; however, these crystals were again salt 
crystals. 
 
As with human PrimPol, first 24 amino acids were then truncated to produce a more 
compact AEP polymerase domain, MPrimPol24-338. MPrimPol24-338, like MPrimPol1-338, 
purified without any evident degradation products (Figure 3.22). This protein was then 
screened for crystal formation at a concentration of 16 mg mL-1, as determined by PCT. 
Whilst no crystals were evident during initial screening, there was a significant level of 
phase separation in conditions containing 2.2 M ammonium sulphate and 0.2 M of 
various potassium salts (Figure 3.23A). Different potassium salts were tested in 
ammonium sulphate at a range of temperatures (4°C, 12°C, 20°C and 37°C) and it was 
discovered that small crystals became evident in potassium acetate when incubated for 
1.5 hours at 37°C, then transferred to room temperature overnight (Figure 3.23B). 
Upon altering the salt concentrations, well-defined crystals were also evident at a 
higher potassium acetate concentration of 0.3 M (Figure 3.23C). The intention was for 
these crystals to be analysed by X-ray diffraction, however when they were transferred 
into a mother liquor solution containing 20% ethylene glycol, the crystals dissolved. 
These crystals were under a ‘skin’ layer of protein that is often present in sitting drops 
with a high concentration of protein and I believe that there was a high local 
concentration of protein under this skin layer that stabilised the crystals; upon 
transferring to a mother liquor solution without protein, the crystals became destabilised 
and dissolved into the solution. 
 
In addition to screening apo MPrimPol24-338, crystal formation was also screened in the 
presence of DNA and 4 mM MgCl2 in a 1:2 molar ratio. A single crystal developed in 
one of the conditions but X-ray diffraction data from this crystal was highly indicative of 
a salt crystal (Figure 3.23D). 
 
As human hydrogen-deuterium exchange indicated that the first ~40 amino acids of 
PrimPol were not core amino acids and these residues align well with between human 
 
 
 
 
Figure 3.22. Purification and polymerase activity of MPrimPol24-338.  
(A) Purification of MPrimPol24-338. MPrimPol24-338 was purified in the same manner as 
MPrimPol1-338 and the SDS-PAGE analysis of samples from fractions following size 
exclusion chromatography is shown (36.2 kDa). (B) MPrimPol24-338 was incubated with 
dNTPs and substrate 1 from Table 2.6 at 0.5, 1, 3, 5 and 60 minute time points 
alongside a control containing no protein. MPrimPol24-338 is proficient at extending an 
undamaged oligonucleotide substrate using dNTPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23. Crystallographic screening of MPrimPol24-338.  
(A) MPrimPol24-338 screened at 16 mg/ml showed significant phase separation in the sitting drops with reservoirs containing 2.2 M ammonium 
sulphate, with a number of potassium salts. Potassium salts shown here from top left include 0.2 M KBr, 0.2 M KCl, 0.2 M K3 Citrate, 0.2 M 
KH2PO4, 0.2 M KF, 0.2 M KCOOH, 0.2 M K2HPO4, 0.2 M KI, 0.2 M KNO3, 0.2 M K/Na Tartrate. (B) Following screening of 2.2 M ammonium 
sulphate with different potassium salts at a number of temperatures, it was discovered that crystals could be grown in the sitting drops of a 
reservoir containing 2.2 M ammonium sulphate and 0.2 M potassium acetate when incubated at 37°C for 1 hour before incubation at 20°C. (C) 
Following variation of salt concentrations, crystals were also evident at 0.3 M potassium acetate. (D) MPrimPol24-338 was screened up at 7 mg 
ml-1 at a molar ratio of 1:2 with DNA in the presence of 4 mM MgCl2. Crystals were present in the reservoir condition 0.1 M Ammonium Acetate, 
0.02 M Magnesium Chloride, 0.05 M Hepes-Na (pH 7), 5% (w/v) PEG 8000. X-ray diffraction patterns were taken φ angles of 0 and 90° and the 
evident high intensity spots at mid-high resolution are indicative of salt crystals. The DNA substrate used in these crystal screens is substrate 
C1 from Table 2.6. 
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and mouse PrimPol, we also removed the first 38 amino acids of Mouse PrimPol. This 
MPrimPol39-338 was cloned and purified (Figure 3.24A). Upon testing for primer 
extension activity, the same unusual signature is apparent that was seen for human 
PrimPol39-354 (Figure 3.24B). This suggests the removal of these 38 amino acids, in 
particular the amino acids between 24 and 38, has an effect on the structure of the 
AEP polymerase domain core. Screening this protein for crystals yielded no significant 
results. 
 
3.13.1. Hydrogen-Deuterium Exchance Reveals the Unstructured 
Regions of the Mouse PrimPol AEP Polymerase Domain 
In collaboration with the Skehel laboratory, hydrogen-deuterium exchange was also 
applied to the Mouse PrimPol AEP polymerase domain (MPrimPol1-338). As with human 
PrimPol, as expected, the three highly conserved motifs, D114 and E116 of motif I, 
S167 and H169 of motif II, and D262 of motif III are all in low exchange regions of the 
protein (Figure 3.25). The exchange was high in the first 34 amino acids, but there was 
actually a protection from exchange from amino acid 35. This suggests that the 
removal of amino acids 35-38 may have an affect on the central, core structure of the 
protein, which would account for the unusual activity evident in Figures 3.19 and 3.24 in 
which the human and mouse PrimPol polymerase domains, respectively, are disrupted 
to some extent. Consequently, the disruption of the polymerase domain could lead to a 
more open, flexible conformation, which is even more disinclined to crystallise. 
 
The hydrogen-deuterium exchange data also suggested that amino acids 314-323 are 
more exposed at the surface of the protein. As such, MPrimPol1-314 was constructed to 
test whether the amino acids C-terminal of 314 are required for activity. This protein 
was expressed but was found to be mostly insoluble (Figure 3.26A). Although in the 
elution step of the affinity chromatography step during SDS-PAGE analysis there 
appears to not be any protein present, spectrophotometry confirmed the presence of a 
low level of protein. As such, this protein was concentrated and subjected to 
chromatography through the use of a Heparin column and the fractions are shown in 
Figure 3.26A. This protein was found to be active (Figure 3.26B), thus the amino acids 
C-terminal of 314 are not essential for activity. However, as the vast majority of this 
protein was insoluble, the purification yields were far too low for crystallography, the 
yields were less than 1 mg per litre of culture, compared to yields of over 50 mg per 
litre of culture for MPrimPol1-338, MPrimPol24-338 and MPrimPol39-338. Whilst amino acids 
 
 
 
 
 
Figure 3.24. Purification and polymerase activity of MPrimPol39-338.  
(A) SDS-PAGE analysis of MPrimPol39-338 showing samples from the protein-containing 
fractions from the size exclusion chromatography of MPrimPol39-338 (34.5 kDa). (B) 
MPrimPol39-338 was incubated with dNTPs and substrate 1 from Table 2.6 at 0.5, 1, 3, 5 
and 60 minute time points, along with a control containing no protein. MPrimPol39-338 
has a similar, strange signature of activity as PrimPol39-354, stalling at various points 
when extending the substrate primer and having very little primer extended fully, even 
after 60 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.25. Hydrogen Deuterium Exchange of MPrimPol24-338.  
Protein areas of high isotopic exchange are indicated in red and those areas of lower isotopic exchange are indicated in blue. Low exchange is 
indicative of the more protected, central regions of protein, whilst high exchange is indicative of more exposed, external regions of protein.  
These experiments were carried out in the laboratory of J. Mark Skehel. 
More Exchange Less Exchange 
1   MLRKWEARVK QIEERASHYE RKPLSSVYRP RLAKPEEPSS IWKLFHRQNQ AFNFVKSCKE SVHVFALECK RGNGQRIYLV TSYAQLWFYY KTRKTLLHCY 100 
101 EVIPENAVCK LYFDLEFNKL ANPGADGKMM VALLIQHVCK ALEEFYNVQC SAEDVFNLDS STEEKFSRHL IFQLHNVAFK DNRHAGNFVR KILQPALHLI 200 
201 AEDDEAKVPE AVGQDASGFS VTPLKQEISE AREKVGLPKQ CDPDLSFLVV KNHMGEKCLF VDLGVYTKNR NFRLYQSSKI GKCVSLEVAE DNRFIPKQSK 300 
301 DISEENQYFL SSLVSNVRFS DTLRVLTCHP SQTKRKRA 338 
 
 
 
 
 
 
 
 
Figure 3.26. Purification and polymerase activity of MPrimPol1-314.  
(A) SDS-PAGE analysis of MPrimPol1-314 showing samples from insoluble and soluble 
(load) fractions from the growth and expression of MPrimPol1-314 showing MPrimPol1-314 
to be mostly insoluble (36.4 kDa). Although little protein is evident in the SDS-PAGE 
analysis of the elution of protein from the IMAC affinity chromatography column, 
spectrophotometry analysis indicated the presence of protein. Following concentration 
and purification by heparin column chromatography, some MPrimPol1-314 protein was 
evident (B) MPrimPol1-314 was incubated with dNTPs and substrate 1 from Table 2.6 at 
0.5, 1, 3, 5 and 60 minute time points, along with a control containing no protein. 
MPrimPol1-314 is active, but present in too low a yield for crystallographic analysis. 
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315-338 may not be essential for catalysis, they are most likely involved in protecting 
the protein from aggregation and entering inclusion bodies in E. coli. 
 
3.14. Summary and Discussion 
Recent studies have identified that PrimPol is a novel eukaryotic AEP superfamily 
polymerase capable of performing both priming and primer extension synthesis 
(Bianchi et al., 2013; Garcia-Gomez et al., 2013; Rudd et al., 2013; Wan et al., 2013). 
In this chapter, we have dissected the molecular activities associated with the major 
structural elements of human PrimPol and determined the cellular requirements for 
these elements in vivo for maintenance of replication fork speed. The DNA polymerase 
activity of PrimPol appears to be independent of the zinc finger domain. However, a 
catalytically active PrimPol lacking the zinc finger domain (PrimPol1-354) shows 
enhanced relative polymerase compared to the wild-type enzyme, and in the next 
chapter this apparent polymerase activity regulation by the zinc finger is explored 
further.  
 
An intact zinc finger is essential for PrimPol’s primase activity in vitro, consistent with 
reports for a similar requirement for the highly related zinc finger domain of herpesvirus 
UL52 (Biswas and S. K. Weller, 1999; Y. Chen et al., 2005). Zinc-binding elements are 
found in most DNA primases (Section 1.7) and play critical functions in such primases 
(Kuchta and Stengel, 2010). It has been proposed that this structural element is 
required for template recognition and regulation of primer length synthesis (Corn et al., 
2005). Interestingly we find that, out of the four homopolymers tested, PrimPol only has 
activity priming opposite a poly(dT) polymer. This specificity for homopyrimidine 
templates is not uncommon among AEPs. For example, the replicative AEPs from M. 
jannaschii and T. kodakaraensis are only able to prime on homopyrimidine templates 
and not homopurine templates and the primase from P. furiosus specifically primes on 
poly(dT) templates (Bocquier et al., 2001; Desogus et al., 1999; Galal et al., 2012b). 
The S. solfataricus preferentially primes in a synthetic thymine-containing bubble 
structure that mimics early replication intermediates (De Falco et al., 2004).  
 
Removal of the last 73 amino acids of human PrimPol at the C-terminal region proximal 
to the zinc finger (PrimPol1-487) did not abolish primase activity, which suggests that the 
C-terminus is not an absolute requirement for activity; however, activity was reduced to 
some extent suggesting that there likely are amino acids in this region responsible for 
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the structural integrity of the zinc finger. As they are not required for catalysis, we 
investigate the potential requirements of the final 80 amino acids in protein-protein 
interactions in Chapter 6. 
 
Complementation of UL52-knockout viral cells with UL52 containing a mutation of 
conserved zinc-chelating residues was unable to support viral growth (Biswas and S. 
K. Weller, 1999). We find, however, that a zinc-finger mutant of PrimPol not only 
successfully complements PrimPol-/- avian cells but in the case of PrimPol1-354, in which 
the zinc finger is removed entirely, replication fork speed is actually increased relative 
to the wild-type. This UL52 protein containing a mutation in its zinc finger motif had a 
92% reduction in forked DNA binding activity and had lost all of its primase activity 
(Biswas and S. K. Weller, 1999). Whilst the disruption of the zinc finger in humans 
indeed had a profound effect on primase activity, it is unlikely that binding to forked 
DNA is hindered due to the observed increase in polymerase activity that is evident 
when the zinc finger of PrimPol has been removed. Additionally, we have shown here 
that the polymerase domain of PrimPol binds both ssDNA and dsDNA in the absence 
of the zinc finger in the high-nanomolar to low-micromolar range. 
 
The activity most closely associated with the AEP superfamily, namely de novo primer 
synthesis, is considered to be somehow different from primer extension activities 
associated with canonical polymerases. However, as discussed in section 1.7, 
primases should be considered to be polymerases that have evolved to catalyse a 
poorly processive extension reaction involving the synthesis a dinucleotide. To do this, 
they have the capacity to bind a single nucleotide as the “primer”, which provides the 
3’OH to initiate attack on a second template-bound nucleotide to form the first 
phosphodiester linkage. As the zinc finger binds single-stranded DNA and its absence 
negates primer synthesis, we propose that the zinc finger acts in concert with the 
polymerase domain to stabilise the binding and configuration of the template, 
polymerase and nucleotides long enough to allow the production of the initial 
dinucleotide “primer” (Figure 3.27). This product is subsequently extended in a more 
processive polymerisation mode. The function of the zinc finger is explored further in 
Chapter 4. 
 
To gain a clearer understanding of how the polymerase domain carries out its catalytic 
activities, we attempted the rational design of a minimal PrimPol polymerase domain 
 
 
 
 
 
 
 
 
 
Figure 3.27. Model of the catalytic activities of PrimPol.  
PrimPol has both DNA primase and polymerase activities. The zinc finger of PrimPol stabilises the binding of the polymerase domain on single-
stranded DNA. The AEP polymerase domain coordinates two adjacent deoxynucleotides opposite the single-stranded DNA template and the 
stability afforded to this complex by zinc finger binding allows synthesis of a dinucleotide. This dinucleotide can then be extended in a more 
processive way to form longer products. PrimPol can also bind primer-template junctions to catalyse more canonical primer extension 
reactions. Both the polymerase and primase activities are intrinsic to the AEP domain. We postulate that the primase and polymerase activities 
of PrimPol are not discrete activities but rather represent different synthesis modes performed under different DNA binding conditions.  
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for human PrimPol to get an X-ray crystal structure of the protein. Hydrogen-deuterium 
exchange revealed potentially unstructured, flexible regions of the protein but we were 
unable to grow any adequate protein crystals. I presume this is in part a result of 
human PrimPol breaking down either during expression or purification. As such, we 
also attempted crystallography through the rational design of a minimal Mouse PrimPol 
polymerase domain. Although a number of crystals developed, these crystals were all 
determined to be salt crystals. A crystal structure would help determine whether a 
structural core is shared with the other AEP primases, given that PrimPol’s zinc-
chelating moiety is separate from the active polymerase domain. Other AEP primase 
structural cores consist of an (α2β2) module and an RRM-like fold that is found in the 
palm region of other polymerases (L. M. Iyer et al., 2005). Given the high conservation 
of motifs I and III it would be rational to assume that PrimPol, like all other 
polymerases, employs the typical di-metal-ion nucleotidyl transferase reaction with the 
amino acids from motif II coordinating an incoming nucleotide. An apo crystal structure 
would help determine which amino acids are in close proximity to these conserved 
motifs in three-dimensional space and potentially support catalysis or template 
orientation. A crystal structure of PrimPol in the presence of DNA would illustrate how 
accommodating the active site is and how it is able to read through distortive DNA 
lesions such as (6-4)PPs (see Chapter 4). 
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CHAPTER 4 
 
 
Characterisation of DNA Polymerase 
Activities of Human PrimPol 
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4.1. Introduction 
PrimPol is present in both the nucleus and mitochondria of eukaryotic cells (Bianchi et 
al., 2013; Garcia-Gomez et al., 2013; Rudd et al., 2013; Wan et al., 2013). The enzyme 
localises to nuclear chromatin during replication (Bianchi et al., 2013; Rudd et al., 2013; 
Wan et al., 2013) and this is more pronounced after treatment with damaging agents 
such as ultraviolet light (UV) or replication stalling drugs such as hydroxyurea (Bianchi 
et al., 2013). Deletion of PrimPol (PrimPol-/-) induced replication fork slowing, which 
was much more pronounced when cells were UV irradiated (Bianchi et al., 2013). 
Knockout cells also exhibited increased formation of chromosomal breaks, particularly 
after aphidicolin treatment. UV irradiation can induce the covalent linkage of adjacent 
pyrimidines leading to the formation of CPDs and (6-4)PPs (Section 1.4.2). These 
helix-distorting lesions interfere with major biological processes, including DNA 
replication and transcription. PrimPol can perform translesion synthesis (TLS) bypass 
of the highly distorting (6-4)PPs but is also involved in replication through oxidative 
lesions, including 8-oxoguanine (8-oxo-G) (Bianchi et al., 2013; Garcia-Gomez et al., 
2013; Rudd et al., 2013). PrimPol is not epistatic with the Pol η-dependant CPD-
bypass pathway and therefore appears to form an independent pathway required for 
the bypass of UV, and other lesions, during replication (Bianchi et al., 2013).   
 
As the polymerase domains of TLS polymerases are more open and accommodating 
than high-fidelity, replicative polymerases to allow for replication past distortive DNA 
lesions (W. Yang, 2005), it is expected that that PrimPol has a similar active site. A 
more open, accommodating active site, however, can have a profound effect on a 
polymerase’s fidelity, its tolerance of mismatched bases, and its kinetic parameters. In 
this chapter I investigate these properties of PrimPol and how they compare to other 
polymerases and what role the zinc finger plays in maintaining these properties. 
 
Although PrimPol’s polymerase activities appeared, initially, to be largely independent 
of the zinc finger domain (chapter 3), the data reported in this chapter suggests that the 
zinc finger domain plays important roles in the processivity and fidelity of DNA 
synthesis, as well as in other polymerase properties such as the tolerance of 
mismatched bases and the read-through of DNA damage. It is demonstrated here that 
a catalytically active fragment of PrimPol, containing only the AEP domain, catalyses 
TLS through both major UV-induced DNA lesions, CPDs and (6-4)PPs. 
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4.2. Processivity of PrimPol on DNA Templates 
We analysed the number of nucleotides incorporated by human PrimPol in a single 
association-dissociation event to measure the processivity of this polymerase. In order 
to determine the processivity of PrimPol, we performed primer extension assays in the 
presence of an excess of DNA (sonicated herring sperm DNA), which acted as a 
“substrate trap” for polymerases that dissociate from the primer-template substrate 
(Washington et al., 1999). Using this approach, we observed that PrimPol inserts up to 
4 nucleotides opposite an undamaged template, rarely inserting more than this (Figure 
4.1A-B). It is worth noting that not all proteins present insert 4 nucleotides, with about 
equal efficiency in incorporating 1, 2 or 3 nucleotides. When the zinc finger domain was 
removed from PrimPol, the maximum number of nucleotides incorporated remained at 
~4 but the average number of nucleotides incorporated was higher, with fewer 
polymerases inserting 1-3 nucleotides (Figure 4.1A-B). Processivity assays were 
carried out in the presence of Taq polymerase to ensure that it was not the trap DNA 
that kept the polymerase from inserting more than four nucleotides. We observe that 
Taq polymerase possesses high processivity and incorporates nucleotides up to the 
end of the template DNA (Figure 4.1C). Therefore, the zinc finger appears to play a role 
in regulating the number of nucleotides that PrimPol inserts, possibly by stabilising the 
interaction of the polymerase domain with the template. 
 
4.3. Single Incorporation Kinetics of Wild-Type PrimPol 
To quantify the processivity of PrimPol in terms of reaction rate, a single-incorporation 
kinetic analysis was performed to determine the catalytic efficiency (kpol) and binding 
constants for dATP (KD(dNTP)) for the incorporation of dATP opposite a templating 
thymine (see Section 2.3.6). This method is based on the quantification of nucleotide 
incorporation given a range of concentrations of dATP. We found the wild-type kpol to 
be 6.98 min-1 and the KD(dNTP) to be 15.51 µM (Figure 4.2). PrimPol is an extremely slow 
enzyme, for comparison the kpol of base excision repair enzyme DNA polymerase β is 
1,944 min-1 (Nemec et al., 2014) and the kpol of replicative enzyme pol ε is 16,500 min-1 
(Zahurancik et al., 2014). The kpol of Y-family polymerase pol ι is closer to the rate of 
PrimPol but is still quicker, at a rate of 37.8 min-1(Washington et al., 2004). The KD(dNTP) 
for pols β, ε and ι were in the same range as that of PrimPol, 5.7 µM, 33 µM and 4.9 
µM respectively (Nemec et al., 2014; Washington et al., 2004; Zahurancik et al., 2014). 
Representative examples of single incorporation experiments are shown in appendix 
III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Processivity of Human PrimPol.  
PrimPol was preincubated for 30 minutes at 37°C with an undamaged fluorescent DNA primer-template substrate (substrate 1 from Table 2.6) 
to allow PrimPol to bind to the DNA. The reaction was initiated through the addition of dNTPs and an excess of sonicated herring sperm DNA 
trap and time points taken at 15 s, 30 s, 60 s, 120 s and 360 s. (A) After 360 s, full length PrimPol incorporates up to 4 nucleotides opposite the 
template but there is a significant fraction of enzyme that incorporates only 1, 2 or 3 nucleotides. To confirm that the trap prevents polymerase 
extending from a second template, the trap was also added into the preincubation mix with PrimPol and the DNA substrate. This reaction was 
supplemented with dNTPs and there is no extension, thus successfully exhibiting the effectiveness of the trap. PrimPol1-354 also predominantly 
incorporates up to 4 nucleotides but, unlike the full-length, there are fewer polymerases that only incorporate 1, 2 or 3 nucleotides. The 
effectiveness of the trap was also successfully confirmed for the 1-354 construct. (B) Percentage of PrimPol molecules incorporating at least n 
dNTPs for each of full-length PrimPol and PrimPol1-354 was calculated using the equation in Section 2.3.4. (C) As a processive polymerase 
control, Klenow Taq polymerase was also assessed for its processivity. Klenow Taq extends DNA the full length of the template when 
preincubated with DNA. In the case of Klenow Taq, less substrate was extended because less Klenow Taq polymerase molecules (20 nM) was 
present than substrate (60 nM) and proteins being quenched when sonicated herring sperm DNA. The effectiveness of the trap in the case of 
Klenow Taq polymerase was also confirmed by the preincubation of Klenow Taq with herring sperm DNA prior to addition of dNTPs. 
A B 
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Figure 4.2. Single incorporation kinetics of PrimPol.  
Single turnover kinetics of wild-type PrimPol were used to determine catalytic efficiency 
(kpol) and dNTP binding efficiency (KD(dNTP)). (A) The concentration of extended DNA 
product, as determined by electrophoresis, was plotted against time and fit to an 
exponential curve for a number of dATP concentrations. These data were fit to 
exponential curves as described in the equation in Section 2.3.6. and kobs was 
determined. Experiments were carried out in triplicate and error bars represent 
standard deviations. (B) kobs was subsequently plot against dATP concentration for 
PrimPol and these data were fit to hyperbolic curves as described in Section 2.3.6. to 
determine kpol and KD(dNTP). kpol for wild-type PrimPol was found to be 6.98 min−1 ± 0.40 
and KD(dNTP) was 15.51 μM ± 2.71. 
A 
B 
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4.4. The Fidelity of PrimPol 
Unlike the replicative polymerases, PrimPol lacks a 3’-5’ exonuclease activity and as 
PrimPol is a poorly processive enzyme similar to other TLS polymerases, which 
themselves have low fidelity, we decided to measure the fidelity of PrimPol as it is 
potentially an error-prone DNA polymerase. We measured fidelity through a series of 
nucleotide incorporation experiments opposite oligonucleotides with different templating 
bases. For each templating nucleotide, adenine, cytosine, guanine or thymine, 
PrimPol’s ability to incorporate an incoming dATP, dCTP, dGTP or dTTP was 
assessed. Wild-type PrimPol in these experiments exhibits little aberrant incorporation 
of nucleotides (Figure 4.3A). There is some evidence of incorporation of a third 
cytosine nucleotide at the N+3 position when incorporating cytosine opposite two 
templating guanines followed by a cytosine, suggesting therefore that PrimPol could 
incorporate cytosine opposite another cytosine if it was already extending a template 
or, perhaps more likely, that the template DNA is ‘scrunched’ by PrimPol and one of the 
guanines is read twice as a templating base. PrimPol1-354 that lacks the entire zinc 
finger domain unexpectedly shows a significantly reduced ability to accurately select 
the incoming nucleotide (Figure 4.3B). PrimPol1-354 also exhibits this incorporation of a 
third, incorrect nucleotide when extending a primer and it is apparent in the case of 
incorporation of guanine, cytosine and adenosine. Also, this polymerase domain of 
PrimPol is evidently capable of insertion of an adenine nucleotide opposite cytosine. 
This observation suggests the potential importance of the zinc finger domain in 
influencing the fidelity of PrimPol’s polymerase activity. 
 
This initial examination of the fidelity of PrimPol is on a limited number of templates in a 
manner that was not quantified. Subsequent experiments by Dr. Stanislaw 
Jozwiakowski from our laboratory have offered additional insights into the fidelity of 
PrimPol. The measurement of fidelity using a plasmid-based gap-filling assay using 
plasmid pSJ4-lacZa demonstrates the error rate of human PrimPol to be 1.0 x 10-4, this 
is almost an order of magnitude more frequent than the 3.6 x 10-5 error rate of the exo- 
Klenow fragment of Taq polymerase from the same method (Guilliam et al., 2015), but 
it remains less error prone than Y-family TLS polymerases pol η, κ and ι (Matsuda et 
al., 2001; Ohashi et al., 2000; Washington et al., 2004), and is in the same range as 
Dpo4 (Fiala and Suo, 2004). Sequencing of errors introduced by PrimPol revealed that 
insertions and deletions, so called indel mutations, accounted for ~65% of these 
  
 
Figure 4.3. Single incorporation fidelity of PrimPol.  
(A) PrimPol was incubated for 5 minutes with individual dNTPs as indicated, all four 
dNTPs or a no dNTP control along with substrates 9-12 from Table 2.6 to allow 
incorporation of single nucleotides opposite two templating bases for each individual 
base. PrimPol exhibits standard Watson-Crick base pairing opposite each template 
nucleotide but appears to erroneously incorporate nucleotides at position N+3 when 
incorporating cytosine opposite two guanines, with the third templating base in this 
case being cytosine. (B) PrimPol1-354 was also tested for its fidelity in the same manner 
as PrimPol. PrimPol1-354 exhibited more misincorporations relative to the wild-type 
protein; PrimPol1-354 incorporates adenine opposite a template cytosine with relatively 
high proficiency. PrimPol1-354 also exhibits more pronounced N+3 misincorporations, 
utilising each of guanine, cytosine and adenine opposite an incorrect N+3 templating 
base. 
A 
B 
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mutations (Guilliam et al., 2015). By far the most significant base substitution mutation 
was an G!A/C!T mutation, accounting for 25% of total mutations caused by PrimPol, 
this is the same type of mutation we see exhibited by PrimPol1-354 (Guilliam et al., 
2015)(Figure 4.3).  
 
4.5. Base Mismatch Tolerance of PrimPol 
Taking into consideration that PrimPol can occasionally incorporate the incorrect 
nucleotides opposite a templating base, we went on to measure whether PrimPol could 
extend from a range of templates that had a mismatched base at its primer-template 
junction, similar to the products you would create following a mismatched base 
incorporation. PrimPol was unable to extend from a range of mismatched bases 
(Figure 4.4); there was only evidence of very weak extension from an A/A mismatch, 
an A/G mismatch and a T/G mismatch. In contrast, the polymerase domain of PrimPol, 
PrimPol1-354, exhibited the ability to incorporate bases following a mismatch opposite a 
range of primer-templates (Figure 4.5; summarised in Table 4.1).  
 
Many of these incorporations are Watson-Crick base pairs with respect to the next 
templating base, suggesting that the polymerase domain of PrimPol is accommodating 
this mismatch and extending it in a template-dependent manner. However, there are a 
few cases in which guanine is incorporated where cytosine is not the next templating 
nucleotide but rather the one in position N+2, suggesting that the polymerase domain is 
scrunching the template and incorporating guanine opposite the downstream cytosine. 
In vivo this would result in deletions. Notably, deletion mutations accounted for 44% of 
total mutations caused by PrimPol in the gap-filling plasmid experiments carried out in 
our laboratory (Guilliam et al., 2015). 
 
4.6. Template-independent Primer Extension Activity in the 
Presence of Manganese 
The flexible extension activities reported previously for NHEJ AEP polymerases 
includes limited template-independent terminal transferase activity on both ssDNA and 
blunt-ended dsDNA (Della et al., 2004; Pitcher et al., 2007). Such activities are often 
stimulated by the presence of manganese ions, which can accelerate the rate of DNA 
synthesis and, as a result, lower the overall fidelity of this process. We therefore tested 
if human PrimPol also possesses a similar terminal transferase activity in the presence 
  
 
 
 
 
 
 
 
 
Figure 4.4. Base mismatch tolerance of wild-type PrimPol.  
PrimPol was incubated for 5 minutes with individual dNTPs as indicated, all four dNTPs 
or a no dNTP control along with substrates 13-28 from Table 2.6. These substrates 
represent primers annealed to templates with the primer template junction representing 
each of the 16 possible combinations of base pairs, including the 4 Watson-Crick base 
pairs. PrimPol only extends the Watson-Crick base paired primer termini and will not 
extend from any base mismatches. 
  
  
 
 
 
 
 
 
 
 
 
Figure 4.5. Base mismatch tolerance of PrimPol1-354.  
PrimPol1-354 was analysed for its tolerance of base mismatches in the same manner as 
wild-type PrimPol in Figure 4.4. In addition to the standard Watson-Crick base pairs, 
PrimPol1-354 shows tolerance for a number of other mismatched primer termini. The 
mismatch tolerance of PrimPol1-354 is summarised in Table 4.1. 
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Table 4.1. Summary of the base mismatch tolerance of PrimPol and PrimPol1-354.  
The conformations of each base pairing combination is described as resolved 
structurally (Johnson & Beese, 2004). Whilst PrimPol appears relatively intolerant to 
the extension of base mismatches, PrimPol1-354 shows some tolerance to many of the 
mismatched base pairs.  
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of manganese. These experiments were carried out in collaboration with Dr. Stanislaw 
Jozwiakowski. Wild type, as well as all three variants, of human PrimPol showed no 
detectable terminal transferase activity when tested on a blunt ended ds DNA substrate 
(Figure 4.6). However, PrimPol’s DNA synthesis activity appeared to be significantly 
increased when primer extension assays were performed in the presence of dNTPs 
(all) and manganese (Figure 4.6). To investigate if this increased activity resulted from 
altered fidelity, we repeated the assays with each of the dNTPs and observed that 
PrimPol catalyses multiple extension of the primer even in presence of a single 
nucleotide pool. This promiscuous DNA synthesis was most efficient when enzyme 
was utilising dATP or dTTP. In both cases, extension of primers by up to ~20 
nucleotides was observed. Notably, this phenomenon was not observed when 
magnesium was used instead of manganese (result not shown). When a single 
incorporation of dCTP was investigated, we observed significantly slower extension 
rates but the enzyme was able to extend the primer to produce predicted full-length 
product. In contrast, incorporation of correct incoming nucleotide (dGTP) resulted in 
least pronounced primer extensions up to 16 nucleotides.  
 
When this experimental strategy was repeated to study this promiscuous DNA 
polymerase activity in the PrimPolZF-KO and PrimPol1-487 variants, we observed minimal 
misincorporation of all four tested single nucleotides. Interestingly, when catalytically 
active fragment of PrimPol1-354 was tested, we observed more efficient misincorporation 
compared to PrimPolZF-KO and PrimPol1-487 variants. However, PrimPol1-354 fragment 
was able to misincorporate between 1 to 2 incorrect incoming nucleotides. We are 
unable to conclude if this unique enzymatic activity of human PrimPol is significant for 
biological function of this enzyme in vivo. We speculate that under the experimental 
conditions tested, the zinc finger module allowed manganese-dependent primer 
extension resulting in the synthesis that is non-complementary to the template strand. 
This hypothetical scenario is only possible when the enzyme was able to bind to a 
single-stranded template strand of the DNA primer-template substrate. This interesting 
observation has raised questions regarding the mechanism by which PrimPol binds to 
and coordinates the primer-template substrate during DNA polymerisation.  
 
4.7. Translesion DNA Synthesis Activity of PrimPol 
PrimPol has the capacity to bypass a number of replication stalling lesions, including 
UV and oxidative lesions (Bianchi et al., 2013; Garcia-Gomez et al., 2013). To address 
 
 
Figure 4.6. Template-independent extension by PrimPol in the presence of 
manganese.  
Human PrimPol was incubated for 30 min with DNA substrate and each of the dNTPs 
in the presence of manganese. Wild-type PrimPol was unable to extend from a dsDNA 
template with a blunt end (substrate 3 from Table 2.6), but could extend from a primer 
annealed to an overhanging template (substrate 1 from Table 2.6), even synthesising 
long tracts of homopolymers. PrimPolZF-KO could extend from an overhanging DNA 
template in the presence of manganese and, con- sistent with the wild-type, did not 
extend from a ds DNA substrate. The incorporation of 1 or 2 nucleotides of guanine or 
adenine opposite an over- hanging template suggests that PrimPolZF-KO incorporates in 
a low-fidelity template-dependent manner when incubated with overhanging DNA.  
PrimPol1–487 exhibited a highly similar terminal transferase activity spec- trum to the 
PrimPolZF-KO. In the presence of manganese, it incorporated bases opposite an 
overhang in a low fidelity, template-dependent manner. PrimPol1–354 also exhibited low 
fidelity extension of a primer annealed to an overhanging template in the presence of 
manganese. 
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whether the TLS activities of PrimPol are independent of the zinc finger domain, we 
assayed the TLS activities of PrimPol1-354 on a range of templates containing a variety 
of DNA modifications. 
 
4.7.1. Error-Free Bypass of a CPD Photoproduct by PrimPol 
As full-length PrimPol appears unable to read through CPDs in vitro, we assayed 
PrimPol1-354 for TLS bypass of this common photolesion by primer extension of a primer 
annealed to a template containing a CPD. Notably, although PrimPol1-354 slowed as it 
reached a CPD lesion, it showed the capacity to read-through this bulky lesion (Figure 
4.7A). In contrast, wild-type PrimPol cannot perform TLS opposite this lesion in the 
presence of magnesium (Bianchi et al., 2013; Rudd et al., 2013) nor can replicative 
polymerases such as the Klenow fragment of Taq polymerase (Figure 4.7A). Single 
nucleotide incorporation assays were employed to determine which bases are 
incorporated opposite CPDs, revealing that it performs error-free bypass of this 
photolesion (Figure 4.7B). Similar TLS activity was also confirmed using XPrimPol1-334, 
which was also capable of reading through CPDs in an error-free manner (Figure 
4.7C). This TLS activity is similar to Pol η, a specialised TLS polymerase known to 
bypass CPDs by in an error-free manner (Biertümpfel et al., 2010; Masutani et al., 
1999). As this read-through of a CPD is only evident in the absence of the zinc finger 
domain, it may be the case that PrimPol requires a conformational change or partner to 
assist in promoting this bypass activity in vivo. 
 
4.7.2. Error-Prone Bypass of a (6-4) photoproduct by PrimPol 
(6-4)PPs are a much more highly distorting UV lesion than CPDs (Section 1.4.2.). Pol η 
can incorporate bases opposite (6-4)PPs but incorporates an incorrect dG opposite the 
3’ dT of the lesion and is unable to subsequently extend from this product (R. E. 
Johnson et al., 2001). However, it has previously been reported that PrimPol exhibits 
both the ability to incorporate opposite and extend through (6-4)PPs (Bianchi et al., 
2013). Although PrimPol’s TLS activity was retained when the zinc finger was deleted 
(Figure 4.8A), the nucleotide incorporation signature was altered (Figure 4.8B), again 
consistent with the proposed regulatory role of the zinc finger domain. Wild-type 
PrimPol incorrectly incorporates thymine opposite the first dT of the (6-4)PP, whereas 
PrimPol1-354 incorporates dA or dC opposite this base. If dA nucleotide is incorporated 
opposite the first thymine of the (6-4)PP, PrimPol1-354 then incorporates either a dC or 
dT. If the first nucleotide is dC, it will then incorporate dA, dC or dT. To confirm whether 
 
 
 
 
 
 
 
 
Figure 4.7. The polymerase domain of PrimPol can bypass a CPD lesion with 
high fidelity.  
(A) PrimPol, PrimPol1-354 and XPrimPol1-334, as well as the replicative Klenow Taq 
polymerase, were incubated with dNTPs and a substrate with a CPD in its template 
(substrate 29 from Table 2.6) at 0.5, 1, 3, 5 and 60 minute time points alongside a 
control containing no protein. As previously shown, PrimPol is unable to read-through a 
CPD. However the polymerase domains of both Human and X. tropicalis PrimPol, 
without the C-terminal zinc finger, are both capable of inserting nucleotides opposite, 
and extending from, a CPD lesion in vitro. Klenow Taq, a replicative polymerase, is 
incapable of reading through the distorting lesion. (B) PrimPol1-354 and XPrimPol1-334 
were analysed for their fidelity opposite a CPD and were both shown to incorporate 
adenine nucleotides opposite both the 3’- and 5’-thymines of the CPD. Substrates 30 & 
31 from Table 2.6 were used in this fidelity evaluation. 
A 
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Figure 4.8. PrimPol can bypass a (6-4) photoproduct with low fidelity.  
(A) PrimPol, PrimPol1-354 and XPrimPol1-334, as well as the replicative Klenow Taq polymerase, were incubated with dNTPs and a substrate with 
a (6-4)PP immediately downstream of the primer-template junction (substrate 33 from Table 2.6) at 0.5, 1, 3, 5 and 60 minute time points 
alongside a control containing no protein. Both wild-type PrimPol and the polymerase domain of PrimPol are capable of proficiently reading 
through the (6-4)PP. Klenow Taq polymerase, however, is incapable of reading through this highly distortive lesion. (B) The fidelity of PrimPol 
when incorporating opposite a (6-4)PP was assessed. PrimPol predominantly incorporates a thymine nucleotide opposite the 3’-thymine of the 
(6-4)PP and then incorporates a cytosine or guanine opposite the 5’-thymine. (C) This fidelity of incorporation is altered for the polymerase 
domain of PrimPol lacking the zinc finger domain. Both Human and X. tropicalis PrimPol polymerase domains can incorporate an adenine or 
cytosine nucleotide opposite the 3’-thymine with approximately equal proficiency. If an adenine is incorporated in opposite the first base, the 
polymerase domain will then incorporate either a cytosine or thymine opposite the 5’-thymine of the (6-4)PP. If a cytosine is incorporated first, 
PrimPol1-354 and XPrimPol1-334 will incorporate adenine, cytosine or thymine opposite the 5’-thymine of the (6-4)PP. 
A B 
C D 
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this altered fidelity was orthologue-specific, we assayed the equivalent Xenopus 
polymerase domain (XPrimPol1-334) and observed a similar fidelity to the human 
PrimPol polymerase domain (Figure 4.8C). 
 
4.7.3. PrimPol Can Read Through an 8-oxoguanine Base 
Next, we examined TLS bypass of an oxidative lesion, 8-oxo-G. In common with wild-
type enzyme, PrimPol1-354 can read through 8-oxo-G lesions with minimal stalling and 
exhibited the ability to insert A and C opposite 8-oxo-G lesions with equal efficiency 
(Figure 4.9A) (Bianchi et al., 2013; Engelke et al., 1990). A similar TLS activity and 
fidelity for this lesion was also evident with XPrimPol1-334 (Figure 4.9A). This was not, 
however, the case for the Klenow fragment of the replicative Taq polymerase, which 
showed significant stalling at the 8-oxo-G lesion (Figure 4.9A). Upon testing the fidelity 
of PrimPol when incorporating opposite 8-oxo-G, we find that PrimPol has 
approximately equal efficiency in incorporation of dA and dC opposite this lesion, but 
Taq polymerase is only capable of inserting the Hoogsteen pairing base dA. This 
reorientation of the incoming base to form a Watson-Crick base pair with an 8-oxo-G 
lesion is evident in a number of other TLS polymerases, including pols η, ι, κ and 
REV1 (Haracska et al., 2000; Y. Zhang et al., 2002; 2001; 2000). 
 
4.7.4. PrimPol is Unable to Read Through a Thymine Glycol Base 
Thymine glycol lesions are, like 8-oxo-G, common products of oxidative damage to 
DNA. Neither wild-type, nor the polymerase domain of PrimPol harbour the ability to 
read through a thymine glycol lesion (Figure 4.10). To check whether this was 
orthologue-specific or whether other PrimPols might be able to read through a thymine 
glycol, we confirmed that this is not specific to human PrimPol using XPrimPol1-334 
(Figure 4.10). Like PrimPol, replicative polymerases, such as Taq polymerase, are also 
unable to read through a thymine glycol base (Figure 4.10). Pol η is capable of reading 
through a thymine glycol lesion, though its ability to extend from a thymine glycol lesion 
is dependent on the geometric isomer state of the thymine glycol lesion (Kusumoto et 
al., 2002). 
 
4.7.5. PrimPol can Read Through Uracil Bases in DNA 
Cytosine in DNA is susceptible to spontaneous deamination to uracil (dU) in vivo, 
which can base pair to adenine, resulting in C!T transition mutations (Duncan and 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. PrimPol can read-through an 8-oxoguanine lesion.  
(A) PrimPol, PrimPol1-354 and XPrimPol1-334, as well as the replicative Klenow Taq 
polymerase, were incubated with dNTPs and a substrate with an 8-oxo-G (denoted 
8oG above) lesion in its template (substrate 36 from Table 2.6) at 0.5, 1, 3, 5 and 60 
minute time points alongside a control containing no protein. PrimPol, PrimPol1-354 and 
XPrimPol1-334 are all capable of reading through this lesion with very little stalling, but 
Klenow Taq polymerase demonstrates an apparent stalling at the 8-oxo-G lesion. (B) 
These proteins were also assessed for their fidelity in incorporation opposite an 8-oxo-
G lesion (substrate 37 from Table 2.6). Whilst Klenow Taq polymerase is only capable 
of inserting an adenine nucleotide opposite the 8-oxo-G lesion, PrimPol inserts both 
adenine and cytosine with approximately equal proficiency. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. PrimPol cannot read-through a thymine glycol lesion.  
PrimPol, PrimPol1-354 and XPrimPol1-334, as well as the replicative Klenow Taq 
polymerase, were incubated with dNTPs and a substrate with a thymine glycol lesion 
(denoted Tg above) in its template (substrate 38 from Table 2.6) at 0.5, 1, 3, 5 and 60 
minute time points alongside a control containing no protein. None of these proteins 
are capable of reading through a thymine glycol lesion. 
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Miller, 1980). Uracil is not recognised by, nor does it stall, eukaryotic replicative or TLS 
polymerases (Bocquier et al., 2001; Connolly et al., 2003; Lao-Sirieix and S. D. Bell, 
2004; L. Liu et al., 2001). Similarly, the polymerase domain of PrimPol does not stall 
when confronted with a dU base (Figure 4.11). PrimPol incorporates an adenine 
opposite dU therefore, as one might expect, it essentially reads the dU base as a 
thymine. This is in common with XPrimPol1-334 and the Klenow fragment of Taq 
polymerase (Figure 4.11). 
 
4.7.6. PrimPol Cannot Read Through Apurinic/Apyrimidinic Sites 
Apurinic/Apyrimidinic (AP) sites are endogenous DNA damage sites caused by 
spontaneous depurination, removal of uracil by uracil DNA glycosylase or as an 
intermediate in base excision repair (Section 1.4.5). Neither wild-type human, nor the 
polymerase domain of either human or Xenopus, PrimPol harbour the ability to read 
through an AP site (Figure 4.12). Whilst PrimPol is unable to bypass an AP site, there 
are a number of other polymerases that are capable of doing so. Incorporation of a 
nucleotide opposite an AP site is will likely be mutagenic as there is no way of knowing 
which nucleotide was there prior to removal. REV1 and pol ι can insert a single base 
opposite an AP site, which is subsequently extended by another TLS polymerase, pol ζ 
(Prakash et al., 2000; Y. Zhang et al., 2002). Pol κ can both insert a nucleotide 
opposite, and extend from, an AP site but the nucleotide inserted is dependent on the 
nucleotide in the primer immediately 5’ of the lesion (Y. Zhang et al., 2000). 
 
4.8. PrimPol can Incorporate dUTP Nucleotides 
The presence of uracil bases in genomic DNA is not only the result of deamination of 
cytosine, but can also be caused by the insertion of free deoxyuridine triphosphate 
(dUTP) in place of dTTP. The essential enzyme Dut1 normally suppresses the 
incorporation of dUTP into genomic DNA (Gadsden et al., 1993), however the levels of 
dUTP in the dNTP pool are elevated during transcription and become available to 
insertion during genomic replication and/or repair synthesis (N. Kim and Jinks-
Robertson, 2009). Whilst uracil itself is not promutagenic, as a polymerase will correctly 
insert an adenine opposite a uracil, the uracil base will be removed by uracil DNA 
glycosylase and this will result in an AP site. We aimed to determine whether PrimPol 
is able to utilise dUTP by measuring its incorporation opposite oligonucleotides 
containing different templating bases. PrimPol was incubated for 30 minutes in the 
presence of dUTP and four substrates containing the four different templating bases 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. PrimPol interprets a uracil base in DNA as it does a thymine base.  
(A) PrimPol, PrimPol1-354 and XPrimPol1-334, as well as the replicative Klenow Taq 
polymerase, were incubated with dNTPs and a substrate with a deoxyuracil (denoted 
dU above) in its template (substrate 39 from Table 2.6) at 0.5, 1, 3, 5 and 60 minute 
time points alongside a control containing no protein. All of these proteins will read 
through a uracil base in DNA without stalling. (B) Each of the proteins were assessed 
for their base incorporation activity opposite a uracil base. All proteins tested 
incorporate an adenine nucleotide opposite uracil, representing mutagenic activity if the 
source of the uracil base is cytosine deamination. 
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Figure 4.12. PrimPol cannot read-through an apurinic/apyrimidinic site.  
PrimPol, PrimPol1-354 and XPrimPol1-334, as well as the replicative Klenow Taq 
polymerase, were incubated with dNTPs and a substrate with an AP site in its template 
(substrate 38 from Table 2.6) at 0.5, 1, 3, 5 and 60 minute time points alongside a 
control containing no protein. None of these proteins are capable of reading through a 
site that doesn’t have a templating base, indicating that an AP site is a significant 
replicative hindrance. 
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adenine, cytosine, guanine or thymine. We find that PrimPol is indeed able to 
incorporate uracil opposite an adenine template but is unable to do so opposite any 
other templating base (Figure 4.13), this is also the case with the polymerase domain 
PrimPol1-354 (Figure 4.13). 
 
4.9. PrimPol cannot Incorporate 8-oxo-dGTP Nucleotides 
8-oxoguanosine triphosphate (8-oxo-dGTP) is a mutagenic DNA synthesis susbstrate 
formed by oxidation of dGTP in the dNTP pool as well as through the phosphorylation 
of 8-oxoguanosine diphosphate (8-oxo-dGDP) by nucleoside diphosphate kinase 
(Hayakawa et al., 1995; Maki and Sekiguchi, 1992). 8-oxo-dGTP is metabolised into 8-
oxoguanosine monophosphate (8-oxo-dGMP) by 8-oxo-GTPase, a product which is 
unable to be rephosphorylated by nucleoside diphosphate kinase; this product is then 
itself further degraded by a specific nucleotidase to 8-oxoguanosine (8-oxo-G) 
(Hayakawa et al., 1995). We aimed to investigate whether PrimPol is able to 
incorporate 8-oxo-dGTP opposite different templating bases and found that PrimPol 
has an inability to incorporate this oxidised base opposite any of the four templating 
bases (Figure 4.14).  
 
4.10. PrimPol’s Zinc Finger Domain is Required for Bypass of 
Lesions In Vivo 
To examine the ability of the different PrimPol variants to support bypass of bulky 
lesions during replication in vivo, a large pulse of UV irradiation (20 J/m2) was 
introduced to cells between the two labelling steps to investigate fork stalling induced at 
UV lesions. This work was carried out in collaboration with my colleague Dr. Laura 
Bailey. PrimPol knockout DT40 cells have previously been shown a pronounced 
stalling phenotype, indicated by a large increase in the ratio of the CldU to IdU ratios 
following UV irradiation (Bianchi et al., 2013). Consistent with previous findings, we 
observe complementation by supplementing with the wild type enzyme (Figure 4.15). 
However, neither PrimPol1-354 nor PrimPolZF-KO were able to correct this fork stalling 
defect (Figure 4.15). Therefore, although the polymerase extension activity of PrimPol 
is sufficient for maintenance of unperturbed replication, these data suggest that its 
primase activity is requisite for timely replication fork progression following the 
introduction of significant DNA damage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13. PrimPol is capable of incorporating dUTP into DNA.  
As cytosine can be deaminated in the cellular nucleotide pool, PrimPol and PrimPol1-354 
were tested for their ability to incorporate deoxyuracil triphosphate (dUTP)  into DNA 
opposite four different templating bases (substrates 9-12 from Table 2.6), alongside a 
control in which no protein was added. dUTP is incorporated proficiently opposite 
adenine but not any other base. This is to be expected as dUTP readily base pairs with 
adenine and PrimPol will insert an adenine opposite a uracil base in template DNA 
(Figure 4.11B). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14. PrimPol is not capable of incorporating 8-oxo-dGTP into DNA.  
As guanine is liable to oxidation in the cellular nucleotide pool, PrimPol and PrimPol1-354 
were also tested for their ability to incorporate 8-oxoguanosine tripohosphate (8-oxo-
GTP) into DNA opposite four different templating bases (substrates 9-12 from Table 
2.6), alongside a control in which no protein was added. Neither PrimPol nor PrimPol1-
354 are capable of inserting 8-oxo-GTP into DNA. This is in contrast to PrimPol’s ability 
to incorporate adenine and cytosine bases opposite a templating 8-oxo-G in DNA 
(Figure 4.#B), which suggests that the ability to accommodate a lesion in the DNA 
substrate and the ability to accommodate a lesion in the incoming nucleotide substrate 
are not homogeneous.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. The zinc finger of PrimPol is required for maintaining fork rate 
following UV irradiation.  
DNA fork rate analysis was carried out with after a 20 J m-2 pulse of UV, between CldU 
and IdU labels, to look for fork-stalling. Data is shown as the ratio of the two labels, 
Cldu, pre-UV : IdU, post UV label (n = 3). The black lines indicate the Cldu:IdU ratio of 
the two labels in the wild-type cells and the blue lines indicate the ratios in PrimPol-/- 
cells complemented with the indicated PrimPol variants. Wild-type PrimPol is able to 
successfully complement the PrimPol-/- cells but the PrimPolZF-KO and PrimPol1-354 
variants, lacking an intact zinc finger, are unable to complement fork rate following UV 
irradiation. The requirement for the zinc finger indicates that the primase activity of 
PrimPol is required for maintaining fork rate following UV irradiation. 
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4.11. Summary and Discussion 
In this chapter, we have probed the polymerase activities of PrimPol and drawn 
comparisons with other polymerases. We have also compared the wild-type enzyme to 
the catalytically active polymerase domain of human PrimPol; although the DNA 
polymerase activity of PrimPol appeared initially to be independent of the zinc finger 
domain, PrimPol polymerase domain lacking the C-terminal zinc finger domain 
(PrimPol1-354) showed enhanced relative polymerase and processivity activities, 
compared to the wild-type enzyme. Further studies revealed that the zinc finger 
modulates the fidelity and extension activities, including TLS activities, of PrimPol and 
therefore it should also be considered to be an important regulator of PrimPol’s 
polymerase functions as well as requisite for primase activity. 
 
PrimPol is a lower fidelity polymerase than replicative polymerases. As such, it is 
required that this protein is regulated in its activity; else it would replicate long tracts of 
DNA in an error-prone manner. PrimPol is a very distributive enzyme, catalysing up to 
4 subsequent incorporations during a single DNA substrate binding event/DNA 
polymerisation cycle in vitro. This distributive character of PrimPol is reminiscent of the 
DNA polymerase processivity reported for the Y-family TLS polymerases, such as Pol 
κ and η, which predominantly incorporate up to 6 or 7 nucleotides (Ohashi et al., 2000; 
Washington et al., 1999). It cannot be ruled out, however, that PrimPol processivity 
may be enhanced through the binding of accessory proteins. 
 
As we see the same type of substitution mutation from PrimPol1-354 here as is evident in 
the gapped-plasmid assay that uses wild-type PrimPol (Guilliam et al., 2015), this 
indicates that the lack of zinc finger does not necessarily alter the fidelity of the 
polymerase domain, rather exacerbate the inherent poor fidelity of PrimPol’s 
polymerase. Additional kinetic analysis is required to determine whether the observed 
fidelity is primarily a result of differences in the incorporation rates for correct versus 
incorrect bases rather than differences in nucleotide binding affinity. Also, given that 
PrimPol is highly selective for insertions and deletions (Guilliam et al., 2015), the 
incorporation of a third nucleotide opposite an incorrect templating base by both wild-
type PrimPol and PrimPol1-354 could actually be the result of PrimPol scrunching the 
primer and using the same templating base more than once in order to adapt and 
continue extension. 
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In the presence of manganese, PrimPol appeared to be much more active than with 
magnesium. However, upon closer inspection, we discovered that the enzyme can 
produce polymeric primer extension products, even when only a single form of dNTP is 
present. Under these manganese-dependent conditions, PrimPol extends from a 
primer to form homopolymeric strands that are non-complementary and therefore 
unlikely to be anneal to the template strand. This suggests that caution should be taken 
when interpreting the results from studies using manganese as the resulting products 
may represent aberrant synthesis products rather that the expected template-
dependent ones. Manganese has the effect of decreasing fidelity amongst 
polymerases (Hays and Berdis, 2002; Tabor and Richardson, 1989). Whilst 
magnesium enforces tetrahedral geometry in the arrangement of its ligands, 
manganese will accommodate square, planar, tetrahedral and octahedral co-
ordinations thus increasing the ability to accelerate the rate of reaction in substrates 
that are perhaps misaligned (Pelletier et al., 1996). The physiological implications of 
this template-independent primer extension activity of PrimPol in the presence of 
manganese remains unclear, as the cellular concentrations of manganese are low, 
suggesting this activity may be irrelevant in vivo or it may be limited to certain cellular 
compartments (e.g. mitochondria).  
 
As PrimPol can incorporate bases opposite, and extend from, highly distorting lesions it 
is likely that the active site involved in production of phosphodiester bond is large and 
flexible to accommodate a range of lesions. The (6-4)PPs, in particular, are highly 
mutagenic due to the high level of distortion they introduce into the DNA backbone. The 
helical bending at these lesions is estimated to be ~44° and the distance between 
phosphorus atoms in the paired bases in the (6-4)PP is ~6Å, compared to to the 7Å 
average corresponding distance at other base pairing steps (J.-K. Kim and Choi, 
1995). Therefore, it is probably unsurprising that PrimPol exhibits low fidelity when 
inserting bases opposite a (6-4)PP, as a polymerase that can accommodate this lesion 
would require a flexible active site. Unexpectedly, the polymerase domain of PrimPol, 
like Pol η, is capable of bypassing CPDs with high fidelity. This contrasts with full 
length PrimPol, which is not capable of bypassing CPDs unless two adenines are 
inserted opposite the CPD (Bianchi et al., 2013; Rudd et al., 2013). This result 
establishes that the active site of PrimPol has the capacity to bypass these lesions but 
this is constrained in the full-length enzyme. A conformation change may be required, 
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potentially induced by binding partners that alters the activity of PrimPol to allow it to 
bind to and bypass CPDs in vivo. 
 
PrimPol is also confronted with a number of lesions as a result of oxidative stress in 
cells. These include apurinic/apyrimidinic (AP Sites) and 8-oxo-G lesions. Pol γ, the 
mitochondrial replicative polymerase, has the ability to bypass an 8-oxo-G site but at a 
reduced rate, and cannot bypass AP site (Graziewicz et al., 2007; Pinz et al., 1995). 
Conversely, PrimPol shows almost no hindrance to base incorporation opposite 8-oxo-
G lesions and, although it cannot incorporate bases opposite an AP site, it has the 
capacity to re-prime post-lesion. 8-oxo-G is expected to pair with C through Watson-
Crick base pairing in its regular anti conformation, but in its syn conformation it forms 
Hoogsteen base pairs with  adenine (van Loon et al., 2010). This ability to insert A, as 
well as C, opposite 8-oxo-G is apparent in a number of polymerases but the addition of 
auxiliary proteins (e.g. RPA and PCNA) can dramatically increase the preference for 
adenine over cytosine, as is the case with Pols λ and η (Maga et al., 2007; van Loon et 
al., 2010). It remains to be seen whether this is also the case with PrimPol. This ability 
to accommodate bulky lesions in the active site comes at the expense of fidelity and, 
therefore, PrimPol is a low fidelity polymerase that is likely to make limited and, 
perhaps, some nonspecific contacts with the replicating base pair. Deoxyuracil is not 
recognised as a lesion by replicative polymerases and results in C:G ! T:A transition 
mutations. Deoxyuracil is recognised by archaeal family B polymerases as a lesion and 
stalls replication to prevent mutation (Fogg et al., 2002) but PrimPol does not have this 
recognition capacity and incorporates an adenine opposite a uracil base.  
 
It is probable, given the activities of PrimPol and its phyletic profile, that PrimPol was 
acquired early in eukaryotic evolution to play a significant role in lesion bypass, 
particularly of oxidative and UV lesions, during DNA replication. PrimPol-mediated 
damage tolerance appears to represent an important mechanism that facilitates 
replication fork restart following stalling of the replisome at sites of DNA damage. 
 
Intriguingly, because PrimPol is able to incorporate an undamaged dNTP opposite an 
8-oxo-G template but is unable to incorporate 8-oxo-GTP opposite an undamaged 
template base. This suggests that although the active site of PrimPol is 
accommodating on the template side, it is less accommodating to incoming damaged 
bases. PrimPol is able to incorporate a dUTP nucleotide because it is not particularly 
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bulky; it has fewer side chains than dCTP and readily forms Watson-Crick base pairs 
with adenine. 
 
Canonical DNA polymerases share a common right-handed architecture with the 
polymerisation domain containing fingers, palm and thumb subdomains. All of the three 
structural elements are clustered together providing accurate, highly structurally 
restrained positioning of the polymerase at the primer-template junction in order to 
promote the highest fidelity and processivity of DNA synthesis. Although this tight and 
very specific binding cleft is perfectly suited for replication of entire genomes, in some 
instances such structural arrangement can be disadvantageous. In particular, it limits 
the capacity of the replicative enzymes to tolerate abnormalities in the topology of DNA 
templates, such as secondary structures or DNA damage-induced distortions. The 
thumb subdomain of replicative polymerases interacts with the sugar-phosphate 
backbone of the DNA to coordinate the DNA. This subdomain is optimised for the 
highly accurate replication of DNA and is sensitive for structural anomalies in the in the 
DNA template. The predicted structure of PrimPol, in addition to the known structures 
of primases, suggests that this polymerase lacks structural elements corresponding to 
the ‘thumb’ domain that is present in replicative polymerases that is implicated in 
processivity (Brautigam and Steitz, 1998). The open planar predicted structure of this 
polymerase indicates a transient binding of the polymerase domain and this is 
consistent with other low fidelity polymerases, such as those of the Y-family of 
polymerases (Lehmann et al., 2007).  
 
The processivity data presented here suggest that the zinc finger domain of PrimPol 
regulates the fidelity of these polymerases, in addition to its essential role in primase 
activity. Whilst there is no reduction in the activity of the polymerase domain lacking the 
zinc finger, it actually appears more active, we propose that the presence of the zinc 
finger reduces the processivity of the enzyme to allow a slower, higher fidelity 
incorporation of complementary nucleotides. We postulate that whilst the AEP 
polymerase domain provides a platform to recognise the primer-template junction of 
the DNA substrate, the zinc finger binds the single-stranded region of the template 
strand to modulate binding and fidelity by the AEP domain. Y-family polymerases have 
a highly truncated thumb domain and, notably, contain an additional functional module 
referred to as the polymerase associated domain (PAD). Interestingly, studies on TLS 
polymerases Dpo4 and Dbh point to a role for PAD in regulation of processivity and 
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fidelity of these enzymes (Boudsocq et al., 2004). This structural element not only 
binds ssDNA and provides an extended flexible platform coordinating the template 
strand during DNA synthesis on damaged DNA templates, but also modulates the 
activity of these TLS DNA polymerases. As part of an adaptation to perform TLS, we 
suggest that the zinc finger is functionally analogous to the PAD subdomain, but is 
spatially separated to allow greater freedom of binding of the enzyme to distorted DNA 
templates, such as those containing UV-induced lesions. 
 
Regarding the bypass of lesions during genome replication in vivo, this and previous 
work (Bianchi et al., 2013) suggests that both of PrimPol’s priming and extension 
activities are requisite for lesion bypass and replication restart. When replicative DNA 
polymerases encounter a blocking lesion, they stall and PrimPol is recruited, possibly 
by RPA (see Chapter 6), to perform TLS or re-prime replication downstream of the 
lesion (Figure 4.16). After production of a primer or polymerisation through the lesion, 
the replicative polymerase can then resume replication.  
 
 
  
  
Figure 4.16. Model of the lesion bypass mechanisms of PrimPol.  
PrimPol utilises both its primase and polymerase activities to bypass DNA damage that blocks replicative polymerases. When replicative 
polymerases encounter a blocking lesion, they are displaced or regress from the site of damage. PrimPol can then access the template 
upstream of the lesion, where it can reprime following the lesion (left) or if it can access the primer-template junction it can carry out TLS (right). 
Once PrimPol-mediated bypass of the lesion has occurred, the replicative polymerase can then resume replication at the fork.  
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CHAPTER 5 
 
 
A Human PrimPol Mutation Associated with 
High Myopia has a DNA Replication Defect 
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5.1. Introduction 
Although recent studies have established the importance of PrimPol in damage 
tolerance during DNA replication in cellular and animal model systems, its association 
with human diseases has only been conjectured. However, exome sequencing of the 
genomes of candidate patients has recently implicated the PrimPol gene as a possible 
susceptibility gene associated with high myopia (Zhao et al., 2013). This study 
identified a missense mutation in human PrimPol caused by a thymine to guanine 
transversion, resulting in the substitution of tyrosine at position 89 by an aspartic acid 
residue (Y89D). This mutation was not only found in a single family but also in four 
additional sporadic patients with high myopia and these patients had high visual 
refractive errors (-6.5 to -32.15 diopters, D) (Zhao et al., 2013). Myopia, or short-
sightedness, is a common problem around the world in those with visual defects and 
this problem is rapidly increasing. Myopia accounts for 41% of decreased vision in 
Western populations and this up from 25% in the early 1970s (Vitale et al., 2009). In 
some Southeast Asian populations up to 80-90% of all children leaving school are now 
myopic (Morgan et al., 2012). 10-20% of these children suffer from high myopia, an 
extreme form of the disease, often characterised by a refractive error of less than -6.00 
D and is often associated with other serious ocular disorders (Morgan et al., 2012; Saw 
et al., 2005). The aetiology of high myopia remains extremely complex and probably 
involves the synergy between many genes.  
 
The active site of PrimPol is predicted to consist of three magnesium-coordinating, 
negatively-charged residues: an aspartate at residue 114, a glutamate at residue 116 
and an aspartate at residue 280. Although the tyrosine at position 89 is not predicted to 
reside directly within the active site, it is in close proximity and therefore may play yet 
undetermined roles in the activities associated with these enzymes. The mutated 
tyrosine (Y89) is highly conserved residue across a wide array of chordate species 
(Figure 5.1) and PolyPhen-2 prediction programme indicates that mutation of this 
residue would be functionally damaging (Zhao et al., 2013). In addition to PrimPol, this 
tyrosine is also present in the related predicted primase PF14_0050 in plasmodium 
falciparum, so its evolutionary conservation is indicative of a significant functional 
residue (L. M. Iyer et al., 2005).  
 
In this study, we aimed to characterise the biochemical properties of the Y89D mutant 
of PrimPol (PrimPolY89D) to determine if this amino acid change alters PrimPol’s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Tyr89 is a highly conserved residue amongst higher eukaryotic 
species. 
The tyrosine at position 89 in human PrimPol is situated in the AEP polymerase 
domain of PrimPol and this residue is highly conserved among higher eukaryotes 
across mammalian, amphibian, reptilian, avian and piscine species.  
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activities thus establishing a molecular basis for its proposed involvement in high 
myopia. Here, we demonstrate that the Y89D mutant loses its ability to prime using 
rNTPs, but can still prime using dNTPs. PrimPolY89D has a greatly reduced template-
dependent processivity activity, when compared with the wild-type enzyme. In addition, 
we report that this mutant has significantly reduced binding for both DNA and dNTPs 
but its fidelity remains largely unchanged. Furthermore, we show that it is the 
hydrophobic ring of the tyrosine at position 89 that is important for maintaining these 
activities. We also demonstrate that changes in enzyme activity are the result of global 
changes in the structure of the polymerase domain of PrimPol. Finally, we report that 
this mutation significant slows replication fork rates in vivo and reduces cell viability 
after DNA damage. Together, these data establish that a point mutation identified in 
PrimPol from patients with high myopia results in a major disruption of the catalytic and 
replication activities associated with human PrimPol thus establishing a potential link 
between replication stress and human disease, particularly high myopia. 
 
5.2. Construction and Purification of PrimPol Point Mutants 
To probe the altered activities of the Y89D variant of PrimPol this point mutant and  
number of others were constructed and purified. The PrimPolY89D construct was 
produced by site-directed mutagenesis (plasmid H13, Table 2.3) and purified by Dr. 
Stanislaw Jozwiakowski. Two other variants of this point mutant, Y89S and Y89F, were 
both constructed (plasmids H15 and H16, Table 2.3) were also constructed by site 
directed mutagenesis and purified as described in Tables 2.4 and 2.5 (Figure 5.2A and 
B). The tyrosine side chain at position 89 consists of a hydrophobic aromatic ring and a 
hydrophilic hydroxyl group; to determine whether altered activities can be attributed to 
one or the other of these moieties, a serine with a hydrophilic hydroxyl group and a 
phenylalanine with a hydrophobic aromatic ring side chain were both constructed. 
Additionally, to compare any changes in the polymerase domain caused by this Y89D 
mutation, this mutant was also introduced into the polymerase domain of PrimPol 
(PrimPolY89D1-354; plasmid H14, Table 2.3) and purified as described in Tables 2.4 and 
2.5 (Figure 5.2C). 
 
5.3. PrimPolY89D retains DNA primase Activity but not RNA 
Primase Activity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Purification of PrimPolY89S, PrimPolY89F and PrimPolY89D1-354 variants. 
Samples from the insoluble and soluble (load) fractions from the growth and expression 
of proteins, as well as samples of the fractions from IMAC affinity purification and 
protein-containing heparin column elution fractions are shown for each of (A) 
PrimPolY89S (68.8 kDa) (B) PrimPolY89F (68.9 kDa) and (C) PrimPolY89D1-354 (43.1 kDa). 
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To determine if PrimPol displays an underlying biochemical defect that contributes to 
the high myopia clinical phenotype, we first examined the primase activity of the 
PrimPolY89D variant. These experiments were carried out in collaboration with my 
colleague Dr. Stanislaw Jozwiakowski as described in Section 3.10. De novo primer 
synthesis remained largely unchanged between the mutant and the wild-type in the 
production of DNA primers from dNTPs (Figure 5.3). However, unlike the wild-type 
enzyme, PrimPolY89D was unable to synthesise RNA primers in the presence of even 
high concentrations of rNTPs. Whilst it has been reported that PrimPol is more 
proficient at producing DNA over RNA primers in vivo, we remained intrigued as to why 
this mutation in PrimPol conferred a defect in RNA primer synthesis. Upon testing 
PrimPolY89S and PrimPolY89F for primase activity (Figure 5.3), we found that the 
PrimPolY89S has an activity comparable to Y89D but the Y89F variant of PrimPol 
returned primase activity back to wild-type, restoring the ability of the enzyme to 
produce RNA primers. This implies that the hydrophobic aromatic ring moiety at 
position 89 is required for optimal PrimPol activity. 
 
5.4. The Y89D Variant of PrimPol has Limited Processivity 
PrimPol possesses two intrinsic catalytic activities (primase and polymerase), therefore 
to determine any catalytic deficiencies associated with the Y89D point mutation, we 
must also consider its polymerase activity in addition to its primase activity. Primer 
extension assays on PrimPol showed that the polymerase activity of PrimPolY89D was 
significantly reduced in comparison to the wild-type enzyme (Figure 5.4). We next 
tested if this activity was restored by either Y89S or Y89F variants of PrimPol (Figure 
5.4) and observed that Y89S had slightly higher activity than the Y89D variant but was 
not restored to wild-type levels. In contrast, Y89F was fully proficient at extending 
primers opposite a templating strand. Notably, although PrimPolY89F was able to fully 
extend primers, and showed full extension at time points as short as 3 minutes (Figure 
5.4, Bottom-right, Lane 4), more primers were left unextended compared with wild-type 
PrimPol, suggesting that this modified enzyme has considerable activity once it has 
bound DNA but coordinates it less efficiently.  
 
PrimPol was previously shown to be a distributive DNA polymerase, inserting only up 
to 4 nucleotides during a single binding event (Figure 5.5). We next determined 
whether the processivity of the Y89D mutant was altered, causing the observed 
reduction in the polymerase activity. PrimPolY89D variant of could only insert a single 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Primase activities of human PrimPol and PrimPolY89D.  
Human PrimPol has primase activity and can produce de novo primers using rNTPs 
and dNTPs in a poly(dT) homopolymer template-dependent fashion. Substrates shown 
here are substrates 4-7 in Table 2.6. PrimPolY89D partially loses its primase activity. 
This variant of PrimPol cannot synthesize RNA primers but is an active primase 
utilising dNTPs. PrimPolY89S shows significant loss of the enzymatic activity with 
residual primase activity observed in presence of dNTPs. PrimPolY89F is an active 
primase variant capable of synthesizing both RNA and DNA primers with efficiency 
comparable to wild-type PrimPol. Experiments shown here were carried out by Dr. 
Stanislaw Jozwiakowski. 
  
 
 
 
 
 
 
Figure 5.4. Primer extension activities of human PrimPol and PrimPolY89D .  
Human PrimPol has primer extension activity and produces full-length templates 
following incubation with dNTPs and substrate 1 from Table 2.6 at 0.5, 1, 3, 5 and 60 
minute time points alongside a control containing no protein. PrimPolY89D shows a 
marked reduction in polymerase activity, incorporating up to eight nucleotides following 
incubation for 60 mins. PrimPolY89S also shows a loss in polymerase activity relative to 
wild-type PrimPol, though it is a more active polymerase than PrimPolY89D. PrimPolY89F 
restores polymerase activity. The Y89F variant can fully extend primers but there is an 
increased level of unextended primer relative to wild-type PrimPol.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Processivity of human PrimPol and PrimPolY89D.  
Primer extension assays were performed in the presence of an excess of herring 
sperm DNA trap to ensure the polymerase only binds once to the template DNA. The 
first lanes represent a no-enzyme control and lanes 2–6 represent time points of 15, 
30, 60, 120 and 360 s. As demonstrated previously in Chapter 3, Human PrimPol is a 
poorly processive enzyme, inserting up to four nucleotides opposite a templating DNA 
strand in a single binding event. PrimPolY89D has marked reduction in processivity, and 
is only able to insert a single nucleotide opposite a templating DNA strand per single 
binding event. PrimPolY89S can also insert only one single nucleotide opposite a 
templating DNA strand. PrimPolY89F restores processivity and has the ability to insert up 
to four nucleotides, similarly to wild-type PrimPol.  
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nucleotide opposite a templating strand of DNA, making it an even more distributive 
enzyme than wild-type PrimPol (Figure 5.5). To determine whether the aromatic ring of 
tyrosine was again the main determinant for enzyme activity, we tested the processivity 
activities of Y89S and Y89F variants. Consistent with Y89D, PrimPolY89S could only 
insert a single nucleotide. However, in common with wild-type enzyme, PrimPolY89F 
could insert up to 4 nucleotides. This establishes that the presence of an aromatic side-
chain at this position is requisite for maintaining more processive extension by PrimPol. 
 
5.5. PrimPolY89D has Reduced DNA Binding Activity 
A reduction in processivity of polymerases can be attributed to alterations in either 
dNTP or substrate DNA binding. To test the DNA binding efficiencies of wild-type and 
PrimPolY89D, we introduced the mutation into the polymerase domain (PrimPol1-354) of 
PrimPol. This ensured that the contributory DNA binding effects of the zinc finger were 
removed to enable accurate assessment of the alteration in binding caused solely by 
this point mutation in the polymerase domain. As the polymerase domain is able to 
bind both single-stranded and double-stranded DNA (Section 3.7), we chose to use a 
labelled overhanging DNA substrate in our EMSAs similar to the substrates PrimPol 
would encounter in vivo. The binding efficiency of PrimPolY89D1-354 to DNA was almost 
four times lower than PrimPol1-354 . The wild-type KD(DNA) was 0.67 μM, compared with 
Y89D KD(DNA) of 2.55 μM (Figure 5.6). These values are the concentrations at which 
50% DNA substrate is bound, as calculated from the sigmoidal fit of DNA binding as 
shown in Figure 5.6. 
 
5.6. Single Incorporation Kinetic Studies of PrimPolY89D 
As a reduction in DNA binding is likely to affect the incorporation of nucleotides but is 
independent of catalytic turnover, we investigated the single-incorporation kinetics of 
this mutant variant of PrimPol. As previously shown in Section 4.3, we measured the 
single incorporation catalytic efficiency of wild-type PrimPol (kpol) and its binding 
efficiency to incoming dNTPs (KD(dNTP)). Wild-type PrimPol has a kpol of 6.98 min-1 and 
binds the incoming dNTP with a KD(dNTP) of 15.51 µM. We determined the Y89D variant 
of PrimPol to be a slightly slower polymerase, with a kpol of 4.07 min-1 (Figure 5.7) 
compared with wild-type 6.98 min-1. However, this rate falls well within the same range 
of experimental error and therefore it is unlikely that the catalytic efficiency of Y89D is 
altered too much relative to the wild-type protein. In contrast, PrimPolY89D binds dNTPs 
over ten-fold less competently with a KD(dNTP) of 170.21 µM (Figure 5.7), compared to a 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6. DNA binding efficiency of polymerase domains of wild-type PrimPol 
and PrimPolY89D.  
(A) The polymerase domains (PrimPol1–354) for both wild-type and PrimPolY89D were 
used to eliminate the effects of binding from the zinc finger domains. Wild-type PrimPol 
domain bound to DNA at a much lower concentration than PrimPolY89D as determined 
by EMSAs. The concentrations used in both of these EMSAs were 0, 0.01, 0.025, 0.05, 
0.075, 0.1, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 5 and 10 μM. (B) 
These assays were subsequently quantified to determine KD(DNA) values for the 
polymerase domains of wild-type PrimPol (solid green line) and its Y89D variant 
(broken purple line). KD(DNA) of wild-type PrimPol was 0.69 μM, while the KD(DNA) of 
PrimPolY89D was 2.55 μM.  
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Figure 5.7. Single incorporation kinetics of PrimPolY89D.  
Single turnover kinetics of PrimPolY89D were used to determine catalytic efficiency (kpol) 
and dNTP binding efficiency (KD(dNTP)) for comparison against the wild-type protein. (A) 
The concentration of extended DNA product over time, as determined by 
electrophoresis, was plotted against time and fit to an exponential curve for a number 
of dATP concentrations. These data were fit to exponential curves as described in the 
equation in Section 2.3.6. and kobs was determined. Experiments were carried out in 
triplicate and error bars represent standard deviations. (B) kobs was subsequently plot 
against dATP concentration for PrimPol and these data were fit to hyperbolic curves as 
described in Section 2.3.6. to determine kpol and KD(dNTP). kpol for PrimPolY89Dwas found 
to be 4.07 min−1 ± 0.19 and KD(dNTP) was 170.21 μM ± 18.80. 
A 
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wild-type KD(dNTP) of 15.51 µM. Representative examples of the single incorporation 
experiments are shown in Appendix III. Further experiments are required to determine 
whether the dramatic reduction in dNTP binding may or may not be dependent on the 
initial binding of DNA. 
 
5.7. PrimPolY89D Incorporation Fidelity Remains Unchanged 
If dNTP coordination had been severely affected in the Y89D variant, we would expect 
quite a deviation from wild-type PrimPol in the fidelity of nucleotide incorporation. 
However, through single incorporation experiments to determine dNTP incorporation 
opposite different templating bases, we found that the Y89D variant of PrimPol did not 
have any appreciable variation from the wild-type enzyme in terms of fidelity (Figure 
5.8), with PrimPolY89D not showing deviation from standard Watson-Crick base pairing.  
 
5.7.1. PrimPolY89D Retains its Translesion DNA Synthesis Activities 
If there were an alteration in the coordination of incoming dNTPs, there would also be a 
lower probability that this enzyme would be able to bypass the highly distortive lesions 
that the wild-type enzyme could bypass. As this enzyme had such low processivity, 
when the lesion bypass activity of PrimPolY89D was initially tested the primer extension 
activity was so low that the primers did not extend up to the lesion. As such, we used 
primers immediately 5’ of the lesion to measure lesion bypass activity. We observed 
that PrimPolY89D was able to synthesize through even highly distortive lesions, such as 
a (6-4)PP (Figure 5.9), indicating that there is no defect in dNTP coordination. 
 
5.7.2. PrimPolY89D Does Not Tolerate Mismatched Base Pairs 
The primer DNA coordination could also be subject to a change in coordination relative 
to the incoming nucleotide for chain extension. DNA polymerases discriminate against 
mismatches both at the binding step and the insertion step (S. J. Johnson and Beese, 
2004), so we would expect the Y89D variant of PrimPol to have a more significantly 
reduced catalytic efficiency than the wild-type protein than is evident if PrimPolY89D 
could tolerate mismatched base pairs. PrimPolY89D was assessed for its ability to 
extend from a range of templates that had a mismatched base at its primer-template 
junction, similar to the products you would create following a mismatched base 
incorporation, using different dNTPs. As expected, our data suggests that PrimPolY89D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8. The fidelity of the PrimPolY89D  variant remains unchanged relative to 
the wild-type PrimPol.  
To provide comparable activity between the two constructs, the PrimPolY89D construct 
was incubated for 30 minutes along with individual dNTPs as indicated, all four dNTPs 
or a no dNTP control along with substrates 9-11, and 42, from Table 2.6 to allow 
incorporation of single nucleotides opposite two templating bases for each individual 
base. There was no deviation from the standard Watson-Crick base pairs from the 
PrimPolY89D  variant. 
  
 
 
 
 
Figure 5.9. The translesion DNA synthesis spectrum of the PrimPolY89D variant 
remains unchanged.  
To determine whether the PrimPolY89D variant retained its TLS activities, the substrates 
used required the lesions immediately downstream of the primer-template junctions; if 
not, the PrimPolY89D variant would not reach the lesion after 60 minutes. Substrates 
used were substrates 30, 32, 37, 40, 42 and 44 from Table 2.6. (A) PrimPol has the 
ability to bypass a 6-4 photoproduct (top-left), an 8-oxoguanine moiety (top-right) and 
deoxyuracil (bottom-left). Wild-type PrimPol cannot read-through a CPD (top-center), 
apurinic/apyrimidinic site (bottom-center) or a thymine glycol lesion (bottom-right). (B) 
PrimPolY89D retains its TLS activity as the wild-type protein, albeit with lower 
polymerase activity. In each case, the first lane represents a control and lanes 2-6 
represent incubation periods of 0.5, 1, 3, 5 and 60 minutes respectively. 
A 
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has little tolerance for mismatched base pairs (Figure 5.10), no different to the wild-type 
enzyme. 
 
5.7.3. PrimPolY89D Cannot Utilise rNTPs for Primer Extension 
Aromatic residues sometimes act as a steric gate for sugar discrimination (Brown and 
Suo, 2011). Mutation of these key residues can result in the incorporation of rNTPs 
instead of dNTPs opposite a templating DNA strand (Donigan et al., 2014).  
PrimPolY89D, like wild-type PrimPol, was also unable to extend primers using rNTPs 
(Figure 5.11). Therefore, it is highly unlikely that this tyrosine residue is involved in 
discerning the sugar of the incoming nucleotide, particularly as the Y89D variant also 
loses its ability to prime using rNTPs, as illustrated in Section 5.3. 
 
5.8. The PrimPolY89D Mutation Induces a Significant Structural 
Alteration in PrimPol 
The observed reduced enzyme activity of PrimPolY89D could be the result of the loss of 
aromatic interactions involved in local base stacking events with either the template or 
the incoming nucleotide. However, it may instead be required for maintaining the 
structural integrity of the enzyme and mutation of this tyrosine causes more global 
effects in the structure of PrimPol. To test this second possibility, we subjected the 
polymerase domains of both the wild-type and PrimPolY89D to thermal denaturation and 
circular dichroism (CD) to check for alterations. There was a striking difference in both 
the thermal denaturation profiles and the CD spectra of the two enzymes (Figure 
5.12A), suggesting this point mutant results in global changes to the enzyme that 
causes the reduction in activity observed above. The melting point of the polymerase 
dropped from 49.12°C for the wild-type polymerase domain compared to 42.50°C for 
PrimPolY89D (Figure 5.12B). This significant drop in melting temperature suggests that 
the enzyme has become less stable and more structurally disordered following the 
point mutation. Analyses of the secondary structure from the circular dichroism spectra 
of the two variants’ polymerase domains by the variable selection algorithm (CDSSTR) 
(Lobley et al., 2002), which provides better fits for globular proteins, revealed a 
difference in the α-helical content of these domains (37% for wild-type PrimPol 
compared with 21% for Y89D), as well as β-strand content (25% for wild-type 
compared with 29% for Y89D). Additionally, this analysis predicted 30% of the structure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10. PrimPolY89D does not exhibit any mismatch tolerance activities.  
PrimPolY89D was incubated for 30 minutes with individual dNTPs as indicated, all four 
dNTPs or a no dNTP control along with the mismatched substrates from substrates 13-
28 from Table 2.6. These substrates represent primers annealed to templates with the 
primer template junction representing each of the 12 possible combinations of base 
pairs that exclude the 4 Watson-Crick base pairs. PrimPolY89D does not extend any of 
the substrate primers with any proficiency. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11. PrimPolY89D does not incorporate ribonucleotides.  
PrimPolY89D was assessed for its DNA-dependent rNTP incorporation activity. PrimPol, 
and PrimPolY89D were incubated with rNTPs and an undamaged DNA substrate 
(substrate 1 from Table 2.6) at 0.5, 1, 3, 5 and 60 minute time points alongside a 
control containing no protein. PrimPolY89D, like wild-type PrimPol, is unable to extend a 
DNA primer using ribonucleotides opposite a DNA template.  
  
 
 
 
 
 
Figure 5.12. Y89D induces a structural perturbation in PrimPol.  
The polymerase domain of the Y89D variant of PrimPol has a different global structure 
and thermal stability compared to wild-type PrimPol. (A) Thermal denaturation of the 
polymerase domain of PrimPol and its Y89D variant. The negative differential of the 
fluorescence profiles of the polymerase domains (PrimPol1–354) of wild-type PrimPol 
(solid green line) and its Y89D (broken purple line) variant plotted against temperature 
to determine their melting points. The melting point of the polymerase domain of the 
wild- type enzyme was found to be 49.12◦C, while the Y89D variant had a considerably 
lower melting point at 42.50◦ C. (B) Circular dichroism spectra of the polymerase 
domains of wild-type PrimPol and PrimPolY89D also show a substantial difference in the 
global structure of PrimPolY89D relative to the wild-type enzyme.  
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of the PrimPolY89D polymerase domain to be unstructured, whereas just 24% of wild-
type was predicted to be unstructured. 
 
5.9. PrimPolY89D Significantly Decreases DNA Replication Fork 
Rates in vivo 
To gain further insights into how the Y89D mutant form of PrimPol may contribute to 
the myopic phenotype observed in human patients, we studied the influence of 
PrimPolY89D on DNA replication in damaged and undamaged cells. We utilised the 
DT40 PrimPol deleted cell line (PrimPol -/-) (Bianchi et al., 2013) to examine the ability 
of PrimPolY89D to complement these cells, as previously reported for other mutant forms 
of PrimPol (Sections 3.11 and 4.10). These studies were carried out in collaboration 
with Dr. Laura Bailey from our laboratory. We stably expressed PrimPolY89D at similar 
levels to wild-type PrimPol in PrimPol knock-out DT40 cells (Figure 5.13A), with no 
obvious effects on cell growth. 
 
We reported previously that PrimPol-/- DT40 cells have a greater sensitivity to UV 
irradiation (Section 4.10) thus we first examined the effects of increasing doses of UV-
C on PrimPolY89D complemented cell lines. Although PrimPol-/- cells complemented with 
wild-type PrimPol showed a reversal of this sensitivity, cells complemented with 
PrimPolY89D maintained a decreased viability after UV damage (Figure 5.13B). Next, we 
measured the replication fork rates in PrimPol complemented cell lines using DNA fibre 
analysis. Strikingly, we observed a dramatic decrease in fork speeds in cells 
complemented with PrimPolY89D (average 0.84 kb/min) compared with cells carrying the 
wild-type PrimPol (average 1.66 kb/min) (Figure 5.13C). This decrease in fork speed 
was significantly greater than that previously reported in PrimPol-/- cells (average 1.45 
kb/min) (Bianchi et al., 2013), suggesting the Y89D mutant form of PrimPol may 
actually impede on-going DNA replication. In contrast, PrimPolY89D complemented the 
increased stalling defect observed in PrimPol-/- cells treated with UV-C, equally as well 
as wild-type PrimPol (Figure 5.13D), demonstrating that the polymerase activity, rather 
than the primase activity, is much more considerably affected by the Y89D mutation. 
 
5.10. Summary and Discussion 
A recent exome sequencing study has implicated a point mutation (Y89D) in the DNA 
damage tolerance polymerase, PrimPol, in high myopia in human patients (Zhao et al., 
  
 
Figure 5.13. PrimPolY89D cannot fully complement the UV sensitivity seen in 
PrimPol−/− DT40 cells due to decreased replication fork speeds.  
(A) Western blot showing overexpression of wild type and Y89D point mutant forms of 
PrimPol in PrimPol knockout (PrimPol−/−) DT40 chicken cells. Primary antibodies used 
are anti-PrimPol and anti-tubulin. (B) Cell viability was measured using CellTiter-Blue 
48 hours after increasing doses of UV-C were administered to the different cell types. 
Results represent three independent repeats and the error bars represent the standard 
deviation across the repeats. (C) DNA fibres were measured after sequential labelling 
with CldU and IdU for 20 min each to calculate replication speed. Results represent 
three independent repeats. There is a severe hindrance in unperturbed replication 
speed. (D) A 20 J/m2 UV-C pulse was included between the two labels and the ratio of 
the pre- and post-UV-C labels was calculated, with increased ratios representing 
replication stalling after UV. Results represent three independent repeats. Experiments 
shown here were carried out by Dr. Laura Bailey and fibre length analysis was carried 
out in collaboration by Dr. Laura Bailey and Benjamin Keen. 
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2013). However, this report did not investigate the molecular consequences of this 
genetic alteration. In this chapter, we report that the Y89D variant of PrimPol, 
previously found to be associated with high myopia, is a low processivity variant of 
PrimPol. Unlike wild-type PrimPol, it inserts just one nucleotide in a single binding 
event and has a significantly lower affinity for both dNTPs and DNA. Notably, this 
mutant did not exhibit any alteration in the fidelity, mismatch tolerance or translesion 
DNA synthesis spectrum relative to wild-type PrimPol. To determine whether this 
altered activity was a result of losing the hydrophilic hydroxyl moiety or the hydrophobic 
ring moiety, we constructed two more variants in which tyrosine 89 was mutated to 
either phenylalanine or serine. The Y89F mutant restored processivity to near-wild-type 
levels but Y89S had a similar activity to Y89D. In addition, we found that the Y89D 
PrimPol variant was unable to produce ribonucleotide primers but this activity was 
restored in the Y89F variant, indicating that PrimPol requires a hydrophobic aromatic 
ring at position 89 to maintain processivity but the presence of a hydroxyl moiety is 
dispensable. 
 
Insights from structural studies on primases and polymerases suggest two different 
potential explanations for the reduction in polymerase processivity observed in this 
study. The conserved tyrosine at position 89 could have an important role in base 
stacking or could be required for the structural integrity of the protein. There is an 
invariant phenylalanine in NHEJ AEPs that plays a vital role in the recognition and 
orientation of both the templating and the incoming bases through stacking interactions 
with both bases and is responsible for moving the incoming nucleotide into the 
enzyme’s active site (Brissett et al., 2011; Pitcher et al., 2007). Phenylalanine 290 in 
human Pol η helps form the hydrophobic core of the thumb domain (Biertümpfel et al., 
2010). Mutation of this residue is associated with the genetic disorder xeroderma 
pigmentosum variant (XPV), which is characterised by a susceptibility to skin cancers 
caused by a failure to perform proficient TLS across UV lesions. This mutation negates 
polymerase activity and is predicted to destabilise the thumb domain, resulting in 
reduced primer binding. Whilst the structure of PrimPol has not yet been elucidated, it 
is conceivable that the tyrosine at position 89 is involved in preserving the structure of a 
protein region analogous to the thumb domain that is found in other polymerases 
involved in binding the templating DNA strand. Tyrosine 89 is situated in a conserved 
hydrophobic pocket containing other conserved aromatic residues including Y87, F88 
and Y90, as well as a hydrophobic residue at position 86 (Figure 5.1) and it is likely that 
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disruption of Y89 disrupts a conserved interaction between these amino acids. A 
secondary structure prediction from PSIPRED (Jones, 1999) predicts that all of these 
amino acids lie within an α-helical region and the Y89 mutation may disrupt this helix. 
The circular dichroism data certainly supports this model, indicating that the Y89D 
variant has less α-helical structure than the wild-type. We postulate that the Y89D 
mutation causes a disruption in the global structure of the polymerase domain of 
PrimPol. As the affinity for DNA and dNTPs is decreased in the Y89D variant, but the 
apparent fidelity of the enzyme remains unchanged, we suggest that dNTP binding is 
dependent on DNA binding, which is disrupted by the structural changes induced by 
this mutation. 
 
In vivo analysis identified a dramatic decrease in replication fork rates in cells 
expressing PrimPolY89D and, despite being able to complement fork stalling in PrimPol-/- 
cells after UV damage, it was unable to prevent decreased cell viability. Consistent with 
in vitro assays, PrimPolY89D causes decreased replication fork rates in cells and it 
appears that this defect is enough to decrease the damage tolerance of these cells. 
Both our in vivo and in vitro studies on this mutant indicate that although PrimPolY89D 
retains the ability to bypass lesions, its capacity to replicate DNA is severely 
compromised. Therefore, it is appears that although PrimPolY89D is recruited to stalled 
replisomes, the underlying replication defect causes a significant slowing of replication 
forks, potentially resulting in incomplete lesion bypass, causing cells to progress 
through the cell cycle with under replicated genomic DNA. Clearly, these cells carry an 
abundance of PrimPol compared to wild-type levels and thus replication fork speed 
alone in endogenous mutants may not be so significantly altered. However, in cases 
where PrimPol is actively recruited to on-going forks or damage sites, this ‘slow’ mutant 
is likely to cause significant problems. Thus, unexpectedly, it appears that harbouring 
the PrimPolY89D mutation is more detrimental than not having PrimPol at all. PrimPol is 
not present in cells in particularly high abundance and is likely to be tightly regulated in 
S/G2 phase; an artificial overexpression of this mutation in these experiments is likely 
to contribute to the defects observed here. This data correlates with the phenotypes 
observed in patients carrying this mutation as problems are observed in tissues where 
levels of UV damage is expected to be high. Thus, in tissues where PrimPol is 
recruited in higher abundance to replicate through DNA damage, such as eyes, cellular 
defects are much more likely to be prevalent. In accordance, the previous study finds 
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that the high myopia phenotype is late onset (Zhao et al., 2013), which is concurrent 
with the accumulation of DNA damage over time. 
 
The link between reduced PrimPol polymerase activity and myopigenicity remains 
unclear. Another ocular disorder has been linked to mutations in a polymerase gene, 
progressive external ophthalmoplegia (PEO) is linked to mutations in the gene for pol γ 
in its catalytic domain (Van Goethem et al., 2001). Mutation results in an autosomal 
dominant phenotype and is characterised by deletions in mtDNA copy number (Van 
Goethem et al., 2001). Similar to the PrimPol variant phenotype this disorder is late 
onset, typically appearing in adults above the age of 18 with patients progressively 
deteriorating over time. However, it is likely that the two disorders are unrelated both 
physiologically and at a molecular level. The high myopia is not related to muscle 
deterioration whereas PEO patients develop a weakness in the muscles involved in 
eye movement and generally also exhibit skeletal muscle weakness that is particularly 
noticeable during exercise due to their mitochondrial defects. Additionally, the major 
mutation in pol γ that cause PEO are the result of enhanced incoming nucleotide 
binding, which results in a 10-100 fold drop in polymerase fidelity (Chan and Copeland, 
2009), a characteristic that is unchanged in PrimPolY89D. However, more severe forms 
of PEO are caused by mutations that result in a reduction in pol γ activity, similar to the 
reduction in activity evident in PrimPolY89D and whilst we have the attributed the 
physiological effects of PrimPolY89D to a reduction in fork rate, it would be interesting to 
see what effect, if any, PrimPolY89D has on mitochondrial copy number. 
 
Previous studies into the genes that predispose high myopia have identified two 
clusters of mutations, one in the outer retina affecting photoreceptors and ON-bipolar 
cell function and another in the scleral extracellular matrix composition and metabolism 
(Morgan et al., 2012). Significantly, mutations in PrimPol do not fit into either category. 
The severity of the clinical phenotype of patients with the Y89D mutation varied (Zhao 
et al., 2013) and it is highly likely that this gene is not a singular, unique aetiological 
factor and that other genetic and environmental factors also contribute to pathogenesis; 
however, it is evident from this previous study that the singular homozygote had a more 
severe phenotype than the heterozygotes that were identified. Although replication 
defects associated with PrimPolY89D suggests that it contributes to the reported clinical 
phenotypes, further work is required to establish if a direct link exists between 
replication stress and onset of high myopia.  
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CHAPTER 6 
 
 
 Characterisation of the Molecular 
Interactions Between PrimPol and 
Replication Protein A 
  
 104 
6.1. Introduction 
Translesion DNA synthesis polymerases are low fidelity enzymes that require strict 
regulation to reduce their mutagenic impact on the genome. The predominant 
mechanism for the regulation of polymerases is through the monoubiquitination of 
PCNA (Section 1.6) (Lehmann et al., 2007); when the replication fork reaches sites of 
DNA damage PCNA becomes monoubiquitinated and this allows access to the 
distributive TLS polymerases to synthesise DNA across the site of damage before the 
replication fork can continue to replicate the genome in a processive manner. PrimPol 
is a novel primase-polymerase involved in DNA damage tolerance through both TLS 
and post-lesion priming mechanisms (Chapter 4). In this chapter the means through 
which PrimPol is regulated is examined. 
 
Although PrimPol has been shown to co-localise with PCNA upon DNA damage 
(Mourón et al., 2013), there remains no evidence that PrimPol interacts with PCNA, 
monoubiquitinated or otherwise. It has recently been shown that, unlike other TLS 
polymerases, PrimPol is not stimulated by monoubiquitinated PCNA and does not 
interact with PCNA in vivo (Guilliam et al., 2015). To identify potential interaction 
partners, Dr. Sean Rudd from our laboratory carried out a mass spectrometry analysis 
of the proteins that were pulled down from human kidney cells (HEK 293) stably 
overexpressing Strep-tagged PrimPol and identified components of the replication 
protein A (RPA) complex as potential binding partners for PrimPol (Guilliam et al., 
2015; Rudd, 2013). Concurrently, a separate mass spectrometry analysis of an RPA 
pull-down from HEK 293T cells identified PrimPol as an interacting partner and that this 
interaction is required for foci formation in vivo (Wan et al., 2013). RPA has previously 
been shown to stimulate the activities of other polymerases, such as pols α and δ 
(Braun et al., 1997; Kenny et al., 1989; Tsurimoto and Stillman, 1989). 
 
The most abundant single-stranded binding protein in the cell (Seroussi and Lavi, 
1993), RPA is heterotrimeric complex composed of subunits 70, 32 and 14 kDa in size 
(Fairman and Stillman, 1988), henceforth referred to as RPA70, RPA32 and RPA14 
respectively. RPA is essential for a large number of genomic DNA metabolic reactions, 
including replication, recombination and DNA repair mechanisms NER, BER, MMR and 
double strand break repair (Reviewed in (Zou et al., 2006)). It is responsible for coating 
ssDNA in response to the generation of DNA lesions to prevent aberrant DNA structure 
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formation and to recruit DNA damage response proteins (Majka et al., 2006; Zou et al., 
2006).  
 
The RPA heterotrimer is comprised of 6 oligosaccharide/oligonucleotide-binding (OB) 
folds, four in RPA70 (RPA70N, RPA70A, RPA70B and RPA70C) and one in each of 
RPA32 and RPA14 (Figure 6.1). The OB folds are five β sheets oriented in a β-barrel 
arrangement, a common structural arrangement amongst oligonucleotide binding 
proteins (Bochkarev and Bochkareva, 2004; Bochkareva et al., 2002). RPA70A and 
RPA70B are responsible for the initial binding to single-stranded DNA, before switching 
to a more stable DNA binding mode involving the RPA70C and RPA32 OB folds 
(Bochkareva et al., 2002). RPA14 is important for trimerisation though its other 
functions remain unclear. RPA70N is involved in protein-protein interactions and 
mediates the interactions with a number of DNA damage response proteins, including 
p53, ATRIP, RAD9 and MRE11 (Feldkamp et al., 2013; Xu et al., 2008). In addition to 
its OB folds, RPA also possesses a winged-helix domain at the C-terminus of RPA32. 
This domain is also involved in protein-protein interactions with a number of DNA repair 
proteins including Uracil-DNA glycosylase 2, XPA, and RAD52 (Mer et al., 2000), all of 
which operate in different repair pathways. 
 
In this chapter, we define the binding site of PrimPol on its replication protein A binding 
partner and identify two protein-interaction motifs in the C-terminus of PrimPol that 
mediate the formation of this complex. The data reported here acts to complement the 
findings by others in our group and our collaborators that were recently published 
(Guilliam et al., 2015). At the end of this chapter, two potential models of regulation of 
the activities of PrimPol are discussed based on the work presented in this, and 
previous chapters. 
 
6.2. The C-terminus of PrimPol is Poorly Structured 
As the C-terminus of PrimPol, downstream of the zinc finger (amino acids 488-560), is 
not predicted to fold into a structural or catalytic domain, based on bioinformatics 
analysis of its primary sequence alone, we decided to determne whether the C-terminal 
portion of the protein acted to reduce the overall stability of the protein. Thermal 
denaturation studies have shown that there is a considerable increase in the stability of 
PrimPol upon removal of amino acids 488–560 (Figure 6.2), implying that this region 
lacks discernible structure that would contribute to protein stability. Disordered regions 
 
 
 
 
 
 
Figure 6.1. The domain architecture and protein interaction domains of RPA.  
(A) RPA is a heterotrimeric single-stranded DNA binding protein, composed of three 
domains of 70 kDa (RPA70), 32 kDa (RPA32) and 14 kDa (RPA14). RPA70 consists of 
four OB folds, indicated in green, RPA70N, RPA70A, RPA70B and RPA70C. RPA32 
consists of a single OB fold, again indicated in green, and a C-terminal winged-helix 
domain (orange). RPA14 consists of a single OB fold, shown in green. (B) The 
RPA70N OB fold and the winged-helix domain of RPA32 are primarily responsible for 
RPA’s interaction with other proteins. RPA70N has been shown to interact with RAD9, 
MRE11, p53 and ATRIP. The winged-helix domain has been shown to interact with 
uracil-DNA-glycosylase, XPA and RAD52. 
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Figure 6.2. The C-terminus of PrimPol is an unstructured, low-stability region of 
protein.  
Wild-type PrimPol and PrimPol1-487 were analysed by thermal denaturation. Full length 
PrimPol has a significantly lower melting temperature (46.6°C ± <0.1) than PrimPol1-487 
(52.6°C ± 0.1), which suggests that the amino acids 487-560 at the C-terminus do not 
form a secondary structure and are instead unstructured regions of protein. 
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of proteins often serve as scaffolds involved in protein–protein interactions and we 
speculate that this portion of human PrimPol might also act as an interaction interface. 
Indeed this is in agreement from the work from Wan et al., who found that the final 80 
amino acids of PrimPol (480-560) are sufficient for RPA-dependent foci formation 
following DNA damage (Wan et al., 2013). 
 
6.3. Identification of PrimPol and RPA Reciprocal Binding 
Domains 
The mass spectrometry data from both our group, and also Wan et al., revealed that 
human PrimPol interacts with the RPA70 subunit of RPA (Guilliam et al., 2015; Wan et 
al., 2013). Wan et al. reported that RPA70 lacking its RPA70C domain failed to co-
immunoprecipitate with PrimPol, suggesting that this is the domain that interacts with 
PrimPol (Wan et al., 2013). However, in the same study, following hydroxyurea 
treatment in the presence of this RPA70 mutant lacking the RPA70C domain, PrimPol 
was still able to form nuclear foci, an apparent contradiction to their conclusion that it is 
the RPA70C domain that interacts with PrimPol (Wan et al., 2013). Furthermore, there 
have been no previous reports that RPA70C acts as a protein-protein interaction 
domain. 
 
6.3.1. PrimPol Binds to RPA70N 
To identify the reciprocal binding domains of human PrimPol and RPA, we established 
a collaboration with the Chazin group (Vanderbilt University, Nashville, USA) who 
employ nuclear magnetic resonance (NMR) approaches to characterise RPA 
interactions. Aaron Ehlinger in the Chazin group performed the NMR-based binding 
studies. As discussed above, the major protein-protein interaction domains of RPA are 
the OB fold RPA70N and the winged helix domain of RPA32, and the NMR studies 
were focused on these two domains. 15N-1H Heteronuclear Single Quantum Coherence 
(HSQC) NMR spectra of 15N-enriched RPA70N (RPA70 1-120) and the winged helix 
domain of RPA32 (172-270) were acquired in the absence and presence of 2-fold 
molar excess of unlabelled PrimPol. Amide chemical shifts are sensitive to their local 
chemical environment and can be measured by NMR spectroscopy. When a ligand is 
bound, the location and/or intensity of NMR peaks at the binding site are altered. In 
addition, chemical shift perturbations can also be induced by the structural changes in 
the protein that are often brought about during ligand binding.  
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The NMR analysis of RPA32172-270 did not reveal any significant amide chemical shifts 
between the absence and presence of PrimPol (Figure 6.3A), chemical shifts were of 
comparable location and intensity, demonstrating no perturbation by the presence of 
PrimPol. However, the NMR analysis of RPA70N following the addition of PrimPol 
showed a significant difference in the amide chemical shifts, specifically in an 
attenuation of peak intensity (Figure 6.3B). This decrease in peak intensity corresponds 
to a reduction in protein tumbling when part of a larger complex with PrimPol. PrimPol 
therefore interacts with the RPA70N OB fold of RPA as opposed to the RPA32 winged 
helix domain of RPA. 
 
6.3.2. RPA70N Binds the C-terminus of PrimPol 
HSQC NMR spectra were also measured on 15N-enriched RPA70N in the absence and 
presence of our purified PrimPol1-487 recombinant protein (Figure 6.3C; see Section 
3.3.1 for purification of PrimPol1-487). The spectrum in the presence of PrimPol1-487 
closely resembles that of RPA70N alone, demonstrating that the C-terminal portion of 
PrimPol is indeed required for RPA binding and that binding is abolished in its absence. 
Taken together, these results indicate that the unstructured C-terminal portion of 
PrimPol and the RPA70N OB fold of RPA mediate the interaction between PrimPol and 
RPA. 
 
6.3.3. Purification of PrimPol480-560 
As these results from the Chazin group indicated that the final 80 amino acids of 
PrimPol are the residues responsible for RPA70N binding, we next aimed to study 
formation of this complex more directly. We constructed and purified PrimPol480-560 as 
described in Tables 2.3-2.5 (Figure 6.4A). The protein has a predicted size of 10,997 
Da but the protein bands run at a size closer to ~20kDa during SDS-PAGE analysis. To 
confirm this protein was indeed the correct protein, in addition to confirmation of the 
plasmid DNA sequence, we carried out two western blots on this protein, one to 
confirm the presence of PrimPol and another to confirm the presence of the 6x-His tag 
used to purify the protein (Figure 6.4B). In addition to the PrimPol480-560 protein, the 
Chazin group provided us with RPA70N protein for our studies (Figure 6.4C). 
 
6.3.4. PrimPol 480-560 Interacts with RPA70N 
 
 
 
 
 
Figure 6.3. The C-terminus of PrimPol interacts with RPA70N.  
(A) HSQC NMR spectra of 15N-enriched winged helix domain of RPA32 (denoted 
RPA32C above) in the absence (black) and presence (red) of PrimPol in a 2:1 ratio. 
There are no significant changes in the NMR spectra upon titration of PrimPol. (B) 
HSQC NMR spectra of 15N-enriched N-terminal OB fold of RPA70 (RPA70N) in the 
absence (black) and presence (red) of PrimPol. Upon titration of PrimPol there is a 
significant signal attenuation, suggesting an interaction between PrimPol and RPA70N. 
(C) This signal attenuation is not observed when PrimPol1-487 is titrated in (red) rather 
than wild-type PrimPol. (D) The C-terminal region downstream of the zinc finger is 
essential for interaction with RPA70N. PrimPol does not interact with RPA32. The 
experiments shown above were carried out by Dr. Aaron Ehlinger from the Chazin 
laboratory. 
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Figure 6.4. Purification of PrimPol480-560 and confirmation of RPA70NE7R purity.  
(A) PrimPol480-560 (11.0 kDa) was purified by IMAC (Ni2+) affinity, anion exchange and 
size exclusion chromatography. SDS-PAGE analysis of samples from purification 
fractions indicate a protein of size ~20 kDa. (B) The protein was confirmed correct by 
western blotting analysis through the use of a polyclonal Anti-PrimPol antibody and an 
antibody against the hexahistidine tag used to purify the protein. DNA sequence 
analysis of the expression vector and mass spectrometry were also utilised to confirm 
that this was indeed the correct protein. (C) SDS-PAGE analysis of purified RPA70N. 
RPA70NE7R (13.2 kDa) was gifted by the Chazin laboratory and analysed by SDS-
PAGE for purity and for any breakdown in transit. 
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To directly assess the interactions between these proteins, we utilised an analytical gel 
filtration chromatography approach. An S75 gel filtration column was initially calibrated 
through the size exclusion fractionation of a number of protein standards, albumin, 
ovalbumin, chymotripsinogen A, ribonuclease A and aprotinin (Figure 6.5A). The 
presence of these proteins in the individual peaks was confirmed by SDS-PAGE 
analysis (Figure 6.5B). The appearance of other proteins in the individual fraction lanes 
is the result of impure standards and the overlapping peaks caused by the resolution 
limits of the column as evident in the chromatograph. The protein peaks from the 
retention volume from the gel filtration were then plotted against the logarithm of the 
molecular weight of the protein standards (Figure 6.5C), from which a standards curve 
can be determined to allow molecular weight predictions from the retention volume of 
proteins. 
 
On three separate gel filtration runs RPA70N, PrimPol480-560, and the two proteins 
together were loaded onto the analytical gel filtration column and their retention volume 
measured (Figure 6.6A). The absorbance peak for PrimPol480-560 is much greater than 
RPA70N, despite both proteins being loaded at the same volume and concentration 
(0.5 mL of 35 μM protein) and having a similar size because the extinction coefficient at 
280 nm of RPA70N is 2980 mol-1 dm3 cm-1 compared with PrimPol480-560, which has an 
extinction coefficient of 8480 mol-1 dm3 cm-1. This difference is largely due to the 
presence of fewer tryptophan and tyrosine residues in RPA70N, which absorb UV light 
at a wavelength of 280 nm. 
 
The PrimPol480-560 has a much lower retention volume for a protein of its predicted size 
at 10.52 mL; this retention rate corresponds to a predicted molecular weight of ~42 
kDa. The likely reason for this is that proteins are separated by their Stokes radius 
during size-exclusion chromatography. Our standards, however, have been calibrated 
for globular proteins by their molecular weight, instead of Stokes radius. It is probably 
unsurprising given that PrimPol480-560 is predicted to be unstructured that it elutes at a 
higher apparent molecular weight as it likely has a greater Stokes radius than if it was 
well-ordered (Section 6.2).  
 
There is a clear interaction between the two proteins, the peak from RPA70N elution 
peak at 12.8 mL has disappeared in the PrimPol-RPA70N interaction chromatograph 
and the main peak (10.15 mL) is distinct from the PrimPol480-560 peak (10.52 mL). As 
 
 
 
Figure 6.5. Calibration of analytical S75 gel filtration column.  
A superdex S200 10/30 size exclusion chromatography column was calibrated through 
the use of protein standards. (A) Chromatograph showing the retention volumes of 
each of the proteins albumin, ovalbumin, chymotrypsinogen A, ribonuclease A and 
aprotinin. (B) Samples were taken at various points during the calibration denoted on 
the chromatograph as 1-5. These were analysed by SDS-PAGE and shown to correlate 
to the correct proteins as expected, corresponding molecular weight values are shown. 
Presence of more than one protein standard, particularly in fractions 1 and 2, are 
caused by overlapping peaks in the chromatograph due to low resolution. (C) The 
logarithmic molecular weight values are plotted against retention volume and a 
regression line plotted that can be used to calculate the predicted molecular weight of a 
complex given its retention volume. 
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Figure 6.6. PrimPol460-580 interacts with RPA70N.  
(A) Chromatograph showing the retention volumes of PrimPol480-560 (Red), RPA70N 
(Green) and PrimPol480-560 and RPA70N in a 1:1 ratio (Blue). 0.5ml of 35μM protein 
was loaded in each case onto a superdex S75 10/30. The lower relative mAU of RPA 
to PrimPol480-560 despite the same concentration and volume is the result of RPA70N 
having a lower molar extinction coefficient than PrimPol. RPA70N has a retention peak 
volume of 12.86 mL and PrimPol480-560 has a retention peak volume of 10.52 mL. The 
PrimPol460-580-RPA70N mixture chromatograph shows both individual proteins’ peaks 
abrogated and a single peak at a retention volume of 10.15 mL, demonstrating an 
interaction between these two proteins. (B) Protein interaction was confirmed by SDS-
PAGE analysis of the single peak from the PrimPol460-580-RPA70N chromatograph, 
showing both proteins present on the gel in an approximately 1:1 ratio. 
  
A 
B 
 109 
the two individual proteins peaks have disappeared completely and there is a single, 
shifted peak with an area approximately the same as the two peaks combined, there is 
likely to be an appreciable 1:1 interaction between the two proteins. This interaction 
was confirmed by SDS-PAGE of the fractions of the PrimPol-RPA70N peak (Figure 
6.6B), which shows both PrimPol480-560 and RPA 70N in the fraction.  
 
The PrimPol-RPA70N peak corresponds to a predicted molecular weight of ~48 kDa. 
As the two proteins are found in the SDS-PAGE analysis to be present at an 
approximately 1:1 ratio, the protein complex could form a stable tetramer of 
(RPA70N)2(PrimPol480-560)2 with a predicted molecular weight of 48,398 Da. I, however, 
hypothesise that the greater Stokes radius of PrimPol480-560 caused by a lack of 
tertiary structure causes this peak. Regardless of whether the protein complex is a 
tetramer or a dimer, the evidence clearly indicates that the two proteins interact. 
 
PrimPol480-560 was isotopically labelled with 15N and analysed for its HSQC spectrum by 
the Chazin group (Figure 6.7). The low dispersion observed in the HSQC spectrum is 
expected of a protein with little appreciative secondary structure. Upon titration of 
RPA70N at a 2:1 molar ratio, there is a remarkable effect on the HSQC spectrum, with 
peaks attenuating, broadening or shifting. Possible explanations for the causes of 
these effects include heterogeneous binding, motif swapping, and/or binding-induced 
partial folding of the domain in the complex. 
 
6.4. Identifying RPA Interaction Motifs in Human PrimPol 
Previous interaction studies with the RPA70N domain have identified a basic cleft into 
which several interacting partners bind, including RAD9, MRE11, ATRIP and p53 (Xu 
et al., 2008). These interacting partners all contain a similar sequence that they utilise 
to bind RPA70N (Xu et al., 2008), this sequence is highly negatively charged and is 
centred around an invariant pair of aspartate resiudes (Figure 6.8A). PrimPol also 
contains a potentially similar sequence towards its C-terminus (Figure 6.8A, amino 
acids 513-527) and our secondary structure prediction (Appendix I) predicts that, like 
with the other interacting partners, this portion of the protein may form an α helical 
structure. This motif of PrimPol is henceforth referred to as RPA-binding motif A (RBM-
A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7. HSQC NMR confirmation of the PrimPol460-580 interaction with 
RPA70N.  
HSQC NMR spectra of 15N-enriched PrimPol460-580 (PrimPol CTD) in the absence 
(black) and presence (red) of RPA70N (70N) titrated in at a 2:1 ratio. Upon titration of 
RPA70N there is a significant alteration in the NMR spectrum, strongly suggestive of 
an interaction between PrimPol460-580 and RPA70N. The experiments shown here were 
carried out by Dr. Aaron Ehlinger from the Chazin laboratory. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. PrimPol contains a putative RPA70N-binding motif is shown to 
interact with RPA70N.  
(A) The RPA70N binding motifs of ATRIP, MRE11, RAD9 and p53 have been 
identified, as well as an optimised RPA70N binding sequence used to obtain the 
structure of RPA in complex with a peptide helix, where Z is 3,4-Dichlorophenyl (Frank 
et al., 2014). PrimPol contains a sequence similar to this previously identified RPA70N-
binding motif towards its C-terminus at amino acids 513-527. (B) PrimPol510-528 
interacts with RPA70N. HSQC NMR data was collected for 15N-enriched RPA70N in the 
absence (black) or presence (red) of PrimPol510-528, a short peptide sequence that 
contains the putative RPA70N-binding motif identified in (A). Locational shifts in the 
NMR spectra indicate that PrimPol510-528 interacts with RPA70N. 
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To test whether RPA70N interacts with this putative interaction motif and how strong 
this interaction is, a 15 amino acid peptide containing RBM-A was synthesised 
(GenScript) and fluorescently labelled with the aim to carry out fluorescence anisotropy. 
However, upon testing anisotropy given an increase in RPA70N concentration, we 
found no changes in the apparent fluorescence polarisation (Appendix IV). Despite 
fluorescence labelling based on the manufacturers instructions and subsequent 
purification by size-exclusion chromatography (Superdex Peptide 10/300 GL column), 
ion exchange chromatography (mono-Q column), and reversed-phase chromatography 
(C18 column), the label that was present in the peptide samples was confirmed not to 
be covalently linked to the peptide by mass spectrometry. 
 
Concurrently with our own attempted binding analysis, the Chazin group carried out 
HSQC NMR to acquire spectra of 15N-enriched RPA70N in the absence (black) and 
presence (red) of PrimPol amino acids 510-528, containing RBM-A, at a 4:1 molar ratio 
to RPA70N (Figure 6.8B). There are significant amide chemical shifts evident in the 
location of the peaks and a weighted average of these shifts were plotted based on the 
difference between RPA70N alone and with the PrimPol peptide present (Figure 6.9A). 
The perturbations above a defined threshold (Δδ>0.1) were mapped onto the structure 
of the RPA70N domain and compared with the perturbations caused by the binding of 
other RPA-interacting proteins ATRIP, Rad9 and MRE11 (Figure 6.9B)(Xu et al., 2008). 
This PrimPol peptide binds to a remarkably similar region to these other RPA70N 
protein partners, along the length of one side of the beta barrel structure and not with 
the helices flanking this domain. The perturbations map to the basic cleft of RPA70N 
(Figure 6.10), which is unsurprising given how the acidic nature of this peptide 
(theoretical pI=3.25). 
 
6.5. Crystal Structure of the PrimPol-RPA70N Interaction 
The X-ray diffraction data used to elucidate the structure of RPA70N revealed that the 
protein crystals conform to a hexagonal crystal lattice (Bochkareva et al., 2005). 
Unfortunately, the basic cleft to which RPA70N-interacting proteins bind is occluded 
from this crystal lattice and this prevents the binding to the interaction surface 
(Feldkamp et al., 2013). Three of the basic arginine residues from the cleft interacted 
with two glutamate residues (E7 and E100) from adjacent molecules. Three charge-
reversal RPA70N variants were constructed by Feldkamp et al., E7R, E100R and an 
E7R/E100R variant that contained both mutations (Feldkamp et al., 2013). All three 
 
 
 
 
 
Figure 6.9. PrimPol interacts with RPA70N in the same region as other 
interacting proteins.  
(A) Alterations in the HSQC NMR spectra following titration of PrimPol510-528 were 
quantified and plotted based on the RPA70N residue number. (B) Perturbations above 
a Δδ threshold of 0.1 were mapped onto the structure of RPA70N (shown in red). The 
interacting region of PrimPol is comparable to that of other RPA70N-interacting 
proteins ATRIP, RAD9 and MRE11, binding mostly on one side of the beta-barrel. 
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Figure 6.10. PrimPol binds at the basic cleft of RPA70N.  
A surface model of RPA70N (top) is shown with the relative charge mapped onto the 
different regions of protein, with blue indicating positive charge and red indicating 
negative charge. The regions that PrimPol interact with are mapped onto the ribbon 
model of RPA70N (bottom) and a comparison of these regions illustrates that PrimPol 
binds to a basic cleft in RPA70N. 
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mutants successfully crystallised in a P212121 orthorhombic lattice that made the basic 
cleft accessible. Their binding affinities for ATRIP were assessed to ensure that there is 
no significant changes in binding interaction partners in the basic cleft caused by these 
point mutants (Feldkamp et al., 2013). To demonstrate that structures of ligand 
complexes could be produced, a co-crystal structure of a binding cleft inhibitor with 
RPA70NE7R was obtained (Feldkamp et al., 2013). Subsequently, another RPA70NE7R 
crystal structure was obtained with an optimised high-affinity variant of the peptide helix 
of ATRIP that interacts with RPA70N in its basic cleft (Frank et al., 2014). 
 
We aimed to obtain the structure of PrimPol peptides/domains bound to RPA70N. The 
RPA70N protein provided by the Chazin group was the E7R modified variant of the 
domain. To confirm that we were able to reproduce previous results, RPA70N was 
screened in the range of conditions that previously brought about crystals for any of 
E7R, E100R or both mutations and crystals formed after just 2 days. The crystals 
grown in 100mM Bis-Tris HCl (pH 5.5), 2M ammonium sulphate were chosen for 
collecting a full X-ray diffraction data set (ϕ angles 0°-359° taken in duplicate) (Figure 
6.11). A molecular replacement using RPA70N as the search model matches the 
electron densities from our data. All of the structural studies described here were 
performed in joint collaboration with my colleague Dr. Nigel Brissett. 
 
The 15 amino acid peptide containing RBM-A was chemically synthesised (sequence 
in Figure 6.8A), and incubated with RPA70NE7R and screened for co-crystallisation with 
700μM RPA70NE7R at a 2.5:1 molar ratio. This concentration and peptide molar ratio 
was previously used to obtain co-crystals with the synthetic optimised ATRIP peptide 
(Frank et al., 2014). The proteins were screened using the Stura Footprint and 
MacroSol screens, which are optimised for the analysis of protein complexes (Stura et 
al., 1992). A number of conditions produced protein crystals suitable for X-ray 
diffraction analysis and four examples are shown in Figure 6.12. 
 
The crystal lattice structures of RPA70NE7R alone and in complex with a helix in its 
basic cleft were significantly different, both in unit cell dimensions and lattice structures. 
Whilst RPA70NE7R crystals conform to a P212121 orthorhombic lattice with 90° α, β and 
γ angles, in complex they crystallise in the C121 space group, forming a monoclinic 
crystal with 90° α and γ angles but a β angle of 120.6° (Feldkamp et al., 2013; Frank et 
al., 2014). RPA70NE7R unit cell a, b and c dimensions were 38.54, 53.72 and 54.36 Å 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11. RPA70NE7R readily forms protein crystals.  
RPA70NE7R forms crystals in a buffer of 100 mM Bis-Tris HCl (pH 5.5) and 2 M AmSO4. 
A data set was taken in duplicate between ϕ angles 0°-359° and a representative 
image taken at a ϕ angle of 278° is shown with a 2.31Å resolution limit. A molecular 
replacement using RPA70NE7R (PDB ID: 4IPC) as the search model matched our 
experimental data, confirming that these crystals were RPA70NE7R. 
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Figure 6.12. Co-crystallising RPA70NE7R with PrimPol513-527.  
RPA70NE7R was screened for cocrystals with a 15 amino acid PrimPol peptide 
(PrimPol513-527) 1:2.5 molar ratio (700 µM with 1750 µM peptide). Representative 
crystals and diffraction patterns taken at φ angles of 0° and 90° are shown. The four 
crystals shown were grown in buffers of 1.6 M NaH2PO4/K2HPO4 (pH7); 2 M 
NaH2PO4/K2HPO4 (pH7); 2% w/v PEG 8000 , 1.0 M lithium sulphate; and 12% w/v PEG 
4000, 5% v/v 2-propanol , 0.1 M sodium citrate (pH5.5). A representative 2.59Å 
resolution limit is shown on the first diffraction pattern image. 
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respectively, whilst the protein complex crystals had unit cell dimensions of 90.15, 
46.80 and 78.79 Å, respectively. As such, when indexing our crystals, we would expect 
to see a significant shift in the crystal lattice structure if the PrimPol peptide is present 
in the basic cleft. However, we found that there were no significant changes in the 
space group or unit cell dimensions of the crystals that were obtained (Table 6.1). 
 
Alongside these studies with the 15 amino acid peptide of PrimPol (resiudes 513-528), 
we also screened for co-crystals of RPA70NE7R bound to PrimPol480-560. PrimPol480-560 
and RPA70NE7R were incubated in a 1:1 ratio and then the mixture was gel filtered to 
allow the bound complex to be purified (see Section 6.3).  This complex was set up in 
the Stura Footprint and MacroSol crysallisation screens, following a pre-crystallisation 
test (PCT) to determine a suitable concentration (9 mg mL-1). A range of conditions 
produced crystals, seven of which are shown in Figure 6.13. Crystals from each of 
these conditions were indexed using iMOSFLM and again there were no significant 
changes in the space group or unit cell dimensions (Table 6.2). 
 
Although there were significant crystal lattice structural changes in the presence of the 
α-helical peptide, RPA70NE7R was crystallised in complex with an inhibitory compound 
(VU079104) in its basic cleft with a P212121 orthorhombic lattice unit cell dimensions of 
38.27, 54.27 and 54.33 Å. Therefore, despite no significant changes in the space group 
or unit cell dimensions, we collected data sets for each to determine if any of these 
crystals exhibited any additional electron density in the binding cleft. A molecular 
replacement, using RPA70NE7R (PDB ID: 4IPC) as the search model, did not reveal any 
unaccounted electron density in the basic binding cleft for the first six conditions. 
However, in the condition containing 0.2 M imidazole malate (pH 6.0) and 30 % (w/v) 
PEG 4000 there was apparent additional electron density in this binding cleft that, 
although weak, was connected and therefore unlikely to be salt or water molecules. 
These crystals were sent for additional analysis using synchrotron radiation at the 
Diamond Light Source, Oxfordshire; synchrotron radiation produces more intense and 
monochromatic high-energy X-ray beams to give greater amplitude of signal and 
greater penetrance. The resolution obtained from the data at the synchrotron was ~1.3 
Å (See diffraction data in Figure 6.14 and data collection and refinement statistics in 
Table 6.3). 
 
 
 
 
 
Table 6.1. Crystal lattice properties of crystals of RPA70NE7R with PrimPol513-527.  
All crystals exhibit a P212121 orthorhombic lattice and similar lattice dimensions suggesting that the small peptide is not present in the 
RPA70NE7R crystals. 
Condition Spacegroup a b c α β γ 
0.15 M sodium citrate (pH5.5), 2 M ammonium sulphate P212121 38.0 53.3 53.8 90 90 90 
2.0 M NaH2PO4/K2HPO4 (pH7.0) P212121 38.4 53.3 53.7 90 90 90 
1.6 M NaH2PO4/K2HPO4 (pH7.0) P212121 38.8 53.2 53.8 90 90 90 
0.01 M sodium borate (pH 8.5), 1.5 M sodium citrate P212121 39.8 52.5 53.6 90 90 90 
0.01 M sodium cacodylate (pH 6.5), 45% (w/v) PEG 2000 MME P212121 39.1 50.8 52.2 90 90 90 
1.0 M ammonium dihydrogen phosphate, 0.1 M sodium citrate (pH 5.5) P212121 38.2 53.1 54.5 90 90 90 
2% w/v PEG 8000, 1.0 M lithium sulphate P212121 38.2 53.0 53.6 90 90 90 
2% w/v PEG 8000, 1.0 M lithium sulphate, 0.1 M imidazole malate (pH 6.5) P212121 38.9 53.3 53.9 90 90 90 
12% w/v PEG 4000, 5% v/v 2-propanol, 0.1 M sodium citrate (pH5.5) P212121 38.2 53.2 53.7 90 90 90 
        
RPA70N E7R P212121 38.5 53.7 54.4 90 90 90 
RPA70N E7R complex with optimised ATRIP helix C121 90.2 46.8 78.8 90 121 90 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.13. Co-crystallising RPA70NE7R with PrimPol480-560.  
RPA70NE7R and PrimPol480-560 mixed at 1:1 ratio, then gel filtered on an analytical gel 
filtration column; the fractions from the main peak in gel filtration were then screened 
for crystals at 9 mg ml-1. Full Data sets were collected and indexed for each of these 
conditions and representative image taken at a ϕ angles of 0° and 90°. Crystals were 
grown in buffers of (A) 0.2M Imidazole malate pH 5.5, 33% (v/v) PEG 600; (B) 0.1M Na 
Hepes (pH 8.2), 40% (v/v) PEG 550 MME; (C) 0.2 M ammonium acetate, 0.1 M sodium 
acetate (pH 4.5), 20% w/v PEG 3350; (D) 0.15 M Sodium citrate (pH 5.5), 1.5M 
Ammonium Sulphate;  (E) 1.32 M NaH2PO4/K2HPO4 pH 7.0; (F) 0.01M Sodium Borate 
pH 8.5, 1.2M Sodium Citrate and (G) 0. 2 M imidazole malate (pH 6.0), 30 % (w/v) PEG 
4000.
 
 
 
 
 
 
 
 
 
Condition Spacegroup a b c α β γ 
0.2 M Imidazole malate (pH 5.5), 33% (v/v) PEG 600 P212121 39.2 51.0 52.5 90 90 90 
0.1 M Na Hepes (pH 8.2), 40% (v/v) PEG 550 MME P212121 38.2 52.8 53.7 90 90 90 
0.2 M ammonium acetate, 0.1 M Na acetate (pH 4.5), 20% (w/v) PEG 3350 P212121 37.8 52.9 54.5 90 90 90 
0.15 M Sodium citrate (pH 5.5), 1 M Ammonium Sulphate   P212121 38.4 53.5 54.1 90 90 90 
1.32 M NaH2PO4/K2HPO4 (pH 7.0) P212121 38.9 52.5 52.0 90 90 90 
0.01 M Sodium Borate (pH 8.5), 1.2 M Sodium Citrate P212121 38.3 53.2 53.9 90 90 90 
0. 2 M imidazole malate (pH 6.0), 30 % (w/v) PEG 4000  P212121 38.0 53.5 53.9 90 90 90 
 
 
Table 6.2. Crystal lattice properties of crystals of RPA70NE7R with PrimPol480-560.  
All crystals exhibit a P212121 orthorhombic lattice and similar lattice dimensions. However, following indexing and molecular replacement, 
unaccounted electron density was evident in the putative binding pocket of RPA70N for crystals grown in 0.2 M imidazole malate (pH 6.0), 30 % 
(w/v) PEG 4000. 
 
 
 
 
Figure 6.14. Diffraction pattern for RPA70NE7R in complex with PrimPol480-560. 
Diffraction pattern is shown from the synchrotron at the Diamond Light Source in 
Oxfordshire for the crystals of RPA70NE7R in complex with PrimPol480-560 grown in a 
buffer of 0.2 M imidazole malate (pH 6.0), 30 % (w/v) PEG 4000. Full Data sets were 
collected and indexed and representative images shown are at a ϕ angles of 0° and 
45°.  A 1.35Å diffraction limit is shown.  
 
 
 
 
 
 
 
Data Collection 
  
Source  Station I03, Diamond 
Space group  P212121 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
 
 
 
38.05, 53.49, 53.90 
90.00, 90.00, 90.00 
Wavelength (Å)  0.91406 
Resolution Range (Å)  16.25 (1.28) 
Total number of observations  352183 
Number of unique observations  29019 
Overall I/(σI)  26.9 (2.7) 
Overall completeness (%)  99.8 (98.2) 
R-merge  0.044 (0.655) 
Redundancy  12.1 (7.4) 
Refinement 
Resolution (Å)  16.25 (1.28) 
Number of reflections  27557 
Rfactor/Rfree  0.238/0.192 
Contents of assymetric unit  2 peptides 
Number of non-hydrogen atoms  
Protein 
Water molecules 
 
 
 
1070 
1021 
49 
Mean B value (Å2)  17.467 
RMSDs 
Bonds (Å) 
Angles (°) 
 
 
 
 
0.021 
2.072 
Ramachandran Statistics 
Favoured regions (%) 
Allowed regions (%) 
Disallowed regions (%) 
 
 
 
 
 
97.32 
0.89 
1.79 
 
 
 
Table 6.3. Data collection and refinement statistics for RPA70NE7R in complex 
with PrimPol480-560.  
Values in parentheses refer to those in the highest resolution shell. RMSD = Root-
mean-square deviation. 
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Following model building into this density and refinement of the crystal structure by Dr. 
Nigel Brissett it was evident that there was a helical peptide that was present in the 
basic binding cleft of RPA70N (Figure 6.15). Unexpectedly, it was not the peptide 
sequence that was previously identified that was found to be interacting with the 
RPA70N binding site, RBM-A. Instead, the sequence that is bound is in fact 
VDEIPDELIIEVLQE at the very C-terminus of PrimPol (amino acids 545-560). This C-
terminal motif is henceforth referred to as protein binding motif B (RBM-B). As the 
amino acids towards the N- and C-terminus of this motif were low resolution as the 
flexibility increases towards the end of the α-helical structure, only amino acids 547-
557 are shown (EIPDELIIEV). 
 
RBM-B, like RBM-A (see Section 6.4), binds between the β-barrel into the basic cleft in 
RPA70N (Figure 6.15). RBM-B also has a low pI, predicted to be 3.34, so it is perhaps 
unsurprising that it binds into the basic cleft of RPA70N.  There is no significant change 
in the structure of RPA70N upon binding of RBM-B. Despite the amino acids 480-544 
not being visible in our area of contiguous electron density, the helix that is bound, 
RBM-B, shows a significantly high goodness of fit to the electron density that is evident 
(Figure 6.16A) for amino acids 548-557. As such, this data is reliable in showing the 
binding region of PrimPol. We expect that residues 480-544, because they are not 
bound to RPA are flexible and this temporal protein disorder does not allow for 
resolution by X-ray crystallography. 
 
The helical orientation is stabilised by a number of electrostatic interactions between 
RBM-B and RPA70N (Figure 6.16B). The aspartate at position 551 of PrimPol is 
perhaps the most important point of contact as it interacts with the two arginines of 
RPA (R31 and R43) and a threonine (T34) side chain, as well as the amine group of 
the protein backbone of T34. The carbonyl group of PrimPol’s isoleucine at position 
549 likely acts as a hydrogen bond acceptor for the RPA’s R43. The glutamate at 
position 548 forms an electrostatic interaction with an arginine (R93) on the other side 
of RPA70N’s β-barrel, acting to secure the helix of PrimPol in this orientation. These 
electrostatic interactions are of paramount importance in the binding of PrimPol to 
RPA70N. In addition to the electrostatic interactions shown in Figure 6.16B, there are a 
number of non-bonding contacts and these are detailed in the Lig plot shown in Figure 
6.17.  
 
 
 
 
 
 
 
 
Figure 6.15. Co-crystal structure of RPA70NE7R with a PrimPol α helix shows interaction of RBM-B with the basic cleft of RPA70N.  
(A) PrimPol PBM-B (green) binds to a cleft between β sheets in the β barrel of RPA70N (purple) (B) The acidic PrimPol PBM-B peptide binds to 
a basic cleft in the OB fold of RPA70N. The electrostatic surface model of RPA70N is shown in which blue indicates a basic surface and red 
indicates an acidic surface. 
A 
B 
  
 
 
Figure 6.16. Electron density and protein-protein interaction contacts of RBM-B with RPA70N.  
(A) The continuous electron density of the RBM-B PrimPol peptide is shown in its binding region of RPA70N. The electron density of three 
continuous residues (I549-D551) is also shown and clearly illustrates the resolution and quality of data, with the electron density clearly 
showing the ring structure of P550. (B) The electrostatic interactions of PrimPol with RPA70N. D551 is of particular importance as it forms a 
number of electrostatic interactions with both the side chains and an amine of the backbone of the RPA70N peptide. 
A 
B 
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Strikingly, the interaction between PrimPol RBM-B and RPA70N is significantly different 
from the interaction between RPA70N and either the modified ATRIP stapled peptide 
and the p53 peptide that have been described previously (Bochkareva et al., 2005; 
Frank et al., 2014). A superposition of the modified ATRIP peptide with RBM-B shows 
that the two helices bind in a similar region to RPA70N but they are in opposite 
orientations (Figure 6.18A). The main interaction of the modified ATRIP peptide is of its 
modified 3,4-dichlorophenyl amino acid into a hydrophobic pocket on RPA70N, and in 
p53 there is a phenylalanine residue that extends into this pocket. This pocket is also 
the region that the VUO79104 RPA70N binding inhibitor was bound in its co-crystal 
structure (Feldkamp et al., 2013). PrimPol RBM-B has an isoleucine (I554) that 
occupies the hydrophobic pocket on RPA70N (Figure 6.18B). I554 forms hydrophobic 
non-bonding contacts with a methionine (M57) and a valine (V93) of RPA70N in this 
pocket. However, these hydrophobic interactions are not the major contacts in the 
RPA70N-PrimPol RBM-B interface.  
 
Despite having a pair of conserved aspartates, the stapled helix of ATRIP and the 
interacting helix of p53 do not have any equivalent electrostatic interactions to that of 
PrimPol RBM-B’s D551. It required a number of unsuccessful attempts to crystallise 
the peptide of p53, the helix (p53 amino acids 33-60) was added as a covalent 
modification to RPA70N as a fusion peptide at the C-terminus of RPA70N. Also there 
was a number of modifications to the ATRIP peptide that did not successfully crystallise 
with RPA70N prior to the high affinity 3,4-dichlorophenyl interaction. The additional 
stabilising electrostatic interactions between PrimPol RBM-B and RPA70N provided by 
D551 could be the reason we were able to get a structure of RBM-B bound to RPA70N. 
 
6.6. PrimPol has Two Protein Interaction Motifs 
 
As the HSQC work from the Chazin laboratory had identified RBM-A as a RPA70N-
interaction motif and our crystallography work had identified RBM-B as a RPA70N-
interaction motif, we decided to check which of the two, if either, interacted with 
RPA70N in gel filtration experiments if the other was knocked out. To do this, two 
PrimPol variants were constructed by Dr. Nigel Brissett. The first, PrimPolRMB-A-KO, is the 
C-terminal 80 amino acids of PrimPol (480-560), but with three charge reversal 
mutations and a single charge abrogation mutation (D514R, D518R, D519R and 
D528A), with the intended effect of removing the interaction between RBM-A and 
 
 
 
 
Figure 6.17. LigPlot showing the molecular interactions between RBM-B and 
RPA70N.  
The electrostatic and non-bonding contacts between PrimPol RBM-B (purple residues) 
and RPA70N (brown residues) are shown in this LigPlot schematic, calculated using 
the LigPlot+ software (Lasowaski and Swindells, 2011). 
 
 
 
 
Figure 6.18. Comparison of the PrimPol RBM-B helix bound to RPA70N with a stapled ATRIP peptide.  
(A) The PrimPol RBM-B helix (green) binds the same region of RPA70N (purple) as the stapled ATRIP peptide (blue; PDB ID: 4NB3), however 
the two peptides are bound in opposite orientations. (B) Binding to a hydrophobic pocket in RPA70N. The major interaction of the stapled 
peptide previously shown to bind RPA70N is of the modified 3,4-dichlorophenyl residue to a hydrophobic pocket in RPA70N. PrimPol PBM-B 
has an isoleucine (I554) that extends into this pocket but the major interactions are the electrostatic interactions shown in Figure 6.#. Amino 
acids 548-550 of PrimPol are not shown in (B) for clarity. 
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RPA70N. The second is PrimPol480-546 with the C-terminal 14 amino acids removed 
from PrimPol to remove the RBM-B interaction with RPA70N. These proteins were 
purified as described in Table 2.5 (Figure 6.19). 
 
These variants were analysed for their interaction with RPA70N by gel filtration in the 
same manner as PrimPol480-560 (Section 6.3.4). Like PrimPol480-560, both PrimPolRBM-A-KO 
and PrimPol480-546, elute as a single defined multimeric complex from the 
chromatography column (Figure 6.20). When added in a 1:1 molar ratio with RPA70N, 
PrimPolRBM-A-KO and PrimPol480-546 both interact with RPA70N. Whereas the RPA70N 
peak is completely removed upon binding to PrimPol for PrimPol480-560, both 
PrimPolRBM-A-KO and PrimPol480-546 show evidence of some unbound RPA70N with a 
small peak at the same elution volume as RPA70N. These small peaks were shown to 
indeed be free, unbound RPA70N by SDS-PAGE analysis (result not shown). This 
suggests that whilst both PrimPolRMB-A-KO and PrimPol480-546 retain RPA binding activity, 
this binding is not as strong as PrimPol480-560, which contains both RPA-binding motifs. 
A more quantitative analysis of the binding activity is required to determine which, if 
either, motif has higher affinity for binding RPA70N. 
 
To ensure that these are the only RPA-binding motifs in PrimPol480-560, two controls 
were constructed to assess whether a double RBM-A and RBM-B knockout would bind 
RPA. The first is a combination of the RBM-A and RBM-B knockouts above, PrimPol480-
546/RBM-A-KO. The second is a 6 point mutation variant (PrimPolRBM-A-KO/RBM-B-KO; D514R, 
D518R, D519R, D551R, I554A, I555A). Both of these double RBM-A/RBM-B knockout 
variants of PrimPol have their RPA-binding capacity completely abrogated (Figure 
6.21). There is no shift in the peaks of the individual proteins’ size exclusion 
chromatograph peaks and the RPA peak remains intact. 
 
6.7. RBM-A and RBM-B Represent Common Protein Interaction 
Motifs 
Both RBM-A and RBM-B are conserved across PrimPol orthologues (Figure 6.22). 
Whilst RBM-B remains conserved down to inverterbrate species such as the sea urchin 
Strongylocentrotus purpuratus as shown, RBM-A splits into two parts in which the 
highly conserved double aspartic acid and the conserved C-terminus of RBM-A move 
away from each other in the primary sequence (for example, compare human 
DNGIDDAYFLEATED with S. purpuratus GYKSDDHLVPPEHPSFTDWDE). However, 
 
 
 
 
 
 
Figure 6.19. Purification of PrimPol480-560/RBM-A-KO and PrimPol480-560. 
(A) Purification of PrimPol480-560/RBM-A-KO (D514R, D518R, D519R, D528A; 11.1 kDa) by 
IMAC (Ni2+) affinity, anion exchange and size exclusion chromatography. (B) 
Purification of PrimPol480-546 (9.4 kDa) missing RBM-B by IMAC (Ni2+) affinity, anion 
exchange and size exclusion chromatography. SDS-PAGE analysis of samples from 
purification fractions of both proteins indicate a protein of a size between 15 and 20 
kDa. As this is lower than PrimPol480-560 (runs at ~20kDa, see figure 6.4), but still higher 
than expected, it is likely that the predicted highly acidic pI of these proteins affect their 
behavior upon electrophoresis. 
  
 
 
 
 
 
 
 
 
Figure 6.20. PrimPol has two RPA70N binding motifs.  
(A) Chromatograph showing the retention volumes of PrimPol480-560/RBM-A-KO (Red), 
RPA70N (Green) and PrimPol480-560/RBM-A-KO and RPA70N in a 1:1 ratio (Blue). RPA70N 
has a retention peak volume of 12.86 mL and PrimPol480-560 has a retention peak 
volume of 11.37 mL. The PrimPol480-560/RBM-A-KO-RPA70N mixture chromatograph shows 
both individual proteins’ peaks abrogated and a single peak at a retention volume of 
10.87 mL, demonstrating an interaction between these two proteins. (B) 
Chromatograph showing the retention volumes of PrimPol480-546 (Red), RPA70N 
(Green) and PrimPol480-546 and RPA70N in a 1:1 ratio (Blue). RPA70N has a retention 
peak volume of 12.86 mL and PrimPol480-546 has a retention peak volume of 11.54 mL. 
These two proteins also interact, illustrated by a single peak at 10.96 mL. 
  
 
 
 
 
 
 
 
 
 
Figure 6.21. RBM-A or RBM-B is required for RPA70N binding.  
(A) Gel Filtration of PrimPol480-546/RBM-A-KO and PrimPol RBM-A-KO/RBM-B-KO RBM-A and RBM-
B double knockouts. (B) Chromatograph showing the retention volumes of PrimPol480-
546/RBM-A-KO (Red), RPA70N (Green) and PrimPol480-546/RBM-A-KO and RPA70N in a 1:1 ratio 
(Blue). There is no shift in the peaks of the individual proteins, suggesting that there is 
no interaction between these proteins. (C) Chromatograph showing the retention 
volumes of PrimPol RBM-A-KO/RBM-B-KO (Red), RPA70N (Green) and PrimPol480-546 and 
RPA70N in a 1:1 ratio (Blue). Again, there is no shift in either of the individual protein 
peaks, suggesting that there is no interaction between these proteins. Both these RBM-
A and RBM-B double knockouts remove the capacity to bind RPA70N. 
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Figure 6.22. RBM-A and RBM-B are conserved motifs.  
(A) The domain architecture of PrimPol showing the positions of RBM-A and RBM-B 
relative to the functional domains of the protein. (B) RBM-A is a conserved motif across 
chordate species. However, in lower species not shown here the motif splits into two 
separate motifs. (C) RBM-B is conserved across higher eukaryotic species. 
 
 
A 
B 
C 
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some PrimPol orthologues have been identified with RBM-A that don’t necessarily 
contain RBM-B, such as the PrimPol orthologue of Ectocarpus siliculosus, which 
contains the sequence NPSIDDGYFLSAGED towards its C-terminus but no apparent 
homology to RBM-B. It remains difficult to predict which of the two motifs are more 
biologically important and in vivo analysis using human PrimPol variants with RBM-A 
and RBM-B knocked out is underway in our laboratory. 
 
Bioinformatics analysis using PSI-BLAST reveals that both RBM-A- and RBM-B-like 
sequences are found in other proteins involved in DNA metabolism. As described, 
RBM-A was identified due to its homology with other DNA damage response proteins 
that bind RPA (Section 6.4). We have also identified highly similar sequences found in 
both Topo I and the Werner helicase (Figure 6.23A). The Werner helicase is a RecQ 
helicase with crucial roles in double strand break repair, both HR and NHEJ, and base 
excision repair (Monnat, 2010). RPA is a known interacting partner of the Werner 
helicase, acting to increase its helicase activity in vitro (Brosh et al., 1999; K. M. 
Doherty et al., 2005). This interaction is mapped to a region on the Werner helicase 
that has a repeated sequence, both repeats contain the RBM-A-like sequence (K. M. 
Doherty et al., 2005). RPA70 binds to this repeated sequence but also binds to one 
individual sequence (K. M. Doherty et al., 2005); the significance of the sequence 
repeat is unknown and this repeat is not present in the Xenopus Werner helicase.  
 
RBM-A also aligns to a sequence in the catalytic subunit (p180, POLA1) of pol α in the 
fungal species Pseudozyma antarctica (Figure 6.23B). A subsequent alignment of this 
sequence identifies a comparable sequence in the homologous protein in 
Saccharomyces cerevisiae and humans (Figure 6.23B). This acidic sequence is found 
towards the N-terminus of the protein, amino acids 56-70 in human pol α. The 
processivity and polymerase activity of pol α is stimulated through interaction with RPA 
(Braun et al., 1997) and the docking site on RPA has been identified in the region 1-
173 of RPA70, i.e. that region containing RPA70N (Taneja et al., 2007). We postulate 
that these are the most likely residues on pol α to interact with RPA, and do so in a 
similar manner to PrimPol. 
 
RBM-B of PrimPol strongly resembles a Ctf4-interaction motif (Figure 6.23C) that is 
also present in the catalytic subunit of pol α the Sld5 subunit of GINS (A. C. Simon et 
al., 2014). A homotrimer of Ctf4 molecules acts to link pol α to the CMG complex (A. C. 
 
 
 
 
 
Figure 6.23. RBM-A and RBM-B represent common protein interaction motifs.  
(A) RBM-A of PrimPol aligns to two DNA processing proteins. Sequences similar to 
that of RBM-A are identified in Topoisomerase I and the Werner helicase. (B) RBM-A 
of PrimPol aligns to a short acidic sequence in the catalytic subunit of pol α of 
Pseudozyma antarctica. A comparable sequence is found in the human homologue 
and it is postulated that this is the RPA-interacting region of pol α. (C) PrimPol RBM-B 
resembles a Ctf4-binding motif. The Ctf4-binding motif that has previously been 
identified in the catalytic polymerase subunit of pol α (Pol1) and Sld5 of GINS is 
present in PrimPol at the C-terminus in RBM-B. This region of PrimPol interacts with 
RPA70N as shown crystallographically and represents a potential multiple protein 
binding motif. A PSI-BLAST of this motif from human PrimPol and pol α identifies a 
number of other proteins involved in the metabolism of DNA. 
A 
B 
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Simon et al., 2014). These motifs also form an α helix and bind Ctf4 in an antiparallel 
fashion to two helices in Ctf4 that form a basic binding channel (A. C. Simon et al., 
2014). It was noted that Ctf4 may be anchored to the CMG complex, it has a higher 
binding efficiency to Sld5 than pol α (A. C. Simon et al., 2014), and allows dynamic 
interaction of other replication components as required, allowing efficient replication 
both under normal conditions and during replication stress. PrimPol is not only active 
under situations of replicative stress, it is also important for the maintenance of 
unperturbed replication fork progression ((Bianchi et al., 2013); Section 3.11). Although 
RPA is essential for PrimPol foci formation during replicative stress (Wan et al., 2013), 
PrimPol may be brought to the replication fork by binding transiently to Ctf4 as required 
during unperturbed replication. Further interaction studies are required to validate this 
hypothesis. 
 
A PSI-BLAST sequence alignment using currently the interaction motifs from PrimPol 
and pol α identifies range of other proteins that have similar sequences to these motifs, 
most of which are involved in DNA metabolism (Figure 6.23C). Those with motifs 
similar to the PrimPol RBM-B motif include ACF1, UBR7, Rev3, INO80, IDN3, RBBP6, 
NEK1 and TopBP1. Rev3 is the catalytic domain of pol ζ, and could provide a role 
similar to PrimPol and pol α in this context. INO80 and ACF1 are parts chromatin-
remodelling proteins and involved sliding the nucleosomes for DNA replication and 
DNA repair (A. J. Morrison and Shen, 2009; Poot et al., 2000); INO80 and ACF1 may 
interact with the Ctf4 complex to slide upstream nucleosomes to allow other Ctf4-
associated proteins to carry out their function. Nek1 is a kinase that interacts with Ku 
and ATR and primes Ku for the loading of other chromatin remodelling proteins, and 
primes ATR for efficient DNA damage response (S. Liu et al., 2013; Patil et al., 2013). 
Ctf4 could, therefore, act as the docking partner that brings Nek1 to the site of Ku and 
ATR. Notably, the aspartate at position 551 of PrimPol that is mainly responsible for the 
electrostatic interactions with RPA70N is highly conserved throughout these motifs. 
 
Those with motifs similar to the pol α Ctf4-interacting motif include replication proteins 
MCM7 and DNA repair protein FANCI (Figure 6.23C). MCM7 is another protein of the 
CMG complex and suggests that the CMG complex could be anchored to the Ctf4 
through two separate interactions from its three interaction domains. FANCI forms a 
complex with FANCD2 is responsible for the repair of interstrand DNA crosslinks (Joo 
et al., 2011). The identification of this motif raises the possibility that the Ctf4 trimer 
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acts not only to anchor the CMG complex to pol α but interacts with a multitude of 
proteins, including PrimPol, to carry out efficient replication. 
 
6.8. Summary and Discussion 
Previous work from our laboratory and others have demonstrated that PrimPol interacts 
with RPA, and that this interaction is essential for foci formation (Guilliam et al., 2015; 
Wan et al., 2013). The work presented in this chapter defines the interaction between 
RPA and PrimPol at two binding motifs in the unstructured C-terminus of PrimPol and 
is the result of a fruitful collaboration between our laboratory and the Chazin laboratory.  
This interaction and regulation by RPA illustrates a novel regulatory mechanism, 
distinct from that employed by other TLS polymerases (Lehmann et al., 2007). 
 
We initially demonstrated that the part of PrimPol C-terminal of the zinc finger is poorly 
structured and reduce the protein’s stability, suggesting an unstructured C-terminal tail 
that is potentially involved in protein-protein interactions. Additionally Wan et al. have 
shown that the C-terminal 80 amino acids of PrimPol (480-560) are sufficient for foci 
formation in vivo (Wan et al., 2013).  
 
RPA has two predominant protein-interaction domains in the RPA70N OB fold and the 
winged helix domain in the C-terminus. HSQC NMR spectral shifts following the 
titration of PrimPol establish that it is the OB fold of RPA70N that binds to PrimPol, not 
the winged helix domain. Following the removal of the C-terminal amino acids 488-560 
this interaction is lost. To verify that the RPA-interaction motif of PrimPol lies in the C-
terminus, PrimPol480-560 was constructed and shown to directly interact with RPA70N. It 
was previously postulated that RPA70C was the RPA interacting partner for PrimPol 
(Wan et al., 2013), but this is disputed by our data and there is no evidence of any 
other proteins interacting with this portion of RPA. 
 
The studies described here have identified two negatively-charged motifs in the C-
terminus of PrimPol that interact with the basic cleft of RPA70N. RPA70N interacts with 
a number of DNA damage response proteins, including ATRIP, MRE11, RAD9 and p53 
and these proteins share a relatively conserved interaction motif, a motif which is also 
present in PrimPol (Figure 6.8; RBM-A). HSQC NMR spectral shifts through the titration 
of this protein to 15N-enriched RPA70N demonstrated that this motif is indeed an RPA-
interacting motif. However, we also report a co-crystal structure of RPA70N with the 
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extreme C-terminus of PrimPol (RBM-B). Although a structure of a fusion peptide of 
RPA70N with p53 has previously been determined (Bochkareva et al., 2005), and a 
modified, stapled ATRIP peptide has been co-crystallised with RPA70N (Frank et al., 
2014), this is the first X-ray crystal structure of an unmodified human protein in the 
basic binding cleft RPA70N. 
 
This crystal structure reveals a novel binding mode to RPA70N than previously 
described structures. Previous structures are centred around an interaction in a 
hydrophobic pocket on RPA70N. Whilst RBM-B has an isoleucine that extends into this 
hydrophobic pocket and forms hydrophobic interactions, the major contacts are 
electrostatic interactions towards the N-terminus of the short RBM-B helix, with D551 of 
RBM-B forming a number of electrostatic interactions at the interface of the two 
proteins. There are no interactions equivalent to these electrostatic interactions in 
previous structures as their N-termini extends away from the hydrophobic pocket in the 
opposite direction than PrimPol’s. 
 
PrimPol has two protein binding sites that both bind RPA70N; these binding sites, 
particularly RBM-B, are likely to bind other protein partners such as Ctf4 to form a 
complex regulation system for PrimPol. The HSQC spectrum shift of PrimPol480-560 was 
pronounced and distribution was wide when RPA70N was titrated (Figure 6.7), and one 
potential indication is that there is heterogeneous binding to the binding site. There 
could, therefore, be exchange events between the two binding motifs at RBM-A and 
RBM-B. Mutagenesis studies are required to define which of the two motifs is more 
superior at binding RPA and is responsible for foci formation in vivo. It may be that 545-
560 is the more relevant binding motif, which is why it is present in the crystal structure, 
or it could be that 513-527 interacts with RPA in vivo but is less stable or somehow 
precluded in the PrimPol480-560 variant that was utilised to obtain the crystal structure. 
 
The data presented here complements the biochemical work carried out in parallel by 
Dr. Stanislaw Jozwiakowski and Thomas Guilliam from our laboratory. Their recent 
publication describes the regulatory effects of single stranded binding (SSB) proteins 
RPA and mtSSB on PrimPol. It was found that these SSB proteins act to constrain both 
the polymerase and primase activities of PrimPol (Guilliam et al., 2015), thus providing 
the opposite effect that it has on the high-fidelity replicative polymerases α, δ and γ 
(Braun et al., 1997; Kenny et al., 1989; Oliveira and Kaguni, 2010; Tsurimoto and 
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Stillman, 1989). This is not the first example of single-stranded binding proteins acting 
to restrict the activity of low-fidelity polymerases, with E. coli SSB selectively inhibiting 
the TLS polymerase pol II (Indiani et al., 2013). 
 
Taken together, three mechanisms of regulation for PrimPol can be proposed. The 
primary regulation mechanism is an intrinsic one; PrimPol only inserts 4 nucleotides in 
a single binding event (Section 4.2). This prevents the polymerase continuing to 
polymerise long stretches of DNA, potentially introducing insertion, deletion or point 
mutations into the genome in doing so. 
 
The other two mechanisms of regulation involve recruitment to the genome as required 
by protein partners. The first of these is regulation by single-stranded binding proteins 
RPA and mtSSB (Figure 6.24). RPA and mtSSB stimulate replicative polymerases 
during unperturbed replication and are displaced by the replication machinery as it 
replicates in a 5’-3’ direction. Upon reaching DNA damage, replicative polymerases 
stall and idle prior to the site of DNA damage; PCNA becomes monoubiquitinated and 
the replicative polymerase is relocated from the site of damage. RPA molecules coating 
the 5’ side of the site of damage remain intact and not displaced by the replication 
machinery. RPA70N recruits PrimPol to carry out TLS past the site of damage, or 
repriming following the site of damage (Section 4.11; Figure 4.16). RPA prevents 
PrimPol from excessive replication following the site of damage, as it is inhibitory to 
PrimPol and PrimPol cannot displace RPA (Guilliam et al., 2015). Following replication 
past the site of DNA damage by PrimPol, the replicative polymerase can proceed and 
continue replication. 
 
The second potential regulation mechanism is through tethering to the CMG complex 
via the Ctf4 trimer (Figure 6.25). The Ctf4 trimer is known to anchor the other primase  
present in higher eukaryotes, pol α, to the CMG complex (A. C. Simon et al., 2014). 
The potential interaction with Ctf4 could allow for pol α priming at sites of replication 
initiation and PrimPol priming following sites of UV damage (Section 4.10). 
Alternatively, tethering to the CMG complex could be required for as yet undefined 
PrimPol role in unperturbed replication ((Bianchi et al., 2013); Section 3.11). Future 
interaction studies with Ctf4 are required to establish if a bona fide interaction with 
PrimPol exists. 
  
 
 
 
Figure 6.24. Model of regulation of PrimPol by RPA.  
The replicative polymerases are proficient at displacing RPA from coated ssDNA as 
they replicate DNA in a processive manner. As the polymerase reaches a DNA lesion, 
the polymerase idles as the 3’-5’ exonucleolytic activity of the replicative polymerase 
prevents replication past the dimer. PrimPol binds to the RPA that has not been 
displaced downstream of the lesion and can extend the nascent DNA chain through the 
lesion or reprime following the lesion if unable to carry out TLS. The replicative 
machinery can then continue replication following lesion bypass. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.25. Model of regulation of PrimPol by Ctf4.  
Ctf4 acts as a trimer and anchors interacting proteins at the replication fork. An 
interaction between GINS and pol α via Ctf4 has previously been established (Simon et 
al., 2014). PrimPol and MCM7 also contain potential Ctf4-binding motifs. Ctf4 could act 
to anchor PrimPol to the CMG helicase complex via Sld5 and MCM7 of the CMG 
complex to allow PrimPol to reprime following lesions or during PrimPol’s currently 
undefined role in unperturbed replication. 
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Appendix I 
Secondary structure of human PrimPol from PSIPRED prediction. 
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Appendix II 
Alignment of PrimPol from X. tropicalis and X. laevis. 
 
xlPrimpol       MRGKKTPESMERKWKEKVKNVENLADYYRRHPLSLIYRPKLAKPWLPSSVWKLFPRQALA 60 
xtPrimpol       -----------------MKACGGLADYYRRHPLSFPYRPKLAKPWLPSSVWKLFPRQALA 43 
                                 :*   .***********: ************************ 
 
xlPrimpol       FNFAKTCKEDVHLFALETVIDDTERRLYLVTTYAEFWFYYVKHPFSLSHCYEVIPADAVC 120 
xtPrimpol       FNFAKMCKEDVHVFALETVIDDTERRLYLVTTYAEFWFYYVKQPISLSHCYEVIPADTVC 103 
                ***** ******:*****************************:*:************:** 
 
xlPrimpol       KLYIDFEFYKSSNPEADGKKMVALVIEYFSIKLEELYGIKCSPEWVLNLDSSSKEKFSRH 180 
xtPrimpol       KLYFDIEFYKPANPEVDGKKMVALVIEYFSTKLKEMYGIKCSPEWVLNLDSTTKEKFSRH 163 
                ***:*:****.:***.************** **:*:***************::******* 
 
xlPrimpol       LIFLLPNAAFKDNIHAGNFIKNVLKPLLPLAGYKSVTRDYVSGANESPCLPEAEVLCGNS 240 
xtPrimpol       LIFVLPNAAFKDNIHAGNFIKHVLQPLLPLAGYKPVSQD-VFGANKSPCLPEAKNFCDAS 222 
                ***:*****************:**:*********.*::* * ***:*******: :*. * 
 
xlPrimpol       GKPSLAKAVKDVQSIENCDLSSLIVRDKYGGNQLCIDLGVYTKNRNFRLYKASKLGKNVP 300 
xtPrimpol       RKPSQANAAKHVHSIENGDLSSLIVRDKYGGSQLLIDLGVYTKNRNFRLYKSSKLGKNVP 282 
                 *** *:*.*.*:**** *************.** ****************:******** 
 
xlPrimpol       FTLAEDNKFRSKPQKDICTEEHIFLCSLISNIRFSDSLKILTCSSPDYGMNKATSPYNKN 360 
xtPrimpol       FMLAEDNKFRSKPPKDFSAEEHIFLCSLISNVRFSDSLKILTCSNPDYRTSKAASHNNKN 342 
                * *********** **:.:************:************.***  .**:*  *** 
 
xlPrimpol       PGVTIKGYQFSPYPEIDDFILSLVTQEGFQGSIRSWNYFSSEELLVYETANYRWCANIGR 420 
xtPrimpol       PGVTMKGFQVSPYPEIDDFILSLVTREGFQGSIRSWHYFSSEELLVYETANYRWCANIRR 402 
                ****:**:*.***************:**********:********************* * 
 
xlPrimpol       AHKSNNVMLLVDLKREVWYQKCHDPICRAQNYKSECYPLPPEVCLPFLFKEEDEESVFTM 480 
xtPrimpol       AHKSNNVMLLVDVKREVWYQKCHDPICRAQNFKSECLPLPSEVCLPFLFKEDDEESIFTM 462 
                ************:******************:**** ***.**********:****:*** 
 
xlPrimpol       DENGNIKETKINRCHVLFADGYLPPQKPSMPRSGNTMASGERHSGSEIDDACILEATEDV 540 
xtPrimpol       DENGNIKETKINRSLVPMAD------KPSIARSGETMGPWERHCDSEIDDACILEAIEDI 516 
                *************. * :**      ***:.***:**.. ***..*********** **: 
 
xlPrimpol       EFVNAVDTSLAPLDLDDVQFSGEDVEFANAVDNSLAHLDLDDVQFSGEDIVFANAVDTSL 600 
xtPrimpol       EFSDAVDTSLAHLELDDVGIPDEDIAFVNAVDTSLAHLELDYVGIPDEDIVFVNAVDTSL 576 
                ** :******* *:**** :..**: *.****.*****:** * :..*****.******* 
 
xlPrimpol       AHLNLE---IPDEDIEFANAVDTSLAHLDSEDVEIPDE---------------------- 635 
xtPrimpol       AHLELDDVGIPDEDIAFVNAVDTSLAHLGSDDVGIPDEDIEFVNAVDNSLAHLDSDDLKI 636 
                ***:*:   ****** *.**********.*:** ****                       
 
xlPrimpol       -----------------------DIEFANAVDTSLAHLDLDDAEIPDTLLLESLYKHEMF 672 
xtPrimpol       SDEDVAFVNAVDNSLAHLDSDDEDIEFVNAVDTSLAHLDSDDVEIPDELLLKSLYEHEMF 696 
                                       ****.*********** **.**** ***:***:**** 
 
xlPrimpol       ASK 675 
xtPrimpol       ASK 699 
                *** 
 
xlPrimPol = X. laevis PrimPol 
xtPrimPol = X. tropicalis PrimPol 
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Appendix III 
Representative single incorporation extension assays for each of the 
concentrations of dATP tested (Figures 4.2 and 5.7) showing extension relative 
to the control bands in the first lane. Each of these gels were repeated in 
triplicate. 
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Appendix IV 
Testing the interaction of RPA70N with a fluorescently labelled RBM-A peptide 
by fluorescence anisotropy. The peptide was subsequently confirmed as 
unlabelled by mass spectrometry. 
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ABSTRACT
PrimPol is a primase–polymerase involved in nu-
clear and mitochondrial DNA replication in eukary-
otic cells. Although PrimPol is predicted to possess
an archaeo-eukaryotic primase and a UL52-like zinc
finger domain, the role of these domains has not
been established. Here, we report that the proposed
zinc finger domain of human PrimPol binds zinc ions
and is essential for maintaining primase activity. Al-
though apparently dispensable for its polymerase ac-
tivity, the zinc finger also regulates the processivity
and fidelity of PrimPol’s extension activities. When
the zinc finger is disrupted, PrimPol becomes more
promutagenic, has an altered translesion synthesis
spectrum and is capable of faithfully bypassing cy-
clobutane pyrimidine dimer photolesions. PrimPol’s
polymerase domain binds to both single- and double-
stranded DNA, whilst the zinc finger domain binds
only to single-stranded DNA. We additionally report
that although PrimPol’s primase activity is required
to restore wild-type replication fork rates in irradi-
ated PrimPol−/− cells, polymerase activity is suffi-
cient to maintain regular replisome progression in
unperturbed cells. Together, these findings provide
the first analysis of the molecular architecture of
PrimPol, describing the activities associated with,
and interplay between, its functional domains and
defining the requirement for its primase and poly-
merase activities during nuclear DNA replication.
INTRODUCTION
DNA replication is an essential biological process, indis-
pensable for the existence of life. DNA replication sys-
tems rely on a semi-conservative mode of replication where
the initiation of DNA synthesis requires a free 3′ hydroxyl
group to which additional nucleotides are subsequently
added by replicative polymerases (1). Genome replication
starts with DNA template-dependent synthesis of short
RNA primers that are further extended with deoxynu-
cleotides by the replication machinery. This initial step in
DNA replication is often defined as de novo primer synthesis
and is catalysed by specialised DNA polymerases known as
primases. Based on their structural topology, these enzymes
can be classified into archaeo-eukaryotic primases (AEPs)
or DnaG-like prokaryotic primases (2,3).
Until recently, the Pol !-associated DNA primase small
subunit (PriS) that is responsible for de novo polymer syn-
thesis through the production of RNA primers was consid-
ered to be the sole AEP superfamily member present in eu-
karyotes (1). However, bioinformatic analysis identified the
existence of an additional uncharacterized DNA primase in
eukaryotes called PrimPol (CCDC111 or FLJ33167) (3–7),
which belongs to the ‘NCLDV-herpesvirus clade’ of viral
AEPs.
Recent studies have reported that PrimPol is a DNA
primase (4–7), with the ability to synthesise primers us-
ing either ribonucleotides (NTPs) or deoxyribonucleotides
(dNTPs), preferring tomakeDNAprimers. In addition, the
enzyme possesses robust template-dependent DNA poly-
merase activity (4–7). PrimPol is present in both the nu-
cleus (4–6) and mitochondria (7) of eukaryotic cells. The
enzyme localises to nuclear chromatin during replication
(4–6) and this recruitment is more pronounced after treat-
ment with damaging agents (e.g. ultraviolet light; UV) or
replication stalling drugs (e.g. hydroxyurea) (4). UV irra-
diation can induce the covalent linkage of adjacent pyrim-
idines leading to the formation of cyclobutane pyrimidine
dimers (CPDs) and pyrimidine (6–4) pyrimidone photo-
products ((6–4)PPs). These helix-distorting lesions interfere
with major biological processes, including DNA replication
and transcription (8). PrimPol can perform translesion syn-
thesis (TLS) bypass of the highly distorting (6–4)PPs but
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is also involved in replication through oxidative lesions, in-
cluding 8-oxoguanine (8-oxoG) (4,5,7). Deletion of PrimPol
(PrimPol−/−) induced replication fork slowing, which was
much more pronounced when cells were UV irradiated (4).
Knockout cells also exhibited increased formation of chro-
mosomal breaks, particularly after aphidicolin treatment.
This study also reported that PrimPol is not epistatic with
the Pol !-dependant CPD-bypass pathway and therefore
appears to form an independent pathway required for the
bypass of UV, and other lesions, during replication (4,5).
Comparative analysis of the amino acid sequence of eu-
karyotic PrimPols identified the presence of two distinctive
domains (3), an enzymatic AEP polymerase and a UL52-
like zinc finger (Zfn) domain (Figure 1A). Mutation of the
conserved zinc-chelating cysteine residues in the UL52 do-
main of herpes simplex virus type 1 resulted in a severe re-
duction in DNA binding (8,9). The AEP polymerase do-
main contains the three signature catalytic motifs. A highly
conserved DxE motif (motif I), together with an aspartic
acid residue from motif III, forms the divalent metal bind-
ing site.Motif II (SxH) forms part of the putative nucleotide
binding motif. Mutagenesis of these motifs abolishes the
catalytic activities of these polymerases (4,5,7,10,11).
In this study, we have dissected the molecular architec-
ture of human PrimPol to define the activities associated
with its two major functional domains. We demonstrate
that the zinc finger domain is crucial for its primase activ-
ity. PrimPol also has DNA template-dependent DNA poly-
merase activities and this bifunctional enzymatic activity
is reminiscent of archaeal replicative primases (11–14). Al-
though PrimPol’s polymerase activities appeared, initially,
to be largely independent of the zinc finger domain, our
data suggests that the zinc finger domain plays important
roles in the processivity and fidelity of DNA synthesis. Ad-
ditionally, we demonstrate that the zinc finger domain has
regulatory roles for both DNA/RNA primase and TLS
activities. We also report that a catalytically active frag-
ment of human PrimPol, containing only the AEP domain
(PrimPol1–354), catalyzes TLS bypass of both major UV-
induced DNA lesions, CPDs and (6–4)PPs. Analysis of the
DNA binding affinities of catalytically active PrimPol1–354
and the C-terminal UL52-like domains established that the
enzymatic domain can bind both single-stranded (ss) and
double-stranded (ds) DNA, whilst the zinc finger domain
can only bind to ss DNA. Finally, we report that although
PrimPol’s polymerase activity is sufficient to maintain wild-
type replication fork rates in unperturbed PrimPol−/− cells,
primase activity is requisite for normal replication in UV-
treated cells. Together, these findings provide the firstmolec-
ular insights into the domain architecture of human Prim-
Pol, defining the activities associated with its major func-
tional modules and delineating the requirement for its spe-
cific catalytic activities during perturbed and unperturbed
DNA replication.
MATERIALS AND METHODS
Construction of human PrimPol mutants
Human PrimPol was cloned as described previously (4).
A number of PrimPol mutants were constructed by poly-
merase chain reaction (Figure 1B) and the primers used can
Figure 1. Domain architecture of eukaryotic PrimPol. (A) PrimPol is com-
posed of an AEP primase–polymerase and a Zn2+ finger (Zfn) domain.
The AEP domain contains three conserved catalytic motifs (I–III). The
first motif (motif I, the first two red stars) is the DxE motif that, along
with the conserved D in the third motif (motif III, third red star), forms
the catalytic triad that coordinates divalent metal ions essential in the syn-
thesis of oligonucleotide chains. The second motif (motif II, two light-
orange stars) is a conserved SxH motif that is required for the coordina-
tion of the incoming nucleotide. The zinc finger domain contains a canon-
ical C–H–C–C motif that coordinates a zinc ion and stabilises the anti-
parallel "-sheet and # helix structure. The numbers below the conserved
residues denote their positions in human PrimPol. (B) A number of hu-
man PrimPol constructs were produced to analyse the domain architec-
ture of PrimPol. A Zfn knockout mutant was produced by mutating the
first conserved cysteine and histidine residues that coordinate the zinc ion
(C419A and H426A, respectively). We constructed a number of trunca-
tion mutants based on secondary structure predictions. PrimPol1–487 lacks
the C-terminus region downstream of the Zfn domain. PrimPol1–354 dele-
tion mutant contains the polymerase domain but lacks the Zfn domain.
PrimPol372–560 possesses the zinc finger domain but lacks the polymerase
domain. PrimPol1–354/ZF-KO contains only the zinc finger domain but the
C419A andH426A aremutated. A 1–334 deletionmutant inXenopus trop-
icalis (XPrimPol1–334) was additionally constructed that is equivalent to
PrimPol1–354.
be found in the supplementary data (Supplementary Table
S1). Xenopus tropicalis PrimPol cDNA was sub-cloned into
pET28a (Novagen) using BamHI andXhoI restriction sites.
Subsequently, a 1–334 C-terminal deletion (XPrimPol1–334)
mutant was also constructed (primers in Supplementary Ta-
ble S1). Additionally, we constructed a PrimPolAXA (cat-
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alytically null) mutant that was cloned and purified, as pre-
viously described (4).
Expression and purification of recombinant PrimPol proteins
Wild-type PrimPol and PrimPol1–487 were expressed in
Escherichia coli BL21(pLysS) cells overnight at 16◦C, as
described previously (4). PrimPol1–354, PrimPol372–560 and
XPrimPol1–334 were expressed overnight at 25◦C. All of the
proteins were then purified by the same protocol, except
where otherwise noted. Cells were pelleted and resuspended
in buffer A (50 mM Tris–HCl (pH 7.5), 200 mM NaCl,
30 mM imidazole, 10% (v/v) glycerol, 17 !g/ml PMSF,
34 !g/ml benzamidine) supplemented with 0.5% IGEPAL.
Cells were disrupted by sonication and proteins isolated by
centrifugation. All proteins were purified by affinity chro-
matography using a 25 ml Ni2+-NTA agarose (Qiagen) col-
umn equilibrated with buffer A and eluted with buffer B (as
A, with 300 mM imidazole). The eluted protein-containing
fractions were then diluted 1 in 10 in buffer C (50 mM
Tris–HCl (pH 7.5), 10% (v/v) glycerol) and separated by
charge by affinity exchange chromatography on a 5 ml Hi-
Trap Heparin HP column (GE Healthcare) equilibrated
with buffer C. PrimPol372–560 was purified on a 5 ml HiTrap
Q HP (GE Healthcare) column equilibrated with buffer C.
All proteins were subject to gradient elution with buffer D
(as C, with 2MNaCl) and protein-containing fractions were
purified by size exclusion chromatography on a Superdex
S-75 analytical gel-filtration column (GE Healthcare) equi-
librated in buffer E (50 mM Tris–HCl (pH 7.5), 300 mM
NaCl, 10% (v/v) glycerol). Protein concentrations were de-
termined by absorption spectra at 280 nm.
DNA primase assays
The sequences of the oligonucleotides used in the primase
assays are sequences 1–4 in Supplementary Table S2. The
non-radioactive primase assay was performed in three sub-
sequent steps. Typically detection of primase activity was
started from incubation of 1!M of the enzyme to be tested
in 20 !l reaction volume containing 500 nM homopoly-
meric ss DNA templates with a biotin modification at the 5′
end (see sequences 1–4 in Supplementary Table S2), 500!M
rNTPs (Invitrogen) or 500!MdNTPs (Roche), 10mMBis-
Tris-Propane-HCl (pH 7.0), 10 mM MgCl2, 50 mM NaCl.
This primer synthesis reaction was carried out for 2 h at
37◦C. Following the primer synthesis reaction, the reaction
mixture was supplemented with 0.2 U of Klenow Taq (pu-
rified as in Engelke et al. (15)) and 15 !M FAM-6-dATP
(Jena-Biosciences), incubated at 37◦C for 45 min to allow
fluorescent labelling of de novo synthesised primers. The
primer synthesis/labelling enzymatic reactions were termi-
nated by adding 450!l of binding-washing (B-W) buffer (10
mMTris-HCl (pH 8.0), 500mMNaCl, 10mMEDTA). The
quenched reactions were subsequently added to 30 !l of
streptavidin-coated beads (Invitrogen) andmixed on a spin-
ning wheel for 1 h at 4◦C. After binding the ss DNA tem-
plates, the suspensions were spun down briefly to sediment
the beads. The supernatant was removed and the beads were
washed three times with 1 ml B-W buffer. The beads were
then suspended in 20 !l of the B-W buffer supplemented
with equal volume of loading buffer (8 M Urea, 10 mM
EDTA). The resulting sample was incubated at 95◦C for
3 min in order to liberate the primers synthesised de novo.
Subsequently, the samples were spun down briefly and 20
!l volume of each reaction was resolved by standard de-
naturing electrophoresis using a 15% (v/v) polyacrylamide
gel matrix containing 7Murea and 1×TBE buffer (100mM
Tris, 100mM Boric Acid, 2mM EDTA). Typically the elec-
trophoretic separation of primase assay products was per-
formed at 850 V for ∼2 h. After electrophoresis gels were
scanned for fluorescent signal detected by a Fujifilm FLA-
5100 image reader.
DNA primer extension assays
Hex-labelled DNA primers were annealed to oligomer tem-
plates (sequences in Supplementary Table S2). 34 nM of
protein was incubated with 20 nM DNA, 10 mM Bis-Tris-
Propane-HCl (pH 7.0), 10 mMMgCl2, 1 mMDTT and 200
!M dNTPs (Roche) to a final volume of 20 !l. In the case
of single nucleotide incorporations 200 !Mof each individ-
ual nucleotide adenosine, cytosine, guanosine or thymidine
triphosphate (dATP, dCTP, dGTP or dTTP respectively)
were added in lieu of dNTPs. The reactions were terminated
by the addition of 2× stop buffer (95% formamide, 0.09%
xylene cyanol, 0.05% bromophenol blue, 200 nM competi-
tor oligonucleotide) and boiled at 95◦C for 5 min. Samples
were resolved by electrophoresis on a 15% (v/v) polyacry-
lamide gel containing 7 M urea and 1× TBE buffer at 850
V for 2.5 h in 1× TBE buffer. Fluorescently labelled DNA
oligomers were detected by scanning using a Fujifilm FLA-
5100 image reader.
Terminal transferase assays
The terminal transferase capability of wild-type PrimPol
and its variants was studied using three types of synthetic
DNA substrates: dsDNA (sequence 6 annealed to sequence
7 fromSupplementary Table S2) and a primer template con-
taining both single-stranded and double-stranded DNA in-
terfaces (sequence 5 annealed to sequence 6; Supplementary
Table S2). Typical reactions were performed in 20 !l vol-
ume containing 10 mM Bis-Tris-Propane-HCl (pH 7.0), 10
mM NaCl, 10 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 20
nMDNA substrate, 200 !M dNTPs (Roche), with 100 nM
recombinant human PrimPol or its variants. All reactions
were incubated at 37◦C for 30min, reactions were quenched
with addition of 2× stop buffer (95% formamide, 0.09% xy-
lene cyanol, 0.05% bromophenol blue, 200 nM competitor
oligonucleotide) and boiled at 95◦C for 5min. Samples were
resolved by electrophoresis as described for the primer ex-
tension assays.
DNA extension processivity assays
Full-length and PrimPol1–354 constructs were analysed for
processivity as described previously (16). PrimPol (100 nM)
was preincubated at 37◦C with 60 nM substrate DNA (se-
quence 5 annealed to sequence 6 from Supplementary Ta-
ble S2), 10 mM Bis-Tris-Propane-HCl (pH 7.0), 10 mM
MgCl2 and 1 mM DTT for 30 min. Reactions were ini-
tiated by adding dNTPs and excess of sonicated herring
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sperm DNA (1 mg/ml) as an enzyme trap. Reactions were
quenched after time points of 15, 30, 60, 120 and 360s
with addition of 2× stop buffer (95% formamide, 0.09%
xylene cyanol, 0.05% bromophenolblue, 200 nM competi-
tor oligonucleotide) and boiled at 95◦C for 5 min. Samples
were resolved by electrophoresis as described for the primer
extension assays. To test the effectiveness of the trap, each of
the enzymes were also preincubated with excess of herring
sperm DNA (1 mg/ml), as well as 40 nM DNA, 10 mM
Bis-Tris-Propane-HCl (pH 7.0), 10 mM MgCl2 and 1 mM
DTT. To ensure the trap did not disrupt the processivity of
the enzyme, the experiment was also carried out with the
Klenow fragment of Taq polymerase.
The band intensities at 360 s were measured using Image-
Quant software (GE Healthcare). The percentage of active
polymerases at a given position is given by Equation (1):
% active polymerases at n
= (In + In+1 + In+2...)× 100%/(I1 + I2 + I3 . . .) (1)
Where I1 is the intensity at position 1, In is the intensity at
position n and so on.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSAs) were car-
ried out on two synthetic substrates: ss DNA (sequence
7 from Supplementary Table S2) and ds DNA (sequence
6 annealed to sequence 7 from Supplementary Table S2).
Varying concentrations of the human PrimPol1–354 and
PrimPol372–560 constructs were added to 40 nM DNA, 10
mMBis-Tris-Propane-HCl (pH 7.0), 10mMMgCl2 and 1.0
mMDTT to a final volume of 20 !l and incubated at 25◦C
for 60 min. The reactions were supplemented with 2 !l 25%
(w/v) ficoll. Samples were resolved by electrophoresis on a
5% (v/v) polyacrylamide gel containing 0.5× TBE buffer at
150V for 0.5 h, then 300V for 2.5 h in 0.5×TBEbuffer. Flu-
orescently labelled DNA oligomers were detected by scan-
ning using a Fujifilm FLA-5100 image reader.
Inductively coupled plasma mass spectrometry
The concentrations of zinc ions in protein samples were de-
termined using inductively coupled plasma mass spectrom-
etry (ICP-MS). For this analysis of humanPrimPol, the pro-
teins were gel filtered in zinc-free solutions to minimise the
concentration of zinc ions that were not chelated by protein.
Quantitative calibrations were made using standards pre-
pared from zinc solutions containing 0, 100, 500 and 1000
ng/ml. Each sample was measured in triplicate and back-
ground measurements of buffer without protein were deter-
mined and subtracted from the appropriate readings. A 2%
nitric acidwashwas performed between standards and sam-
ples.
PrimPol protein denaturation assays
The full-length and PrimPol1–487 constructs were both dial-
ysed into a buffer of 200 mM NaF, 15 mM Tris-HCl (pH
7.5). 45 !l of 1 !M protein solution was added to 15 !l of
SYPRO Orange, resulting in a final protein concentration
of 0.75 !M. A control of 45 !l buffer was also added to 15
!l of SYPRO Orange. 20 !l of each sample was aliquoted
in triplicate into a 96-well plate. Protein melting experi-
ments were carried out using the LightCycler 480 System
II (Roche). The instrument was configured with a detection
format of 465 nm as the wavelength of excitation and 580
nm as the emission wavelength to detect SYPRO Orange-
specific signal. Denaturation curve fluorescent signal was
acquired within a range of 20–80◦C using a ramping rate
of 0.03◦C s−1 and an acquisition of 20 data points per de-
gree celsius. Melting temperatures (Tm) were determined
through themeasurement of the lowest point of the negative
differential of the denaturation curve. Data was corrected
for the background signal of the buffer conditions and pre-
sented as units of fluorescence with respect to temperature
± 1 SD.
Complementation and survival assays in PrimPol−/− avian
cells
DT40 cells were grown at 39◦C in RPMI 1640 medium
supplemented with 10 !M "-mercaptoethanol, penicillin,
streptomycin, 10% foetal calf serum and 1% chicken serum
(Sigma). DT40 cells deleted of PrimPol made previously (4)
were stably complemented with wild-type and truncated or
mutated forms of human PrimPol cloned into the pCI-neo
vector by electroporation as described previously (4). Stable
expressing cells were selected using 2 mg/ml G418 (Sigma)
and confirmed by western blot. DNA fibre analysis was car-
ried out as described previously (4). Fibre analysis was car-
ried out in triplicate (n = 3).
RESULTS
Zinc finger domain of PrimPol coordinates a zinc ion
The C-terminal domain of human PrimPol contains a
highly conserved UL52-like Cys-His-Cys-Cys (CHC2) mo-
tif, predicted to fold into a functional zinc finger (Zfn)motif.
(Figure 1A) To establish if this is a bona fide zinc-binding
motif, we produced C-terminal truncations in PrimPol
containing either an intact (PrimPol372–560) or mutated
(PrimPol372–560/ZF-KO) Zfn motif. PrimPol372–560/ZF-KO has
the first two residues of the Zfn motif mutated to alanine.
The proteins were gel filtered in the absence of zinc and con-
centrations of zinc were thenmeasured using ICP-MS (Sup-
plementary Table S3). The ICP-MS analysis revealed that
the concentration of the zinc in the UL52-like domain rep-
resented an occupancy of 80.38%, suggesting that a small
fraction of the protein is either unfolded or has another di-
valentmetal ion chelated. In contrast, the zinc finger knock-
out had an occupancy of 3.90%, suggesting that the first two
cysteine and histidine residues of this motif are required for
the coordination of zinc. We also measured the zinc occu-
pancy in the polymerase domain (PrimPol1–354) after pu-
rification in the absence of zinc and the occupancy in this
case was 1.57%. The detection of low levels of zinc in the
polymerase domain is to be expected as it contains divalent
cation-binding motifs. These motifs generally bind magne-
sium or manganese, which have respective ionic radii of 86
and 81 pm, but could conceivably bind zinc, with a compa-
rable ionic radius of 88 pm (17).
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Figure 2. Primase activity of human PrimPol. (A) Human PrimPol has pri-
mase activity and can produce de novo primers using rNTPs and dNTPs
opposite a poly(dT) template. (B) PrimPolZF-KO lacks de novo primer syn-
thesis activity, suggesting that an intact zinc finger is required for primase
activity. (C) PrimPol1–487 also has primase activity similar to the wild-type
PrimPol. The unstructured region that is downstream of the zinc finger
is therefore not required for primase activity. (D) PrimPol1–354 has no pri-
mase activity, which indicates that PrimPol requires a functional zinc finger
for primer synthesis.
PrimPol’s zinc finger domain is essential for primase activity
Previously, we and others have shown that PrimPol
has DNA primase activity in vitro (4–7), preferentially
catalysing synthesis of primers composed of DNA. Previ-
ous studies on the viral HSV1 helicase/primase complex
showed that mutation of key residues in the UL52 zinc-
binding domain of this enzyme resulted in loss of primase
activity (8,9). Alignment of human PrimPol with other
eukaryotic orthologues identified the conserved residues
(C419, H426, C446 and C451; Figure 1A) predicted to
coordinate a zinc ion. We prepared a zinc finger knock-
out enzyme carrying C419A and H426A point mutations
(PrimPolZF-KO) (Figure 1B).
As previously observed (4,5), wild-type PrimPol exhib-
ited primase activity on a 60-mer poly-dT ss DNA tem-
plate, however, PrimPolZF-KO showed no detectable pri-
mase activity (Figure 2). Furthermore, we analysed the pri-
mase activity of two deletion mutants, PrimPol1–487 and
PrimPol1–354, which were constructed to determine whether
elimination of primase activity resulted from a structural
change brought about by the point mutations or whether
the zinc-finger domain is necessary for primase activity.
As expected, a deletion mutant lacking the entire zinc fin-
ger (PrimPol1–354) showed no detectable primase activity
(Figure 2). However, PrimPol1–487, containing the entire
Figure 3. Polymerase activity and fidelity of human PrimPol. (A) Human
PrimPol was incubatedwith dNTPs and substrate at 1, 3, 5 and 30min time
points. PrimPol was proficient at extending an undamaged oligonucleotide
template using dNTPs. Human PrimPol did not require an intact zinc fin-
ger in order to carry out primer extension, as evidenced by the extension
of primers by PrimPolZF-KO and PrimPol1–354. PrimPol1–487 that lacked
the unstructured C-terminus of the protein was also polymerase proficient.
PrimPol1–354 exhibited a higher rate of polymerase activity compared to
the other constructs. (B) Incorporation of nucleotides opposite two tem-
plating cytosine bases. PrimPol was incubated for 5 min with the DNA
substrate and each of the dNTPs. All four of these PrimPol constructs in-
serted two guanine nucleotides opposite two cytosines in Watson–Crick
base-pairing manner. PrimPol1–354 could additionally incorporate a single
adenine opposite the first cytosine.
zinc-finger domain but lacking the smaller C-terminal por-
tion, predicted to be disordered, was an active DNA pri-
mase (Figure 2). Notably, the observed primase activity of
PrimPol1–487 was lower than the activity observed for the
parental enzyme, possibly as this truncation results in par-
tial loss of UL52 domain functionality. Together, our data
provide experimental evidence that the zinc-finger domain,
but not the disordered region proximal to this domain, is
essential for the primase activity of human PrimPol.
PrimPol’s DNA polymerase activity is modulated by the zinc
finger domain
As the zinc-finger domain is required for the priming ac-
tivity of human PrimPol, we also evaluated the impor-
tance of this functional module in the context of Prim-
Pol’s DNA polymerase activity. To address this, we em-
ployed standard primer extension assays using unmodified
synthetic primer templates and dNTPs. We compared the
relative DNA polymerase activities of four different vari-
ants of human PrimPol including the wild-type enzyme,
PrimPolZF-KO, PrimPol1–487 and PrimPol1–354 (Figure 1B;
Table 1A).Although all tested variants of PrimPolwere pro-
ficient at DNA template-dependent DNA synthesis, we ob-
served variation in the relative specific polymerase activity,
processivity and fidelity among these enzymes (Figure 3A).
PrimPolZF-KO showed a pronounced decrease in specific
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DNA polymerase activity. In contrast, PrimPol1–354 exhib-
ited both increased relativeDNAprocessivity and extension
activities. Despite variations in specific DNA polymerase
activities across the variants of human PrimPol tested, the
zinc-finger module does not appear to be essential for DNA
polymerase activity of this enzyme. However, a regulatory
role in catalysis for this functional module cannot be ex-
cluded.
Consequently, we next examined the potential regulatory
role of this functional module. In particular, we tested the
fidelity of incorporation of each of the four single deoxynu-
cleotides opposite two templating cytosines (Figure 3B).
Wild-type PrimPol, PrimPolZF-KO and PrimPol1–487 all in-
corporated two correct incoming guanine nucleotides op-
posite the templating cytosines at the N+1 and N+2 po-
sitions. In contrast, PrimPol1–354 that lacks the entire zinc
finger domain showed a significantly reduced ability to ac-
curately select the incoming nucleotide. In particular, we ob-
served significant mis-incorporation of adenine nucleotides
opposite templating cytosine at the N+1 position and mis-
incorporation of another guanine nucleotide opposite a
templating adenine at N+3. This observation suggests the
potential importance of the Zfn domain in influencing the
fidelity of PrimPol’s polymerase activity. PrimPol cannot in-
corporate NTPs during primer extension in vitro and muta-
tion of the Zfn domain did not alter this preference (unpub-
lished data). This is in contrast to the AEP domain of LigD,
which can extend primers using both dNTPs and NTPs
(18,19).
PrimPol exhibits template-independent primer extension ac-
tivity in the presence of manganese
The flexible extension activities reported previously forNon
homologous end-joining (NHEJ) AEP polymerases include
limited template-independent terminal transferase activity
on both ss DNA and blunt-ended ds DNA (18,19). Such
activities are often stimulated by the presence of manganese
ions, which can accelerate the rate of DNA synthesis and, as
a result, lower the overall fidelity of this process. We there-
fore tested if human PrimPol also possesses terminal trans-
ferase activity in the presence of manganese. Wild type, as
well as all three variants, of human PrimPol showed no de-
tectable terminal transferase activity when tested on a blunt
ended ds DNA substrate (Figure 4, left panels). However,
PrimPol’s DNA synthesis activity appeared to be signifi-
cantly increased when primer extension assays were per-
formed in the presence of dNTPs (all) and manganese (Fig-
ure 4A, right panel). To investigate if this increased activity
resulted from altered fidelity, we repeated the assays with
each of the dNTPs and observed that PrimPol catalysed
multiple extension of the primer even in the presence of
a single nucleotide pool. This promiscuous DNA synthe-
sis was most efficient when enzyme was utilising dATP or
dTTP. In both cases, extension of primers by up to ∼20
nucleotides was observed. Notably, this phenomenon was
not observed when magnesium was used instead of man-
ganese. When a single incorporation of dCTP was investi-
gated, we observed significantly slower extension rates but
the enzyme was able to extend the primer to produce pre-
dicted full-length product. In contrast, incorporation of the
Figure 4. Template-independent extension in the presence of manganese.
Human PrimPol was incubated for 30 min with DNA substrate and each
of the dNTPs in the presence of manganese. (A) Wild-type PrimPol was
unable to extend from a ds DNA template with a blunt end, but could
extend from a primer annealed to an overhanging template, even synthe-
sising long tracts of homopolymers. (B) PrimPolZF-KO could extend from
an overhanging DNA template in the presence of manganese and, con-
sistent with the wild-type, did not extend from a ds DNA substrate. The
incorporation of 1 or 2 nucleotides of guanine or adenine opposite an over-
hanging template suggests that PrimPolZF-KO incorporates in a low-fidelity
template-dependent manner when incubated with overhanging DNA. (C)
PrimPol1–487 exhibited a highly similar terminal transferase activity spec-
trum to the PrimPolZF-KO. In the presence of manganese, it incorporated
bases opposite an overhang in a low fidelity, template-dependent manner.
(D) PrimPol1–354 also exhibited low fidelity extension of a primer annealed
to an overhanging template in the presence of manganese.
correct incoming nucleotide (dGTP) resulted in least pro-
nounced primer extensions up to 16 nucleotides.
When this experimental strategy was repeated to study
potential promiscuous DNA polymerase activities in the
PrimPolZF-KO and PrimPol1–487 variants, we observed
minimal mis-incorporation of all four tested single nu-
cleotides. Interestingly, when a catalytically active frag-
ment (PrimPol1–354) was tested, we observed more effi-
cient mis-incorporation compared to PrimPolZF-KO and
PrimPol1–487 variants. However, PrimPol1–354 fragment was
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Table 1. Extension, TLS and fidelity activities associated with full-length and mutated forms of human PrimPol
Summary of the DNA synthesis activities of wild-type and mutant PrimPol. (A) PrimPol exhibits primase activity, polymerase activity and, in the presence of
manganese, template-independent primer extension. Whilst the polymerase activity and template-independent primer extension activity appear to reside
in the AEP polymerase domain alone, the primase activity requires the associated zinc finger. (B) PrimPol can read through a number of common DNA
lesions and we have determined some of the lesions PrimPol can read through and which bases are incorporated opposite these lesions. As the UV lesions
span two adjacent bases, a ‘→’ is used to separate the bases incorporated opposite the first and second damaged bases.
able to mis-incorporate between 1 and 2 incorrect incoming
nucleotides. We are unable to conclude if this unique enzy-
matic activity of human PrimPol is significant for the bio-
logical functions of this enzyme in vivo. We speculate that,
under the experimental conditions tested, the Zfn module
allowed manganese-dependent primer extension resulting
in the synthesis of DNA that is non-complementary to the
template strand. This hypothetical scenario is only possible
when the enzyme was able to bind to a single-stranded tem-
plate strand of the DNA primer-template substrate. This
interesting observation has raised questions regarding the
mechanism by which PrimPol binds to and coordinates the
primer-template substrate during DNA polymerisation.
DNA binding activities of human PrimPol
Next, we analysed the binding of the AEP polymerase and
Zfn domains of PrimPol to a number of DNA substrates to
determine whether they bind specifically to ss or ds DNA.
The Zfn domain is presumed to be a DNA-recognition do-
main, in addition to contributing to its primase activity, as
previous studies demonstrated altered DNA binding activ-
ity associated with mutations in a related UL52 Zfn do-
main (8,20). EMSAs were performed to analyse the bind-
ing capabilities of the AEP polymerase (PrimPol1–354) and
Zfn (PrimPol372–560) domains. PrimPol1–354 showed a simi-
lar binding capacity to ds and ss DNA, suggesting that the
polymerase can bind both substrates (Figure 5A). The ob-
served DNA binding specificity reflects the likely presence
of two closely clustered binding sites allowing recognition
of a primer-template junction, which is an essential require-
ment for all DNApolymerases. Observed binding values for
both ss DNA and ds DNA were evident at a minimum of
∼500 nM DNA and a complete shift of the DNA was ev-
ident at 5 !M DNA. This relatively weak coordination of
DNA substrates is consistent with previously postulated bi-
ological functions of human PrimPol (4–7).
Analogous EMSA experiments were also performed
to analyse the DNA binding capacity of the Zfn do-
main (PrimPol372–560). In contrast with the AEP do-
main, PrimPol’s Zfn domain was unable to bind ds DNA
but did show specific binding to ss DNA (Figure 5B).
This intriguing result provides experimental evidence sup-
porting the potential importance of the Zfn module in
recognition/coordination of the single-stranded template
DNAdownstreamof the primer-template junction. The sig-
nificance of this interaction will be discussed below. To de-
termine if DNA binding was performed by the Zfn, we as-
sayed a Zfn knockout domain (PrimPol372–560/ZF-KO) for ss
DNA binding activity (Figure 5C) and observed an absence
of binding with this mutant, confirming the importance of
the Zfn motif for nucleic acid recognition.
PrimPol’s AEP domain possesses TLS activities
PrimPol has the capacity to bypass a number of replication
stalling lesions, including UV ((6–4)PP) (4) and oxidative
lesions (4,6). To address whether the TLS activities of Prim-
Pol are independent of the zinc finger domain, we assayed
the TLS activities of PrimPol1–354 on a range of templates
containing a variety of DNA modifications (Table 1B). As
full-length PrimPol appears unable to read throughCPDs in
vitro, we assayed PrimPol1–354 for TLS bypass of this com-
mon photolesion. Notably, although PrimPol1–354 slowed
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Figure 5. PrimPol’s polymerase domain binds ss and ds DNA but the zinc finger domain binds only ss DNA. (A) PrimPol1–354 was tested for its ability
to bind DNA by shift assays. PrimPol polymerase domain was incubated with 40 nM DNA at various protein concentrations (0.05, 0.1, 0.5, 1.0, 5.0, 10.0
and 20.0 !M) for 60 min at 25◦C. The polymerase domain binds to ds DNA and ss DNA with approximately equal proficiency. Binding was evident at
concentrations ∼0.5 !M but a complete shift was observed at 5.0 !M for each DNA substrate tested. (B) PrimPol372–560 (Zfn domain) was also assayed
for binding to DNA activity. It was incubated with 40 nMDNA at various protein concentrations (0.05, 0.1, 0.5, 1.0, 5.0, 10.0 and 20.0 !M). A DNA shift
was not observed with ds DNA substrate but a clear shift was evident with ss DNA, suggesting that the zinc finger binds single-stranded regions of DNA.
(C) PrimPol372–560/ZF-KO, lacking a functional Zfn, was incubated with 40 nM DNA at the same protein concentrations and ss DNA binding activity was
not observed.
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as it reached a CPD lesion, it showed the capacity to read
through this bulky lesion (Figure 6A). In contrast, wild-type
PrimPol cannot performTLS opposite this lesion (4,5). Sin-
gle nucleotide incorporation assays were employed to de-
termine which bases are incorporated opposite CPDs, re-
vealing that PrimPol performs error-free bypass of this pho-
tolesion (Figure 6A). A similar TLS activity was also con-
firmed with Xenopus PrimPol1–334, which was also capable
of reading through CPDs in an error-free manner (Supple-
mentary Figure S1A). This TLS activity is similar to Pol !,
a specialised TLS polymerase known to bypass CPDs in an
error-free manner (21,22). As this read through of a CPD
is only evident in the absence of the Zfn domain, it may be
the case that PrimPol requires a conformational change or
partner to assist in promoting this lesion bypass activity in
vivo.
(6–4)PPs are a much more highly distorting UV lesion
than CPDs. Pol ! can incorporate bases opposite (6–4)PPs
but incorporates an incorrect dG opposite the 3′ dT of
the lesion and is unable to subsequently extend from this
product (23). However, we previously reported that Prim-
Pol exhibits the ability to incorporate opposite and extend
through (6–4)PPs (4). Although PrimPol’s TLS activity was
retained when the Zfn was deleted, the nucleotide incor-
poration signature was altered (Figure 6B), again consis-
tent with the proposed regulatory role of the Zfn domain.
Wild-type PrimPol incorrectly incorporates thymine oppo-
site the first dT of the (6–4)PP, whereas PrimPol1–354 in-
corporates dA or dC opposite this base. If dA nucleotide
is incorporated opposite the first thymine of the (6–4)PP,
PrimPol1–354 then incorporates either dC or dT. If the first
nucleotide added is dC, it will then incorporate dA, dC or
dT. To confirm whether this altered fidelity of nucleotide in-
corporation was orthologue-specific, we assayed the equiv-
alent Xenopus PrimPol domain (XPrimPol1–334) and ob-
served showed a similar fidelity to the human PrimPol poly-
merase domain (Supplementary Figure S1B).
Next, we examined TLS bypass of an oxidative lesion,
8-oxoG. In common with wild-type enzyme, PrimPol1–354
can read through 8-oxoG lesions with minimal stalling and
exhibited the ability to insert A and C opposite 8-oxoG
lesions (Figure 7A), as previously observed for wild-type
PrimPol (4). A similar TLS activity and fidelity for this le-
sion was also evident with XPrimPol1–334 (Supplementary
Figure S2A). Cytosine in DNA is susceptible to sponta-
neous deamination to deoxyuracil (dU) in vivo, which can
base pair to adenine, resulting in C→T transitionmutations
(10,11,24). Deoxyuracil is not recognised by, nor does it
stall, eukaryotic TLS polymerases (10,13,14,25). Similarly,
the polymerase domain of PrimPol does not stall when con-
fronted with a dU base (Figure 7B). PrimPol incorporates
an adenine opposite dU therefore, as one might expect, it
reads the dU base as a thymine. This is in common with
XPrimPol1–334 (Supplementary Figure S2B) and wild-type
PrimPol (Supplementary Figure S3).
Finally, we examined TLS bypass of
apurinic/apyrimidinic (AP sites) and thymine glycol
(TG) lesions. PrimPol1–354 was unable to extend through
either AP (Supplementary Figure S4A) or TG (Supple-
mentary Figure S4B) lesions but there was some single
nucleotide incorporated opposite the TG lesion. This
insertion activity could potentially promote extension by
another polymerase that is capable of extending following
nucleotide insertion opposite the TG. XPrimPol1–334 was
also unable to read through either of these lesions (Sup-
plementary Figure S4). The inability of PrimPol1–354 to
read through AP sites and TG lesions is also evident in
wild-type PrimPol (4). This inability to extend through AP
and TG sites, as well as other lesions, does not preclude the
possibility that PrimPol reprimes following these lesions,
allowing replicative polymerases to resume synthesis in a
post-lesion fashion, see below.
Human PrimPol is a distributive DNA polymerase
We next analysed the number of nucleotides incorporated
by human PrimPol in a single association-dissociation event
to measure the processivity of this polymerase. In order
to determine the processivity of PrimPol, we performed
primer extension assays in the presence of an excess ofDNA
(herring sperm), which acted as a ‘substrate trap’ for poly-
merases that dissociate from the primer-template substrate.
Using this approach, we identified that PrimPol inserts up
to 4 nucleotides opposite an undamaged template, rarely
inserting more than this (Figure 8A). When the Zfn do-
main was removed from PrimPol, the maximum number
of nucleotides incorporated remained at∼4 but the average
number of nucleotides incorporated was higher, with fewer
polymerases inserting 1–3 nucleotides (Figure 8B). We also
carried out processivity assays in the presence of Taq poly-
merase to ensure that it was not the trap DNA that kept
the polymerase from inserting more than 4 nucleotides. We
observed that Taq polymerase possessed high processivity
and incorporated nucleotides to the end of the template
DNA (Supplementary Figure S5). Therefore, the Zfn ap-
pears to play a role in regulating the number of nucleotides
that PrimPol inserts, possibly by stabilizing the interaction
of the polymerase domain with the template, see the discus-
sion.
PrimPol’s zinc finger domain is required for bypass of lesions
in vivo
We previously reported that avian PrimPol−/− cells showed
significantly decreased rates of replication fork progression
(4). To evaluate the requirement for the Zfn domain of hu-
man PrimPol in vivo, we produced cell lines, in a DT40
PrimPol−/− knockout background (4), stably expressing
human PrimPol, PrimPolZF-KO, PrimPolAXA (catalytically
null) or PrimPol1–354 (Figure 9A). Using DNA fibre anal-
ysis, we confirmed that normal replication fork rates was
restored by adding back humanPrimPol, however this repli-
cation fork defect was not corrected by adding back the
catalytically dead PrimPolAXA mutant (Figure 9B). Next,
we studied the replication fork speed in PrimPol1–354 and
PrimPolZF-KO complemented clones and observed that both
proteins were able to restore replication fork rates to near
wild-type levels (Figure 9B). This suggests that the poly-
merase activity of PrimPol is largely responsible for the
maintenance of fork progression in unperturbed replica-
tion. Indeed, PrimPol1–354 complemented cells showed even
greater average replication fork rates compared to wild-type
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Figure 6. PrimPol1–354 can replicate through CPD and (6–4(PP)) lesions. (A) PrimPol1–354 was incubated with a primer-template substrate in which the
template contained a CPD lesion downstream of the primer-template junction in the presence of dNTPs. Time points were taken between 0.5 and 60 min.
PrimPol1–354 extends from the primer up to the CPD, before stalling, it will then added a base opposite the first thymine of the CPD and continue to extend
until the end of the template (left panel). PrimPol1–354 was then incubated with each dNTP to test which nucleotide it incorporates opposite a CPD (right
panels). PrimPol1–354 incorporated adenine opposite the first and second thymine of the CPD. (B) The polymerase domain of PrimPol can also perform
TLS bypass of a 6–4(PP) lesion immediately downstream of the primer-template junction (left panel). PrimPol1–354 incorporates either an adenine or
cytosine nucleotide opposite the first thymine of the 6–4(PP) (right panels). If an adenine is incorporated opposite the first thymine, a cytosine or thymine
is then incorporated opposite the second. If a cytosine is incorporated opposite the first thymine, an adenine, cytosine or thymine will be incorporated
opposite the second thymine of the 6–4(PP).
cells (Figure 9B), fitting with the superior polymerase activ-
ity observed in vitro (Figure 3A).
To examine the ability of the different PrimPol variants
to support bypass of bulky lesions during replication in
vivo, a large pulse of UV irradiation (20 J/m2) was intro-
duced to cells between the two labelling steps to investigate
fork stalling induced at UV lesions. PrimPol knockout cells
show a pronounced stalling phenotype, indicated by a large
increase in the ratio of the CldU to IdU ratios (4). Con-
sistent with these previous findings, we observed comple-
mentation by adding back the wild-type enzyme. However,
PrimPolAXA, PrimPol1–354 or PrimPolZF-KO were unable to
correct this fork-stalling defect (Figure 9C). Therefore, al-
though the polymerase extension activity of PrimPol is suffi-
cient formaintenance of unperturbed replication, these data
suggest that its primase activity is requisite for timely repli-
cation fork progression following the introduction of signif-
icant DNA damage.
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Figure 7. PrimPol1–354 can replicate through an 8-oxoguanine (8oxoG) lesion and a deoxyuracil (dU) base. (A) The polymerase domain exhibited minimal
stalling opposite an 8oxoG lesion and extended fully to the end of the template. PrimPol incorporated an adenine or cytosine opposite the 8oxoG, which
are the expected bases to be incorporated by Hoogsteen base pairing or Watson–Crick base pairing, respectively. (B) PrimPol1–354 efficiently synthesised
through a templating dU site. PrimPol incorporates an adenine nucleotide opposite the dU lesion through Watson–Crick base pairing.
DISCUSSION
Recent studies have identified that PrimPol is a novel eu-
karyotic DNA polymerase capable of performing both
priming and primer extension synthesis (4–7). It is likely
that PrimPol was acquired early in eukaryotic evolution to
play a significant role in lesion bypass during DNA replica-
tion. PrimPol-mediated damage tolerance appears to pro-
vide additional mechanisms that facilitate replication fork
progression following stalling of replisomes at sites of DNA
damage or secondary structure.
In this study, we have dissected themolecular activities as-
sociated with the major structural elements of human Prim-
Pol (Table 1A) and determined the cellular requirements
for these activities in vivo. PrimPol is both an active pri-
mase and polymerase with the capacity to perform TLS
(Table 1B). An intact zinc finger is essential for PrimPol’s
primase activity in vitro (Figure 2), consistent with reports
for a similar requirement for many diverse DNA primases
(8,9,26,27). It has been proposed that this structural ele-
ment is required for template recognition and regulation
of primer length synthesis (28). Although the DNA poly-
merase activity of PrimPol appeared initially to be inde-
pendent of the zinc finger domain, as a catalytically ac-
tive domain lacking the zinc finger domain (PrimPol1–354)
showed enhanced relative polymerase and processivity ac-
tivities compared to the wild-type enzyme. Further studies
revealed that the zinc finger modulates the extension activ-
ities and fidelity of PrimPol and therefore it should also
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Figure 8. Processivity of the polymerase activity of PrimPol. PrimPol was pre-incubated for 30 min at 37◦C with an undamaged DNA primer-template
substrate to allow PrimPol to bind to the DNA. The reaction was initiated by the addition of dNTPs and an excess of sonicated herring sperm DNA
(trap) and time points taken at 15, 30, 60, 120 and 360 s. (A) After 360 s, wild-type PrimPol incorporated up to 4 nucleotides opposite the template but a
significant fraction of enzyme incorporated only 1, 2 or 3 nucleotides (left panel). To confirm that the trap prevents polymerase extending from a second
template, the trap was also added into the pre-incubation mix with PrimPol and the DNA substrate. This reaction was supplemented with dNTPs and there
is no extension (right panel), thus successfully exhibiting the effectiveness of the trap. (B) PrimPol1–354 also predominantly incorporates up to 4 nucleotides
but there were fewer polymerases incorporating only 1, 2 or 3 nucleotides (left panel). The effectiveness of the trap was also successfully confirmed (right
panel). (C) Percentage of PrimPol molecules incorporating at least n dNTPs for either full-length PrimPol or PrimPol1–354, calculated using Equation (1).
be considered to be an important regulator of PrimPol’s
polymerase functions. PrimPol is a very distributive en-
zyme, catalysing up to four nucleotide incorporations dur-
ing a single DNA substrate binding/polymerisation cycle
in vitro. This distributive character of PrimPol is reminis-
cent of the DNA polymerase processivity reported for the
Y-family TLS polymerases, such as Pol ! and ", which pre-
dominantly incorporate up to 6 or 7 nucleotides (16,29).
Although removal of the last 80 amino acids at the C-
terminal region of human PrimPol (PrimPol1–487) did not
abolish primase activity, which suggests that the C-terminus
is not an absolute requirement for activity, it did reduce ac-
tivity to some extent. Thermal denaturation studies have
shown that there is a considerable increase in the stability
of PrimPol upon removal of amino acids 488–560 (Supple-
mentary Figure S6), suggesting that this region lacks dis-
cernible structure that would contribute to protein stabil-
ity. Disordered regions of proteins often serve as scaffolds
involved in protein–protein interactions and we speculate
that this portion of human PrimPol might also act as an
interaction interface. Indeed, it has been reported that the
carboxyl-terminus of PrimPol mediates an interaction with
the large subunit of human replication protein A (6).
In the presence of manganese, PrimPol appeared to be
much more active than with magnesium. However, upon
closer inspection, we discovered that the enzyme can pro-
duce polymeric primer extension products, even when only
a single form of dNTP is present. Under these manganese-
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Figure 9. PrimPol’s zinc finger domain is required for UV lesion bypass in vivo. (A) PrimPol−/− DT40 cells were complemented with variants of PrimPol
and their in vivo expression confirmed by western blot. (B) Unperturbed replication fork rates were analysed by DNA fibre analysis using CldU and IdU
labels for all the complemented cell types. The data represent the mean of three or more experiments with error bars showing the mean standard deviation.
(C) DNA fork rate analysis was also carried out with after a 20 J/m2 pulse of UV, between CldU and IdU labels, to look for fork-stalling. Data is shown
as the ratio of the two labels, Cldu, pre-UV : IdU, post UV label (n = 3). The black lines indicate the Cldu:IdU ratio of the two labels in the wild-type cells
and the red lines indicate the ratios in cells complemented with the indicated PrimPol variants.
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dependent conditions, PrimPol extends from a primer to
form homopolymeric strands that are non-complementary
and therefore unlikely to be annealed to the template strand.
This suggests that caution should be taken when inter-
preting the results from studies using manganese as the
resulting products may represent aberrant synthesis prod-
ucts rather than the expected template-dependent ones.
Manganese has the effect of decreasing fidelity amongst
polymerases (30,31). Whilst magnesium enforces tetrahe-
dral geometry in the arrangement of its ligands, man-
ganese will accommodate square, planar, tetrahedral and
octahedral coordinations thus increasing the ability to ac-
celerate the rate of reaction in substrates that are per-
haps misaligned (32). The physiological implications of this
template-independent primer extension activity of PrimPol
in the presence of manganese remain unclear, as the cellular
concentrations of manganese are low, suggesting this activ-
ity may be irrelevant in vivo or it may be limited to certain
cellular compartments (e.g. mitochondria).
The translesion bypass activities associated with wild-
type PrimPol and PrimPol1–354 are compared in Table 1B.
As PrimPol can incorporate bases opposite and extend from
highly distorting lesions, it is likely that the active site in-
volved in production of phosphodiester bond is large and
flexible to accommodate a range of lesions. The (6–4) pho-
toproducts, in particular, are highly mutagenic due to the
high degree of distortion they introduce into the DNA
backbone. The helical bending at these lesions is estimated
to be ∼44◦ and the distance between phosphorus atoms in
the paired bases in the (6–4)PP is∼6 A˚, compared to the 7 A˚
average corresponding distance at other base-pairing steps
(33). Therefore, it is probably unsurprising that PrimPol ex-
hibits low fidelity when inserting bases opposite a (6–4)PP,
as a polymerase that can accommodate this lesion would
require a flexible active site. Unexpectedly, the polymerase
domain of PrimPol, like Pol!, is capable of bypassing CPDs
with high fidelity. This contrasts with full-length PrimPol,
which is not capable of bypassingCPDs unless two adenines
are inserted opposite the CPD (4,5). This result establishes
that the active site of PrimPol has the capacity to bypass
these lesions but this is constrained in the full-length en-
zyme. A conformation change may be required, potentially
induced by binding partners, such as Replication Protein A
(RPA), that alters the activity of PrimPol to allow it to bind
to and bypass CPDs in vivo.
PrimPol is also confronted with a number of lesions as a
result of oxidative stress in cells. These include AP sites and
8-oxoG lesions. Pol " , the mitochondrial replicative poly-
merase, has the ability to bypass an 8-oxoG site but at a re-
duced rate, and cannot bypass AP sites (34,35). Conversely,
PrimPol shows no hindrance to incorporate bases opposite
8-oxoG lesions and, although it cannot incorporate bases
opposite an AP site, it has the capacity to re-prime post le-
sion. 8-oxoG is expected to pair with C through Watson–
Crick base pairing in its regular anti conformation, but in its
syn conformation it forms Hoogsteen base pairs with ade-
nine (36). This ability to insert A, as well as C, opposite 8-
oxoG is apparent in a number of polymerases but the ad-
dition of auxiliary proteins (e.g. RPA and PCNA) can dra-
matically increase the preference for adenine over cytosine,
as is the case with Pol # and ! (36,37). It remains to be seen
whether this is also the case with PrimPol. This ability to
accommodate bulky lesions comes at the expense of fidelity
and, therefore, PrimPol is a low fidelity polymerase that is
likely to make limited, and perhaps, nonspecific contacts
with the replicating base pair. Deoxyuracil is not recognised
as a lesion by replicative polymerases and results in C:G→
T:A transition mutations. Deoxyuracil is recognised by ar-
chaeal family B polymerases as a lesion and stalls replica-
tion to preventmutation (38) but PrimPol does not have this
recognition capacity and incorporates an adenine opposite
a deoxyuracil lesion.
Canonical DNA polymerases share a common right-
handed architecture containing fingers, palm and thumb
subdomains. All of the three structural elements are clus-
tered together providing accurate, highly structurally re-
strained positioning of the polymerase at the primer-
template junction in order to promote the highest fidelity
and processivity of DNA synthesis. Although this tight and
specific binding cleft is perfectly suited for replication of
long stretches of DNA, in some instances such structural
arrangements can be disadvantageous. In particular, it lim-
its the capacity of the replicative enzymes to tolerate ab-
normalities in the topology of DNA templates, such as sec-
ondary structures orDNAdamage-induced distortions.The
thumb subdomain of replicative polymerases interacts with
the sugar-phosphate backbone of the DNA to coordinate
the DNA. This subdomain is optimised for the highly ac-
curate replication of DNA and is sensitive for structural
anomalies in the in the DNA template. The predicted struc-
ture of PrimPol, in addition to the known structures of pri-
mases, suggests that this polymerase lacks structural ele-
ments corresponding to the ‘thumb’ domain that is present
in the replicative polymerases that is implicated in proces-
sivity (39). The open planar predicted structure of this poly-
merase indicates a transient binding of the polymerase do-
main and this is consistent with other low fidelity poly-
merases, such as those of the Y-family of polymerases (40).
The processivity data presented here suggests that the zinc
finger domain of PrimPol regulates the fidelity of these poly-
merases. Whilst there is no reduction in the activity of the
polymerase domain lacking the zinc finger, it actually ap-
pears more active, we propose that the presence of the zinc
finger reduces the processivity of the enzyme to allow a
slower, higher fidelity incorporation of complementary nu-
cleotides. We postulate that whilst the AEP polymerase do-
main provides a platform to recognise the primer-template
junction of the DNA substrate, the zinc finger binds the
single-stranded region of the template strand to modulate
binding and fidelity by the AEP domain (Figure 10A). Y-
family polymerases have a highly truncated thumb domain
and, notably, contain an additional functional module re-
ferred to as the polymerase associated domain (PAD). Inter-
estingly, studies on TLS polymerases Dpo4 and Dbh point
to a role for PAD in regulation of processivity and fidelity of
these enzymes (41). This structural element not only binds
ss DNA and provides an extended flexible platform coordi-
nating the template strand during DNA synthesis on dam-
aged DNA templates, but also modulates the activity of
these TLS DNA polymerases. As part of an adaptation to
perform TLS, we suggest that the zinc finger is functionally
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Figure 10. Models of the mechanisms of action of PrimPol. (A) Prim-
Pol has both DNA primase and polymerase activities. The zinc finger
of PrimPol stabilises the binding of the polymerase domain on single-
stranded DNA. The AEP polymerase domain coordinates two adjacent
deoxynucleotides opposite the single-stranded DNA template and the sta-
bility afforded to this complex by the Zfn binding allows synthesis of a
dinucleotide. This dinucleotide can then be extended in a more processive
way to form longer products. PrimPol can also bind primer-template junc-
tions to catalyse more canonical primer extension reactions. Both the poly-
merase and primase activities are intrinsic to the AEP domain. Although
the zinc finger is essential for maintaining less ‘stable’ primer synthesis, it
is also important for modulating the fidelity and processivity of the poly-
merase activities. This stabilizing influence of the Zfn may be particularly
important for allowing productive synthesis during TLS bypass of distort-
ing lesions and structures. We postulate that the primase and polymerase
activities of PrimPol are not discrete activities but rather represent different
synthesis modes performed under different DNA binding conditions. (B)
PrimPol uses these activities to bypassDNAdamage that blocks replicative
polymerases. When replicative polymerases encounter a blocking lesion,
they are displaced or regress from the site of damage. PrimPol can then
access the template upstream of the lesion, where it can reprime following
the lesion (left) or if it can access the primer-template junction it can carry
out TLS (right). Once PrimPol-mediated bypass of the lesion has occurred,
the replicative polymerase can then resume replication at the fork.
analogous to the PAD subdomain, but is spatially separated
from the polymerase domain to allow greater freedom of
binding of the enzyme to distorted DNA templates, such as
those containing UV-induced lesions.
The activity most closely associated with the primase
superfamily, namely primer synthesis, is considered to be
somehow different from primer extension activities associ-
atedwith canonical polymerases. However, primases should
be considered to be polymerases that have evolved to catal-
yse a poorly processive extension reaction involving the syn-
thesis of a dinucleotide. To do this, they have acquired the
capacity to bind a single nucleotide as the ‘primer’, which
provides the 3′OH to initiate attack on a second template-
bound nucleotide to form the first phosphodiester linkage.
As Zfn binds single-stranded DNA and its absence negates
primer synthesis, we propose that the Zfn acts in concert
with the polymerase domain to stabilise the binding and
configuration of the template, polymerase and nucleotides
long enough to allow the production of the initial dinu-
cleotide ‘primer’ (Figure 10A). This product is subsequently
extended in a more processive polymerisation mode. In
replicative primases, the primase large subunit probably
provides a similar role (12). In addition to primer synthe-
sis, the zinc finger domain of PrimPol also plays additional
roles in regulating the fidelity of these enzymes. By lowering
the processivity of PrimPol, it appears to increase its fidelity,
thus reducing its potential to be pro-mutagenic.
Finally, regarding the bypass of lesions during genome
replication in vivo, this and previous work (4) suggest that
both of PrimPol’s priming and extension activities are requi-
site for lesion bypass and replication restart. When replica-
tive DNA polymerases encounter a blocking lesion, they
stall and PrimPol is recruited, possibly by RPA, to perform
TLS or re-prime replication downstream of the lesion (Fig-
ure 10B). After production of a primer or polymerisation
through the lesion, the replicative polymerase can then re-
sume replication. PrimPol’s extension activities appear to be
PCNA-independent as no stimulation was observable in the
presence of this protein (unpublished data). Although it has
been reported that RPA can bind to and potentially recruit
PrimPol toDNA, themechanism bywhich it interfaces with
stalled replisomes to restart fork progression remains to be
established.
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ABSTRACT
PrimPol is a primase-polymerase found in humans,
and other eukaryotes, involved in bypassing le-
sions encountered during DNA replication. PrimPol
employs both translesion synthesis and repriming
mechanisms to facilitate lesion bypass by the repli-
some. PrimPol has been reported to be a poten-
tial susceptibility gene associated with the develop-
ment of myopia. Mutation of tyrosine 89 to aspartic
acid (PrimPolY89D) has been identified in a number of
cases of high myopia, implicating it in the aetiology
of this disorder. Here, we examined whether this mu-
tation resulted in any changes in the molecular and
cellular activities associated with human PrimPol.
We show that PrimPolY89D has a striking decrease
in primase and polymerase activities. The hydropho-
bic ring of tyrosine is important for retaining wild-
type extension activity. We also demonstrate that the
decreased activity of PrimPolY89D is associated with
reduced affinities for DNA and nucleotides, resulting
in diminished catalytic efficiency. Although the struc-
ture and stability of PrimPolY89D is altered, its fidelity
remains unchanged. This mutation also reduces cell
viability after DNA damage and significantly slows
replication fork rates in vivo. Together, these find-
ings establish that the major DNA replication defect
associated with this PrimPol mutant is likely to con-
tribute to the onset of high myopia.
INTRODUCTION
Cells are required to replicate their genomes in a faithful
way to avoid mutagenesis thus maintaining genetic stabil-
ity. However, DNA is highly prone to damaging agents, in-
cluding oxygen-free radicals, ultraviolet (UV) light, ionizing
radiation and desiccation, resulting in the production of le-
sions and breaks that disrupt the structure of the double
helix. One of the many undesirable consequences of such
damage is the disruption of the progression of DNA repli-
cases (1), which copy the genetic material. These replica-
tion machines are exquisitely sensitive to the conformation
of the template and are prone to stalling upon encounter-
ing DNA damage. To overcome such genetic obstacles, cells
have evolved a variety of lesion tolerance pathways to allow
bypass of damage and resumption of replication (2,3).
PrimPol is a recently characterized primase-polymerase,
belonging to archaeo-eukaryotic primase (AEP) superfam-
ily, that is involved in lesion bypass during both nuclear and
mitochondrial replication in eukaryotic cells (4–6). PrimPol
is required for the replication past particular lesions, such as
UV photoproducts, that block the cellular replication ma-
chinery. It can deploy two differentmechanisms, utilizing ei-
ther of its polymerase and primase activities to facilitate effi-
cient lesion bypass. PrimPol can replicate directly through a
number of obstructing lesions by translesion DNA synthe-
sis (TLS) and it can also reprime replication post-damage
to facilitate fork restart (4,7,8), although the exact timing
of their usage remains to be established. PrimPol knockout
cells are sensitive to damaging agents (e.g. UV, 4NQO and
MMS) and murine PrimPol−/− cells show significant lev-
els of DNA breaks, particularly after treatment with agents
that stall replication (4).
Although recent studies have established the importance
of PrimPol in damage tolerance during DNA replication
in cellular and animal model systems, its association with
human diseases has only been conjectured. However, ex-
ome sequencing of the genomes of candidate patients has
recently implicated the PrimPol gene as a possible suscepti-
bility gene associated with highmyopia (9). This study iden-
tified a missense mutation in human PrimPol caused by a
thymine to guanine transversion, resulting in the substitu-
tion of tyrosine at position 89 by an aspartic acid residue
(Y89D). This mutation was not only found in a single fam-
ily but also four additional sporadic patients with high my-
opia and these patients had high refractive errors (−6.5 to
−32.15 diopters, D) (9). Myopia, or short-sightedness, is
a common problem around the world in those with visual
defects and this problem is rapidly increasing. Myopia ac-
counts for 41% of decreased vision in Western populations
and this up from 25% in the early 1970s (10). In some South-
East Asian populations up to 80–90% of all children leaving
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school are now myopic (11). Notably 10–20% of these chil-
dren suffer from high myopia, an extreme form of the dis-
ease, often characterized by a refractive error of less than
−6.00 D and is often associated with other serious ocular
disorders (11,12). The aetiology of high myopia remains ex-
tremely complex and involves the synergy between a num-
ber of genes.
The active site of PrimPol is predicted to consist of three
magnesium-coordinating, negatively charged residues: an
aspartate at residue 114, a glutamate at residue 116 and an
aspartate at residue 280 (4). Although the tyrosine at posi-
tion 89 is not predicted to reside directly within the active
site, it is in close proximity and therefore may play yet un-
determined roles in the activities associated with these en-
zymes. The mutated tyrosine (Y89) is a highly conserved
residue across a wide array of chordate species (Figure 1)
and PolyPhen-2 prediction programme indicates that mu-
tation of this residue would be functionally damaging (9).
In addition to PrimPol, this tyrosine is also present in the
related predicted primase PF14 0050 in plasmodium falci-
parum, so its evolutionary conservation is indicative of a
significant functional residue (13).
In this study, we aimed to characterize the biochemical
properties of the Y89D mutant of PrimPol (PrimPolY89D)
to determine if this amino acid change alters PrimPol’s
activities thus establishing a molecular basis for its pro-
posed involvement in high myopia. Here, we demonstrate
that the Y89D mutant loses its ability to prime using ri-
bonucleotides (rNTPs), but can still prime using deoxyri-
bonucleotides (dNTPs). PrimPolY89D has a greatly reduced
template-dependent processivity activity, when compared
with the wild-type enzyme. In addition, we report that this
mutant has significantly reduced binding for bothDNAand
dNTPs but its fidelity remains largely unchanged. Further-
more, we show that it is the hydrophobic ring of the tyrosine
at position 89 that is important for maintaining these activ-
ities. We also demonstrate that changes in enzyme activity
are the result of global changes in the structure of the poly-
merase domain of PrimPol. Finally, we report that this mu-
tation significantly slows replication fork rates in vivo and
reduces cell viability after DNA damage. Together, these
data establish that a point mutation identified in PrimPol
frompatients with highmyopia results in amajor disruption
of the catalytic and replication activities associated with hu-
man PrimPol thus establishing a link between replication
stress and human disease, particularly high myopia.
MATERIALS AND METHODS
Construction of human PrimPol mutants
Wild-type human PrimPol was cloned as described previ-
ously (4). PrimPolY89D, PrimPolY89F and PrimPolY89S were
cloned by site-directed mutagenesis using the primers that
can be found in Supplementary Table S1. PrimPol1–354 was
cloned as described previously (14) and PrimPolY89D1–354
was cloned by site-directed mutagenesis from this construct
using the primers in Supplementary Table S1.
Expression and purification of recombinant PrimPol proteins
Wild-type PrimPol, PrimPolY89D, PrimPolY89F and
PrimPolY89S were expressed in BL21 (pLysS) Es-
cherichia coli cells overnight at 16◦C and PrimPol1–354
and PrimPolY89D1–354 were expressed overnight at 25◦C.
The proteins were then purified as described previously
(14). Protein concentrations were determined using the
absorbance at 280 nm and the extinction coefficient for
each of the protein constructs.
DNA primase assays
DNA primase assays were carried out as described previ-
ously (14). The templating oligonucleotide sequences can be
found as sequences 1–4 in Supplementary Table S2. Prod-
ucts were resolved on a 15% (v/v) polyacrylamide gel con-
taining 7Murea and 1×TBE buffer at 850 V for 2.5 h in 1×
TBEbuffer. Fluorescently labelledDNAoligomers were de-
tected by scanning using a Fujifilm FLA-5100 image reader.
DNA primer extension assays
Polymerase activity was determined by DNA primer exten-
sion assays. Hex-labelled fluorescent primers were annealed
to unlabelled templates (sequences in Supplementary Table
S2). Note that 100 nM of enzyme was incubated at 37◦C
with 20 nM DNA, 10 mM Bis-Tris-Propane-HCl (pH 7.0),
10 mM MgCl2, 1 mM DTT and 200 !M dNTPs (Roche)
to a final volume of 20 !l for time points increasing up
to 60 min. Reactions were quenched using 2× stop buffer
(95% formamide, 0.09% xylene cyanol, 0.05% bromophe-
nol blue, 200 nM competitor oligonucleotide) and boiled at
95◦C for 5 min. Products were resolved by electrophoresis
as in the DNAprimase assays. For assessment of the fidelity
of PrimPolY89D, oligonucleotides with two adjacent, identi-
cal bases downstream of the primer were incubated, along
with 100 nM enzyme, with single nucleotides for 20 min at
37◦C and were subsequently resolved as above.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were carried out on an overhanging DNA sub-
strate (sequences 5 and 6 annealed from Supplementary
Table S2). Varying concentrations of PrimPol1–354 and
PrimPolY89D1–354 were added to 60 nM DNA, 10 mM Bis-
Tris-Propane-HCl (pH 7.0), 10 mM MgCl2 and 1.0 mM
DTT to a final volume of 20 !l and incubated at 25◦C for
60 min. The reactions were supplemented with 2 !l 25%
(w/v) ficoll. Samples were resolved by electrophoresis on a
5% (v/v) polyacrylamide gel containing 0.5× TBE buffer at
150V for 0.5 h, then 300V for 2.5 h in 0.5×TBEbuffer. Flu-
orescently labelled DNA oligomers were detected by scan-
ning using a Fujifilm FLA-5100 image reader.
Single turnover kinetic assays
The single turnover assays were based on a previously de-
scribed protocol (15). Hex-labelled fluorescent DNA (20
nM; sequences 6 and 11 annealed from Supplementary Ta-
ble S2) was incubated with wild-type and Y89D PrimPol
(200 nM). The DNA/PrimPol mixture was incubated with
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Figure 1. PrimPolY89D mutation is located adjacent to active siteMotif I. An alignment of PrimPol protein sequences from a variety of chordates, including
examples of mammals, reptiles, amphibians, birds and fish. The position of the mutated tyrosine 89 in human PrimPol is denoted by an arrow and is labelled
‘Y89’. The relative proximity of this residue to the catalytic motifs (I–III) is shown in the AEP domain. The zinc finger domain is denoted by ‘Zfn’.
varying concentrations of dATP for time points ranging
from 0.5 to 60 min and each reaction was carried out in
triplicate. Reactions were quenched by the addition of 2×
stop buffer. The products were resolved by electrophoresis
as in the primase assays. The concentrations of extended
and unextended fluorescent DNA primers were measured
using ImageQuant software (GE Life Sciences). The con-
centration of extended product relative to total fluorescent
DNA loaded was plotted as a function of time and the data
were fit to a single-exponential curve to obtain the kobs for
the different dATP concentrations using the following ex-
ponential equation:
[product] = A(1− e−kobst)
A secondary plot of kobs as a function of dATP concen-
tration was fitted to the following hyperbolic equation:
kobs = kpol[dATP]Kd(dNTP) + [dATP]
where kpol is the rate of polymerization and Kd(dNTP) is the
equilibrium dissociation constant for dATP.
DNA extension processivity assays
The PrimPol variants were analysed for processivity as
described previously (16). PrimPol (100 nM) was pre-
incubated at 37◦C with 60 nM substrate DNA (sequences
5 and 6 annealed in Supplementary Table S2), 10 mM Bis-
Tris-Propane-HCl (pH 7.0), 10 mMMgCl2 and 1mMDTT
for 30 min. Reactions were initiated by adding deoxyri-
bonucleotides and excess sonicated herring sperm DNA (1
mg/ml) as an enzyme trap. Reactions were quenched after
time points of 15, 30, 60, 120 and 360 s with addition of
2× stop buffer and boiled at 95◦C for 5 min. Samples were
resolved by electrophoresis as described above.
Circular dichroism (CD) spectroscopy
Samples were buffer exchanged into a buffer of 400 nM
NaF, 15 mM Tris-HCl (pH 7.5) and concentrated to 3
mg/ml. The concentration of recombinant protein was de-
termined before and after the CD scans, to ensure accurate
secondary structure predictions. Samples were placed in a
0.1 mm quartz cuvette (Starna, Essex, UK) and measure-
ments were taken using a JASCO J-715 spectropolarimeter
(JASCO). The CD spectrum of the empty buffer was sub-
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tracted from that of the sample and time constant was set to
4 s with a scan rate of 50 nm/min. The bandwidth was 1 nm
and the sensitivity set to standard. Scans were performed in
triplicate from 320 to 180 nm with a 0.1 nm data pitch and
continuous scan mode. A Peltier device was used to main-
tain a temperature at 20◦C.
Protein denaturation curves
The PrimPol1–354 and PrimPolY89D1–354 constructs were
both buffer exchanged into a buffer of 200 mM NaF, 15
mM Tris-HCl (pH7.5). Note that 45 !l of 1 !Mprotein so-
lution was added to 15 !l of SYPRO Orange, resulting in a
final protein concentration of 0.75 !M. A control of 45 !l
was also added to 15 !l of SYPRO Orange. 20 !l of each
sample was aliquoted in triplicate into a 96-well plate. Pro-
tein melting experiments were carried out using the Light-
Cycler 480 System II (Roche). The instrument was config-
ured with a detection format of 465 nm as the wavelength of
excitation and 580 nm as the emission wavelength to detect
SYPROOrange-specific signal. Denaturation curve fluores-
cent signal was acquired within a range of 20◦C–80◦C using
a ramping rate of 0.03◦C s−1 and an acquisition of 20 data
points per degree celsius. Melting temperatures (Tm) were
determined through the measurement of the lowest point
of the negative differential of the denaturation curve. Data
was corrected for the background signal of the buffer con-
ditions.
Complementation and survival assays in PrimPol−/− avian
cells
DT40 cells were grown at 39◦C in RPMI 1640 medium
supplemented with 10 !M "-mercaptoethanol, 1% L-
glutamine, 1% penicillin streptomycin, 10% fetal calf serum,
1% chicken serum (Sigma). PrimPol−/− cells were comple-
mented with human PrimPolY89D cloned into pCI-neo as
described previously (14) and expression was confirmed by
western blotting alongside wild-type complemented stable
cells generated previously (14). DNA replication fork speed
and stalling after UV damage was measured by fibre anal-
ysis as described previously and carried out in triplicate
(4). Cell survival after UV-C damage was measured using
CellTiter-blue (Promega). Briefly, 40 × 104 cells (or a serial
dilution for decreased damage) were resuspended in a small
volume of phosphate buffered saline and exposed to in-
creasing doses of UV-C, media was replaced and cells were
grown for 48 h. Cells were then transferred to 96-well plates
and viability was measured with CellTiter-blue.
RESULTS
PrimPolY89D retains DNA primase but loses its RNA primase
activity
To determine if PrimPol displays an underlying biochemi-
cal defect that contributes to the high myopia clinical phe-
notype, we first examined the primase activity of the Prim-
Pol Y89D (PrimPolY89D) variant. De novo primer synthe-
sis remained largely unchanged between the mutant and
the wild-type in the production of DNA primers from
dNTPs (Figure 2). However, unlike the wild-type enzyme,
29nt 
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Figure 2. Primase activities of human PrimPol and PrimPolY89D. (A) Hu-
man PrimPol has primase activity and can produce de novo primers using
rNTPs and dNTPs in a homo-polymer template-dependent fashion. (B)
PrimPolY89D partially loses its primase activity. This variant of PrimPol
cannot synthesize RNA primers but is an active primase utilizing dNTPs.
(C) PrimPolY89S shows significant loss of the enzymatic activity with resid-
ual primase activity observed in presence of dNTPs. (D) PrimPolY89F is
an active primase variant capable of synthesizing both RNA and DNA
primers with efficiency comparable to wild-type PrimPol.
PrimPolY89D was unable to synthesize RNA primers in the
presence of even high concentrations of rNTPs.While it has
been reported that PrimPol is more proficient at producing
DNA over RNA primers in vivo, we remained intrigued as
to why this mutation in PrimPol conferred a defect in RNA
primer synthesis. To determine whether this disruption in
activity was a result of the carboxylic acid moiety of the as-
partate or was due to the removal of the hydrophobic ring
of tyrosine, we produced two additional PrimPol variants,
Y89S and Y89F. The serine side-chain of Y89S could dis-
criminate whether the charge of the aspartate caused the al-
tered activity we observed with Y89D while retaining the
hydroxyl group of tyrosine, and the phenylalanine of Y89F
could help determine if it was the hydrophobic ring of tyro-
sine that was important for retaining rNTP primase activ-
ity. Upon testing Y89S and Y89F for primase activity (Fig-
ure 2), we found that the PrimPolY89S has an activity com-
parable to Y89D but the Y89F variant of PrimPol returned
primase activity back to wild-type, restoring the ability of
the enzyme to produce RNA primers.
PrimPolY89D mutant has limited processivity
PrimPol comprises two intrinsic catalytic activities. To de-
termine any catalytic deficiencies associated with the Y89D
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Figure 3. Primer extension activities of human PrimPol and PrimPolY89D.
(A)HumanPrimPol has primer extension activity and produces full-length
templates following incubation for up to 60 min (lane 1 is a control and
lanes 2–6 represent time points at 0.5, 1, 3, 5 and 60 min). (B) PrimPolY89D
shows amarked reduction in polymerase activity, incorporating up to eight
nucleotides following incubation for 60 min. (C) PrimPolY89S also shows
a loss in polymerase activity relative to wild-type PrimPol, though it is a
more active polymerase than PrimPolY89D. (D) PrimPolY89F restores poly-
merase activity. The Y89F variant can fully extend primers but there is an
increased level of unextended primer relative to wild-type PrimPol.
point mutation, we must also consider its polymerase ac-
tivity in addition to its primase activity (Figure 3). Primer
extension assays on PrimPol showed that the polymerase ac-
tivity of PrimPolY89D was significantly reduced in compari-
son to the wild-type enzyme. We next tested if this activity
was restored by either Y89S or Y89F variants of PrimPol
(Figure 3) and observed that Y89S had slightly higher activ-
ity than the Y89D variant but was not restored to wild-type
levels. In contrast, Y89F was fully proficient at extending
primers opposite a templating strand. Notably, although
PrimPolY89F was able to fully extend primers, and showed
full extension at time points as short as 3 min (Figure 3D,
lane 4), more primers were left unextended compared with
wild-type PrimPol, suggesting that this enzyme has higher
activity once it has bound DNA but coordinates it less effi-
ciently.
PrimPol was previously shown to be a distributive DNA
polymerase, inserting only up to four nucleotides during
a single binding event (Figure 4). We next determined
whether the processivity of the mutant was altered, caus-
ing the observed reduction in the polymerase activity.
PrimPolY89D variant could only insert a single nucleotide
opposite a templating strand of DNA, making it an even
more distributive enzyme than wild-type PrimPol (Fig-
Con 
   Time 
Con 
Con 
Wild-type PrimPol PrimPolY89D 
PrimPolY89S 
Con 
PrimPolY89F  
Time 
     A         B 
C   D 
Time Time 
Figure 4. Processivity of human PrimPol and PrimPolY89D. Primer exten-
sion assays were performed in the presence of an excess of herring sperm
DNA trap to ensure the polymerase only binds once to the template DNA.
Control reactions were also carried out to test the effectiveness of the trap
DNA (data not shown). The first lanes represent a no-enzyme control and
lanes 2–6 represent time points of 15, 30, 60, 120 and 360 s. (A) Human
PrimPol is a poorly processive enzyme, inserting up to four nucleotides op-
posite a templatingDNA strand in a single binding event. (B) PrimPolY89D
has marked reduction in processivity, and is only able to insert a single nu-
cleotide opposite a templating DNA strand per single binding event. (C)
PrimPolY89S can also insert only one single nucleotide opposite a templat-
ing DNA strand. (D) PrimPolY89F restores processivity and has the ability
to insert up to four nucleotides, similarly to wild-type PrimPol.
ure 4). To determine whether the aromatic ring of tyrosine
was the main determinant for enzyme activity, we tested the
processivity activities of Y89S and Y89F variants. Consis-
tent with Y89D, PrimPolY89S could only insert a single nu-
cleotide. However, in common with the wild-type enzyme,
PrimPolY89F could insert up to four nucleotides. This estab-
lishes that the presence of an aromatic side-chain at this po-
sition is requisite for maintainingmore processive extension
by PrimPol.
Reduced DNA binding contributes to the low processivity of
PrimPolY89D
A reduction in processivity can be attributed to alter-
ations in either dNTP or substrate DNA binding. To
test the binding efficiencies of wild-type and PrimPolY89D,
we introduced the mutation into the polymerase domain
(PrimPol1–354) of PrimPol. This ensured that the contribu-
tory binding effects of the zinc finger were removed to en-
able assessment of the alteration in binding caused solely
by this point mutation in the polymerase domain. As the
polymerase domain is able to bind both single- and double-
stranded DNA (14), we chose to use a labelled overhang-
ing DNA substrate in our EMSAs, similar to the substrates
PrimPol would encounter in vivo. The binding efficiency of
PrimPol1–354Y89D to DNAwas almost four times lower than
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PrimPol1–354. The wild-type KD(DNA) was 0.67 !M, com-
pared with Y89D KD(DNA) of 2.55 !M (Figure 5).
PrimPolY89D has reduced dNTP binding but its fidelity is not
altered
To evaluate the effects of this mutation on the enzymatic
properties of PrimPol, a kinetic analysis was performed to
determine the catalytic efficiency (kpol) and binding con-
stants for dATP (KD(dNTP)) opposite a templating thymine
(Supplementary Figure S1). We found the wild-type kpol to
be 6.98 min−1 and the KD(dNTP) to be 15.51 !M (Figure 6).
PrimPol is an extremely slow enzyme––for comparison the
kpol of base excision repair enzyme DNA polymerase " is
1944 min−1 (17). We determined the Y89D variant of Prim-
Pol to be a slightly slower polymerase, with a kpol of 4.07
min−1 and binds dNTPs over 10-fold less competently, with
a KD(dNTP) of 170.21 !M (Figure 6). The reduction in cat-
alytic efficiency and dramatic reduction in dNTP binding
may or may not be dependent on the initial binding of
DNA.
If dNTP coordination had been severely affected in the
Y89D variant, we would expect quite a deviation fromwild-
type PrimPol in the fidelity of nucleotide incorporation.
However, we found that the Y89D variant of PrimPol did
not have any appreciable variation from the wild-type en-
zyme in terms of fidelity (SupplementaryFigure S2). If there
was an alteration in the coordination of incoming dNTPs,
there would also be a lower probability that this enzyme
would be able to bypass the highly distortive lesions that the
wild-type enzyme could bypass. However, we observed that
PrimPolY89D was able to synthesize through even highly dis-
tortive lesions, such as a 6–4 photoproduct (Supplementary
Figure S3).
Aromatic residues often act as a steric gate for sugar dis-
crimination (18). Mutation of these key residues can result
in the incorporation of rNTPs instead of dNTPs opposite
a templating DNA strand (19). PrimPolY89D, like wild-type
PrimPol, was also unable to extend primers using rNTPs
(Supplementary Figure S4). Therefore, it is highly unlikely
that this tyrosine residue is involved in discerning the sugar
of the incoming nucleotide, particularly as the Y89D vari-
ant also loses its ability to prime using rNTPs.
Y89D mutation induces significant structural changes to
PrimPol
The observed reduced enzyme activity of PrimPolY89D
could be the result of the loss of aromatic interactions in-
volved in local base stacking events with either the tem-
plate or the incoming nucleotide. However, it may instead
be required for maintaining the structural integrity of the
enzyme and mutation of this tyrosine causes more global
effects in the structure of PrimPol. To test this second pos-
sibility, we subjected the polymerase domains of both the
wild-type and PrimPolY89D to thermal denaturation and
CD to check for alterations. There was a striking differ-
ence in both the thermal denaturation profiles and the CD
spectra of the two enzymes (Figure 7), suggesting this point
mutant results in global changes to the enzyme that causes
the reduction in activity observed above. The melting point
of the polymerase dropped from 49.12◦C for the wild-type
polymerase domain compared to 42.50◦C for PrimPolY89D
(Figure 7A). This significant drop in melting temperature
suggests that the enzyme has become less stable and more
structurally disordered following the point mutation. Anal-
yses of the secondary structure from the CD spectra of the
two variants’ polymerase domains by the variable selection
algorithm (CDSSTR) (20), which provides better fits for
globular proteins, revealed a difference in the #-helical con-
tent of these domains (37% for wild-type PrimPol compared
with 21% for Y89D), as well as "-strand content (25% for
wild-type compared with 29% for Y89D). Additionally, this
analysis predicted 30% of the structure of the PrimPolY89D
polymerase domain to be unstructured, whereas just 24% of
wild-type was predicted to be unstructured.
PrimPolY89D significantly decreases DNA replication fork
rates in vivo
To gain further insights into how the Y89Dmutant form of
PrimPol may contribute to the myopic phenotype observed
in human patients, we studied the influence of PrimPolY89D
on DNA replication in damaged and undamaged cells. We
utilized a DT40 PrimPol deleted cell line (PrimPol −/−) (4)
to examine the ability of PrimPolY89D to complement this
loss, as previously reported for other mutant forms of Prim-
Pol (14). We stably expressed human PrimPolY89D at simi-
lar levels to WT PrimPol in PrimPol knockout cells (Fig-
ure 8A), with no obvious effects on cell growth.
We reported previously that PrimPol−/− cells have a
greater sensitivity to UV irradiation thus we first exam-
ined the effects of increasing doses of UV-C on PrimPolY89D
complemented cell lines. Although PrimPol−/− cells com-
plemented with wild-type PrimPol showed a reversal of
this sensitivity, cells complemented with PrimPolY89D main-
tained a decreased viability after UV damage (Figure 8B).
Next, we measured the replication fork speeds in Prim-
Pol complemented cell lines using DNA fibre analysis,
as previously described (4,14). Strikingly, we observed a
dramatic decrease in fork speeds in cells complemented
with PrimPolY89D (0.84 kb/min) compared with cells car-
rying the wild-type PrimPol (1.66 kb/min) (Figure 8C).
This decrease in fork speed was significantly greater than
that previously reported in PrimPol−/− cells (1.45 kb/min;
(4,14)), suggesting the Y89D mutant form of PrimPol may
actually impede on-going DNA replication. In contrast,
PrimPolY89D complemented the increased stalling defect
observed in PrimPol−/− cells treated with UV-C, equally as
well as WT PrimPol (Figure 8D).
DISCUSSION
A recent exome sequencing study has implicated a point
mutation (Y89D) in the DNA damage tolerance poly-
merase, PrimPol, in high myopia in human patients. How-
ever, this report did not investigate the molecular conse-
quences of this genetic alteration. Here, we report that the
Y89D variant of PrimPol, previously found to be associated
with high myopia, is a low processivity variant of PrimPol.
Unlike wild-type PrimPol, it inserts just one nucleotide in
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Figure 5. DNA binding efficiency of polymerase domains of wild-type and PrimPolY89D. (A) The polymerase domains (PrimPol1–354) for both wild-type
and PrimPolY89D were used to eliminate the effects of binding from the zinc finger domains. Wild-type PrimPol domain bound to DNA at a much lower
concentration than PrimPolY89D as determined by EMSAs. The concentrations used in both of these EMSAs were 0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25, 0.5,
0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 5 and 10 !M. (B) These assays were subsequently quantified to determine KD(DNA) values for the polymerase
domains of wild-type PrimPol (solid green line) and its Y89D variant (broken purple line). KD(DNA) of wild-type PrimPol was 0.69 !M, while the KD(DNA)
of PrimPolY89D was 2.55 !M.
a single binding event and has a significantly lower affinity
for both dNTPs andDNA.Notably, this mutant did not ex-
hibit any alteration in the fidelity or TLS spectrum relative
to wild-type PrimPol. To determine whether this altered ac-
tivity was a result of losing the hydrophilic hydroxyl moiety
or the hydrophobic ring moiety, we constructed two more
variants in which tyrosine 89 was mutated to either pheny-
lalanine or serine. The Y89F mutant restored processivity
to near-wild-type levels but Y89S had a similar activity to
Y89D. In addition, we found that the Y89D PrimPol vari-
ant was unable to produce ribonucleotide primers, but this
activity was restored in the Y89F variant, indicating that
PrimPol requires a hydrophobic aromatic ring at position
89 to maintain processivity but the presence of a hydroxyl
moiety is dispensable.
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Figure 6. Kinetic analysis of human PrimPol and PrimPolY89D. Single
turnover kinetics of wild-type and PrimPolY89D to determine catalytic ef-
ficiency (kpol) and dNTP binding efficiency (KD(dNTP)). (A) The concen-
tration of extended DNA product, as determined by electrophoresis, was
plotted against time and fit to an exponential curve for a number of dATP
concentrations for wild-type and PrimPolY89D. These data were fit to ex-
ponential curves as described in Equation (1) and kobs was determined.
(B) kobs was subsequently plot against dATP concentration for wild-type
PrimPol and PrimPolY89D and these data were fit to hyperbolic curves as
described in Equation (2) to determine kpol and KD(dNTP). kpol for wild-
type PrimPol was found to be 6.98 min−1 ± 0.40 and KD(dNTP) was 15.51
!M± 2.71. kpol for PrimPolY89D was 4.07min−1 ± 0.19 andKD(dNTP) was
170.21 !M ± 18.80.
Insights from structural studies on primases and poly-
merases suggest two different potential explanations for
the reduction in polymerase processivity observed in this
study. The conserved tyrosine at position 89 could have an
important role in base stacking or could be required for
the structural integrity of the protein. There is an invari-
ant phenylalanine in nonhomologous end-joining (NHEJ)
AEPs that plays a vital role in the recognition and orienta-
tion of both the templating and the incoming bases through
stacking interactions with both bases and is responsible for
moving the incoming nucleotide into the enzyme’s active
site (21,22). Phenylalanine 290 in human Pol " helps form
the hydrophobic core of the thumb domain (23). Mutation
of this residue is associated with the genetic disorder xe-
roderma pigmentosum variant, which is characterized by a
susceptibility to skin cancers caused by a failure to per-
form proficient TLS opposite UV lesions. This mutation
negates polymerase activity and is predicted to destabilize
the thumb domain, resulting in reduced primer binding.
While the structure of PrimPol has not yet been elucidated,
it is conceivable that the tyrosine at position 89 is involved
in preserving the structure of a domain analogous to the
Figure 7. Y89A induces a structural perturbation in PrimPol. The poly-
merase domain of theY89Dvariant of PrimPol has a different global struc-
ture and thermal stability compared to wild-type PrimPol. (A) Thermal
denaturation of the polymerase domain of PrimPol and its Y89D variant.
The negative differential of the fluorescence profiles of the polymerase do-
mains (PrimPol1–354) of wild-type PrimPol (solid green line) and its Y89D
(broken purple line) variant plotted against temperature to determine their
melting points. The melting point of the polymerase domain of the wild-
type enzyme was found to be 49.12◦C, while the Y89D variant had a con-
siderably lowermelting point at 42.50◦C. (B) CD spectra of the polymerase
domains of wild-type PrimPol and PrimPolY89D show a substantial differ-
ence in the global structure of PrimPolY89D relative to the wild-type en-
zyme.
thumb domain that is found in other polymerases involved
in binding/coordinating the templating DNA strand. Tyro-
sine 89 is situated in a conserved hydrophobic pocket con-
taining other conserved aromatic residues including Y87,
F88 and Y90, as well as a hydrophobic residue at position
86 (Figure 1) and it is likely that disruption of Y89 dis-
rupts a conserved interaction between these amino acids.
A secondary structure prediction from PSIPRED (24) pre-
dicts that all of these amino acids lie within an #-helical
region and the Y89 mutation may disrupt this helix. The
CD data certainly supports this model, indicating that the
Y89Dvariant has less#-helical structure than thewild-type.
We postulate that the Y89D mutation causes a disruption
in the global structure of the polymerase domain of Prim-
Pol. As the affinity for DNA and dNTPs is decreased in the
Y89D variant, but the apparent fidelity of the enzyme re-
mains unchanged, we suggest that dNTP binding is depen-
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Figure 8. PrimPol Y89D cannot fully complement the UV sensitivity seen
in PrimPol−/− DT40 cells due to decreased replication fork speeds. (A)
Western blot showing overexpression of wild type and Y89D point mutant
forms of PrimPol in PrimPol knockout (PrimPol−/−) DT40 chicken cells.
(B) Cell viability was measured using CellTiter-Blue 48 h after increasing
doses of UV-C were administered to the different cell types. Results repre-
sent three independent repeats and the error bars represent the standard
deviation across the repeats. (C) DNA fibres were measured after sequen-
tial labelling with CldU and IdU for 20 min each to calculate replication
speed. Results represent three independent repeats. (D) A 20 J/m2 UV-C
pulse was included between the two labels and the ratio of the pre- and
post-UV-C labels was calculated, with increased ratios representing repli-
cation stalling after UV. Results represent three independent repeats.
dent on DNA binding, which is disrupted by the structural
changes induced by this mutation.
In vivo analysis identified a dramatic decrease in repli-
cation fork rates in cells expressing PrimPolY89D and, de-
spite being able to complement fork stalling in PrimPol−/−
cells after UV damage, it was unable to prevent decreased
cell viability. Consistent with in vitro assays, PrimPolY89D
causes decreased replication fork rates in cells and it ap-
pears that this defect is enough to decrease the damage tol-
erance of these cells. Both our in vivo and in vitro studies
on this mutant indicate that although PrimPolY89D retains
the ability to bypass lesions, its capacity to replicate DNA is
severely compromised. Therefore, it appears that although
PrimPolY89D is recruited to stalled replisomes, the underly-
ing replication defect causes a significant slowing of repli-
cation forks, potentially resulting in incomplete lesion by-
pass, causing cells to progress through the cell cycle with
underreplicated genomic DNA. Clearly, these cells carry an
abundance of PrimPol compared to wild-type levels and
thus replication fork speed alone in endogenous mutants
may not be so significantly altered. However, in cases where
PrimPol is actively recruited to on-going forks or damage
sites, this ‘slow’ mutant is likely to cause significant prob-
lems. Therefore, unexpectedly, it appears that harbouring
the PrimPolY89D mutation ismore detrimental than not hav-
ing PrimPol at all. This data correlates with the phenotypes
observed in patients carrying this mutation as problems are
observed in tissues where levels of UV damage are expected
to be high. Thus, in tissues where PrimPol is recruited in
higher abundance to replicate through DNA damage, such
as eyes, cellular defects aremuchmore likely to be prevalent.
The link between reduced PrimPol polymerase activity
and myopigenicity remains unclear. Previous studies into
the genes that predispose high myopia have identified two
clusters of mutations, one in the outer retina affecting pho-
toreceptors andON-bipolar cell function and another in the
scleral extracellular matrix composition and metabolism
(11). Significantly, mutations in PrimPol do not fit into ei-
ther category. The severity of the clinical phenotype of pa-
tients with the Y89D mutation varied (9) and it is highly
likely that this gene is not a singular, unique aetiological
factor and that other genetic and environmental factors also
contribute to pathogenesis. Although replication defects as-
sociatedwith PrimPolY89D suggests that it contributes to the
reported clinical phenotypes, further work is required to es-
tablish if a direct link exists between replication stress and
onset of high myopia.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENT
The authors would like to thank Prof. Shigenori Iwai who
kindly provided DNA containing a 6–4 photoproduct.
FUNDING
BBSRC [BB/J018643/1, BB/H019723/1 and BB/M004236/1
to A.J.D.]; MRC [G080130]. Funding for open access charg
e: RCUK.
Conflict of interest statement.None declared.
REFERENCES
1. Aguilera,A. and Go´mez-Gonza´lez,B. (2008) Genome instability: a
mechanistic view of its causes and consequences. Nat. Rev. Genet., 9,
204–217.
2. Li,X. and Heyer,W.-D. (2008) Homologous recombination in DNA
repair and DNA damage tolerance. Cell Res., 18, 99–113.
3. Sale,J.E., Lehmann,A.R. and Woodgate,R. (2012) Y-family DNA
polymerases and their role in tolerance of cellular DNA damage. Nat.
Rev. Mol. Cell Biol., 13, 141–152.
4. Bianchi,J., Rudd,S.G., Jozwiakowski,S.K., Bailey,L.J., Soura,V.,
Taylor,E., Stevanovic,I., Green,A.J., Stacker,T.H., Lindsay,H.D.
et al. (2013) Eukaryotic PrimPol bypasses UV photoproducts during
chromosomal DNA replication.Mol. Cell, 52, 566–573.
 at Pilkington Library Loughborough University on December 8, 2014
http://nar.oxfordjournals.org/
Downloaded from 
Nucleic Acids Research, 2014, Vol. 42, No. 19 12111
5. Rudd,S.G., Glover,L., Jozwiakowski,S.K., Horn,D. and Doherty,A.J.
(2013) PPL2 translesion polymerase is essential for the completion of
chromosomal DNA replication in the African Trypanosome.Mol.
Cell, 52, 554–565.
6. Wan,L., Lou,J., Xia,Y., Su,B., Liu,T., Cui,J., Sun,Y., Lou,H. and
Huang,J. (2013) hPrimpol1/CCDC111 is a human DNA
primase-polymerase required for the maintenance of genome
integrity. EMBO Rep., 14, 1104–1112.
7. Mouro´n,S., Rodriguez-Acebes,S., Martı´nez-Jime´nez,M.I.,
Garcia-Gomez,S., Chocron,S., Blanco,L. and Mendez,J. (2013)
Repriming of DNA synthesis at stalled replication forks by human
PrimPol. Nat. Struct. Mol. Biol., 20, 1383–1389.
8. Garcia-Gomez,S., Reyes,A., Martı´nez-Jime´nez,M.I., Chocro´n,E.S.,
Mouro´n,S., Terrados,G., Powell,C., Salido,E., Mendez,J., Holt,I.J.
et al. (2013) PrimPol, an archaic primase/polymerase operating in
human cells.Mol. Cell, 52, 541–553.
9. Zhao,F., Wu,J., Xue,A., Su,Y., Wang,X., Lu,X., Zhou,Z., Qu,J. and
Zhou,X. (2013) Exome sequencing reveals CCDC111 mutation
associated with high myopia. Hum. Genet., 132, 913–921.
10. Vitale,S., Sperduto,R.D. and Ferris,F.L. (2009) Increased prevalence
of myopia in the United States between 1971–1972 and 1999–2004.
Arch. Ophthalmol., 127, 1632–1639.
11. Morgan,I.G., Ohno-Matsui,K. and Saw,S.M. (2012) Myopia. Lancet,
379, 1739–1748.
12. Saw,S.M., Gazzard,G., Shih-Yen,E.C. and Chua,W.H. (2005) Myopia
and associated pathological complications. Oph. Phys. Optics, 25,
381–391.
13. Iyer,L.M., Koonin,E.V., Leipe,D.D. and Aravind,L. (2005) Origin
and evolution of the archaeo-eukaryotic primase superfamily and
related palm-domain proteins: structural insights and new members.
Nucleic Acids Res., 33, 3875–3896.
14. Keen,B.A., Jozwiakowski,S.K., Bailey,L.J., Bianchi,J. and
Doherty,A.J. (2014) Molecular dissection of the domain architecture
and catalytic activities of human PrimPol. Nucleic Acids Res., 42,
5830–5845.
15. Nemec,A.A., Donigan,K.A., Murphy,D.L., Jaeger,J. and Sweasy,J.B.
(2012) Colon cancer-associated DNA polymerase ! variant induces
genomic instability and cellular transformation. J. Biol. Chem., 287,
23840–23849.
16. Washington,M.T., Johnson,R.E., Prakash,S. and Prakash,L. (1999)
Fidelity and processivity of Saccharomyces cerevisiae DNA
polymerase eta. J. Biol. Chem., 274, 36835–36838.
17. Nemec,A.A., Murphy,D.L., Donigan,K.A. and Sweasy,J.B. (2014)
The S229L colon tumor-associated variant of DNA polymerase beta
induces cellular transformation as a result of decreased
polymerization efficiency. J. Biol. Chem., 289, 13708–13716.
18. Brown,J.A. and Suo,Z. (2011) Unlocking the sugar ‘Steric Gate’ of
DNA polymerases. Biochemistry, 50, 1135–1142.
19. Donigan,K.A., McLenigan,M.P., Yang,W., Goodman,M.F. and
Woodgate,R. (2014) The steric gate of DNA polymerase " regulates
ribonucleotide incorporation and deoxyribonucleotide fidelity. J.
Biol. Chem., 289, 9136–9145.
20. Lobley,A., Whitmore,L. and Wallace,B.A. (2002) DICHROWEB: an
interactive website for the analysis of protein secondary structure
from circular dichroism spectra. Bioinformatics, 18, 211–212.
21. Pitcher,R.S., Brissett,N.C., Picher,A.J., Andrade,P., Juarez,R.,
Thompson,D., Fox,G.C., Blanco,L. and Doherty,A.J. (2007)
Structure and function of a mycobacterial NHEJ DNA repair
polymerase. J. Mol. Biol., 366, 391–405.
22. Brissett,N.C., Martin,M.J., Pitcher,R.S., Bianchi,J., Juarez,R.,
Green,A.J., Fox,G.C., Blanco,L. and Doherty,A.J. (2011) Structure of
a preternary complex involving a prokaryotic NHEJ DNA
polymerase.Mol. Cell, 41, 221–231.
23. Biertu¨mpfel,C., Zhao,Y., Kondo,Y., Ramo´n-Maiques,S.,
Gregory,M., Lee,J.Y., Masutani,C., Lehmann,A.R., Hanaoka,F. and
Yang,W. (2010) Structure and mechanism of human DNA
polymerase #. Nature, 465, 1044–1048.
24. Jones,D.T. (1999) Protein secondary structure prediction based on
position-specific scoring matrices. J. Mol. Biol., 292, 195–202.
 at Pilkington Library Loughborough University on December 8, 2014
http://nar.oxfordjournals.org/
Downloaded from 
